0001214659-23-004301.txt : 20230328 0001214659-23-004301.hdr.sgml : 20230328 20230328160555 ACCESSION NUMBER: 0001214659-23-004301 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VerifyMe, Inc. CENTRAL INDEX KEY: 0001104038 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 233023677 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39332 FILM NUMBER: 23769523 BUSINESS ADDRESS: STREET 1: 801 INTERNATIONAL PARKWAY STREET 2: FIFTH FLOOR CITY: LAKE MARY STATE: FL ZIP: 32746 BUSINESS PHONE: 585-736-9400 MAIL ADDRESS: STREET 1: 801 INTERNATIONAL PARKWAY STREET 2: FIFTH FLOOR CITY: LAKE MARY STATE: FL ZIP: 32746 FORMER COMPANY: FORMER CONFORMED NAME: LASERLOCK TECHNOLOGIES INC DATE OF NAME CHANGE: 20001004 10-K 1 vm32123010k.htm
0001104038 false 2022 FY 0001104038 2022-01-01 2022-12-31 0001104038 vrme:CommonStockParValue0.001PerShareMember 2022-01-01 2022-12-31 0001104038 vrme:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-12-31 0001104038 2022-06-30 0001104038 2023-03-23 0001104038 2022-12-31 0001104038 2021-12-31 0001104038 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001104038 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001104038 2021-01-01 2021-12-31 0001104038 2020-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2020-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2020-12-31 0001104038 us-gaap:CommonStockMember 2020-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001104038 vrme:TreasuryStocksMember 2020-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001104038 us-gaap:RetainedEarningsMember 2020-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2021-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2021-12-31 0001104038 us-gaap:CommonStockMember 2021-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001104038 vrme:TreasuryStocksMember 2021-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001104038 us-gaap:RetainedEarningsMember 2021-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001104038 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001104038 vrme:TreasuryStocksMember 2021-01-01 2021-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001104038 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001104038 vrme:TreasuryStocksMember 2022-01-01 2022-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001104038 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2022-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2022-12-31 0001104038 us-gaap:CommonStockMember 2022-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001104038 vrme:TreasuryStocksMember 2022-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001104038 us-gaap:RetainedEarningsMember 2022-12-31 0001104038 vrme:EquipmentForLeaseMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001104038 vrme:CoSponsorMember 2021-04-12 0001104038 us-gaap:IPOMember 2021-07-05 2021-07-06 0001104038 us-gaap:OverAllotmentOptionMember 2021-07-05 2021-07-06 0001104038 us-gaap:PrivatePlacementMember 2021-07-05 2021-07-06 0001104038 vrme:SponsorEntityMember 2021-07-05 2021-07-06 0001104038 vrme:MaximPartnersLLCMember 2021-07-05 2021-07-06 0001104038 vrme:GVRMHoldingsLLCandMaximPartnersLLCMember us-gaap:PrivatePlacementMember 2021-07-05 2021-07-06 0001104038 us-gaap:BeneficialOwnerMember us-gaap:PrivatePlacementMember 2021-07-05 2021-07-06 0001104038 vrme:GVRMHoldingsLLCMember 2021-07-06 0001104038 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001104038 srt:ParentCompanyMember vrme:ProactiveServicesMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember vrme:ProactiveServicesMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember vrme:ProactiveServicesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember vrme:ProactiveServicesMember 2021-01-01 2021-12-31 0001104038 vrme:ProactiveServicesMember 2022-01-01 2022-12-31 0001104038 vrme:ProactiveServicesMember 2021-01-01 2021-12-31 0001104038 srt:ParentCompanyMember vrme:PremiumServicesMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember vrme:PremiumServicesMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember vrme:PremiumServicesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember vrme:PremiumServicesMember 2021-01-01 2021-12-31 0001104038 vrme:PremiumServicesMember 2022-01-01 2022-12-31 0001104038 vrme:PremiumServicesMember 2021-01-01 2021-12-31 0001104038 srt:ParentCompanyMember vrme:BrandProtectionServicesMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember vrme:BrandProtectionServicesMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember vrme:BrandProtectionServicesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember vrme:BrandProtectionServicesMember 2021-01-01 2021-12-31 0001104038 vrme:BrandProtectionServicesMember 2022-01-01 2022-12-31 0001104038 vrme:BrandProtectionServicesMember 2021-01-01 2021-12-31 0001104038 srt:ParentCompanyMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember 2021-01-01 2021-12-31 0001104038 vrme:BusinessCombinationMember 2022-04-21 2022-04-22 0001104038 2022-04-01 2022-04-22 0001104038 vrme:BusinessCombinationMember 2022-04-22 0001104038 us-gaap:RestrictedStockMember vrme:BusinessCombinationMember 2022-04-22 0001104038 us-gaap:RestrictedStockMember vrme:BusinessCombinationMember 2022-09-22 0001104038 vrme:BusinessCombinationMember 2022-01-01 2022-12-31 0001104038 vrme:PeriShipMember 2022-04-22 0001104038 vrme:PeriShipMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:DevelopedTechnologyRightsMember 2022-04-22 0001104038 us-gaap:DevelopedTechnologyRightsMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:TrademarksMember 2022-04-22 0001104038 us-gaap:TrademarksMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:CustomerRelationshipsMember 2022-04-22 0001104038 us-gaap:CustomerRelationshipsMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:NoncompeteAgreementsMember 2022-04-22 0001104038 us-gaap:NoncompeteAgreementsMember 2022-04-21 2022-04-22 0001104038 srt:ParentCompanyMember 2021-12-31 0001104038 srt:SubsidiariesMember 2021-12-31 0001104038 srt:ParentCompanyMember 2022-12-31 0001104038 srt:SubsidiariesMember 2022-12-31 0001104038 us-gaap:TrademarksMember 2022-12-31 0001104038 vrme:CapitalizedSoftwareMember 2022-12-31 0001104038 us-gaap:CustomerRelationshipsMember 2022-12-31 0001104038 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001104038 vrme:InternallyUsedSoftwareMember 2022-12-31 0001104038 us-gaap:NoncompeteAgreementsMember 2022-12-31 0001104038 us-gaap:TrademarksMember 2021-12-31 0001104038 vrme:CapitalizedSoftwareMember 2021-12-31 0001104038 us-gaap:ForeignCountryMember 2022-12-31 0001104038 us-gaap:DomesticCountryMember 2022-12-31 0001104038 vrme:PromissoryNoteMember 2022-04-22 0001104038 vrme:PromissoryNoteMember 2022-04-21 2022-04-22 0001104038 2022-10-17 0001104038 2022-10-01 2022-10-17 0001104038 vrme:PaycheckProtectionProgramTermNoteMember vrme:PNCBankNAMember 2020-05-17 0001104038 vrme:PaycheckProtectionProgramTermNoteMember vrme:PNCBankNAMember 2020-05-16 2020-05-17 0001104038 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001104038 2022-08-11 0001104038 2022-08-01 2022-08-11 0001104038 2022-04-22 0001104038 2022-02-28 0001104038 2022-08-31 0001104038 2020-11-01 2020-11-30 0001104038 vrme:StockOptionsRestrictedStockandUnitsandOtherStockbasedAwardsMember vrme:OmnibusEquityCompensationPlan2013Member 2013-12-31 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2017Member 2017-11-13 2017-11-14 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2017Member 2020-08-09 2020-08-10 0001104038 vrme:IncentiveStockOptionsMember 2022-01-01 2022-12-31 0001104038 vrme:IssuedUnderThe2020PlanMember 2022-01-01 2022-12-31 0001104038 vrme:Plan2019Member 2022-01-01 2022-12-31 0001104038 vrme:Plan2019Member 2021-01-01 2021-12-31 0001104038 vrme:Plan2019Member 2022-12-31 0001104038 vrme:Plan2019Member 2021-12-31 0001104038 us-gaap:RestrictedStockMember 2022-12-31 0001104038 us-gaap:RestrictedStockMember 2021-12-31 0001104038 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001104038 vrme:RestrictedStockUnitsMember 2022-12-31 0001104038 vrme:RestrictedStockUnitsMember 2021-12-31 0001104038 vrme:RestrictedStockUnitsMember 2022-01-01 2022-12-31 0001104038 vrme:NonvestedStockOptionsMember 2022-12-31 0001104038 vrme:NonvestedStockOptionsMember 2022-01-01 2022-12-31 0001104038 vrme:DirectorAndOfficerMember vrme:Debentures2022Member 2022-04-14 0001104038 vrme:DirectorAndOfficerMember vrme:Debentures2020Member 2020-01-01 2020-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2020-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2021-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2022-12-31 0001104038 vrme:NonvestedStockOptionsMember 2020-12-31 0001104038 vrme:NonvestedStockOptionsMember 2021-01-01 2021-12-31 0001104038 vrme:NonvestedStockOptionsMember 2021-12-31 0001104038 us-gaap:RestrictedStockMember 2020-12-31 0001104038 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001104038 vrme:RestrictedStockUnitsMember 2020-12-31 0001104038 vrme:RestrictedStockUnitsMember 2021-01-01 2021-12-31 0001104038 vrme:UnvestedPerformanceRestrictedStockUnitsMember 2021-12-31 0001104038 vrme:UnvestedPerformanceRestrictedStockUnitsMember 2022-01-01 2022-12-31 0001104038 vrme:UnvestedPerformanceRestrictedStockUnitsMember 2022-12-31 0001104038 us-gaap:WarrantMember 2022-12-31 0001104038 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001104038 vrme:StockOptionsMember 2022-01-01 2022-12-31 0001104038 vrme:StockOptionsMember 2021-01-01 2021-12-31 0001104038 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001104038 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001104038 vrme:StockPurchasePlanMember 2022-01-01 2022-12-31 0001104038 vrme:StockPurchasePlanMember 2021-01-01 2021-12-31 0001104038 vrme:RestrictedStockUnitsAndRestrictedStockAwardsMember 2022-01-01 2022-12-31 0001104038 vrme:RestrictedStockUnitsAndRestrictedStockAwardsMember 2021-01-01 2021-12-31 0001104038 vrme:G3VRMMember 2022-04-07 0001104038 srt:DirectorMember 2021-09-16 2021-09-17 0001104038 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember vrme:OneCustomerMember 2022-01-01 2022-12-31 0001104038 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember vrme:FiveCustomerMember 2021-01-01 2021-12-31 0001104038 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember vrme:TwoCustomerMember 2022-01-01 2022-12-31 0001104038 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember vrme:ThreeCustomerMember 2021-01-01 2021-12-31 0001104038 vrme:TransportationCostMember us-gaap:ProductConcentrationRiskMember vrme:OneVendorMember 2022-01-01 2022-12-31 0001104038 us-gaap:SubsequentEventMember 2023-02-27 2023-03-01 0001104038 us-gaap:SubsequentEventMember 2023-03-01 0001104038 us-gaap:SubsequentEventMember vrme:NonqualifiedStockPurchasePlanMember 2023-02-01 2023-02-28 0001104038 us-gaap:SubsequentEventMember vrme:N2020PlanMember vrme:FormerChiefExecutiveOfficerMember 2023-03-02 2023-03-15 0001104038 us-gaap:SubsequentEventMember vrme:N2020PlanMember vrme:GreenbergMember 2023-03-02 2023-03-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-K

 

 

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from                      to                     

 

Commission File Number 001-39332

 

 

VERIFYME, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Nevada 23-3023677

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

   

801 International Parkway, Fifth Floor

Lake Mary, FL 

 32746
(Address of Principal Executive Offices) (Zip Code)
   
(585) 736-9400  
(Registrant’s Telephone Number, Including Area Code)  

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Title of each class   Trading
Symbol(s)		   Name of each exchange on which registered
 Common Stock, par value $0.001 per share   VRME   The Nasdaq Capital Market
Warrants to Purchase Common Stock   VRMEW   The Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  o  No  x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  o No  x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x No  o

 

   
 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes x   No o  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company,” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer x    Smaller reporting company x
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ¨

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    o   Yes  x No 

 

The aggregate market value of the voting stock held by non-affiliates of the registrant was $14,839,432 as of June 30, 2022. Shares of common stock held by executive officers and directors of the registrant have been excluded from this computation in that such persons may be deemed to be affiliates of the registrant. As of June 30, 2022, there were no persons known to the registrant to own 5% or more of the outstanding common stock, and therefore no other persons have been deemed affiliates of the registrant. This determination of affiliate status is not a conclusive determination for other purposes.

 

The registrant had 9,361,772 shares of common stock outstanding as of the close of business on March 23, 2023. 

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of VerifyMe, Inc.’s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with its 2023 annual meeting of stockholders are incorporated by reference into Part III Items 10, 11, 12, 13 and 14 of this Annual Report on Form 10-K.

 

 

   
 

 

TABLE OF CONTENTS  

 

      Page
PART I      
Item 1.   Business 2
Item 1A.   Risk Factors 9
Item 1B.   Unresolved Staff Comments 21
Item 2.   Properties 21
Item 3.   Legal Proceedings 21
Item 4.   Mine Safety Disclosures 21
     
PART II      
Item 5.   Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchase of Equity Securities 22
Item 6.   [Reserved] 22
Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
Item 7A.   Quantitative and Qualitative Disclosures About Market Risk 29
Item 8.   Financial Statements and Supplementary Data 29
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 29
Item 9A.   Controls and Procedures 29
Item 9B.   Other Information 30
Item 9C.   Disclosure Regarding Foreign Jurisdictions that prevent Inspection 30
     
PART III      
Item 10.   Directors, Executive Officers and Corporate Governance 31
Item 11.   Executive Compensation 31
Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 31
Item 13.   Certain Relationships and Related Transactions, and Director Independence 32
Item 14.   Principal Accountant Fees and Services 32
     
PART IV      
Item 15.   Exhibits and Financial Statement Schedules 32
Item 16.   Form 10-K Summary 35

 

   

 

Cautionary Note Regarding Forward-Looking Statements

 

This Annual Report on Form 10-K (“Report”) includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions are intended to identify forward-looking statements. All statements other than statements of historical facts contained in this Report, including among others, our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth are forward-looking statements.

 

Our actual results and financial condition may differ materially from those expressed or implied in such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, but are not limited to, those factors set forth under Item 1A - Risk Factors and those other risks and uncertainties detailed in our periodic reports and registration statements filed with the Securities and Exchange Commission (“SEC”).  We caution that these risk factors may not be exhaustive.   

 

All forward-looking statements in this Report are made only as of the date hereof or as indicated and represent our views as of the date of this Report or as indicated. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise, except as required by law.

 

 1 

 

PART I

 

ITEM 1. BUSINESS. 

 

Overview

 

VerifyMe, Inc. (“VerifyMe”) together with its subsidiaries PeriShip Global, LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”), is a software driven predictive analytics logistics provider of high-touch end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, unit level traceability and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. Further information regarding our business segments is discussed below:

 

Business Update

 

Recent Developments 

 

On March 1, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) effective as of February 28, 2023 by and among the Company, Trust Codes Global, Trust Codes Limited, a New Zealand limited liability company (“Trust Codes”) and Signum Holdings Limited. Pursuant to the terms of the APA Trust Codes Global agreed to purchase from Trust Codes and Trust Codes agreed to sell to Trust Codes Global substantially all of the assets of Trust Codes and certain specified liabilities (the “Transaction”). The Transaction closed simultaneously with the execution of the APA on March 1, 2023. Trust Codes Global is based in New Zealand and provides brand protection based on a digital identity assigned at the unique item level delivered to customers through a software as a service model. The use of unique QR codes or IoT, coupled with GS1 standards, connects brands to consumers. Trust Codes Global leverages advanced algorithms to protect authenticity and brand value and provides data-driven storytelling which allows visibility of the journey for each item through the supply chain to the consumer’s hands. We believe combining the solutions of Trust Codes Global and PeriShip Global will allow the Company to provide a competitive advantage in the software logistics space, securing supply chains from products manufacture all way to the point of delivery, elevating a consumer’s trust and their brand experience. Please refer to Note 17 – Subsequent Events – to the Audited Consolidated Financial Statements appended to this Report and incorporated by reference into Item 8 in this Annual Report on Form 10-K.

 

In January 2023 we signed a mutual sales referral agreement with The Agrarian Group. The agreement is structured to help advance food safety and customer loyalty, as well as increase revenue for both companies. The food industry is a focus area for our VerifyMe Solutions segment and perishable food has been a long-standing focus of our PeriShip Global segment.  

In November 2022 we entered into an amended five-year renewal agreement with HP Indigo to provide VerifyInkTM security ink taggants for HP Indigo digital presses. This amended agreement also increases the scope of cooperation, in which HP Indigo will refer opportunities for additional VerifyMe technologies.

 

In September 2022 we entered into a $2 million term loan agreement and a $1 million line of credit with PNC Bank and repaid the $2 million promissory note from the acquisition of PeriShip LLC.

 

In August 2022, we entered into a multi-year contract extension with our strategic partner and largest customer of PeriShip Global to continue to provide proactive customer service to their customers. The term of the agreement has been extended to March 1, 2026.

 

Our Solutions

 

PeriShip Global Solutions: The PeriShip Global Solutions segment specializes in predictive analytics through its proprietary software platform for optimizing delivery of time and temperature sensitive perishable products. We manage complex industry-specific shipping logistic processes that require critical time, temperature control and handling to prevent spoilage and extended delivery times. Utilizing predictive analytics from multiple data sources including weather, traffic, flight data, major carrier feeds, and time of day data, we provide our clients an end-to-end vertical approach for their most critical service delivery needs. Using the IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries.

 

 2 

 

Through our proprietary PeriTrack ® customer dashboard, we provide an integrated tool that gives our customers an in-depth look at their shipping activities and allows them access to critical information in support of the specific needs of the supply chain stakeholders. In addition, we provide proactive alerts to address on-coming weather issues to make changes in scheduling to meet critical deadlines for shipments. We offer post-delivery services such as customized reporting for trend analysis, system performance reports, power outage maps, and other tailored reports.

 

PeriShip Global generates revenue from three business service models.

 

· Proactive Service – PeriShip Global clients pay us directly for carrier service coupled with our proactive logistics assistance.
· Direct Premium Service –PeriShip Global clients pay us directly for carrier service coupled with our complete white-glove shipping monitoring and predictive analytics service. This service includes the customer web portal access, weather monitoring, temperature control, full call center support and last mile resolution.
· Indirect Premium Service – Our carrier partner also offers a “white label” version of our Premium Service to its customers and pays us a fixed contractual fee.

 

PeriShip Service Products: The PeriShip Global Solutions segment includes the following bundled services as part of our service offerings to our customers:

 

PeriTrack ®: Our proprietary PeriTrack® customer dashboard was developed utilizing our extensive logistics operational knowledge. This integrated web portal tool gives our customers an in-depth look at their shipping activities and alerts based on real-time data. The PeriTrack® dashboard was designed to provide critical information in support of the specific needs of supply chain stakeholders and gives our customer resolution specialists a 360° view of shipping activity. PeriTrack® features tools tailored for shippers of perishable goods, which includes the In-Transit Shipment Tracker. This tool provides details on the unique shipper’s in-transit shipments, with the ability to select and analyze data on individual shipments.

 

Call Center Service: PeriShip Global has assembled a team of customer resolution specialists based in the U.S. This human intervention service team resolves shipping problems on behalf of our customers. The call center acts as a help desk and monitors shipping to delivery for our customers.

 

Pre-Transit Service: PeriShip Global helps clients prepare their products for shipments by advising clients on packaging requirements for various types of perishable products. Each product type requires its own particular packaging to protect it during the shipment, and we utilize our extensive knowledge and research to provide our customers with packaging recommendations to meet their unique needs.

 

Post-Delivery: PeriShip Global provides customized reporting for trend analysis, system performance reports, power outage maps, and many other reports to help our customers improve their processes and customer service outcomes.

 

Weather/Traffic Service: PeriShip Global has full-time meteorologists on staff to monitor weather. A package may experience a variety of weather conditions between the origin and destination, and our team actively monitors these conditions to minimize the changes of timely and safe transit of shipments. Similarly, traffic and construction also create unpredictable delays which our team works diligently to mitigate. If delays or other issues occur the PeriShip team informs clients and works with them to proactively resolve such shipment issues.

 

VerifyMe Solutions: The VerifyMe Solutions segment in traceability to connect brands with consumers through their product. Brands can gain unit level traceability through the supply chain. Through VerifyMe technologies brand inspectors can authenticate product with visible and invisible unique serialized codes. Brand owners have the ability to gather business intelligence while engaging directly with their consumers and can receive programmable alerts related to counterfeit products or if their products are in unexpected geographical markets. Consumers can authenticate products with their smart phone prior to usage and engage with the brand in unique and innovative ways. Engagement can come in many forms such as free giveaways, product specifications, seed to table tracking, cross-selling of products, contests, videos, and recipes.

 

VerifyMe Products: VerifyMe has a custom suite of products that offer clients traceability and consumer engagement. These products are combined with “software as a service” or “SAAS” which is stored in the cloud and accessed through the internet.

 

· VerifyMe Engage™ for consumer engagement allowing the brand owner to gather business intelligence and engage with their customers
· VerifyMe Authenticate™ using rare earth-based ink taggants for instant authentication of labels, packages and products
· VerifyMe Track & Trace™ for unit level traceability and supply chain control

 

 3 

 

PeriShip Global and VerifyMe Synergies:

 

We believe that PeriShip Global and our VerifyMe solutions have synergistic product centric technology platforms and combined have a compelling technology offering for brand owners. For example, currently PeriShip Global ships vaccines for major pharmaceutical companies. With the addition of VerifyMe technology, PeriShip Global can add unit level traceability and authentication to protect clients’ vaccines from product diversion and sub-standard counterfeits. In addition, VerifyMe’s consumer engagement solutions could give PeriShip Global food and beverage clients the ability to gather rich business intelligence, turn “unknown consumers” into “known consumers” and build customer loyalty with engagement functions like videos, discounts, contests, etc.

 

Strategic Partnerships

 

PeriShip Global has a direct partnership with a major global carrier company. This partnership includes the ability for both companies to white label each partner’s services. In addition, PeriShip Global has data feeds directly from the carrier into our proprietary logistics optimization software which provides shippers much more detailed information and predictive analytics on their shipment versus a standard shipping code look up which is provided by the carrier.

 

VerifyMe has a contract with HP Indigo, and a strategic partnership with INX International, the third largest producer of inks in North America. We believe these partnerships can be used to enable brand owners to securely prevent product diversion, engage with their consumers and authenticate labels, packaging and products, alleviating liability from counterfeit products that harm consumers. INX International manufactures VerifyInk™ for printing static images for labels, packaging and products such as aluminum twist caps for the spirits industry. INX International also successfully created ink jet variable images containing the VerifyInk™ which can be used with flexo, silkscreen and offset printing presses. Our security pigments are manufactured from naturally occurring inorganic rare earth materials. There are many manufacturers of these types of specialized pigments, and we intend to maintain multiple simultaneous relationships to ensure ample sources of supply. Accordingly, we are not dependent on any principal suppliers. We rely on third-party strategic partners to manufacture and distribute our VerifyInkTM products. We provide these strategic partners with pigment mixing instructions for the specific uses of each client based on their existing equipment and processes. We maintain policies and procedures to monitor, track and log access to and disposition of all pigment. Our customers are also required to agree to and implement these policies and procedures. In relation to our other products, such as our hand held VerifyChecker™ and VerifyAuthenticatorTM Smartphone Authenticator devices, as well as our VerifyLabel™ tamper-proof labels, we provide instructions for the design of these products and rely on our strategic partners for manufacturing and distribution.

 

PeriShip Global Opportunities

 

According to a 2023 report entitled, “Perishable Goods Transportation Market in the US 2023-2027”, written by Infiniti research Limited, the Perishable Goods logistics market size was $4.0 billion in 2022 and is estimated to be $4.3 billion in 2023 and is expected to grow to $5.9 billion by 2027. That represents a compound average market acceleration with a growth rate of approximately 8% per year. This report is based on perishable product segments including meat, poultry, seafood, dairy, fruits and vegetables, and bakery and confectionary. PeriShip Global services all of these product segments.

 

Currently most shipping businesses utilize the carriers’ data platform for tracking which generally informs the shipping enterprise, and their customers, when a package is in transit, when a package has been delivered, and some level of detail of the path which a package traveled. We believe taking the data feeds from a carrier and adding real-time visibility with predictive analytics and the human intervention factor of PeriShip Global’s call center gives us a major competitive advantage against other third-party platforms that solely rely on the carrier’s data feeds. PeriShip Global utilizes a variety of input sources beyond just the carrier’s data feed. PeriShip Global’s proprietary “Predictive Analytics” technology is fed real-time meteorology data, traffic and road construction data, and power grid information to help predict issues before they happen. If an alert is created the shipper and our call center will work to address the issue and save the perishable product from spoiling, saving the shipper significant costs and reducing the need to replace products that are no longer viable. PeriShip Global has two meteorologists on staff that track world-wide weather patterns to address predicted issues before they happen. We believe the pharmaceutical and healthcare industries represent the biggest areas of opportunity and we are focusing our PeriShip Global sales emphasis on those industries. In addition, we believe that combining VerifyMe’s solutions into the product offering for PeriShip Global clientele, including food and beverage and healthcare industries, gives PeriShip Global a competitive advantage to generate revenue by enhancing PeriShip Global’s clients’ ability to grow revenue, gain business intelligence and build brand loyalty.

 

The current global logistics industry worldwide is facing an economic slowdown. We believe this represents an opportunity for PeriShip Global since major global carriers are cutting internal staff and are reducing research and development investments. To maintain their credibility in the market, these carriers will need to ensure they meet their customers’ demands for time and temperature sensitive shipments, while maintaining their overheads. We believe outsourcing this function to PeriShip Global provides the ideal solution for all parties involved.

 

 4 

 

Building logistics infrastructure is a capital-intensive process as the investment is locked in for a considerably long period. Due to the current economic downturn, we believe several companies will opt to outsource their logistics services to reduce their operational costs and maintain cash flows. The outsourcing of supply chain logistics operations to service providers such as PeriShip Global allows companies to improve the efficiency of their businesses by focusing their resources on core competencies.

 

VerifyMe Opportunities

 

We believe VerifyMe’s products have applications in many areas. Currently, we are aggressively marketing opportunities in the following areas:

 

· Food and Beverage – Food safety is becoming more common as supply chains become more global and as imaging and manufacturing technology become more accessible. Food traceability, sustainability and carbon neutral production is becoming a significant consideration for brand and governments. We believe our unit level traceability and authentication solutions can help brands tell their story about sustainability and battle against tainted or substandard foods and beverages.
· Pharmaceuticals/nutraceuticals – We believe counterfeit prescription pharmaceuticals and nutraceuticals are a growing problem, widely recognized as a public health risk and a serious concern to public health officials, private companies, and consumers. Counterfeiting can apply to both branded and generic products and counterfeit pharmaceuticals may include products with the correct ingredients but fake packaging, with the wrong ingredients, without active ingredients or with insufficient active ingredients. The United States enacted legislation requiring the implementation of a comprehensive system designed to combat counterfeit, diluted or falsely labelled pharmaceuticals, referred to as serialization or electronic pedigree (e-Pedigree). Our consumer facing visible codes and unique pigments embedded in the ink of a unique serialized barcode can provide a layered security foundation for a customer solution in this market. We are seeking to expand our business in this market and believe that as additional pharmaceutical companies seek to comply with the legislation, our products will provide attractive alternatives to address the need for product identifiers. 
· Consumer Products –We believe our technology solutions are particularly suited for the cosmetics, health and beauty and apparel industries. We give the consumer the ability to test a products authenticity instantly with a smartphone. We can protect brand owners from liability litigation, product diversion and lost financial sales with our consumer facing visible codes and unique ink pigments which can be incorporated in dyes and used by manufacturers in these industries to combat counterfeiting and piracy of actual physical goods. Our pigments expressed as inks can also be used on packaging, as well as to track products that have been lost in transit, whether misplaced or stolen.

 

In addition, in each of these markets, our SaaS software allows brand owners and consumers to track the products and will alert the consumer or brand owner of product diversion with 24/7 monitoring. As each product has a unique code, this allows consumers and brand owners to authenticate the product in real time and link directly to the brand owner’s website for additional product information, discounts, and more.

 

Current Economic Environment

 

In early September 2022, the major global carrier company that PeriShip partners with, disclosed that a global recession could be coming based on various indicators in its business, including the demand for packages weakening considerably in the final weeks of August 2022, a negative impact on its express delivery business due to the weakening global economy, particularly in Asia and Europe, and a decline in the volume of freight it handles in every region around the world. The major global carrier stated that it expects business conditions to further weaken during its current quarter and is responding by reducing flights, temporarily parking aircraft, trimming hours for its staff, delaying some hiring plans, laying off more than 10% of its officers and directors, and closing ninety office locations as well as five corporate offices. It also stated it is cutting $500 million from its capital expenditure budget for its fiscal year, which runs through May of 2023.

 

We have seen a softening in demand for some services related to high-end perishable items which seem to be impacted by reduced discretionary spending by U.S. consumers. While a recession, whether global or more localized to the U.S., may decrease the demand for our services that are more discretionary in nature, we believe that the internal cost cutting measures, if implemented by the major global carrier, may benefit out-sourced service providers, including PeriShip Global. Additionally, PeriShip Global is working with this major global carrier to address their small and medium sized business clients, which we believe is an underserved segment and presents considerable growth opportunities for PeriShip Global. However, we can provide no assurances that a decline in discretionary consumer spending will not have a negative impact on our revenues and results of operations.

 

 5 

 

Business Combination

 

On March 1, 2023, we acquired, through Trust Codes Global, the business and certain assets of Trust Codes Limited, which provides unique item level codes for brand protection, data intelligence and consumer engagement technology with an expertise in the food and agriculture industry. Using unique QR codes or IoT, coupled with GS1 standards, we provide brand protection based on a digital identity assigned at the unique item level delivered to customers through a software as a service model. Leverages advanced algorithms to protect authenticity and brand value we provide data-driven storytelling which allows visibility of the journey for each item through the supply chain to the consumer’s hands. The purchase price was approximately $1,000,000, which consisted of approximately $350,000 in cash paid at closing, and 353,492 shares of restricted common stock of the Company, representing $650,000 in Stock Consideration. The acquired Trust Codes business is included in the VerifyMe Solutions segment and we expect the results of its operations will be included in the consolidated financial statement beginning March 1, 2023. Please refer to Note 17 – Subsequent Events – to the Audited Consolidated Financial Statements appended to this Report and incorporated by reference into Item 8 in this Annual Report on Form 10-K.

 

On April 22, 2022, we acquired, through PeriShip Global, the business and certain assets of PeriShip, LLC, a value-added service provider for time and temperature sensitive parcel management.  PeriShip Global provides shipping logistics services utilizing proprietary predictive analytics software and supporting call center services.  Using our proprietary IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. The purchase price was $10.5 million which consisted of $7.5 million in cash paid at closing, a promissory note of $2.0 million with a fixed interest rate of 6% per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing, and 305,473 shares of restricted common stock of the Company, representing $1.0 million in stock consideration. We expect that all of the goodwill recorded for financial statement purposes is deductible for tax purposes. The acquired PeriShip business is included in the PeriShip Global Solutions segment and the results of its operations have been included in the consolidated financial statements beginning April 22, 2022.

 

SPAC Investment

 

On July 6, 2021, we co-sponsored the initial public offering of G3 VRM Acquisition Corp, a special purpose acquisition company, or “SPAC,” through a contribution into G3 VRM Holdings LLC, or the “Sponsor Entity.” The closing of the IPO of 10,626,000 Units, including 626,000 Units pursuant to the partial exercise of the underwriter’s over-allotment, generated gross proceeds of $106,260 thousand. G3 VRM commenced trading on NASDAQ under the symbol “GGGVU” and was targeting businesses with enterprise values of approximately $250 million to $500 million within the technology and business services industry. VerifyMe, indirectly through the Sponsor Entity beneficially owned approximately 9.42% of the common stock of the SPAC.

 

The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO and the Sponsor Entity decided not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved and liquidated in accordance with its charter. The SPAC redeemed 100% of the public shares for cash, the rights expired worthless, and the founder shares and the private placement securities have become worthless. In December 2022, it was determined that the costs to dissolve the SPAC were ultimately less than the remaining assets of the SPAC and the SPAC made a distribution to the Company of $32 thousand.

 

The fair value of the equity investment was $0 million as of December 31, 2022, and $11.0 million as of December 31, 2021.

 

As of December 31, 2022, we have recognized the impairment loss of $10,932 thousand included in Loss on equity investments in the accompanying Consolidated Statements of Operations.

 

Our Intellectual Property

 

Intellectual property is important to our business. Our current patent and trademark portfolios consist of eleven granted U.S. patents and one granted European patent validated in four countries (France, Germany, United Kingdom, and Italy), six pending U.S. and foreign patent applications, fifteen registered U.S. trademarks (of which seven trademarks were acquired through our wholly owned subsidiary, PeriShip Global), two EU trademark registrations, one Colombian trademark registration, one Australian trademark registration, one Japanese trademark registration, one Mexican trademark registration, one Singaporean trademark registration, two UK trademark registrations, and twenty-one pending US and foreign trademark applications.

 

While some of our granted patents are commercially ready, we believe that others may have commercial application in the future but will require additional capital and/or a strategic partner in order to reach the potential markets. All of our patents are related to the inventions described above. Our registered patents expire between the years 2023 and 2039. The expiration date of a pending application that matures into a registration depends upon the issuance date and any adjustment under 35 U.S.C. 154(b).

 

 6 

 

It is cost prohibitive to register patents in every country. We continue to develop new technologies and we apply for patent protection for these technologies in countries with the most market potential and strong patent enforcement tools. When a new product or process is developed, we may seek to preserve the economic benefit of the product or process by applying for a patent in each jurisdiction in which the product or process is likely to be exploited.

 

The issuance of a patent is considered prima facie evidence of validity.  The granting of a patent does not prevent a third party from seeking a judicial determination that the patent is invalid. Such challenges to the validity of a patent are not uncommon and can be successful. There can be no assurance that a challenge will not be filed to one or more of our patents, if granted, and that if filed, such a challenge will not be successful.

 

We have trademarked the VerifyMeTM brand in the United States and have registered and pending applications with respect to our brand internationally. However, our name and brand could be confused with brands that have similar names, including but not limited to Verified.Me, a service offered to Canadians by SecureKey Technologies Inc. We have a pending application for the VerifyMe name in Canada but can make no assurances regarding its approval. We are aware of names and marks similar to our service marks being used from time to time by other persons that could result in confusion and may diminish the value of our brands and adversely affect our business. See Item 1A “Risk Factors” for additional information regarding the risk of confusion of our name with other brands and other intellectual property risks.

 

Research and Development

 

Current research and development efforts are focused on expanding our technology into new areas of implementation and to develop unique customer applications. We spent approximately $89 thousand and $51 thousand during the years ended December 31, 2022, and 2021, respectively, on research and development.

 

Research in our PeriShip Global Solutions segment is currently focused on developing:

 

· multi-carrier software support so our services can be provided to clients no matter which carrier they choose to ship their packages;
· the ability to print labels utilizing our own label printing software rather than relying on a carrier’s print engine;
· an mobile app for smart phones so our clients can access our portal from their phones rather than a personal computer;
· the imbedding of artificial intelligence into our proprietary IT portal to expand and improve our predictive analytics capabilities;
· imbedding a new temperature sensitive ink solution that will give an indication if a temperature exceeded a certain level on packaging for vaccines, food and beverages, and other temperature sensitive packaging, that need constant cold storage temperatures during transit;
· creating revenue from our weather analytics.

 

Our legacy ink technology in our VerifyMe Solution Segment is effectively complete, and we are concentrating on the marketing of our technologies. VerifyMe continues to monitor the market for state-of-the-art innovation and may add new products and services in the future, if we believe it would provide a competitive market advantage and could be successfully monetized.

 

Sales and Marketing Strategy

 

Business development and sales resources are aligned to support existing customer accounts and new customer development. We use social media channels, such as LinkedIn, Facebook and Twitter as a means of marketing our services. By staying in contact and engaging with customers, we are able to identify possible needs and look for opportunities to expand the services we are providing. We are currently revising the PeriShip Global website, with an on-line chat system as well as aligning with the VerifyMe website to advertise our synergistic offerings. We believe many of the clients of PeriShip Global will benefit from the legacy VerifyMe business consumer engagement and food safety technologies. We will also continue to re-establish trade show attendance which had declined during the height of the COVID pandemic. 

 

In lieu of building, training, and supporting a world-wide internal sales force, we have engaged with multiple strategic partners who have existing relationships in their particular geographical locations. For our VerifyMe Solutions segment, these strategic partners have relationships with government and brands and include both paid and commissioned sales only contract arrangements. They are located in the Middle East, Europe, United Kingdom, India, South Africa, United Arab Emirates, China and Pakistan. We plan to continue to build new strategic partnerships throughout the globe. We have also established a network of commission only paid consultants within the United States. These consultants mainly focus on brand owners, and they are not constricted geographically.

 

 7 

 

Competition

 

PeriShip Global has developed its own software portal with predictive analytics for weather, traffic, power grids, and data feeds it receives from one of the world’s largest logistics carriers. There are approximately 10 U.S. companies that operate a similar business model, however most of these companies specialize in a particular field such as healthcare or non-perishable building materials. PeriShip Global is operating in all of the perishable segments. In addition, the major carriers such as FedEx, UPS and DHL all have internal operations servicing the critical time, temperature, and cold storage shipping segment, however we believe with the economic downturn, major carriers are seeking to outsource perishable shipping services rather than invest additional funds to provide internal support.

 

The market for protection from diversion, theft and forgery is a mature industry dominated by a number of large, well-established companies, particularly in the area of traditional overt security technologies where repeating static produced images are commonly used. Security printing for currency production began in Europe over a century ago and has resulted in the establishment of old-line security printers which have branched out into brand and product protection as well. In North America, brand protection products, such as tamper-resistant packaging, security labels, and anti-theft devices are readily available and utilized on a widespread basis. In recent years, however, demand has increased for more sophisticated overt and covert security technologies with a strong desire for technologies that can provide variable images and data. Competitors can be segregated into the following groups: (i) security ink manufacturers who are generally well-established companies whose core business is manufacturing and selling printing inks; (ii) system integrators who have often evolved from other sectors in the printing industry, mainly security printing manufacturers, technology providers, or packaging and label manufacturers, and who typically offer a range of security solutions that enable them to provide a complete suite of solutions tailored to the customer’s specific needs and requirements; (iii) system consultancy groups who offer a range of technologies from several different providers and tailor specific solutions to end-users; (iv) traditional authentication technology providers which provide holograms and digital watermarking; (v) product diversion tracking providers which provide on-product and in-product tagging technologies; and (vi) traditional security printers whose core products are printing the world’s currencies. In general, we believe competition in our principal markets is primarily driven by product performance, features and liability; price; ease of implementation, technology effectiveness, digital instant verification; new laws and regulations; product innovation and timing of new product introductions; ability to develop, maintain and protect proprietary products and technologies; sales and distribution capabilities; technical support and service; brand loyalty; applications support; and breadth of product line.

 

Amazon has become a competitor with their new “Project Zero” brand protection system utilizing their “Transparency” serialization product. Amazon’s product serialization service provides a unique code for every unit that is manufactured, and the brand puts these codes on its products as part of its manufacturing process, which Amazon scans and verifies. Amazon’s solution must be used within the Amazon ecosystem. This differs from our visible unit level traceability codes and our covert luminescent pigment which may be incorporated in the labeling and packaging process as static or variable covert codes. Competition is building in the consumer engagement market as more companies enter the space but are using mainly NFC technology imbedded into apparel. In addition to this technology, we have the ability to print labels on more applications including fabrics and metals.

 

Some of our competitors have substantially greater financial, human and other resources than we have. As a result, we may not have sufficient resources to develop and market our services to the market effectively. We expect competition with our products and services to continue and intensify in the future.

 

Major Customers/Vendors

 

During the year ended December 31, 2022, one customer accounted for 13% of total revenue.  During the year ended December 31, 2021, five customers accounted for 95% of total revenue.

 

During the years ended December 31, 2022, one vendor accounted for 99% of transportation cost in our PeriShip Global Solutions segment.

 

As of December 31, 2022, two customers accounted for 23% of total accounts receivable. As of December 31, 2021, three customers accounted for 91% of total accounts receivable.

 

Employees and External Sales Force

 

As of December 31, 2022, we employed approximately 50 persons and several consultants. Of these employees, approximately 40 were employed in our PeriShip Global operations and 8 were employed by our legacy business, VerifyMe. Because of the nature of our business, many of our employees and consultants can, and do, conduct their work for us remotely.

 

In lieu of building, training and supporting a world-wide internal sales force for our VerifyMe legacy business, we have engaged with multiple strategic partners who have existing government and brand owner relationships in their particular geographical locations. These strategic partnerships include both paid and commissioned sales only contract arrangements. These strategic partners are located in the Middle East, Europe, United Kingdom, India, South Africa, United Arab Emirates, Australia, New Zealand, China and Pakistan. We plan to continue to build new strategic partnerships throughout the globe.

 

 8 

 

We have also established a network of over a dozen commission-paid sales consultants within the United States. These consultants mainly focus on brand owners, and they are not constricted geographically.

 

We have also entered into commissioned sales contract arrangement with our strategic partner, HP Indigo.

 

Available Information

 

We make available free of charge on our website, www.verifyme.com, all materials that we file electronically with the Securities and Exchange Commission (“SEC”), including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports, filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable after electronically filing such materials with, or furnishing them to, the SEC. We have not incorporated by reference into this Report the information included, or that can be accessed through, our website and you should not consider it to be part of this Report.

 

The SEC maintains an Internet website, www.sec.gov that contains reports, proxy and information statements and other information that we file electronically with the SEC.

 

ITEM 1A. RISK FACTORS

 

Any investment in our securities involves a high degree of risk. You should consider carefully the risks and uncertainties described below and all information contained in this Report, before you decide whether to purchase our securities. If any of the following risks or uncertainties actually occur, our business, financial condition, results of operations and prospects would likely suffer, possibly materially. In addition, the trading price of our common stock could decline due to any of these risks or uncertainties, and you may lose part or all of your investment.

 

Risks Relating to Our Business

 

We have engaged, and may engage in future, acquisitions or strategic partnerships that increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities, and subject us to other risks.  

 

We may evaluate various acquisitions and strategic partnerships, including licensing or acquiring complementary products, intellectual property rights, technologies or businesses. For example, in April 2022, we acquired the business of PeriShip, LLC (“PeriShip”) through our wholly owned subsidiary PeriShip Global and in March 2023, we acquired the business of Trust Codes Limited, (“Trust Codes”) through our wholly owned subsidiary Trust Codes Global Limited (“Trust Codes Global”). To realize the anticipated benefits of these acquisitions, we must successfully integrate these businesses with ours. The integration of these businesses and any potential acquisition or strategic partnership entails numerous risks, including: 

 

· increased operating expenses and cash requirements;
· the assumption of indebtedness or contingent liabilities;
· dilution of our stockholder’s equity due to the issuance of additional equity securities;
· assimilation of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new personnel;
· the diversion of our management’s attention from our existing product programs and initiatives in pursuing such a strategic merger or acquisition;
· retention of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships; and
· our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs.

 

In addition, if we undertake acquisitions, we may issue dilutive securities, assume or incur debt obligations, incur large one-time expenses and acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able to locate suitable acquisition opportunities and this inability could impair our ability to grow or obtain access to technology or products that may be important to the development of our business.

 

 9 

 

Our PeriShip Global Solutions segment relies on one key strategic partner for shipping services for our customers and as a source for customers representing a substantial percentage of our revenues.

 

Our business is dependent, and we believe that it will continue to depend, on our relationship with one strategic partner. PeriShip Global partners with one major global carrier for all its customers’ shipping needs. While we work closely with this key strategic partner and have transportation services and pricing agreements in place covering the shipping services they provide to our customers, such agreements are subject to termination or modification from time to time. If our strategic partner is unwilling or unable to supply to us the shipping services we market and sell on acceptable terms, or at all, or otherwise elects to terminate its business relationship with us, we may not be able to obtain alternative shipping services from other providers on acceptable terms, in a timely manner, or at all, and our business may be materially and adversely impacted. We do not currently have any alternative shipping service suppliers from which we can obtain the shipping services we currently receive from our strategic partner. Establishing the necessary information technology infrastructure and business relationship with another shipping services provider would be costly and time consuming and may ultimately not be successful or cost-effective. Further, any increase in the prices charged by our single strategic partner or failure to perform by our strategic partner could cause our costs to increase or could cause us to experience short-term unavailability of shipping services on which our business relies.

 

In particular, delays and other shipping disruptions at our strategic partner significantly negatively impact our business. Our business involves the shipment of time and temperature sensitive goods, so our customers are significantly negatively impacted by delays and other shipping disruptions that cause product loss, spoilage and reputational harm. An increase in delays and other shipping disruptions on the part of our strategic partner could cause our clients to seek shipping solutions from our competitors who use alternative shipping service providers. If these events occur, it may reduce our profitability or may cause us to increase our prices. In addition, any material interruptions in shipping services by this strategic partner may result in significant cost increases and reduce sales, which could harm our business, financial condition and results of operations and may have a material adverse impact on our business.

 

In addition to relying on this strategic partner for shipping services, a significant portion of our revenue is generated through a service agreement pursuant to which this strategic partner resells our services to its customers under a “white label” arrangement. Under this arrangement we provide our logistics services to our strategic partner’s customers in exchange for a pre-negotiated service fee per shipment. Sales through our strategic partner accounted for approximately 13% of revenue of our PeriShip Global Solutions segment for the year ended December 31, 2022. If we fail to maintain certain minimum service level requirements related to our service with this strategic partner, it may terminate our agreement to provide them with such service. If our strategic partner terminates our agreement, requires us to renegotiate the terms of our existing agreement or we are unable to renew such agreement on mutually agreeable terms, no longer makes our services available to its customers, replaces our services with one or more competitors, develops and supplants our services for its own service offerings, or we experience a significant reduction in business from this strategic partner, our business, financial condition and results of operations would be materially adversely affected.

 

Our key strategic partner has announced that it is developing a service that may be competitive to our own, and others may do the same.

 

In the second quarter of 2020 our key strategy partner publicly announced that it plans to develop an inhouse software solution in collaboration with a multinational software company that may ultimately be competitive with our service offerings. In January 2022, our key strategy partner announced the development of a logistics as a service solution as a result of this collaboration. The details regarding this product offering, and whether this inhouse solution will ultimately be developed and successfully launched commercially, are unclear. To date we do not believe that this product offering has been adopted by our existing clients or adversely impacted our results in a material way. However, if our key strategic partner takes steps to position this product offering as a replacement or competitor to our service offerings, there can be no assurance that such steps would not increase our cost of delivering our services to our customers, hinder our ability to deliver our services to our customers, entice our existing customers to discontinue using our services, or reduce the number of customers referred to us by our strategic partner. In addition, other carriers or companies, such as Amazon, may develop services that compete with ours. Further, some of our existing customers may develop their own logistics capabilities such that they no longer require our services. Any of these events could harm our business, financial condition and results of operations and may have a material adverse impact on our business.

 

Our business is subject to seasonal trends.

 

Historically, our operating results in the PeriShip Global Solutions segment have been subject to seasonal trends when measured on a quarterly basis. Our first and second quarters have traditionally been the weakest compared to our third and fourth quarters. This trend is dependent on numerous factors including economic conditions, customer demand and weather. Because revenue is directly related to the available working days of shippers, national holidays and the number of business days during a given period may also create seasonal impact on our results of operations. After the winter holiday season and during the remaining winter months, our freight volumes are typically lower because some customers reduce shipment levels. In addition, a substantial portion of our revenue is derived from customers in industries whose shipping patterns are tied closely to consumer demand which can sometimes be difficult to predict or are based on just-in-time production schedules. Therefore, our revenue is, to a large degree, affected by factors that are outside of our control. There can be no assurance that our historic operating patterns will continue in future periods as we cannot influence or forecast many of these factors.

 

 10 

 

Severe climate conditions and other catastrophic events can have an adverse impact on our business.

 

Our business involves the shipment of time and temperature sensitive goods, so our customers are significantly negatively impacted by delays and other shipping disruptions that cause product loss, spoilage and reputational harm. Disasters, severe weather, public health issues, such as pandemics, earthquake, cyber-attack, heightened security measures, actual or threatened terrorist attack, strike, civil unrest, or other catastrophic event may cause shipment delays or an inability to ship, which could prevent, delay or reduce shipment volumes and could have an adverse impact on consumer spending and confidence levels, all of which could result in decreased revenues. In particular, certain weather-related conditions such as ice and snow can disrupt the operations of our carrier partners during the peak holiday season, which could have a disproportionately large negative impact on our business and revenues.

 

We operate in a highly competitive industry and our business may suffer if we are unable to adequately address potential downward pricing pressures and other competitive factors.

 

The transportation and logistics industry is highly competitive and cyclical, and is expected to remain so for the foreseeable future. The traceability and consumer engagement industry is also highly competitive. We face competition in all geographic markets and each industry sector in which we operate. Many of these competitors have significantly more resources and are actively pursuing acquisition opportunities and are developing new technologies to gain competitive advantages. The primary competitive factors are price and quality of service. Increased competition or our inability to compete successfully may lead to a reduction in our volume, reduced revenues, reduced profit margins, increased pricing pressure, or a loss of customer relationships, any one of which could affect our business and financial results. Numerous competitive factors could impair our ability to maintain our current profitability, including the following:

 

· our competitors may periodically reduce their prices to gain business, especially during times of weak economic conditions, which may limit our ability to maintain or increase prices or impede our ability to maintain or grow our customer relationships;
· our inability to achieve expected customer retention levels or sales growth targets;
· we compete with many other transportation and logistics service providers, and companies providing traceability and consumer engagement solutions, some of which have greater capital resources or lower cost structures than us;
· our inability to compete with new entrants in the market that may offer similar services at lower cost or have greater technological capabilities;
· customers may choose to provide for themselves the services that we now provide;
· many customers periodically accept proposals from multiple carriers for their shipping needs, and this process may depress rates or result in the loss of some of our business to competitors; and
· advances in technology require increased investments to remain competitive, and our customers may not be willing to accept higher prices to cover the cost of these investments; and
· we may not have sufficient resources to develop and market our services effectively, or at all.

 

The shipping and logistics industry is rapidly evolving. We expect to continue to face significant competition, which could materially adversely affect us.

 

The shipping and logistics industry is rapidly evolving, including demands for faster deliveries and increased visibility into shipments. We expect to face significant competition on a local, regional, national and international basis. Competitors include the U. S. and other international postal services, various motor carriers, express companies, freight forwarders, air couriers, large transportation and e-commerce companies that have made and continue to make significant investments in their own logistics capabilities, some of whom are currently our customers. We also face competition from start-ups and other smaller companies that combine technologies with crowdsourcing to focus on local market needs. Competition may also come from other sources in the future as new technologies are developed. Competitors have cost, operational and organizational structures that differ from ours and may offer services or pricing terms that we are not willing or able to offer. Additionally, to sustain the level of service and value that we deliver to our customers, from time to time we may raise prices and our customers may not be willing to accept these higher prices. If we do not timely and appropriately respond to competitive pressures, including replacing any lost volume or maintaining our profitability, we could be materially adversely affected.

 

Damage to our brand image and corporate reputation could materially adversely affect us.

 

Our success depends on our ability to consistently deliver operational excellence and strong customer service. Our inability to deliver our services and solutions as promised on a consistent basis, or our customers having a negative experience or otherwise becoming dissatisfied, can negatively impact our relationships with new or existing customers and adversely affect our brand and reputation, which could, in turn, adversely affect revenue and earnings growth. Adverse publicity (whether or not justified) relating to activities by our employees, contractors, suppliers, agents or others with whom we do business, such as customer service mishaps or noncompliance with laws, could tarnish our reputation and reduce the value of our brand. With the increase in the use of social media outlets such as Facebook, YouTube, Instagram, LinkedIn and Twitter, adverse publicity can be disseminated quickly and broadly, making it increasingly difficult for us to effectively respond. Damage to our reputation and loss of brand equity could have a material adverse effect on us, and could require additional resources to rebuild our reputation and restore the value of our brand.

 

 11 

 

The Company has significant goodwill and other intangible assets, and future impairment of these assets could have a material adverse impact on the Company's financial results.

 

The Company has recorded significant goodwill and other identifiable intangible assets on its balance sheet as a result of its acquisition of the PeriShip business in 2022. A number of factors may result in impairments to goodwill and other intangible assets, including significant negative industry or economic trends, disruptions to our business, increased competition and significant changes in the use of the assets. Impairment charges could adversely affect the Company's financial condition or results of operations in the periods recognized. 

 

Our customers’ businesses may be negatively affected by various economic and other factors such as recessions, downturns in the economy, inflation, global uncertainty and instability, the effects of pandemics, changes in United States social, political, and regulatory conditions and/or a disruption of financial markets, which may decrease demand for our services or increase our costs.

 

Adverse economic and other conditions, both in the United States and internationally, can negatively affect our customers’ business levels, the amount of logistics services they need, their ability to pay for our services and overall freight levels, any of which might impair our profitability. For example, inflation and uncertainty and instability in the global economy and geopolitical events may lead to fewer goods being transported. Many of the products our clients ship are luxury or discretionary products and the demand for such products may decrease in adverse economic times. Further, when adverse economic times arise, customers may select competitors that offer lower rates or choose to ship their goods without logistical support in an attempt to lower their costs. These and other economic factors such as recessions could have an adverse effect on our business, financial conditions and results of operations and we might be forced to lower our rates or lose customers.

 

Overall economic conditions that reduce freight volumes could have a material adverse impact on our operating results and ability to achieve growth.

 

We are sensitive to changes in overall economic conditions that impact customer shipping volumes. The transportation and logistics industry historically has experienced cyclical fluctuations in financial results due to economic recession, downturns in business cycles of our customers, interest and currency rate fluctuations, inflation and other economic factors beyond our control. Changes in U.S. trade policy could lead to ‘trade wars’ impacting the volume of economic activity in the United States, and as a result, shipping volumes may be materially reduced. Such a reduction may materially and adversely affect our business.

 

Reductions in discretionary consumer spending could have an adverse effect on our business, financial condition, and results of operations.

 

The services and products we provide are sensitive to reductions from time to time in discretionary consumer spending. For example, demand for high-end perishable items and cannabis products, and subsequently the demand for shipping, brand protection, and other services related to such, can be affected by changes in the economy and consumer tastes, both of which are difficult to predict and beyond our control. Unfavorable changes in general economic conditions, including recessions, economic slowdowns, sustained high levels of unemployment, and rising prices or the perception by consumers of weak or weakening economic conditions, may reduce consumer’s disposable income or result in a decrease in demand for our services and products. As a result, we cannot ensure that demand for our services and products will materialize or remain constant. In early September, 2022, the major global carrier company that PeriShip partners with disclosed that a global recession could be coming based on various indicators in its business including the demand for packages weakening considerably in the final weeks of August 2022, a negative impact on its express delivery business due to the weakening global economy, particularly in Asia and Europe, and a decline in the volume of freight it handles in every region around the world. The major global carrier stated that it expects business conditions to further weaken during its current quarter and is responding by reducing flights, temporarily parking aircraft, trimming hours for its staff, delaying some hiring plans and closing ninety office locations as well as five corporate offices. It also stated it is cutting $500 million from its capital expenditure budget for its fiscal year, which runs through May of 2023.

 

We have seen a softening in demand for some services related to high-end perishable items which seem to be impacted by reduced discretionary spending by U.S. consumers. While a recession, whether global or more localized to the U.S., may decrease the demand for our services that are more discretionary in nature, we believe that the internal cost cutting measures, if implemented by the major global carrier may benefit out-sourced service providers, including PeriShip Global. Additionally, PeriShip Global is working with this major global carrier to address their small and medium sized business clients, which we believe is an underserved segment and presents considerable growth opportunities for PeriShip Global. However, we can provide no assurances that a decline in discretionary consumer spending will not have a negative impact on our revenues and results of operations. Adverse developments affecting economies throughout the world, including a general tightening of availability of credit, decreased liquidity in certain financial markets, increased interest rates, foreign exchange fluctuations, increased energy costs, acts of war or terrorism, transportation disruptions, natural disasters, declining consumer confidence, sustained high levels of unemployment or significant declines in stock markets, as well as concerns regarding pandemics, epidemics and the spread of contagious diseases, could lead to a further reduction in consumer discretionary spending and have an adverse effect on our business, financial condition, and results or operations.

 

 12 

 

Global supply-chain delays and shortages may adversely impact our customers or potential customers.

 

Global supply-chain delays and shortages, which are out of our control, are currently affecting a wide variety of businesses globally including one of our customers. Supply-chain delays shortages may affect our customers or potential customers which would adversely affect our operations.

 

We have a history of losses and we may never achieve or maintain profitability.

 

Since our inception, we have incurred operating losses in each year due to costs incurred in connection with research and development activities and general and administrative expenses associated with our operations. In addition, we have made significant expenditures on acquisitions and may continue to complete acquisitions in the future. We expect to continue to incur expenditures to develop and market our services and to make acquisitions and could continue to incur operating losses and negative operating cash flow. We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. Our ability to generate profits will depend, in part, on our expenses and our ability to generate revenue. Our prior losses and any future losses have had and may continue to have an adverse effect on our working capital. If we fail to generate revenue and become profitable, or if we are unable to fund our continuing losses, our shareholders could lose all or part of their investments.

 

Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations.

 

Our net operating loss carryforwards ("NOLs"), and certain other tax attributes could be unavailable to offset future income tax liabilities because of restrictions under U.S. tax law. Under the Tax Cuts and Jobs Act, or the TCJA, federal NOLs generated in tax years ending after December 31, 2017 may be carried forward indefinitely. The carryforwards are limited to 80% of each subsequent year's net income.

 

In addition, Sections 382 and 383 of the Code, contain rules that limit the ability of a corporation that undergoes an "ownership change" (generally, any change in ownership of more than 50% of the corporation's stock over a three-year period) to utilize its pre-change NOLs and tax credit carryforwards to offset future taxable income. These rules generally operate by focusing on ownership changes involving stockholders owning directly or indirectly 5% or more of the stock of a corporation and any change in ownership arising from a new issuance of stock by the company. Generally, if an ownership change occurs, the yearly taxable income limitation on the use of NOLs and tax credit carryforwards and certain built-in losses is equal to the product of the applicable long-term, tax-exempt rate and the value of the corporation's stock immediately before the ownership change. In 2022, we completed the IRC Section 382 analysis, and determined that an ownership change occurred sufficient to impose additional limitations on the use of NOL carryforwards. For the year ended December 31, 2022, Federal and state NOLs of $23.1 million and $0, respectively, will expire unutilized due to the limitations of Section 382, leaving Federal and state NOL carryforwards of $24.4 million and $13.1 million, respectively that may be offset against future taxable income. In the event future ownership changes are determined, we might be unable to offset our taxable income with losses, or our tax liability with credits, before such losses and credits expire, in which event we could incur larger federal and state income tax liabilities than we would have had we not experienced an ownership change.

 

Because our name and brand could be confused with brands that have similar names, we may be adversely affected by any confusion or negative publicity related to others that use a name similar to VerifyMe in their brand names. 

 

We have trademarked the VerifyMeTM brand in the United States and have pending applications with respect to our brand internationally. However, our name and brand has been and could be in the future confused with brands that have similar names, including but not limited to Verified.Me, a service offered to Canadians by SecureKey Technologies Inc. and www.verifyme.ng, a website offering verification services in Nigeria. We have deleted classifications in our Canada trademark application for the VerifyMe name, in an effort to avoid confusion with the prior-registered SecureKey trademark. We have also attempted to contact the operators of the Nigeria website to resolve the confusion caused there but to date have been unsuccessful in our efforts. Further, we have registered certain trademarks and service marks in the United States and foreign jurisdictions. We are aware of names and marks similar to our service marks being used from time to time by other persons. Although we oppose any such infringement, further or unknown unauthorized uses or other misappropriation of our trademarks or service marks may diminish the value of our brands and adversely affect our business. 

 

If our technologies do not work as anticipated once we achieve meaningful sales, we will not be successful.

 

Our business depends on our ability to market and sell our technology. Without material sales and acceptance from customers with respect to our technologies, we will not be successful. We can provide no assurances that the market will accept our products or that we will achieve any meaningful sales.

 

 13 

 

If our technology cannot be used successfully to proactively provide analytics logistics management, we may not be able to generate material revenue.

 

Our proprietary technology is the core of our PeriShip Global operations. The failure of our technology will result in the stoppage of our operation. Due to the fact our business is the monitoring of time sensitive goods movement, any stoppage will result in the financial loss and service liability damage. In order to stay competitive, we need to ensure the continuity and the timeliness of our service, it is essential that the technology platform has redundancy built in, high performing and scalable.

  

Because many of our current and target customers are large companies, their internal policies and resistance to change may impair our ability to successfully commercialize our products.

 

Our ability to become successful and generate positive cash flow will be dependent upon the extent of commercialization of products using our technology. Commercialization of new technology products often has a very long lead time. This problem is exacerbated when customers are large entities. Our current and target customers are large entities. These factors may adversely affect our ability to commercialize our technologies, or any products or services related to our technologies. Further, we cannot assure you that commercialization will result in profitability.

 

Our future growth will depend upon the success of our strategic partners who integrate our solutions into their product offerings. 

 

We rely on strategic partnerships with one large logistics carrier for our PeriShip Global Solutions segment and larger companies which integrate our technologies into their product offerings for our legacy VerifyMe Solutions segment. These strategies leave us largely dependent upon the success of our partners. If any of our strategic partners who include our technology in their products cease to do so, or we fail to obtain other partners who will incorporate, embed, integrate or bundle our technology, or these partners are unsuccessful in their efforts, expanding deployment of our technology, our business and future growth would be materially and adversely affected.

 

If we cannot manage our growth effectively, we may not become profitable. 

 

Businesses which grow rapidly often have difficulty managing their growth. If we continue to grow as rapidly as we anticipate, we will need to expand our management by recruiting and employing experienced key employees capable of providing the necessary support. We cannot assure you that our management will be able to manage our growth effectively or successfully. Our failure to meet these challenges could harm our financial condition and ability to become profitable.

 

Because a small number of customers account for most of our revenue, the loss of any of these customers would have a material adverse impact on our operating results and cash flows.

 

We derive our revenue from a limited number of customers and our revenue in 2022 grew to $19,576 thousand with the acquisition of PeriShip Global, compared to $867 thousand in 2021. Our principal revenue has been generated from thirty customers in 2022, compared to five customers in 2021. Certain of our agreements with customers have short terms or can be terminated on short notice. Any termination of a business relationship with, or a significant sustained reduction in business received from, one of these customers could have a material adverse effect on our operating results and cash flows. If we are unable to materially increase the number of our customers and the number of products for which they use our service, it could adversely impact our financial condition and our business.

 

We will need to expand our sales, marketing and support organizations and our distribution arrangements to increase market acceptance of our products and services.

 

We currently have a limited number of sales, marketing, customer service and support personnel and may need to increase our staff, or further outsource our sales process, to generate a greater volume of sales and to support any new customers or the expanding needs of existing customers. The employment market for sales, marketing, customer service and support personnel in our industry is very competitive, and we may not be able to hire the kind and number of sales, marketing, customer service and support personnel we are targeting. Our inability to hire or outsource qualified sales, marketing, customer service and support personnel may harm our business, operating results and financial condition. We may not be able to sufficiently build out our distribution network or enter into arrangements with qualified sales personnel on acceptable terms or at all. If we are not able to develop greater distribution capacity, we may not be able to generate sufficient revenue to continue our operations. 

 

If we fail to protect or enforce our intellectual property rights, or if the costs involved in protecting and defending these rights are prohibitively high, our business and operating results may suffer. 

 

Our patent rights, trade secrets, copyrights, trademarks, domain names and other product rights are critical to our success. We strive to protect our intellectual property rights by relying on federal, state and common law rights, as well as contractual restrictions. We may enter into confidentiality and invention assignment agreements with our employees and confidentiality agreements with parties with whom we conduct business to limit access to, and disclosure and use of, our proprietary information. However, these contractual arrangements and the other steps we have taken to protect our intellectual property may not prevent the misappropriation of our proprietary information or deter independent development of similar technologies by others.

 

 14 

 

As management deems appropriate, we will pursue the registration of our domain names, trademarks, and service marks in the U.S. and in certain locations outside the U.S. We will seek to protect our trademarks, patents and domain names in an increasing number of jurisdictions, a process that is expensive and time-consuming and may not be successful or which we may not pursue in every location. It may be expensive and cost prohibitive to file patents worldwide and we may be financially required to file patents in select countries where we see the greatest potential for our technologies. We may, over time, increase our investment in protecting our innovations through increased patent filings that are expensive and time-consuming and may not result in issued patents that can be effectively enforced.

 

If we are required to sue third parties who we allege are violating our intellectual property rights, or if we are sued for violating a third party’s patents or other intellectual property rights, we may incur substantial expenses, and we could incur substantial damages, including amounts we cannot afford to pay. 

 

Litigation may be necessary to enforce our intellectual property rights, protect our trade secrets or determine the validity and scope of proprietary rights claimed by others. Patent and intellectual property litigation is extremely expensive and beyond our ability to pay. While third parties do, under certain circumstances, finance litigation for companies that file suit, we cannot assure you that we could find a third party to finance any claim we choose to pursue. Moreover, third parties frequently refuse to finance companies that are sued. Any litigation of this nature, regardless of outcome or merit, could result in substantial costs, adverse publicity or diversion of management and technical resources, any of which could adversely affect our business and operating results. If we fail to maintain, protect and enforce our intellectual property rights, our business and operating results may be harmed.

 

From time-to-time, we may face allegations that we have infringed the trademarks, copyrights, patents and other intellectual property rights of third parties, including from our competitors and inactive entities. Patent and other intellectual property litigation may be protracted and expensive, and the results are difficult to predict. As the result of any court judgment or settlement, we may be obligated to cancel the launch of a new feature or product, stop offering certain features or products, pay royalties or significant settlement costs, purchase licenses or modify our products and features. 

 

If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired. 

 

As a public company, we are subject to the reporting requirements of the Exchange Act and the Sarbanes-Oxley Act of 2002 (“SOX”). We expect that the requirements of these rules and regulations will continue to increase our legal, accounting, and financial compliance costs, make some activities more difficult, time-consuming and costly, and place significant strain on our personnel, systems, and resources.

 

SOX requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we will file with SEC is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight. 

 

Our management concluded that our disclosure controls and procedures were effective as of December 31, 2022, and the remediated material weaknesses in our internal control over financial reporting identified in Item 9A of the Report covering the year ended December 31, 2021 have been remediated. Any failure to develop or maintain effective controls or any difficulties encountered in their implementation or improvement could harm our results of operations or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we will eventually be required to include in our periodic reports that will be filed with the SEC.

 

Material weaknesses in our disclosure controls and internal control over financial reporting may be identified in the future.  Any failure to maintain existing or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in additional material weaknesses, cause us to fail to meet our periodic reporting obligations or result in material misstatements in our financial statements. If we are unable to effectively remediate material weaknesses in a timely manner, investors could lose confidence in the accuracy and completeness of our financial reports, which could have an adverse effect on our stock price.

 

 15 

 

Because we do business outside of the United States, we may be exposed to liabilities under the Foreign Corrupt Practices Act, violations of which could have a material adverse effect on our business.

 

We are subject to the Foreign Corrupt Practice Act, or FCPA, and other laws that prohibit improper payments or offers of payments to foreign governments and their officials and political parties by U.S. persons and issuers as defined by the statute for the purpose of obtaining or retaining business. We have operations and agreements with third parties and make sales in jurisdictions which may be subject to corruption. These activities create the risk of unauthorized payments or offers of payments by one of the employees, consultants or agents of our Company, because these parties are not always subject to our control. It is our policy to implement safeguards to discourage these practices by our employees. However, our existing safeguards and any future improvements may prove to be less than effective, and the employees, consultants, sales agents or distributors of our company may engage in conduct for which we might be held responsible. Violations of the FCPA may result in severe criminal or civil sanctions, and we may be subject to other liabilities, which could negatively affect our business, operating results and financial condition.

 

Our business depends on our ability to successfully develop, implement, maintain, upgrade, enhance, protect and integrate information technology systems.

 

We rely heavily on the proper functioning and availability of our information technology systems for our operations as well as for providing value-added services to our customers. Our information systems are integral to the efficient operation of our business. We strive to be best in class, and in order to do so, we must correctly interpret and address market trends and enhance the features and functionality of our technology platform in response to these trends, which may lead to significant ongoing software development costs and capital investments in information technology infrastructure. We may be unable to accurately determine the needs of our customers and integrate cohesively with our key strategic partner, and identify the trends in the transportation services industry, in a timely and cost-effective manner, which could result in decreased demand for our services and a corresponding decrease in our revenues. Despite testing, external and internal risks, such as malware, insecure coding, “Acts of God,” data leakage and human error pose a direct threat to our information technology systems and operations. We may also be subject to cybersecurity attacks and other intentional hacking. Any failure to identify and address such defects or errors or prevent a cyber-attack could result in service interruptions, operational difficulties, loss of revenues or market share, liability to customers or others, diversion of resources, injury to our reputation and increased service and maintenance costs. Addressing such issues could prove to be impossible or very costly and responding to resulting claims or liability could similarly involve substantial cost. We must maintain and enhance the reliability and speed of our information technology systems to remain competitive and effectively handle higher volumes of shipments. If our information technology systems are unable to manage additional volume for our operations as our business grows, or if such systems are not suited to manage the various service modes we offer or businesses we acquire, our service levels and operating efficiency could decline. If we fail to hire and retain qualified personnel to implement, protect and maintain our information technology systems or if we fail to upgrade our systems to meet our customers’ and strategic operating partners’ demands, our business and results of operations could be seriously harmed. This could result in a loss of customers or a decline in the volume of shipments we receive from customers.

 

Our information technology systems also depend upon the Internet, third-party service providers, global communications providers, satellite-based communications systems, the electric utilities grid, electric utility providers and telecommunications providers as well as their respective vendors. The services and service providers have all experienced significant system failures and outages at some point in the past. We have minimal control over the operation, quality, or maintenance of these services or whether vendors will improve their services or continue to provide services that are essential to our business. Disruptions due to transitional challenges in upgrading or enhancing our technology systems; failures in the services upon which our information technology platforms rely, including those that may arise from adverse weather conditions or natural calamities, such as floods, hurricanes, earthquakes or tornadoes; illegal acts, including terrorist attacks; human error or systems modernization initiatives; and/or other disruptions, may adversely affect our business, which could increase our costs or result in a loss of customers that could have a material adverse effect on our results of operations and financial position.

 

Our information technology systems are subject to cyber and other risks some of which are beyond our control. A security breach, failure or disruption of these services could have a material adverse effect on our business, results of operations and financial position.

 

Our information systems are integral to the efficient operation of our business and handle sensitive customer and shipment data. It is critical that the data processed by these systems remain secure, as it often includes competitive customer information, confidential transaction data, employee records and key financial and operational results and statistics. The sophistication of efforts by hackers, foreign governments, cyber-terrorists, and cyber-criminals, acting individually or in coordinated groups, to launch distributed denial of service attacks, ransomware or other coordinated attacks that may cause service outages, gain inappropriate or block legitimate access to systems or information, or result in other business interruptions has continued to increase in recent years. We utilize third-party service providers who have access to our systems and certain sensitive data, which exposes us to additional security risks, particularly given the complex and evolving laws and regulations regarding privacy and data protection. While we and our third-party service providers have experienced cyber-attacks and attempted breaches of our and their information technology systems and networks or similar events from time to time, no such incidents have been, individually or in the aggregate, material to us. Cyber incidents that impact the security, availability, reliability, speed, accuracy or other proper functioning of our systems, information and measures, including outages, computer viruses, theft or misuse by third parties or insiders, break-ins and similar disruptions, could have a significant adverse impact on our operations.

 

 16 

 

It is difficult to fully protect against the possibility of power loss, telecommunications failures, cyber-attacks, ransomware and other cyber incidents in every potential circumstance that may arise. A significant cyber incident, including system failure, security breach, disruption by malware or ransomware, or other damage, could interrupt or delay our operations, damage our reputation and brand, cause a loss of customers, expose us to a risk of loss or litigation, result in regulatory scrutiny, investigations, actions, fines or penalties and/or cause us to incur significant time and expense to remedy such an event, any of which could have a material adverse impact on our results of operations and financial position. Furthermore, any failure to comply with data privacy, biometric privacy, data security or other laws and regulations could result in claims, legal or regulatory proceedings, inquiries or investigations. To comply with this changing landscape, we may be required to further segregate our systems and operations, implement additional controls, or adopt new systems, all of which could increase the cost and complexity of our operations. In addition, our insurance is intended to address costs associated with aspects of cyber incidents, network failures and privacy-related concerns, may not sufficiently cover all types of losses or claims that may arise.

 

Evolving regulations concerning data privacy may result in increased regulation and different industry standards, which could prevent us from providing our current products to our users, or require us to modify our products, thereby harming our business. 

 

The regulatory framework for privacy issues worldwide is currently in flux and is likely to remain so for the foreseeable future. Practices regarding the collection, use, storage, transmission and security of personal information by companies operating over the Internet and mobile platforms have recently come under increased public scrutiny, and civil claims alleging liability for the breach of data privacy have been asserted against companies. The U.S. government, including the Federal Trade Commission and the Department of Commerce, has announced that it is reviewing the need for greater regulation for the collection of information concerning consumer behavior on the Internet, including regulation aimed at restricting certain targeted advertising practices.

 

Many jurisdictions have already taken steps to restrict and penalize companies that collect and utilize information from their users and the general public. For example, in May 2018 the European Union made sweeping reforms to its existing data protection legal framework by enacting the General Data Protection Regulation (the “GDPR”), which resulted in a greater compliance burden for many companies with users in Europe. The GDPR includes operational requirements for companies that receive or process personal data of residents of the European Union that are broader and more stringent than those previously in place in the European Union and in most other jurisdictions around the world. The GDPR also imposes significant penalties for non-compliance, including fines of up to €20 million or 4% of total worldwide revenue.

 

Additionally, we may be subject to increasingly complex and expansive data privacy regulations within the United States. For example, California enacted the California Consumer Privacy Act (the “CCPA”), which became effective in 2020. The CCPA requires covered companies to provide California consumers with disclosures and expands the rights afforded consumers regarding their data. Fines for noncompliance of the CCPA can be as high as $8 thousand per violation. Since the CCPA was enacted, Nevada and Maine have enacted similar legislation designed to protect the personal information of consumers and penalize companies that fail to comply, and other states have proposed similar legislation. The costs of compliance with, and other burdens imposed by, the GDPR, CCPA, and similar laws may limit the use and adoption of our products and services and/or require us to incur substantial compliance costs, which could have a material adverse impact on our business.

 

We rely on the services of third-party data center hosting facilities. Interruptions or delays in those services could impair the delivery of our service and harm our business.

 

We utilize cloud computing technology. It is hosted pursuant to agreements on technology platforms by third-party service providers. We do not control the operation of these providers or their facilities, and the facilities are vulnerable to damage, interruption or misconduct. Unanticipated problems at these facilities could result in lengthy interruptions in our services. If the services of one or more of these providers are terminated, disrupted, interrupted or suspended for any reason, we could experience disruption in our ability to provide our services, which may harm our business and reputation. Further, any damage to, or failure of, the cloud services we use could result in interruptions in our services. Interruptions in our service may damage our reputation, reduce our revenue, cause customers to terminate their agreements and adversely affect our ability to attract new customers. While we believe our strong partnerships reduce our risk, our business would be harmed if our customers and potential customers believe our services are unreliable. Additionally, if our service providers fail to meet their obligations, provide poor, inaccurate or untimely service, or we are unable to make alternative arrangements for these services, we may fail, in turn, to provide our services or to meet our obligations to our users, and our business, financial condition and operating results could be materially and adversely affected.

 

 17 

 

Fluctuations in labor costs, raw materials, changes in the availability of key suppliers, or catastrophic events may increase the cost of our products and services.

 

Increases in labor costs might be difficult to pass on to our customers. In our VerifyMe Solutions segment, security pigments, ink canisters, labels and bar codes are key elements in the cost of our products. Our inability to offset material price inflation could adversely affect our results of operations. We rely on one global carrier for transportation services, one supplier to procure our raw materials, one strategic partner to produce our ink canisters, and it is difficult to predict what effects shortages or price increases for the raw materials we use to make our products may have in the future. Our ability to manage inventory and meet delivery requirements may be constrained by our supplier’s inability to scale production and adjust delivery during times of volatile demand. Our inability to fill our supply needs would jeopardize our ability to fulfill obligations under current contracts or enter new contracts to sell our products, which would, in turn, result in reduced sales and profits, contract penalties or terminations, and damage to customer relationships.

 

Our ability to become profitable is largely dependent upon our ability to continually improve our platforms and acquiring new customers in increasingly competitive markets.

 

Our ability to become profitable depends upon a number of factors, including our ability to (i) identify and evolve with emerging technological and broader industry trends, (ii) develop and maintain competitive products, (iii) defend our market share against an ever-expanding number of competitors including many new and non-traditional competitors, (iv) enhance our products by adding innovative features that differentiate our products from those of our competitors and prevent commoditization of our products, (v) develop, manufacture and bring compelling new products to market quickly and cost-effectively, (vi) monitor disruptive technologies and business models, (vii) achieve sufficient return on investment for new products introduced based on capital expenditures and research and development spending, (viii) respond to changes in overall trends related to end market demand, (ix) leverage our strategic partnerships to develop and commercialize new and existing products and (x) attract, develop and retain individuals with the requisite skill, expertise and understanding of customers’ needs to develop new technologies and introduce new products and sell our current products. The failure of our technologies or products to gain market acceptance due to more attractive offerings by our competitors or the failure to address any of the above factors could significantly reduce our revenues and adversely affect our competitive standing and prospects.

 

The expenses or losses associated with lack of widespread market acceptance of our solutions may harm our business, operating results and financial condition.

 

Rapid technological changes and frequent new product introductions are typical in the markets we serve. Our future success will depend in part on continuous, timely development and introduction of new products that address evolving market requirements. To the extent we fail to introduce new and innovative products, we may lose any market share we have to our competitors, which may be difficult or impossible to regain. Any inability, for technological or other reasons, to successfully develop and introduce new products could harm our business. Additionally, we may experience delays in the development and introduction of products, we may be unable keep pace with the rapid rate of change in anti-counterfeiting and security products’ research, and any new products acquired or developed by us may not meet the requirements of the marketplace or achieve market acceptance. If we are unable to develop new products to meet market demands, our business could be materially adversely affected.

 

As a company with revenues deriving from clients in the cannabis industry, we face many unique and evolving risks.

 

We currently derive approximately 5% of revenues from clients in the cannabis industry from use of our track and trace and customer engagement technologies. As such, any risks related to the cannabis industry may adversely impact our clients, and potential clients, which may in turn, impact the demand for our products and services. Specific risks impacting the cannabis industry include, but are not limited, to the following:

 

United States federal law prohibits Marijuana

 

Under the Controlled Substances Act (“CSA”), marijuana is a Schedule-I controlled substance making it illegal under federal law to grow, cultivate, distribute, sell or possess marijuana for any purpose or to assist or conspire with those who do so. Although the use of marijuana is legal in certain states under state law, since federal law supersedes state law, strict enforcement of federal law would likely result in adverse effects on our clients’ operations, which would in turn, adversely impact our revenues.

 

 18 

 

Banking regulations could limit access to banking services and expose us to risk

 

Funds received from our clients in the cannabis industry, operating legally under state law, may subject us to a variety of federal laws and regulations involving money laundering, financial record keeping and proceeds of crime, since the funds are considered illegal under the CSA and as such banks and other financial institutions providing services to us risk violation of anti money laundering statutes and other applicable statutes. Furthermore, banks often refuse to provide banking services to businesses involved in the cannabis industry due to the federal and state laws and regulations governing financial institutions. The difficulty and potential inability to open bank accounts that our clients in the cannabis industry deal with, makes it difficult to conduct business and as such could affect our ability to collect revenues earned. Furthermore, our clients in this industry are more susceptible to theft, and potentially lack the ability to insure themselves against theft. We may experience similar difficulties in obtaining banking and financial services because of the activities of our clients in the cannabis industry.

 

The legality of cannabis could be reversed in one or more states

 

The voters or legislatures of states in which marijuana has already been legalized could potentially repeal applicable laws that permit the operation of both medical and retail marijuana businesses. These actions might force businesses, including those that are our clients, to cease operations in one or more states entirely. Additionally, these actions could negatively impact us and lead to a decrease of our revenue through the loss of current and potential customers.

 

Recent and changing interpretations of the law regarding medical and recreational use of marijuana

 

State laws and regulations surrounding medical and recreational use of marijuana are fairly recent and constantly changing resulting in a potential challenge to maintain compliance. As such, violations of these laws, or allegations of such violations, could be disruptive to our clients’ business and in return cause a disruption in our operations. Future modifications of state and local laws surrounding marijuana, may limit operations of our clients’ business in this industry, which could negatively impact our revenues.

 

Dependence on client licensing

 

Our clients in the cannabis industry must obtain various licenses from various local and state licensing agencies. As such, there is a risk that our existing clients will not be able to retain their licenses going forward, should they violate applicable rules and regulations, or should renewal become more stringent. If our customers are not able to maintain or renew their licenses, this would adversely impact our operations.

 

Insurance Risk

 

Insurance companies may limit policies to only cover claims legal under federal law. As such our clients in the cannabis industry may not be properly insured. Any claims against our clients may have a negative impact on our ability to collect revenues from our clients in the cannabis sector.

 

Risks Relating to our Common Stock 

 

Upon exercise of our outstanding options or warrants, conversion of our Series B Convertible Preferred Stock and vesting of our restricted stock units, we will be obligated to issue a substantial number of additional shares of common stock which will dilute our present shareholders. 

 

We are obligated to issue additional shares of our common stock in connection with our outstanding options, warrants and shares of our Series B Convertible Preferred Stock. As of December 31, 2022, there were options, warrants, shares of Series B Convertible Stock outstanding, and restricted stock units convertible into 337,471; 5,103,455; 144,444; and 413,626 shares of common stock, respectively. The exercise, conversion or exchange of warrants or convertible securities, including for other securities, will cause us to issue additional shares of our common stock and will dilute the percentage ownership of our shareholders. In addition, we have in the past, and may in the future, exchange outstanding securities for other securities on terms that are dilutive to the securities held by other shareholders not participating in such exchange.

 

Offers or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline. Sales of large blocks of our common stock over a short time in the spring of 2022 had a significant adverse effect on our common stock price. Further sales could depress the price of our common stock. The existence of these shares and shares of common stock issuable upon conversion of outstanding shares of Series B Convertible Preferred Stock, warrants and options create a circumstance commonly referred to as an “overhang” which can act as a depressant to our common stock price. The existence of an overhang, whether or not sales have occurred or are occurring, also could make our ability to raise additional financing through the sale of equity or equity-linked securities more difficult in the future at a time and price that we deem reasonable or appropriate. If our existing shareholders and investors seek to sell a substantial number of shares of our common stock, such selling efforts may cause significant declines in the market price of our common stock.

 

 19 

 

Our common stock may be affected by limited trading volume and price fluctuations, which could adversely impact the value of our common stock. Our common stock has experienced, and is likely to experience in the future, significant price and volume fluctuations, which could adversely affect the market price of our common stock without regard to our operating performance. In addition, we believe that factors such as quarterly fluctuations in our financial results and changes in the overall economy or the condition of the financial markets could cause the price of our common stock to fluctuate substantially. These fluctuations may also cause short sellers to periodically enter the market in the belief that we will have poor results in the future. We cannot predict the actions of market participants and, therefore, can offer no assurances that the market for our common stock will be stable or appreciate over time.

 

Because we may issue preferred stock without the approval of our shareholders and have other anti-takeover defenses, it may be more difficult for a third party to acquire us and could depress our stock price. In general, our Board of Directors may issue, without a vote of our shareholders, one or more additional series of preferred stock that have more than one vote per share, although the Company’s ability to designate and issue preferred stock is currently restricted by covenants under our agreements with prior investors. Without these restrictions, our Board of Directors could issue preferred stock to investors who support us and our management and give effective control of our business to our management. Additionally, issuance of preferred stock could block an acquisition resulting in both a drop in our stock price and a decline in interest of our common stock. This could make it more difficult for shareholders to sell their common stock. This could also cause the market price of our common stock shares to drop significantly, even if our business is performing well.

 

Because we do not intend to pay cash dividends on our shares of common stock, any returns will be limited to the value of our shares. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any return to shareholders will therefore be limited to the increase, if any, of our share price.

 

There can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Capital Market, a failure of which could result in a de-listing of our common stock and certain warrants. The Nasdaq Capital Market requires that the trading price of its listed stocks remain above one dollar in order for the stock to remain listed. If a listed stock trades below one dollar for more than 30 consecutive trading days, then it is subject to delisting from the Nasdaq Capital Market. In addition, to maintain a listing on the Nasdaq Capital Market, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, and certain corporate governance requirements. If we are unable to satisfy these requirements or standards, we could be subject to delisting, which would have a negative effect on the price of our common stock and warrants and would impair your ability to sell or purchase our common stock or warrants when you wish to do so. In the event of a delisting, we would expect to take actions to restore our compliance with the listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock or warrants to become listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the minimum bid price requirement, or prevent future non-compliance with the listing requirements.

 

 

Provisions of our publicly traded warrants could discourage an acquisition of us by a third party. In addition to certain provisions of our amended and restated articles of incorporation, as amended, and our amended and restated by-laws, certain provisions of our outstanding warrants could make it more difficult or expensive for a third party to acquire us. The warrants prohibit us from engaging in certain transactions constituting “fundamental transactions” unless, among other things, the surviving entity assumes our obligations under the warrants. These and other provisions of the warrants could prevent or deter a third party from acquiring us even where the acquisition could be beneficial to you.

 

Risks Related to our Debt

 

If we do not timely pay amounts due and comply with the covenants under our debt facilities, our business, financial condition and results of operations may be adversely impacted.

 

Our consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Term Note, among other things, requires high interest payments, and both the Term Note and the PNC Facility place encumbrances on our assets, and subject us to restrictive covenants that limit our operating flexibility. Additionally, under the terms of the Term Note, the Company is required to make monthly loan principal payments of $41,667 per month plus interest, through September 15, 2026.

 

 20 

 

The terms of the Term Note and the PNC Facility have been structured in such a way that, if we default under one, we will also default under the other. In the event of a continuing default, our senior secured lenders would have the right to accelerate the then-outstanding amounts under each such facility and to exercise their respective rights and remedies to collect such amounts, which would include foreclosing on collateral constituting substantially all of our assets and the assets of our PeriShip Global subsidiary. Any continuing default on the Term Note or the PNC Facility could result in the outstanding principal balance under each such facility becoming immediately due and payable, which could harm our business, financial condition and results of operations and may have a material adverse impact on our business.

 

Our cash flows and operating results could be adversely affected by required payments of debt or related interest and other risks of our debt financing.

 

We are generally subject to risks associated with debt financing. These risks include: (1) our cash flow may not be sufficient to satisfy required payments of principal and interest; (2) we may not be able to refinance existing indebtedness or the terms of any refinancing may be less favorable to us than the terms of existing debt; (3) debt service obligations could reduce funds available for other uses such as growing our business; (4) any default on our indebtedness could result in acceleration of those obligations and possible loss of assets or capital; and (5) the risk that necessary capital expenditures cannot be financed on favorable terms. Any of these risks could place strains on our cash flows, reduce our ability to grow, and adversely affect our results of operations.

 

Covenants in our debt agreements may restrict our operating activities and adversely affect our financial condition.

 

Our existing debt agreements contain, and future debt agreements may contain, financial and/or operating covenants including, among other things, certain coverage ratios, as well as limitations on the ability to incur additional secured and unsecured debt, and/or otherwise affect our distribution and operating policies. These covenants may limit our operational flexibility and acquisition and disposition activities. Moreover, if any of the covenants in these debt agreements are breached and not cured within the applicable cure period, we could be required to repay the debt immediately, even in the absence of a payment default. A default under one of our debt agreements could result in a cross-default under other debt agreements, and our lenders could elect to declare outstanding amounts due and payable, terminate their commitments, require the posting of additional collateral, and enforce their respective interests against existing collateral. The terms of the Term Note and the PNC Facility have been structured in such a way that, if we default under one, we will also default under the other. In the event of a continuing default, our senior secured lenders would have the right to accelerate the then-outstanding amounts under each such facility and to exercise their respective rights and remedies to collect such amounts, which would include foreclosing on collateral constituting substantially all of our assets and the assets of our PeriShip Global subsidiary As a result, a default under applicable debt covenants could have an adverse effect on our financial condition or results of operations. These covenants may restrict our ability to engage in transactions that we believe would otherwise be in the best interests of our stockholders.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

None.

 

ITEM 2. PROPERTIES.

 

We do not own any significant real property, but our subsidiary leases approximately 5,000 square feet of primarily office space in Connecticut used in connection with our PeriShip Solutions segment. The lease expires in 2027. We believe that our property has been well maintained, is suitable and adequate for us to operate and upon expiration of this lease, we do not anticipate any difficulty in obtaining renewals or alternative space.

 

ITEM 3. LEGAL PROCEEDINGS.

 

From time-to-time, we may be a party to, or otherwise involved in, legal proceedings arising in the ordinary course of business. As of the date of this Report, we are not aware of any proceedings, threatened or pending, against us which, if determined adversely, would have a material effect on our business, results of operations, cash flows or financial position.

  

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

 21 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Our common stock, par value $0.001 per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market under the trading symbols “VRME” and “VRMEW,” respectively.

 

Common Shareholders

 

As of March 16, 2023, we had approximately 1,440 shareholders of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of shareholders, this number is not indicative of the total number of shareholders represented by these shareholders of record.

 

Dividends

 

We have never declared or paid a cash dividend. At this time, we do not anticipate paying dividends in the foreseeable future. The declaration and payment of dividends is subject to the discretion of Board and will depend upon our earnings (if any), our financial condition, and our capital requirements. Nevada law permits a corporation to pay dividends out of earnings or surplus. Accordingly, we cannot pay dividends as a matter of law.

 

Use of Proceeds

 

On June 17, 2020, our Registration Statement on Form S-1 (File No. 333-234155), as amended (the “Registration Statement”) relating to an underwritten public offering of an aggregate of 2,173,913 units consisting of one share of the Company’s common stock and a warrant to purchase one share of common stock at an exercise price equal to $4.60 per share of common stock was declared effective by the SEC. The cash proceeds from the offering were $9,023 thousand, net of underwriting discounts and commissions of approximately $800 thousand and fees and expenses of approximately $450 thousand. All proceeds from the offering have been utilized and there were no material changes in our use of the net proceeds from the offering, as described in our final prospectus filed with the SEC on June 19, 2020.

 

 Share Repurchase Plan

 

The following table provides information about our share repurchase activity for the three months ended December 31, 2022

 

ISSUER PURCHASES OF EQUITY SECURITIES

 

Period   Total Number
of Shares
(or Units) Purchased		     Average Price Paid per
Share (or Units)		     Total Number
of Shares
Purchased as Part of
Publicly Announced
Plans
or Programs(1)		     Approximate Dollar
Value of Shares that
May Yet Be Purchased
Under the Plans
or Programs(1)
(In thousands)		  
10/01/2022-10/31/2022     -       -       -     $ 1,390  
11/01/2022-11/30/2022     28,201       1.36       28,201       1,353  
12/01/2022-12/31/2022     56,175       1.21       56,175       1,285  
Total     84,376       1.26       84,376     $ 1,285  

 

(1) Effective July 1, 2022, the Company’s Board of Directors terminated the existing share repurchase program and approved a new share repurchase program to replace the existing program due to expire in August 2022 to allow the Company to spend up to $1.5 million to repurchase shares of its common stock, so long as the price does not exceed $5.00 until July 1, 2023. During the three months ended December 31, 2022, the Company repurchased 84,376 shares of common stock under the Company’s current program.

 

ITEM 6. [RESERVED.]

   

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operation and other parts of this Report contain forward-looking statements that involve risks and uncertainties. All forward-looking statements included in this Report are based on information available to us on the date hereof, and except as required by law, we assume no obligation to update any such forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors. The following should be read in conjunction with our annual financial statements contained elsewhere in this Report.

 

 22 

 

Overview

 

VerifyMe, Inc. (“VerifyMe”) together with its subsidiaries PeriShip Global, LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”), is a software driven predictive analytics logistics provider of high-touch end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. Further information regarding our business segments is discussed below:

  

PeriShip Global Solutions: The PeriShip Global Solutions segment specializes in predictive analytics through its proprietary software platform for optimizing delivery of time and temperature sensitive perishable products. We manage complex industry-specific shipping logistic processes that require critical time, temperature control and handling to prevent spoilage and extended delivery times. Utilizing predictive analytics from multiple data sources including weather, traffic, flight data, major carrier feeds, and time of day data, we provide our clients an end-to-end vertical approach for their most critical service delivery needs. Using the IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries.

 

Through our proprietary PeriTrack ® customer dashboard, we provide an integrated tool that gives our customers an in-depth look at their shipping activities and allows them access to critical information in support of the specific needs of the supply chain stakeholders. In addition, we provide proactive alerts to address on-coming weather issues to make changes in scheduling to meet critical deadlines for shipments. We offer post-delivery services such as customized reporting for trend analysis, system performance reports, power outage maps, and other tailored reports.

 

PeriShip Global generates revenue from three business service models.

 

· Proactive Service – PeriShip Global clients pay us directly for carrier service coupled with our proactive logistics assistance.
· Direct Premium Service –PeriShip Global clients pay us directly for carrier service coupled with our complete white-glove shipping monitoring and predictive analytics service. This service includes the customer web portal access, weather monitoring, temperature control, full call center support and last mile resolution.
· Indirect Premium Service – Our carrier partner also offers a “white label” version of our Premium Service to its customers and pays us a fixed contractual fee.

 

PeriShip Service Products: The PeriShip Global Solutions segment includes the following bundled services as part of our service offerings to our customers:

 

· PeriTrack ®: Our proprietary PeriTrack® customer dashboard was developed utilizing our extensive logistics operational knowledge. This integrated web portal tool gives our customers an in-depth look at their shipping activities and alerts based on real-time data. The PeriTrack® dashboard was designed to provide critical information in support of the specific needs of supply chain stakeholders and gives our customer resolution specialists a 360° view of shipping activity. PeriTrack® features tools tailored for shippers of perishable goods, which includes the In-Transit Shipment Tracker. This tool provides details on the unique shipper’s in-transit shipments, with the ability to select and analyze data on individual shipments.

 

· Call Center Service: PeriShip Global has assembled a team of customer resolution specialists based in the U.S. This human intervention service team resolves shipping problems on behalf of our customers. The call center acts as a help desk and monitors shipping to delivery for our customers.

 

· Pre-Transit Service: PeriShip Global helps clients prepare their products for shipments by advising clients on packaging requirements for various types of perishable products. Each product type requires its own particular packaging to protect it during the shipment, and we utilize our extensive knowledge and research to provide our customers with packaging recommendations to meet their unique needs.

 

 23 

 

· Post-Delivery: PeriShip Global provides customized reporting for trend analysis, system performance reports, power outage maps, and many other reports to help our customers improve their processes and customer service outcomes.

 

· Weather/Traffic Service: PeriShip Global has full-time meteorologists on staff to monitor weather. A package may experience a variety of weather conditions between the origin and destination, and our team actively monitors these conditions to minimize the changes of timely and safe transit of shipments. Similarly, traffic and construction also create unpredictable delays which our team works diligently to mitigate. If delays or other issues occur the PeriShip team informs clients and works with them to pro-actively resolve such shipment issues.

 

VerifyMe Solutions: The VerifyMe Solutions segment specializes in traceability to connect brands with consumers through their product. Through VerifyMe technologies brand inspectors can authenticate product with visible and invisible unique to product serialized codes. Brand owners have the ability to gather business intelligence while engaging directly with their consumers and can receive programmable alerts related to counterfeit products or if their products are in unexpected geographical markets. Consumers can authenticate products with their smart phone prior to usage and engage with the brand in unique and innovative ways. Engagement can come in many forms such as free giveaways, product specifications, seed to table tracking, cross-selling of products, contests, videos, and recipes.

 

VerifyMe Products: VerifyMe has a custom suite of products that offer clients traceability and consumer engagement. These products are combined with “software as a service” or “SAAS” which is stored in the cloud and accessed through the internet.

 

· VerifyMe Engage™ for consumer engagement allowing the brand owner to gather business intelligence and engage with their customers
· VerifyMe Authenticate™ using rare earth-based ink taggants for instant authentication of labels, packages and products
· VerifyMe Track & Trace™ for unit level traceability and supply chain control

 

PeriShip Global and VerifyMe Synergies:

 

We believe that PeriShip Global and our VerifyMe solutions have synergistic product centric technology platforms and combined have a compelling technology offering for brand owners. For example, currently PeriShip Global ships vaccines for major pharmaceutical companies. With the addition of VerifyMe technology, PeriShip Global can add unit level traceability and authentication to protect clients’ vaccines from product diversion and sub-standard counterfeits. In addition, VerifyMe’s consumer engagement solutions could give PeriShip Global food and beverage clients the ability to gather rich business intelligence, turn “unknown consumers” into “known consumers” and build customer loyalty with engagement functions like videos, discounts, contests, etc.

 

PeriShip Global Opportunities

 

According to a 2023 report entitled, “Perishable Goods Transportation Market in the US 2023-2027”, written by Infiniti research Limited, the Perishable Goods logistics market size was $4.0 billion in 2022 and is estimated to be $4.3 billion in 2023 and is expected to grow to $5.9 billion by 2027. That represents a compound average market acceleration with a growth rate of approximately 8% per year.

 

This report is based on perishable product segments including meat, poultry, seafood, dairy, fruits and vegetables, and bakery and confectionary. PeriShip Global services all of these product segments

 

Currently most shipping businesses utilize the carrier’s data platform for tracking which generally informs the shipping enterprise, and their customers, when a package is in transit, when a package has been delivered, and some level of detail of the path which a package traveled. We believe taking the data feeds from a carrier and adding real-time visibility with predictive analytics and the human intervention factor of PeriShip Global’s call center gives us a major competitive advantage against other third-party platforms that solely rely on the carrier’s data feeds. PeriShip Global utilizes a variety of input sources beyond just the carrier’s data feed. PeriShip Global’s proprietary “Predictive Analytics” technology is fed real-time meteorology data, traffic and road construction data, and power grid information to help predict issues before they happen. If an alert is created the shipper and our call center will work to address the issue and save the perishable product from spoiling, saving the shipper significant costs and reducing the need to replace products that are no longer viable. PeriShip Global has two meteorologists on staff that track world-wide weather patterns to address predicted issues before they happen. We believe the Pharmaceutical and healthcare industries represent the biggest areas of opportunity and we are focusing our PeriShip Global sales emphasis on those industries. In addition, we feel that combining VerifyMe’s solutions into the product offering for PeriShip Global clientele, including food and beverage and healthcare industries, gives PeriShip Global a competitive advantage to generate revenue by enhancing PeriShip Global’s clients’ ability to grow revenue, gain business intelligence and build brand loyalty.

 

 24 

 

The current global logistics industry worldwide is facing an economic slowdown. We believe this represents an opportunity for PeriShip Global since major global carriers are cutting internal staff and are reducing research and development investments. To maintain their credibility in the market, these carriers will need to ensure they meet their customers’ demands for time and temperature sensitive shipments, while maintaining their overheads. We believe outsourcing this function to PeriShip Global provides the ideal solution for all parties involved.

 

Building logistics infrastructure is a capital-intensive process as the investment is locked in for a considerably long period. Due to the current economic downturn, we believe several companies will opt to outsource their logistics services to reduce their operational costs and maintain cash flows. The outsourcing of supply chain related and other logistics operations to service providers such as PeriShip Global which allows companies to improve the efficiency of their businessed by focusing their resources on core competencies.

 

VerifyMe Opportunities

 

We believe VerifyMe’s products have applications in many areas. Currently, we are aggressively marketing opportunities in the following areas:

 

· Food and Beverage – Food safety is becoming more common as supply chains become more global and as imaging and manufacturing technology become more accessible. Food traceability, sustainability and carbon neutral production is becoming a significant consideration for brand and governments. We believe our unit level traceability and authentication solutions can help brands tell their story about sustainability and battle against tainted or substandard foods and beverages.
· Pharmaceuticals/nutraceuticals – We believe counterfeit prescription pharmaceuticals and nutraceuticals are a growing problem, widely recognized as a public health risk and a serious concern to public health officials, private companies, and consumers. Counterfeiting can apply to both branded and generic products and counterfeit pharmaceuticals may include products with the correct ingredients but fake packaging, with the wrong ingredients, without active ingredients or with insufficient active ingredients. The United States enacted legislation requiring the implementation of a comprehensive system designed to combat counterfeit, diluted or falsely labelled pharmaceuticals, referred to as serialization or electronic pedigree (e-Pedigree). Our consumer facing visible codes and unique pigments embedded in the ink of a unique serialized barcode can provide a layered security foundation for a customer solution in this market. We are seeking to expand our business in this market and believe that as additional pharmaceutical companies seek to comply with the legislation, our products will provide attractive alternatives to address the need for product identifiers.
· Consumer Products –We believe our technology solutions are particularly suited for the cosmetics, health and beauty and apparel industries. We give the consumer the ability to test a product’s authenticity instantly with a smartphone. We can protect brand owners from liability litigation, product diversion and lost financial sales with our consumer facing visible codes and unique ink pigments which can be incorporated in dyes and used by manufacturers in these industries to combat counterfeiting and piracy of actual physical goods. Our pigments expressed as inks can also be used on packaging, as well as to track products that have been lost in transit, whether misplaced or stolen.

 

In addition, in each of these markets, our SaaS software allows brand owners and consumers to track the products and will alert the consumer or brand owner of product diversion with 24/7 monitoring. As each product has a unique code, this allows consumers and brand owners to authenticate the product in real time and link directly to the brand owner’s website for additional product information, discounts, and more.

 

Results of Operations

 

Comparison of the Years Ended December 31, 2022, and 2021

 

The following discussion analyzes our results of operations for the years ended December 31, 2022, and 2021. The following information should be considered together with our financial statements for such periods and the accompanying notes thereto.

 

Revenue

 

    Twelve Months Ended
December 31,		  
    2022     2021  
    (In thousands)     (In thousands)  
PeriShip Global Solutions   $ 18,190       -  
VerifyMe Solutions     1,386       867  
 Total Revenue   $ 19,576     $ 867  

 

 25 

 

Consolidated revenue for the year ended December 31, 2022, was $19,576 thousand, a 2,158% increase compared to $867 thousand, for the year ended December 31, 2021. The increase in revenue primarily relates to the acquisition of the PeriShip Global business on April 22, 2022, which contributed $18,190 thousand for the twelve months ended December 31, 2022. VerifyMe Solutions segment increased revenue by $519 thousand, a 60% increase, primarily driven by growth in our agriculture segment.

 

Gross Profit 

 

    Twelve Months Ended
December 31,		  
    2022     2021  
    (In thousands)     % of Revenue     (In thousands)     % of Revenue  
PeriShip Global Solutions     5,505       30 %     -       -  
VerifyMe Solutions     983       71 %     599       69 %
 Total Gross Profit   $ 6,488       33 %   $ 599       69 %

 

Consolidated gross profit for the years ended December 31, 2022, and 2021, was $6,488 thousand and $599 thousand, respectively. The resulting gross margin was 33% for the year ended December 31, 2022, compared to 69% for the year ended December 31, 2021. The decrease in our gross margin is due to the acquisition of the PeriShip Global business which has significantly lower margins than the VerifyMe Solutions segment.

 

General and Administrative Expenses

 

General and administrative expenses were $8,428 thousand for the year ended December 31, 2022, compared to $4,216 thousand for the year ended December 31, 2021, an increase of $4,212 thousand. The increase related to the acquisition of the PeriShip Global business, and primarily made up of salaries and related expenses for approximately 35 employees in the IT and operations department. 

 

Research and Development

 

Research and development expenses increased by $38 thousand to $89 thousand for the year ended December 31, 2022, from $51 thousand for the year ended December 31, 2021. The increase related to the acquisition of the PeriShip Global business and research and development related to their IT platform.

 

Sales and Marketing

 

Sales and marketing expenses for the year ended December 31, 2022, were $1,718 thousand compared to $1,163 thousand for the year ended December 31, 2021, an increase of $555 thousand. The increase is related to the acquisition of the PeriShip Global business, primarily consisting of salaries and related expenses for four employees.

 

Net Income (Loss)

 

Our net loss for the year ended December 31, 2022, was $14,398 thousand, compared to net income of $3,612 thousand for the year ended December 31, 2021. The decrease was primarily due to the impairment of the SPAC of $10,932 thousand during 2022 compared to an unrealized gain on the SPAC of $8,371 in 2021, partially offset by a gain on extinguishment of debt of $326 thousand and the changes discussed above for the acquisition of the PeriShip Global business. The resulting consolidated loss per diluted share for the year ended December 31, 2022, was $1.70 compared to a consolidated income per diluted share of $0.49 for the year ended December 31, 2021.

 

Liquidity and Capital Resources

 

Our operations used $2,551 thousand of cash during the year ended December 31, 2022, compared to $3,254 thousand during the year end December 31, 2021. The decrease in cash used from operations is due to a net change in non-cash addbacks to net income and the acquisition of PeriShip Global, which generates cash, that occurred during the year ended December 31, 2022.

 

Net cash used in investing activities was $7,884 thousand for the year ended December 31, 2022, compared to $2,851 thousand for the year ended December 31, 2021.  During the year ended December 31, 2022, $7,500 thousand was used for the acquisition of the PeriShip Global business. The use of cash in 2021 relates primarily to the acquisition of sponsor units in the SPAC of $2,593 thousand.

 

 26 

 

Net cash provided by financing activities for the year ended December 31, 2022, was $4,424 thousand compared to $7,588 thousand for the year ended December 31, 2021, related to proceeds from debt and offerings of our common stock in 2022 and 2021.

 

On April 12, 2022, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with the selling stockholder and certain directors, providing for the issuance and sale to purchasers therein of an aggregate of 880,208 shares of our common stock, pre-funded warrants to purchase up to 675,000 shares of our common stock, and warrants to purchase up to 1,555,208 shares of our common stock, for gross proceeds to us of approximately $5.0 million and net proceeds of $4.6 million. The pre-funded warrant was exercisable immediately and terminated when fully exercised and had an exercise price of $0.001 per share. The pre-funded warrant was fully exercised in August 2022, with an exercise price of $0.001, and as a resulted, 675,000 shares of our common stock were issued. The warrants are exercisable for a period of five years commencing six months from the date of issuance and have an exercise price of $3.215 per share. The warrants contain price adjustment provisions which may, under certain circumstances, reduce the applicable exercise price. The transaction closed on April 14, 2022.

 

On September 22, 2022, we entered into the PNC Facility with PNC Bank, National Association. The PNC Facility includes a $1 million RLOC with a term of one-year, expiring in September 2023. The RLOC has no scheduled payments of principal until maturity, and bears interest per annum at a rate equal to the sum of Daily SOFR plus 2.85% with monthly interest payments. The PNC Facility also includes a four-year Term Note for $2 million which matures in September of 2026 and requires equal quarterly payments of principal and interest. The Term Note incurs interest per annum at a rate equal to the sum of Daily SOFR plus 3.1%. The RLOC and Term Note are guaranteed by the Company and secured by the assets of PeriShip and the Company.

 

The PNC Facility includes a number of affirmative and restrictive covenants applicable to PeriShip, including, among others, a financial covenant to maintain a fixed charge coverage ratio of at least 1.10 to 1.00 at the end of each fiscal year, affirmative covenants regarding delivery of financial statements, payment of taxes, and establishing primary depository accounts with PNC Bank, and restrictive covenants regarding dispositions of property, acquisitions, incurrence of additional indebtedness or liens, investments and transactions with affiliates. PeriShip is also restricted from paying dividends or making other distributions or payments on its capital stock if an event of default (as defined in the PNC Facility) has occurred or would occur upon such declaration of dividend. We were in compliance with all affirmative and restrictive covenants under the PNC Facility at December 31, 2022.

 

Effective October 17, 2022, we entered into an interest rate swap agreement, with a notional amount of $1,958 thousand, effectively fixing the interest rate on our outstanding debt at 7.602%.

 

Of the proceeds of $2.0 million, we used $1.8 million to settle debt outstanding issued in connection with the PeriShip Global acquisition, including the redemption of 61,000 shares of our common stock. As of December 31, 2022, our short-term debt outstanding under the Term Note was $0.5 million and total long-term debt outstanding under the Term Note was $1.4 million.

 

We believe that our cash and cash equivalents, together with the net proceeds from the April 12, 2022, offering and proceeds from debt issued, will fund our operations for the next 12 months.

 

In June 2022, we announced a new $1.5 million share repurchase program to repurchase shares of the Company’s common stock commencing July 1, 2022, for a period of 12 months. This new repurchase program replaces our existing share repurchase program that was due to expire in August 2022 and is now terminated.  To date, 158,906 shares have been purchased for a total of $215 thousand and a remaining $1,285 thousand may be purchased under the program.

 

We expect to grow our business organically and through key acquisitions that will help accelerate the growth of our business. We expect to continue to fund our operations primarily through utilization of our current financial resources and future revenue and may issue additional debt or equity.

 

Critical Accounting Policies and Estimates

 

Our financial statements are impacted by the accounting policies used and the estimates and assumptions made by management during their preparation. We have identified below the accounting policies that are of particular importance in the presentation of our financial position, results of operations and cash flows and which require the application of significant judgment by management. We have identified that the estimates used in the valuation of the assets of the PeriShip acquisition are critical and require significant judgment. We believe estimates and assumptions related to these accounting policies are appropriate under the circumstances; however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial position, results of operations or cash flows.

 

Revenue Recognition

 

We recognize revenue based on the principals established in ASC Topic 606, “Revenue from Contracts with Customers.” Revenue recognition is made when our performance obligation is satisfied at a point in time of delivery of the service. Over 90% of our revenue is derived from logistics management for time and temperature sensitive packages with the remaining from our traceability solutions. Our terms vary based on the solutions we offer and are examined on a case-by-case basis. For licensing of our VerifyInkTM technology we depend on the integrity of our clients’ reporting.

 

 27 

 

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, and unbilled revenue when billings occur after the end of the month (contract assets) on the consolidated balance sheets. Amounts charged to our clients become billable when the performance obligation has been met at a point in time. Unbilled amounts will generally be billed and collected within 30 days but typically no longer than 60 days. These assets are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. Changes in the contract assets increased significantly as of December 31, 2022, compared to December 31, 2021, due to the business combination. No other factors materially impacted the balances.

 

Business Combinations

 

Accounting for business combinations requires management to make significant estimates and assumptions to determine the fair values of assets acquired and liabilities assumed at the acquisition date. Although we believe the assumptions and estimates we have made in relation to the acquisition of the PeriShip business are appropriate, they are based, in part, on historical experience and information obtained from management of the acquired companies and are inherently uncertain. Critical estimates in valuing certain acquired intangible assets include, but are not limited to, future expected cash flows including revenue growth rate assumptions from product sales, customer contracts and acquired technologies, estimated royalty rates used in valuing technology related intangible assets, and discount rates. The discount rates used to discount expected future cash flows to present value are typically derived from a weighted-average cost of capital (“WACC”) analysis and adjusted to reflect inherent risks. Unanticipated events and circumstances may occur that could affect either the accuracy or validity of such assumptions, estimates or actual results.

 

We allocate the fair value of the purchase price of our acquisitions to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values at acquisition date. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. As a result, during the measurement period, which will not exceed one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the conclusion of the measurement period or final determination of the fair value of the purchase price of our acquisitions, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Operations…

 

Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred.

 

Goodwill

 

We have recorded goodwill as part of our acquisition of the PeriShip business, which represents the excess of purchase price over the fair value of net assets acquired in the business combinations. Pursuant to ASC 350, the Company will test goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price. For our annual goodwill impairment test as of December 31, 2022, we performed a qualitative assessment as permitted by ASU 2017-04 for our reporting unit PeriShip Global and determined that it was more likely than not that the fair value exceeded their respective carrying value.

 

Stock-based Compensation

 

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method.

 

For RSUs with stock price appreciation targets, we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.

 

 28 

 

We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.

 

All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed. 

 

Recently Adopted Accounting Pronouncements

 

Recently adopted accounting pronouncements are discussed in Note 1 – Summary of Significant Accounting Policies in the notes accompanying the financial statements.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable for smaller reporting companies.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

The financial statements required to be filed pursuant to this Item 8 are appended to this Report beginning on page F-1 located immediately after the signature page and incorporated by reference in this Item 8.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

(a) Evaluation of Disclosure Controls and Procedures

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Our disclosure controls and procedures are designed to ensure information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. The Company’s Chief Executive Officer, our principal executive officer, and Chief Financial Officer, our principal financial officer, have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the year ended December 31, 2022. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2022, our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management, including our principal executive and principal financial officers, conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2022, using criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Our management has concluded that our internal controls over financial reporting was effective as of December 31, 2022

 

 29 

 

(b) Changes in Internal Control over Financial Reporting

 

2022 Remediation Activities

During the fiscal year ended December 31, 2022, we implemented remediation actions to address a material weakness due to a lack of segregation of duties identified in our annual report on Form 10-K for our fiscal year ended December 31, 2021. Specifically, we defined key controls in accordance with the five components and seventeen principles of the COSO 2013 Framework. In addition to the VP of Finance and Financial Controller hired in 2021, we hired an HR Manager in September 2022 to further enhance our segregation of duties controls. Through our control testing of the applicable controls over a sufficient period of time during the year ended December 31, 2022, management has concluded that these controls are operating effectively and that as of December 31, 2022, we no longer have a material weakness due to a lack of segregation of duties. Except as set forth above, there were no other changes in internal control over financial reporting during the fiscal year ended December 31, 2022, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

(c) PeriShip Acquisition

 

On April 22, 2022, we acquired, through PeriShip Global, the business and certain assets of PeriShip, LLC, a value-added service provider for time and temperature sensitive parcel management. For additional information regarding the acquisition, refer to Note 4 to the Audited Consolidated Financial Statements appended to this Report and incorporated by reference into Item 8 in this Annual Report on Form 10-K and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in Item 7 in this Annual Report on Form 10-K. Based on the recent completion of this acquisition and, pursuant to the Securities and Exchange Commission’s guidance that an assessment of a recently acquired business may be omitted from the scope of an assessment for a period not to exceed one year from the date of acquisition, the scope of our assessment of the effectiveness of internal control over financial reporting as of December 31, 2022 does not include PeriShip Global. We plan to include PeriShip Global within the timeframe set forth by the SEC’s guidance. 

 

Auditor’s Report on Internal Control Over Financial Reporting

 

This Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to the rules of the SEC that permit us to provide only management’s report in this Report.

 

ITEM 9B. OTHER INFORMATION.

 

None.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

 

Not Applicable.

 

 30 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 

The information required by this Item 10 is incorporated herein by reference from our proxy statement for our 2023 annual meeting of stockholders under the headings “Questions and Answers About these Proxy Materials and Voting,” “Proposal One: Election of Directors,” “Corporate Governance,” “Management and Executive Officers” and, if necessary, “Delinquent Section 16(a) Reports,” which proxy statement will be filed within 120 days after the December 31, 2022, fiscal year end.

 

ITEM 11. EXECUTIVE COMPENSATION.

 

The information required by this Item 11 is incorporated herein by reference from our proxy statement for our 2023 annual meeting of stockholders under the headings “Executive Compensation” and “Director Compensation,” which proxy statement will be filed within 120 days after the December 31, 2022, fiscal year end.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

Except for the information regarding securities authorized for issuance under equity compensation plans (which is set forth below), the information required by this Item 12 is incorporated herein by reference from our proxy statement for our 2023 annual meeting of stockholders under the heading “Security Ownership of Management and Certain Beneficial Owners,” which proxy statement will be filed within 120 days after the December 31, 2022, fiscal year end.

 

The following table summarizes the number of shares subject to currently outstanding equity awards, their weighted-average exercise price, and the number of shares available for future grants under our equity compensation plans as of December 31, 2022.

 

Equity Compensation Plan Information as of December 31, 2022

 

Plan Category  

Number of securities

to be issued upon

exercise of

outstanding options,
warrants and rights

 

Weighted average

exercise price of

outstanding options,
warrants and rights
(1)

  

Number of securities

remaining available for

future issuance under

equity compensation

plans (excluding

securities reflected in

column (a))

    (a)   (b)   (c)

Equity compensation

plans approved by

security holders

  157,000 (2)   $5.68   1,292,225 (3)

Equity compensation

plans not approved

by security holders

  180,471 (4)   4.19   -
Total   337,471   4.63   1,292,225

 

(1) Represents the weighted-average exercise price of outstanding stock options. The weighted-average exercise price does not take into account the shares issuable upon vesting of outstanding restricted stock units under the 2020 Equity Incentive Plan (the “2020 Plan”) or 2013 Plan, which do not have an exercise price.

 

(2) Represents shares of common stock issuable upon exercise of stock options granted under the 2017 Equity Incentive Plan (the “2017 Plan”) and the 2013 Omnibus Equity Compensation Plan, as amended (the “2013 Plan”)

 

(3) Includes 877,511 shares remaining available for issuance under the 2020 Plan and 44,770 shares remaining for issuance under the 2013 Plan and 369,944 shares remaining available for issuance under the 2021 Plan.

 

(4) Includes individual grants to employees and consultants for services rendered to the Company which were not made under the Company’s existing equity incentive plans.

 

 31 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

The information required by this Item 13 is incorporated herein by reference from our proxy statement for our 2023 annual meeting of stockholders under the heading “Certain Relationships and Related Person Transactions,” which proxy statement will be filed within 120 days after the December 31, 2022, fiscal year end.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

The information required by this Item 14 is incorporated herein by reference from our proxy statement for our 2023 annual meeting of stockholders under the numbered proposal with the heading “Ratification of the Appointment of our Independent Registered Public Accounting Firm,” which proxy statement will be filed within 120 days after the December 31, 2022, fiscal year end.

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

Exhibit No.   Description
3.1   Certificate of Amendment to Amended and Restated Articles of Incorporation (incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 22, 2020)
3.2   Second Amended Certificate of Designation for Series A Convertible Preferred Stock (incorporated herein by reference from Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on June 18, 2015)
3.3   Certificate of Designation for Series B Convertible Preferred Stock (incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on June 18, 2015)
3.4   Certificate of Withdrawal of Certificate of Designation for Series C and Series D Convertible Preferred Stock (incorporated herein by reference from Exhibit 4.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018)
3.5   Amended and Restated Bylaws of VerifyMe, Inc., as amended through July 24, 2020 (incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 29, 2020)
4.1   Form of Warrant for the Purchase of Shares of Common Stock (incorporated herein by reference from Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on March 3, 2020)
4.2   Form of Common Stock Purchase Warrant (incorporated herein by reference from Exhibit 4.3 to the Company’s Registration Statement on Form S-1/A (File No. 333-234155) filed on May 22, 2020)
4.3   Form of Warrant for the Purchase of Shares of Common Stock (incorporated herein by reference from Exhibit 4.6 to the Company’s Registration Statement on Form S-1/A (File No. 333-234155) filed on June 2, 2020)
4.4   Warrant Agent Agreement dated June 22, 2020 between the Company and West Coast Stock Transfer, Inc. (incorporated herein by reference from Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on June 22, 2020)
4.5   Form of Representative’s Warrant (incorporated herein by reference from Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on June 22, 2020)
4.6   Form of Pre-Funded Warrant (incorporated herein by reference from Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 18, 2022)
4.7   Form of Common Warrant (incorporated herein by reference from Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on April 18, 2022)
4.8*   Description of Securities
10.1#   Form of Indemnification Agreement (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 18, 2021)
10.2#   Employment Agreement with Patrick White, dated February 15, 2022 (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K file on February 22, 2022)
10.3#   Employment Agreement with Margaret Gezerlis, dated February 15, 2022 (incorporated herein by reference from Exhibit 10.3 to the Company’s Current Report on Form 8-K file on February 22, 2022)
10.4#   Employment Agreement with Keith Goldstein, dated February 15, 2022 (incorporated herein by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K file on February 22, 2022)
10.5#   Employment Agreement with Nancy Meyers, dated February 15, 2022 (incorporated herein by reference from Exhibit 10.4 to the Company’s Current Report on Form 8-K file on February 22, 2022)
10.6#   Employment Agreement between PeriShip Global, LLC and Curt Kole, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.5 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.7#   Employment Agreement between PeriShip Global, LLC and Fred Volk III, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.6 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.8#   Employment Agreement between PeriShip Global, LLC and Jack Wang, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.7 to the Company’s Current Report on Form 8-K filed on April 26, 2022)

 

 32 

 

10.9#   LaserLock Technologies, Inc. 2013 Omnibus Equity Compensation Plan (incorporated herein by reference from the Company’s Definitive Proxy Statement filed on November 19, 2013)
10.10#   2017 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 20, 2017)
10.10.1#   Amendment to the 2017 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 29, 2019)
10.11#   2020 Equity Incentive Plan (incorporated herein by reference from Exhibit 4.4 to the Company’s Registration Statement on Form S-8 (File No. 333-249520) filed on October 16, 2020)
10.12#   VerifyMe, Inc. 2021 Stock Purchase Plan (incorporated herein by reference from Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed on April 28, 2021)
10.13#   Non-Qualified Stock Option Agreement dated August 2017 between the Company and Patrick White (incorporated herein by reference from Exhibit 10.14 to the Company’s Registration Statement on Form S-1 (File No. 333-234155) filed on October 10, 2019)
10.14#   Non-Qualified Stock Option Agreement dated April 17, 2018 between the Company and Patrick White (incorporated herein by reference from Exhibit 10.13 to the Company’s Registration Statement on Form S-1 (File No. 333-234155) filed on October 10, 2019)
10.15#   Amendment to Non-Qualified Stock Option Agreement dated April 16, 2020 to that Non-Qualified Stock Option Agreement dated August 2017 and that Non-Qualified Stock Option Agreement dated April 17, 2018 between the Company and Patrick White (incorporated herein by reference from Exhibit 10.12 to the Company’s Registration Statement on Form S-1 (File No. 333-237950) filed on May 1, 2020)
10.16#   Incentive Stock Option Agreement dated August 14, 2019 between the Company and Patrick White (incorporated herein by reference from Exhibit 10.15 to the Company’s Registration Statement on Form S-1 (File No. 333-234155) filed on October 10, 2019)
10.17#   Incentive Stock Option Agreement dated March 11, 2019 between the Company and Margaret Gezerlis (incorporated herein by reference from Exhibit 10.16 to the Company’s Registration Statement on Form S-1 (File No. 333-234155) filed on October 10, 2019)
10.18#   Incentive Stock Option Agreement dated January 7, 2020 between the Company and Margaret Gezerlis (incorporated herein by reference from Exhibit 10.15 to the Company’s Registration Statement on Form S-1 (File No. 333-237950) filed on May 1, 2020)
10.19#   Form of Restricted Stock Agreement (incorporated herein by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018)
10.20#   Restricted Stock Agreement dated April 16, 2020 between the Company and Patrick White (incorporated herein by reference from Exhibit 10.19 to the Company’s Registration Statement on Form S-1 (File No. 333-237950) filed on May 1, 2020)
10.21#   Form of Director Non-Qualified Stock Option Agreement (immediate vesting) (incorporated herein by reference from Exhibit 10.20 to the Company’s Registration Statement on Form S-1 (File No. 333-237950) filed on May 1, 2020)
10.22#   Form of Director Non-Qualified Stock Option Agreement (quarterly vesting) (incorporated herein by reference from Exhibit 10.21 to the Company’s Registration Statement on Form S-1 (File No. 333-237950) filed on May 1, 2020)
10.23#   Form of Restricted Stock Agreement pursuant to the 2013 Omnibus Equity Compensation Plan (incorporated herein by reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020)
10.24#   Form of Restricted Stock Agreement pursuant to the 2017 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020)
10.25#   Form of Restricted Stock Unit Agreement (immediate vesting) pursuant to the 2020 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020)
10.26#   Form of Restricted Stock Award Agreement (Employees) pursuant to the 2020 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021)
10.27#   Form of Restricted Stock Award Agreement (Non-employees) pursuant to the 2020 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021)
10.28#   Form of Restricted Stock Unit Award Agreement (Employees) pursuant to the 2020 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021)
10.29#   Form of Restricted Stock Unit Award Agreement (Non-employees) pursuant to the 2020 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021)

 

 33 

 

10.30#   Form of Restricted Stock Unit Award Agreement (Subsidiary Employees) (incorporated herein by reference from Exhibit 10.8 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.31   Agreement dated as of June 15, 2020 (incorporated herein by reference from Exhibit 10.28 to the Company’s Registration Statement on Form S-1 (File No. 333-234155) filed on June 15, 2020)
10.32   Form of Securities Purchase Agreement, dated April 12, 2022 (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 18, 2022)
10.33   Form of Registration Rights Agreement, dated April 12, 2022 (incorporated herein by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on April 18, 2022)
10.34   Form of Lock-Up Agreement, dated April 12, 2022 (incorporated herein by reference from Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on April 18, 2022)
10.35   Asset Purchase Agreement, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.36   Promissory Note payable by PeriShip Global, LLC to PeriShip, LLC, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.37   Guaranty, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.38   Transition Services Agreement, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.39   Lease Agreement between PeriShip Global and Mordo, LLC, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.9 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.40   Lease Guarantee between VerifyMe, Inc. and Mordo, LLC, dated April 22, 2022 (incorporated herein by reference from Exhibit 10.10 to the Company’s Current Report on Form 8-K filed on April 26, 2022)
10.41   Professional Services Agreement between PeriShip Global (as successor to PeriShip, LLC) and FedEx Corporate Services, Inc. dated June 1, 2019 (incorporated herein by reference to Exhibit 10.14 to the Company’s Quarterly Report on Form 10-Q filed on August 15, 2022)
10.42   Form of FedEx Transportation Services Agreement Pricing Agreement between PeriShip Global (as successor to PeriShip, LLC) and Federal Express Corporation, et al (incorporated herein by reference to Exhibit 10.15 to the Company’s Quarterly Report on Form 10-Q filed on August 15, 2022)
10.43   Amendment to Professional Services Agreement with FedEx Corporate Services, Inc. dated August 25, 2022 (incorporated herein by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 10, 2022)
10.44   Loan Agreement between PeriShip Global LLC and PNC Bank, National Association, effective September 15, 2022 (incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 27, 2022)
10.45   Term Note between PeriShip Global LLC and PNC Bank, National Association, effective September 15, 2022 (incorporated herein by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on September 27, 2022)
10.46   Revolving Line of Credit Note between PeriShip Global LLC and PNC Bank, National Association, effective September 15, 2022 (incorporated herein by reference from Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on September 27, 2022)
10.47   Guaranty and Suretyship Agreement between VerifyMe, Inc., and PNC Bank, National Association, effective September 15, 2022 (incorporated herein by reference from Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on September 27, 2022)
10.48   Security Agreement between PeriShip Global LLC and PNC Bank, National Association, effective September 15, 2022 (incorporated herein by reference from Exhibit 10.5 to the Company’s Current Report on Form 8-K filed on September 27, 2022)
10.49   Security Agreement between VerifyMe, Inc. and PNC Bank, National Association, effective September 15, 2022 (incorporated herein by reference from Exhibit 10.6 to the Company’s Current Report on Form 8-K filed on September 27, 2022)
10.50   Asset Purchase Agreement, effective February 28, 2023 (incorporated herein by reference3 from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 2, 2023)
21.1*   Subsidiaries of VerifyMe, Inc.
31.1*   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 34 

 

101.INS*   XBRL Instance Document
101.SCH*   XBRL Taxonomy Extension Schema Document
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File

 

* Filed or furnished herewith, as applicable

# Denotes management compensation plan or contract

 

ITEM 16. FORM 10-K SUMMARY

 

Not applicable.

 

 35 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  VerifyMe, Inc.  
       
  By: /s/ Scott Greenberg  
   

Scott Greenberg

Interim Chief Executive Officer and Executive Chairman

  
    Date: March 28, 2023  

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

 

Signature   Title   Date
         
/s/ Scott Greenberg   Interim Chief Executive Officer,Executive Chairman and Director   March 28, 2023
Scott Greenberg   (Principal Executive Officer)    
         
         
/s/ Margaret Gezerlis   Executive Vice President and Chief Financial Officer   March 28, 2023
Margaret Gezerlis   (Principal Financial Officer and    
    Principal Accounting Officer)    
         
         
         
/s/ Chris Gardner   Director   March 28, 2023
Chris Gardner        
         
         
/s/ Marshall Geller   Director   March 28, 2023
Marshall Geller        
         
         
/s/Howard Goldberg   Director   March 28, 2023
Howard Goldberg        
         
         
/s/ Arthur Laffer    Director     March 28, 2023 
Arthur Laffer        
         
         
/s/ Adam Stedham   Director     March 28, 2023 
Adam Stedham        

 

 36 

 

INDEX TO

FINANCIAL STATEMENTS

 

CONTENTS

 

    PAGE
     
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 206)   F-1
     
CONSOLIDATED BALANCE SHEETS   F-2
     
CONSOLIDATED STATEMENTS OF OPERATIONS   F-3
     
CONSOLIDATED COMPREHENSIVE INCOME(LOSS)   F-4
     
CONSOLIDATED STATEMENTS OF CASH FLOWS   F-5
     
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY   F-6
     
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS   F-7

 

 37 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Shareholders and Board of Directors of

VerifyMe, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of VerifyMe, Inc. and its subsidiary (collectively, the “Company”) as of December 31, 2022 and 2021, and the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

 

 

/s/ MaloneBailey, LLP

www.malonebailey.com

We have served as the Company's auditor since 2018.

Houston, Texas

March 28, 2023

 

 F-1 

 

VerifyMe, Inc.

Consolidated Balance Sheets

(In thousands, except share data)

 

         
   As of 
   December 31, 2022   December 31, 2021 
ASSETS        
         
CURRENT ASSETS          
Cash and cash equivalents, including restricted cash  $3,411   $9,422 
Accounts receivable, net of allowance for credit loss reserve, $37 and $0 as of December 31, 2022 and December 31, 2021, respectively   4,448    297 
Unbilled revenue   1,185    - 
Prepaid expenses and other current assets   333    240 
Inventory   81    52 
TOTAL CURRENT ASSETS   9,458    10,011 
           
INVESTMENTS          
Equity Investment  $-   $10,964 
           
PROPERTY AND EQUIPMENT, NET   292    204 
           
RIGHT OF USE ASSET   469    - 
           
INTANGIBLE ASSETS, NET   6,412    509 
           
GOODWILL   3,988    - 
           
DEFERRED IMPLEMENTATION COSTS   133    - 
           
TOTAL ASSETS  $20,752   $21,688 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
           
CURRENT LIABILITIES          
Current portion of debt  $500   $- 
Accounts payable   3,912    341 
Other accrued expense   902    109 
Lease liability- current   115    - 
TOTAL CURRENT LIABILITIES   5,429    450 
           
LONG-TERM LIABILITIES          
Long-term lease liability  $359   $- 
Long-term derivative liability   3    71 
Term note   1,375    - 
TOTAL LIABILITIES  $7,166   $521 
           
STOCKHOLDERS' EQUITY          
Series A Convertible Preferred Stock, $.001 par value, 37,564,767 shares authorized; 0 shares issued and outstanding as of December 31, 2022; 0 shares issued and outstanding as of December 31, 2021   -    - 
          
Series B Convertible Preferred Stock, $.001 par value; 85 shares authorized; 0.85 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively   -    - 
           
Common stock, $0.001 par value; 675,000,000 authorized; 9,341,002 and 7,420,633 issued, 8,951,035 and 7,196,677 shares outstanding as of December 31, 2022 and December 31, 2021, respectively   10    7 
           
Additional paid in capital   92,987    86,059 
           
Treasury stock as cost; 389,967 and 223,956 shares at December 31, 2022 and December 31, 2021, respectively   (949)   (838)
           
Accumulated deficit   (78,459)   (64,061)
           
Accumulated other comprehensive loss   (3)   - 
           
STOCKHOLDERS' EQUITY   13,586    21,167 
           
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $20,752   $21,688 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-2 

 

VerifyMe, Inc.

Consolidated Statements of Operations

(In thousands, except per share data)

 

           
   Years Ended 
   December 31, 2022   December 31, 2021 
         
NET REVENUE  $19,576   $867 
           
COST OF REVENUE   13,088    268 
           
GROSS PROFIT   6,488    599 
           
OPERATING EXPENSES          
General and administrative (a)   8,428    4,216 
Research and development   89    51 
Sales and marketing (a)   1,718    1,163 
Total operating expenses   10,235    5,430 
           
LOSS BEFORE OTHER INCOME (EXPENSE)   (3,747)   (4,831)
           
OTHER INCOME (EXPENSE)          
Interest income (expenses), net   (88)   2 
Loss on equity investment   (10,932)   - 
Unrealized gain on equity investment   12    8,371 
Other income, net   31    - 
Gain on extinguishment of debt   326    - 
Payroll protection program debt forgiveness   -    70 
TOTAL OTHER INCOME (EXPENSE), NET   (10,651)   8,443 
           
NET (LOSS)/ INCOME  $(14,398)  $3,612 
           
EARNINGS / (LOSS) PER SHARE          
           
BASIC   (1.70)   0.51 
DILUTED   (1.70)   0.49 
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING          
           
BASIC   8,466,075    7,110,907 
DILUTED   8,466,075    7,383,364 

 

(a)Includes share-based compensation of $1,468 thousand for the year ended December 31, 2022, and $1,716 thousand for the year ended December 31, 2021.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-3 

 

VerifyMe, Inc.

Consolidated Statements of Comprehensive Income/(Loss)

(In thousands)

 

           
   Year Ended 
   December 31, 2022   December 31, 2021 
         
NET (LOSS)/INCOME  $(14,398)  $3,612 
           
Change in fair value of interest rate, swap   (3)   - 
           
TOTAL COMPREHENSIVE (LOSS)/INCOME  $(14,401)  $3,612 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-4 

 

VerifyMe, Inc.

Consolidated Statements of Cash Flows

(In thousands)

 

           
   Years Ended 
   December 31, 2022   December 31, 2021 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net (Loss) Income  $(14,398)  $3,612 
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Allowance for bad debt   37    - 
Stock based compensation   145    151 
Fair value of options in exchange for services   -    85 
Fair value of restricted stock awards issued in exchange for services   239    784 
Fair value of restricted stock units issued in exchange for services   1,084    696 
Payroll Protection Program Debt Forgiveness   -    (70)
Loss on equity investment   10,932    - 
Unrealized gain on equity investment   (12)   (8,371)
Gain on extinguishment of debt   (326)   - 
Amortization and depreciation   770    117 
Changes in operating assets and liabilities:          
Accounts receivable   (3,352)   (354)
Unbilled revenue   (1,185)   - 
Inventory   (29)   2 
Prepaid expenses and other current assets   (77)   25 
Accounts payable, other accrued expenses and net change in operating leases   3,621    69 
Net cash used in operating activities   (2,551)   (3,254)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of patents  $(40)  $(95)
Purchase of equipment for lease   -    (45)
Purchase of equity investment   -    (2,593)
Purchase of office equipment   -    (12)
Acquisition of PeriShip   (7,500)   - 
Equity received from SPAC Equity Investment   32    - 
Deferred implementation costs   (140)   - 
Capitalized software costs   (236)   (106)
Net cash used in investing activities   (7,884)   (2,851)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from public offering of securities  $4,528   $8,447 
Proceeds from issuance of notes payable   2,000    (3)
Proceeds from exercise of pre-funded warrant   1    - 
Proceeds from SPP Plan   102    - 
Tax withholding payments for employee stock-based compensation in exchange for shares surrendered   (34)   (131)
Increase in treasury shares (share repurchase program)   (291)   (725)
Repayment of Debt   (1,882)   - 
Net cash provided by financing activities   4,424    7,588 
           
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS   (6,011)   1,483 
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH – BEGINNING OF PERIOD   9,422    7,939 
           
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH - END OF PERIOD  $3,411   $9,422 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid during the period for:          
Interest  $33   $- 
Income taxes  $-   $- 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
           
Initial recognition of right-of-use asset and lease liability during the period  $552   $- 
           
Change in fair value of interest rate, swap  $(3)  $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-5 

 

VerifyMe, Inc.

Consolidated Statements of Stockholders' Equity

(In thousands, except share data)

 

                                             
   Series A   Series B                     
   Convertible   Convertible                     
   Preferred   Preferred   Common       Treasury         
   Stock   Stock   Stock   Additional   Stock         
   Number of       Number of       Number of       Paid-In   Number of       Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Deficit   Total 
                                             
Balance at December 31, 2020   -    -    0.85    -    5,596,877    6    76,099    7,011    (113)-   (67,673)   8,319 
Fair value of stock options   -    -    -    -    -    -    85    -    -    -    85 
Restricted stock awards, net of shares withheld
for employee tax		   -    -    -    -    56,971    -    654    -    -    -    654 
Restricted Stock Units   -    -    -    -    -    -    696    -    -    -    696 
Stock Purchase Plan   -    -    -    -    -    -    40    -    -    -    40 
Common stock issued for services   -    -    -    -    9,774    -    39    -    -    -    39 
Common stock issued in relation to public
offering of securities		   -    -    -    -    1,750,000    1    8,446    -    -    -    8,447 
Repurchase of Common Stock   -    -    -    -    (216,945)   -    -    216,945    (725)   -    (725)
Net income        -    -    -    -    -    -    -    -  -  3,612    3,612 
Balance at December 31, 2021   -    -    0.85    -    7,196,677    7    86,059    223,956    (838) -  (64,061)   21,167 

 

                                                 
   Series A   Series B                         
   Convertible   Convertible                         
   Preferred   Preferred   Common       Treasury   Accumulated         
   Stock   Stock   Stock   Additional   Stock   Other          
   Number of       Number of       Number of       Paid-In   Number of       Comprehensive   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Loss   Deficit   Total 
                                                 
Balance at December 31, 2021   -    -    0.85    -    7,196,677    7    86,059    223,956    (838)   -    (64,061)   21,167 
Restricted stock awards, net of shares withheld
for employee tax		   -    -    -    -    29,688    -    205    -    -    -    -    205 
Restricted Stock Units   -    -    -    -    -    -    1,084    -    -    -    -    1,084 
Stock Purchase Plan   -    -    -    -    -    -    121    -    -    -    -    121 
Common stock issued in relation to Stock
Purchase Plan		   -    -    -    -    53,895    -    (78)   (53,895)   180    -    -    102 
Common stock issued in relation to private placement   -    -    -    -    880,208    2    4,526    -    -    -    -    4,528 
Common stock issued for services   -    -    -    -    30,000    -    96    -    -    -    -    96 
Common stock issued in relation to
Acquisition		   -    -    -    -    305,473    -    974    -    -    -    -    974 
Repurchase of Common Stock   -    -    -    -    (219,906)   -    -    219,906    (291)   -    -    (291)
Exercise of Pre-funded Warrants   -    -    -    -    675,000    1    -    -    -    -    -    1 
Accumulated other comprehensive loss   -    -    -    -    -    -    -    -    -    (3)   -    (3)
Net loss        -    -    -    -    -    -    -    -    -    (14,398)   (14,398)
Balance at December 31, 2022   -    -    0.85    -    8,951,035    10    92,987    389,967    (949)   (3)   (78,459)   13,586 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-6 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of the Business

 

VerifyMe, Inc. (“VerifyMe”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, together with its subsidiaries, including PeriShip Global LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”) is based in Lake Mary, Florida and its common stock, par value $0.001 per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.

 

VerifyMe, through PeriShip Global, is a software driven predictive analytics logistics provider of high-touch, end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions, which includes Trust Codes Global. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.

 

Basis of Presentation

 

The accompanying consolidated financial statements include the accounts of VerifyMe and its wholly owned subsidiary PeriShip Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

Segment Reporting

 

Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) PeriShip Global Solutions and (ii) VerifyMe Solutions. See Note 16 Segment Reporting, for further discussion of the Company’s segment reporting structure. 

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, (“CECL”), which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded.  This guidance was to be effective for reporting periods beginning after December 15, 2022, with early adoption permitted. The Company has elected to early adopt ASU 2016-13, as of January 1, 2022, and the impact has been disclosed on the face of the Consolidated Balance Sheets. The Company’s accounts receivable is currently the only financial instrument subject to the new CECL model. The Company has considered relevant internal and/or external information about past events, e.g., historical loss experience with similar assets, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the reported amount of financial assets in determining the credit loss.

 

 F-7 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, equity investments, and long-term derivative liabilities. The carrying value of accounts receivable, unbilled revenue, accounts payable and accrued expenses approximate their fair value because of their short maturities.  The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.

 

The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures,” and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities

 

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data

 

Level 3: Unobservable inputs that are not corroborated by market data

 

The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

 

The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of December 31, 2022 and December 31, 2021.

 

Amounts in Thousands ('000)

 

                
   Short Term Investment   Equity Investment   Derivative Liability   Derivative Liability 
   (Level 1)   (Level 3)   (Level 2)   (Level 3) 
                 
Balance as of December 31, 2021  $88    10,964    -    (71)
                     
Realized loss on fair value recognized in other (expense)/income   -    (10,932)   -    - 
                     
Distribution from Sponsor Entity   -    (32)   -    - 
              -    - 
Unrealized gain on fair value recognized in other (expense)/income   12    -    -    - 
                     
Realized gain on fair value recognized in share-based compensation   -    -         71 
                     
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss             (3)   - 
    -    -           
Balance at December 31, 2022  $100   $-   $(3)  $- 

 

Variable Interest Entity

 

The Company determined that G3 VRM Acquisition Corp. (NASDAQ: GGGVU) (the “SPAC”, see Note 2 – Equity Investments), a Delaware corporation and special purpose acquisition company, was a variable interest entity (“VIE”) in which the Company had a variable interest but was not the primary beneficiary. Making the determination as to whether a VIE should be consolidated requires judgement in assessing if the Company is the primary beneficiary. To make this determination, the Company evaluated its power to direct the activities that most significantly impacted the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the SPAC. The Company concluded that it was not the primary beneficiary of the VIE and as such, did not consolidate the SPAC. The Company reassessed its evaluation of whether an entity is a VIE and if it continues to be a VIE, whether the Company is the primary beneficiary of the VIE, on an ongoing basis based on the current facts and circumstances surrounding the entity. The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO, and the Sponsor Entity made the decision not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved, and liquidated according to its charter. The SPAC redeemed 100% of the public shares for cash, the rights have expired worthless, and the founder shares and the private placement securities have become worthless.

 
 F-8 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

Equity Investments

 

When the Company does not have a controlling financial interest in an entity but can exert influence over the entity’s operations and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under applicable generally accepted accounting policies. The Company has elected the fair value option for its equity investment in the SPAC (see Note 2 –Equity Investments) and its equity security under short term investment on the balance sheets, as it has determined the fair value best reflects the economic performance of the equity investment. Changes in unrealized gain on equity investment include unrealized gain of the fair value of the equity investments and loss on equity investment includes realized loss on equity investments on the accompanying Consolidated Statements of Operations.

 

Goodwill

 

Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

 

Business Combinations

 

The Company applies the provisions of Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, in the accounting for business acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the Consolidated Statements of Operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results.

 

Basic and Diluted Net Loss per Share of Common Stock

 

The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents. As of December 31, 2022, the Company held $63 thousand subject to restrictions.

 

 F-9 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

Accounts Receivable

 

Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. Bad debts expense or write offs of receivables are determined on the basis of loss experience, known and inherent risks in the receivable portfolio and current economic conditions. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, such allowances may be required. The Company recognized $37 thousand and $0 for allowance for credit losses as of December 31, 2022, and 2021, respectively.

 

Concentration of Credit Risk Involving Cash and Cash Equivalents

 

The Company’s cash and cash equivalents are held at various financial institutions. At times, the Company’s deposits may exceed Federal Deposit Insurance Corporation (FDIC) coverage limits which are currently set at $250,000 per depositor. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.

 

Inventory

 

Inventory principally consists of canisters and pigments and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.

 

Equipment for Lease

 

Equipment for lease principally consists of costs associated with the development, certification and production of the VerifyChecker™ and the VerifyAuthenticatorTM Smartphone Authenticator technology. These technologies are leased to customers typically for a period of one year in length with automatically renewable leases cancellable by either party by written notice provided 90 days in advance. We examined the effect of Accounting Standards Update (“ASU”) No. 2016-02- “Lease (Topic 842)” and determined the impact is not material. Our policy is to capitalize the costs related to this equipment and depreciate on a straight-line basis over the estimated lives of the equipment which was determined to be 5 years.

 

Capitalized Software  

 

Costs incurred in connection with the development of software related to our proprietary proactive end-to-end logistics management products are accounted for in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 “Hosting Arrangements and Internally Used Software.” Costs incurred prior to the establishment of technological feasibility are charged to research and development expense. Software development costs are capitalized after a product is determined to be technologically feasible and is in the process of being developed for market. Amortization of capitalized software development costs begins once the product is available to the market. Capitalized software development costs are amortized over the estimated life of the related product, generally six years, using the straight-line method. The Company will evaluate its software assets for impairment whenever events or change in circumstances indicate that the carrying amount of such assets may not be recoverable.

 

Long-Lived Assets

 

The Company evaluates the recoverability of its long-lived assets in accordance with ASC 360 “Property, Plant, and Equipment.” The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.

 

Derivative Instruments

 

The Company evaluates its equity investments, long-term derivative liabilities, preferred stock, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguish by Liabilities from Equity” (FASB ASC 480), and FASB ASC 815, “Derivatives and Hedging” (“FASB ASC 815”). The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the Consolidated Statement of Operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

 

 F-10 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified as liabilities at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

 

Reclassifications

 

Certain accounts in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements. These reclassifications had no effect on the previously reported net income (loss).

 

 Revenue Recognition

 

The Company accounts for revenues according to Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. 

 

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

·identify the contract with a customer;
·identify the performance obligations in the contract;
·determine the transaction price;
·allocate the transaction price to performance obligations in the contract; and
·recognize revenue as the performance obligation is satisfied.

 

During the year ended December 31, 2022, over 90% of the Company’s revenues primarily consisted of revenue related to our logistics management for time and temperature sensitive packages generated by our subsidiary PeriShip Global. During the year ended December 31, 2021, the Company’s revenue primarily consisted of VerifyInkTM and labels with our VerifyMe traceability solutions.

 

Income Taxes

 

The Company follows FASB ASC 740, “Income Taxes,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2003 remain subject to examination by major tax jurisdictions due the carryforward of unutilized NOLs.

 

Stock-Based Compensation

 

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. We recognize forfeitures as they occur with a reduction in compensation expense in the period of forfeiture. For performance restricted stock units with stock price appreciation targets (see Note 10 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.

 
 F-11 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.

  

All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed. 

 

Advertising Costs

 

Advertising costs are expensed as incurred. Advertising costs were $60 thousand and $51 thousand for the years ended December 31, 2022, and 2021, respectively, and are included in Sales and Marketing on the Consolidated Statements of Operations.

 

Research and Development Costs

 

In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the years ended December 31, 2022, and 2021 were $89 thousand and $51 thousand, respectively.

 

Basic and Diluted Earnings (Loss) per Share of Common Stock

 

The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the year ended December 31, 2022, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same. 

 

NOTE 2 – EQUITY INVESTMENTS

 

On February 26, 2021, the Company formed VMEA Holdings Inc. (the “Sponsor Entity”), a Delaware corporation that was the founder of G3 VRM Acquisition Corp. (the “SPAC”) that was being co-sponsored by the Company.  The SPAC was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

 

On April 12, 2021, the Sponsor Entity converted to a Delaware limited liability company, changed its name to “G3 VRM Holdings LLC” and a co-sponsor was added as a member of the Sponsor Entity resulting in an equity interest of 44.40% attributed to the Company. On July 6, 2021, the SPAC consummated the IPO of 10,626,000 units (the “Units”), including 626,000 Units pursuant to the partial exercise of the underwriter’s over-allotment option, generating gross proceeds of $106,260 thousand. Each Unit consisted of one share of SPAC common stock, $0.0001 par value, and one right to receive one-tenth (1/10) of a share of SPAC common stock upon the consummation of an initial business combination. Simultaneously with the closing of the IPO, the SPAC consummated the Private Placement of an aggregate of 569,410 Units with the Sponsor Entity purchasing 516,280 Units and Maxim Partners LLC purchasing 53,130 Units, generating total proceeds of $5,694 thousand. Of this amount, the Company was the indirect beneficial owner of 229,228 Units purchased by the Sponsor Entity for a total of $2,581 thousand. Upon consummation of the IPO, VerifyMe, as co-sponsor, indirectly through the Sponsor Entity, beneficially owned approximately 9.42% of the outstanding shares of the SPAC, which shares were subject to forfeiture upon certain conditions and restrictions on transfer.

 

As a result of ceasing to have a controlling financial interest in the Sponsor Entity on April 12, 2021, the Company accounted for the Sponsor Entity as an equity investment and has elected the fair value option.

 
 F-12 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO and the Sponsor Entity decided not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved and liquidated in accordance with its charter. The SPAC redeemed 100% of the public shares for cash on July 19, 2022, the rights expired worthless, and the founder shares and private placement securities became worthless. The SPAC was dissolved on July 29, 2022, and no distributions were made to the Sponsors. In December 2022, it was determined that the costs to dissolve the SPAC were ultimately less than the remaining assets of the SPAC and the SPAC made a distribution to the Company of $32 thousand.

 

The fair value of the equity investment was $0 million as of December 31, 2022 and $11.0 million as of December 31, 2021. The fair value of the equity investment was classified as Level 3 in the fair value hierarchy as the calculation was dependent upon company specific adjustments to the observable trading price of the SPAC’s public units and shares, and related risk of forfeiture should no business combination occur. The Company recognized a loss on equity investments of $10,932 thousand for the year ended December 31, 2022, included in the Loss on equity investments in the accompanying Consolidated Statements of Operations.

 

In December 2021, the Company acquired 8,841 shares of 10% Cumulative Convertible Series D Preferred Stock at a price of $10.00 per share as payment for a customer’s outstanding AR balance of $88,410. This instrument is considered an equity security within the scope of Topic 321 since the issuing entity has the option but no contractual obligation to redeem the preferred stock, and the Company can convert the preferred shares to common stock. For the year ended December 31, 2022, a fair value gain of $12 thousand, was recognized and included in Loss on equity investments, in the accompanying Consolidated Statements of Operations. The fair value of the equity investment was $100 thousand as of December 31, 2022, and $88 thousand as of December 31, 2021, and included in Prepaid expenses and other current assets on the accompanying Consolidated Balance Sheets. The fair value of the equity investment is classified as Level 1 in the fair value hierarchy as the calculation is dependent upon the quoted market price of the entity.

 

NOTE 3 – REVENUE

 

Revenue by Category

 

The following table presents our revenue disaggregated by various categories (dollars in thousands).

 

                              
   VerifyMe   PeriShip Global   Consolidated 
Revenue  Year Ended
December 31,		   Year Ended
December 31,		   Year Ended
December 31,		 
   2022   2021   2022   2021   2022   2021 
                         
Proactive services  $-    -   $15,202    -   $15,202   $- 
Premium services   -    -    2,988    -    2,988    - 
Brand protection services   1,386    867    -    -    1,386    867 
   $1,386   $867   $18,190   $-   $19,576   $867 

 

Contract Balances

 

The timing of revenue recognition, billings and cash collections results in unbilled revenue (contract assets) and deferred revenue (contract liabilities) on the consolidated balance sheets. Amounts charged to our clients become billable according to the contract terms, which usually consider the delivery completion. Unbilled amounts will generally be billed and collected within 30 days but typically no longer than 60 days. When we advance bill clients prior to the work being performed, generally, such amounts will be earned and recognized in revenue within the 30 days. These assets and liabilities are reported on the consolidated balance sheet on a contract-by-contract basis at the end of each reporting period. Changes in the contract asset and liability balances during the year ended December 31, 2022, were not materially impacted by any other factors.

 

Applying the practical expedient in ASC Topic 606, we recognize the incremental costs of obtaining contracts (i.e. sales commissions) as an expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. As of December 31, 2022, we did not have any capitalized sales commissions.

 
 F-13 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

NOTE 4 – BUSINESS COMBINATION

 

PeriShip LLC

On April 22, 2022, we acquired, through PeriShip Global, the business and certain assets of PeriShip, LLC (“PeriShip”), a value-added service provider for time and temperature sensitive parcel management.  PeriShip Global provides shipping logistics services utilizing proprietary predictive analytics software and supporting call center services.  Using our proprietary software platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. The purchase price was $10.5 million which consisted of $7.5 million in cash paid at closing, a promissory note of $2.0 million with a fixed interest rate of 6% per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing, and 305,473 shares of common stock of the Company, representing $1.0 million in stock consideration. The goodwill recognized is due to the expected synergies from combining the operations of the acquire with the Company. All of the goodwill recorded for financial statement purposes is deductible for tax purposes. The acquired PeriShip business is included in the PeriShip Global Solutions segment and the results of its operations have been included in the consolidated financial statements beginning April 22, 2022. 

 

On September 22, 2022, the Company entered into an agreement with the owner of PeriShip, LLC to resolve certain disputes among the parties, reduce the principal and interest on the promissory note, repay the amended promissory note in full, and repurchased 61,000 shares of the Company’s common stock (see Note 9). The Company accounted for the agreement in accordance with Topic 250, through earnings, with the full amount included as a Gain on extinguishment of debt on the accompanying Consolidated Statements of Operations for a total of $326 thousand, for the year ended December 31, 2022.

 

The following table summarizes the purchase price allocation for the acquisition (dollars in thousands).

 

             
Cash   7,500         
Promissory note   2,000         
Stock (issuance of 305,473 shares of common stock) (1)   974         
Total purchase price   10,474         
         
       Amortization 
       Period 
Purchase price allocation:          
Accounts receivable, net   836      
Prepaid expenses   5      
Developed Technology   3,143    6 years 
Trade Names/Trademarks   1,111    13 years 
Customer Relationships   1,839    10 years 
Non-Compete Agreement   191    5 years 
Property and Equipment, net   193      
Goodwill   3,988      
Accounts payable and other accrued expenses   (832)     
    10,474      

 

(1)Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736.

 

Unaudited Pro forma Financial Information

 

The following unaudited proforma financial information presents the combined results of operations of the Company and gives effect to the acquisition discussed above for the years ended December 31, 2022, and 2021, as if the acquisition had occurred as of the beginning of the first period presented instead of on April 22, 2022.

 

The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations that would have been realized if the acquisition had been completed on January 1, 2021, nor does it purport to project the results of operations of the combined company in future periods. The pro forma financial information does not give effect to any anticipated integration costs related to the acquired company during the periods presented.

 
 F-14 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The below table summarizes proforma financial information for the Company, and the acquired PeriShip business, assuming the acquisition date of PeriShip occurred on January 1, 2021 (dollars in thousands):

 

        
   Years Ended
December 31,		 
Description  2022   2021 
         
Revenues  $25,397   $29,500 
Net Income (loss)  $(14,298)  $5,465 

 

NOTE 5 – INTANGIBLE ASSETS AND GOODWILL

 

Goodwill

 

Goodwill represents costs in excess of values assigned to the underlying net assets of acquired businesses. Intangible assets acquired are recorded at estimated fair value. Goodwill is deemed to have an indefinite life and is not amortized but is tested for impairment annually, and at any time when events suggest an impairment more likely than not has occurred. We test goodwill at the reporting unit level.

 

ASC Topic 350, Intangibles - Goodwill and Other (ASC Topic 350), permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test.  Under ASC Topic 350, an entity is not required to perform a quantitative goodwill impairment test for a reporting unit if it is more likely than not that its fair value is greater than its carrying amount. A reporting unit is an operating segment, or one level below an operating segment, as defined by U.S. GAAP.

 

Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, future economic and market conditions and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The timing and frequency of our goodwill impairment tests are based on an ongoing assessment of events and circumstances that would indicate a possible impairment. We will continue to monitor our goodwill and intangible assets for impairment and conduct formal tests when impairment indicators are present.

 

Each of our two reportable segments represents an operating segment under ASC Topic 280, Segment Reporting. We test our goodwill at the reporting unit level, or one level below an operating segment, under ASC Topic 350, Intangibles - Goodwill and Other. We determined that we have two reporting units for purposes of goodwill impairment testing, which represent our two reportable business segments, as discussed below.

 

For the year ended December 31, 2021, there were no goodwill activities. Changes in the carrying amount of goodwill by reportable business segment for the year ended December 31, 2022, were as follows (in thousands):

 

            
   VerifyMe   PeriShip Global   Total 
Net book value at            
January 1, 2022  $ -   $ -   $ - 
             
2022 Activity               
Acquisition   -    3,988    3,988 
                
Net book value at               
December 31, 2022  $-   $3,988   $3,988 

 

Intangible Assets Subject to Amortization

 

Our intangible assets include amounts recognized in connection with patents and trademarks, capitalized software and acquisitions, including customer relationships, tradenames, developed technology and non-compete agreements. Intangible assets are initially valued at fair market value using generally accepted valuation methods appropriate for the type of intangible asset. Amortization is recognized on a straight-line basis over the estimated useful life of the intangible assets. Intangible assets with definite lives are reviewed for impairment if indicators of impairment arise. Except for goodwill, we do not have any intangible assets with indefinite useful lives.

 
 F-15 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

Intangible assets with finite lives are subject to amortization over their estimated useful lives. The primary assets included in this category and their respective balances were as follows (in thousands):

 

               
December 31, 2022  Gross Carrying
Amount		   Accumulated
Amortization		   Net Carrying
Amount		 
Patents and Trademarks  $1,858   $(445)  $1,413 
Capitalized Software   206    (91)   115 
Customer Relationships   1,839    (133)   1,706 
Developed Technology   3,143    (360)   2,783 
Internally Used Software   236    (4)   232 
Non-Compete Agreement   191    (28)   163 
   $7,473   $(1,061)  $6,412 
December 31, 2021               
Patents and Trademarks  $707   $(354)  $353 
Capitalized Software   206    (50)   156 
   $913   $(404)  $509 

 

Amortization expense for intangible assets was $657 thousand and $64 thousand for the year ended December 31, 2022, and 2021, respectively.

 

Patents and Trademarks

 

As of December 31, 2022, the current patent and trademark portfolios consist of eleven granted U.S. patents and one granted European patent validated in four countries (France, Germany, United Kingdom, and Italy), six pending U.S. and foreign patent applications, fifteen registered U.S. trademarks (of which seven trademarks were acquired through our wholly owned subsidiary, PeriShip Global), two EU trademark registrations, one Colombian trademark registration, one Australian trademark registration, one Japanese trademark registration, one Mexican trademark registration, one Singaporean trademark registration, two UK trademark registrations, and twenty-one pending US and foreign trademark applications.

 

The Company expects to record amortization expense of intangible assets over the next 5 years and thereafter as follows (in thousands):

 

      
Fiscal Year ending December 31,     
2023   $1,057 
2024    877 
2025    857 
2026    842 
2027    836 
Thereafter    1,943 
Total   $6,412 

 

As of December 31, 2022, our intangible assets with definite lives had a weighted average remaining useful life of 8.4 years.  We have no amortizable intangible assets with indefinite useful lives.

 
 F-16 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

NOTE 6 – INCOME TAXES

 

The reconciliation of income tax expense computed at the U.S. federal statutory rate to the income tax provision for the years ended December 31, 2022, and 2021 is as follows (in thousands):

 

          
   Year Ended December 31, 
US  2022   2021 
         
Income (loss) before income taxes  $(14,400)  $(3,612)
Taxes under statutory US tax rates   (3,024)   759 
Increase (decrease) in taxes resulting from:          
Increase (decrease) in valuation allowance   (1,188)   (6,149)
Change in State tax rate   (57)   - 
All other   5,045    5,204 
State taxes   (776)   186 
Income tax expense  $-   $- 

  

The decrease in the Company's net valuation allowance was due primarily to a realized loss in our equity investment (See Note 2-Equity Investment), and to net operating losses which will expire unutilized due to limitations resulting from application of Section 382 of the Internal Revenue Code of 1986, as amended (“IRC”).

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities consist of the following (in thousands):

 

          
   December 31, 
   2022   2021 
US        
Net operating loss carryforwards  $6,495   $5,208 
Restricted Stock (RSA’s, RSU’s)   503    180 
Stock Options   562    678 
Stock Purchase Plan (SPP)   8    - 
Depreciation   (71)   (33)
Intangibles   22    9 
Acquisition Transaction Costs   110    - 
Capitalized Research and Development   17    - 
Unrealized Gain on Investment   (1)   (2,188)
Bad Debt   9    - 
Dividend Income   (2)   - 
Gross deferred tax assets  $7,652   $3,854 
           
Less valuation allowance   (7,652)   (3,854)
Total deferred tax assets  $-   $- 
           
Deferred tax liabilities:          
Total deferred tax liabilities   -    - 
Net deferred tax assets / (liabilities)  $-   $- 

 

 

Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.

 

In 2022, the Company completed the IRC Section 382 analysis, and determined that an ownership change occurred sufficient to impose additional limitations on the use of NOL carryforwards. For the year ended December 31, 2022, Federal and state NOLs of $23.1 million and $0, respectively, will expire unutilized due to the limitations of Section 382, leaving Federal and state NOL carryforwards of $24.4 million and $13.1 million, respectively that may be offset against future taxable income. Some of the Federal and state tax NOL carryforwards will expire at various dates through 2037. Generally, these can be carried forward and applied against future taxable income at the tax rate applicable at that time. We are currently using an effective income tax rate of 26.6% for our projected available net operating loss carry-forward. No tax benefit has been reported in the December 31, 2022, due to the uncertainty surrounding the realizability of the benefit.

 
 F-17 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

In accordance with FASB ASC 740 “Income Taxes”, valuation allowances are provided against deferred tax assets, if based on the weight of available evidence, some or all of the deferred tax assets may or will not be realized. The Company has evaluated its ability to realize some or all of the deferred tax assets on its balance sheet and has established a valuation allowance of approximately $7.7 million at December 31, 2022. The Company did not utilize any NOL deductions for the year ended December 31, 2022.

 

The Company applied the "more-likely-than-not" recognition threshold to all tax positions taken or expected to be taken in a tax return, which resulted in no unrecognized tax benefits as of December 31, 2022, and December 31, 2021, respectively.

 

The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest and penalties on the balance sheets and has not recognized interest and/or penalties in the Statements of Operations for the years ended December 31, 2022, and 2021.

 

The Company is subject to taxation in the United States and various state jurisdictions. The Company’s tax years from 2003 are subject to examination by the United States and state taxing authorities due to the carryforward of unutilized NOLs.

 

There are no taxes payable as of December 31, 2022, or December 31, 2021.

 

NOTE 7—DEBT

 

On April 22, 2022, the Company issued a $2.0 million unsecured promissory note through our subsidiary PeriShip Global as part of the acquisition of the PeriShip business. The note had a fixed interest rate of 6% per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing. On September 22, 2022, the Company entered into an agreement with the note holder whereby the Company repaid the outstanding principal balance and accrued interest outstanding on the note and redeemed 61,000 shares of its common stock from the holder of the note, for a total of $1.8 million, at which point the guarantee agreement entered into by the Company in connection therewith was automatically terminated and has no further effect.

 

The Company accounted for the early extinguishment of debt in accordance with ASC 405-20 - Extinguishment of Liabilities, and recognized a gain included in Gain on extinguishment of debt on the accompanying Consolidated Statements of Operations of $326 thousand for the year ended December 31, 2022.

 

Contemporaneously, the Company entered into a new debt facility with PNC Bank, National Association (the “PNC Facility”). The PNC Facility includes a $1 million revolving line of credit (the “RLOC”) with a term of one-year, expiring in September 2023. The RLOC has no scheduled payments of principal until maturity, and bears interest per annum at a rate equal to the sum of Daily SOFR plus 2.85% with monthly interest payments. The PNC Facility also includes a four-year term note (the “Term Note”) for $2 million which matures in September of 2026 and requires equal quarterly payments of principal and interest. The Term Note incurs interest per annum at a rate equal to the sum of Daily SOFR plus 3.1%.  The RLOC and Term Note are guaranteed by the Company and secured by the assets of PeriShip Global and the Company.

 

The PNC Facility includes a number of affirmative and restrictive covenants applicable to PeriShip Global, including, among others, a financial covenant to maintain a fixed charge coverage ratio of at least 1.10 to 1.00 at the end of each fiscal year, affirmative covenants regarding delivery of financial statements, payment of taxes, and establishing primary depository accounts with PNC Bank, and restrictive covenants regarding dispositions of property, acquisitions, incurrence of additional indebtedness or liens, investments and transactions with affiliates. PeriShip Global is also restricted from paying dividends or making other distributions or payments on its capital stock if an event of default (as defined in the PNC Facility) has occurred or would occur upon such declaration of dividend. PeriShip Global was in compliance with all affirmative and restrictive covenants under the PNC Facility at December 31, 2022.

 

Effective October 17, 2022, the Company entered into an interest rate swap agreement, with a notional amount of $1,958 thousand, effectively fixing the interest rate on the Company’s outstanding debt at 7.602%. The Company has designated the intertest rate swap, expiring September 2026, as a cash flow hedge and have applied hedge accounting. The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and is included in Long-term Derivative Liability on the Consolidated Balance Sheets.

 

As of December 31, 2022, our short-term debt outstanding under the Term Note was $0.5 million and total long-term debt outstanding under the Term Note was $1.4 million.

 

No amounts were drawn on the RLOC as of December 31, 2022.

 
 F-18 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

On May 17, 2020, the Company entered into a paycheck protection program term note for $72 thousand (the “SBA Loan”) with PNC Bank, N.A. under the recently enacted Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) pursuant to the Paycheck Protection Program (the “PPP”), which is administered by the U.S. Small Business Administration. The SBA Loan was scheduled to mature on May 17, 2022, and bore interest at a rate of 1.00% per annum and is subject to the terms and conditions applicable to loans administered by the U.S. Small Business Administration under the CARES Act.

 

The Company applied for and was notified in June 2021 that $69 thousand in eligible payroll expenditures as described in the CARES Act, has been forgiven. Loan forgiveness is reflected in Other Income (Expense), Net in the accompanying Consolidated Statements of Operations. The forgiveness recognized during the year ended December 31, 2021, included principal of $69 thousand, and interest payable of $1 thousand. The remaining loan balance of $3 thousand was paid in full in June 2021.

 

 NOTE 8 – CONVERTIBLE PREFERRED STOCK

 

The Company is authorized to issue Series A Convertible Preferred Stock, par value of $0.001 per share (the “Series A”) and Series B Convertible Preferred Stock, par value of $0.001 per share (the “Series B”). As of December 31, 2022, and 2021, there were no shares of Series A outstanding and 0.85 of a share of Series B outstanding convertible into 144,444 shares of common stock. Each share of Series A and Series B has limited voting rights, is entitled to participate with the common stock on liquidation and holders of Series A and Series B are subject to beneficial ownership limitations.

 

NOTE 9 – STOCKHOLDERS’ EQUITY

 

The Company expensed $239 thousand and $784 thousand related to restricted stock awards for the years ended December 31, 2022, and December 31, 2021, respectively.

 

The Company expensed $1,084 thousand and $696 thousand related to restricted stock units for the years ended December 31, 2022, and December 31, 2021, respectively.

 

During the year ended December 31, 2022, and 2021, the Company issued 30,000 and 9,774 shares of common stock in relation to services with a stock-based compensation expense of $96 thousand and $39 thousand, respectively.

 

On August 11, 2022, we received an exercise notice to exercise 675,000 pre-funded warrants with an exercise price of $0.001 per share. Upon receipt of $675 the Company issued 675,000 shares of its common stock.

 

On April 22, 2022, 305,473 shares of common stock were issued in relation to the acquisition of the PeriShip business, see Note 4 – Business Combinations, for details.

 

On April 15, 2022, the Company withheld and retired 750 shares of common stock in order to satisfy U.S. payroll tax withholding obligations on restricted stock awards held by our Chief Financial Officer. 

 

On April 12, 2022, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with a selling stockholder and certain directors, providing for the issuance and sale to purchasers therein of an aggregate of 880,208 shares of our common stock, pre-funded warrants to purchase up to 675,000 shares of our common stock, and warrants to purchase up to 1,555,208 shares of our common stock, for gross proceeds to us of approximately $5.0 million and net proceeds of $4.6 million. The pre-funded warrant is exercisable immediately and shall terminate when fully exercised and has an exercise price of $0.001 per share. The pre-funded warrant was exercised in full on August 11, 2022. The warrants will be exercisable for a period of five years commencing six months from the date of issuance and have an exercise price of $3.215 per share. Both the pre-funded warrants and warrants contain price adjustment provisions which may, under certain circumstances, reduce the applicable exercise price. The transaction closed on April 14, 2022.

 

On March 29, 2022, the Company withheld and retired 8,870 shares of common stock in order to satisfy U.S. payroll tax withholding obligations on restricted stock awards held by our Chief Executive Officer.

 

Non-Qualified Stock Purchase Plan

 

On June 10, 2021, the stockholders of the Company approved a non-qualified stock purchase plan (the “2021 Plan”). The 2021 Plan provides eligible participants, including employees, directors and consultants of the Company, the opportunity to purchase shares of the Company’s common stock thereby increasing their interest in the Company’s continued success. The maximum numbers of common stock reserved and available for issuance under the 2021 Plan is 500,000 shares. The purchase price of shares of common stock acquired pursuant to the exercise of an option will be the lesser of 85% of the fair market value of a share (a) on the enrollment date, and (b) on the exercise date. The 2021 Plan is not intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”). The Company applied FASB ASC 718, “Compensation-Stock Compensation” and estimated the fair value using the Black-Scholes model, as the plan is considered compensatory. In relation to the non-qualified stock purchase plan the Company expensed $122 thousand and $40 thousand for the years ended December 31, 2022 and December 31, 2021, respectively.

 

 F-19 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

Shares Held in Treasury

 

As of December 31, 2022, and December 31, 2021, the Company had 389,967 and 223,956 shares, respectively, held in treasury with a value of approximately $949 thousand and $838 thousand, respectively.  

 

On February 28, 2022, five participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 25,000 shares were issued from treasury with a purchase price of $2.69 per share.

 

On August 31, 2022, four participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 28,895 shares were issued from treasury with a purchase price of $1.20 per share.

 

On September 22, 2022, the Company paid $1.8 million of the $2.0 million principal amount promissory note issued to the seller in connection with the PeriShip acquisition, inclusive of the Company redeeming 61,000 shares of its common stock from the seller, pursuant to an agreement with the seller, see Note 4.

 

Shares Repurchase Program

 

In November 2020, the Company’s Board of Directors approved a share repurchase program for up to $1.5 million of the Company’s common stock until August 16, 2021. On August 12, 2021, the Company’s Board of Directors extended the share repurchase program to expire on August 16, 2022. Effective July 1, 2022, the Company’s Board of Directors terminated the existing share repurchase program and approved a new share repurchase program to replace the existing program due to expire on August 16, 2022, to allow the Company to spend up to $1.5 million to repurchase shares of its common stock, so long as the price does not exceed $5.00 until July 1, 2023. During year ended December 31, 2022, the Company repurchased 158,906 shares of common stock under the Company’s current program.

 

NOTE 10– STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS

 

During 2013, the Company adopted the 2013 Omnibus Equity Compensation Plan (the “2013 Plan”). Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards up to an aggregate of 400,000 shares of common stock.  The 2013 Plan is intended to permit certain stock options granted to employees under the 2013 Plan to qualify as incentive stock options.  All options granted under the 2013 Plan, which are not intended to qualify as incentive stock options are deemed to be non-qualified stock options.  

 

On November 14, 2017, the Executive Committee of the Company’s Board of Directors adopted the 2017 Equity Incentive Plan (the “2017 Plan”) which covered the potential issuance of 260,000 shares of common stock. The 2017 Plan provided that directors, officers, employees, and consultants of the Company were eligible to receive equity incentives under the 2017 Plan at the discretion of the Board or the Board’s Compensation Committee.

 

On August 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”), subject to stockholder approval, which authorizes the potential issuance of up to 1,069,110 shares of common stock. On September 30, 2020, the Company’s stockholders approved the 2020 Plan, and upon such approval the 2020 Plan became effective and the 2017 Plan was terminated. Shares of common stock underlying existing awards under the 2017 Plan may become available for issuance pursuant to the terms of the 2020 Plan under certain circumstances. Employees and non-employee directors of the Company or its affiliates, and other individuals who perform services for the Company or any of its affiliates, are eligible to receive awards under the 2020 Plan at the discretion of the Board of Directors or the Board’s Compensation Committee.

 

The 2020 Plan is administered by the Compensation Committee which determines the persons to whom awards will be granted, the number of awards to be granted and the specific terms of each grant, including the vesting thereof, subject to the provisions of the plan.

 
 F-20 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate, 1,000,000.

 

The Company has issued non-qualified stock options pursuant to contractual agreements with non-employees. Options granted under the agreements are expensed when the related service or product is provided. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value represent management’s best estimates and involve inherent uncertainties and judgements.

 

Stock Options

 

                     
    Options Outstanding 
              Weighted -      
              Average      
              Remaining   Aggregate 
         Weighted-   Contractual   Intrinsic 
    Number of   Average   Term   Value 
    Shares   Exercise Price   (in years)   (in thousands)(1) 
Balance as of December 31, 2020    473,771   $4.48           
                      
Granted    -    -           
                      
Forfeited/Cancelled/Expired    (8,300)   9.72           
                      
Balance as of December 31, 2021    465,471    4.38           
                      
Exercisable as of December 31, 2021    465,471   $4.38    3.2   $47 
                      
Granted    -    -           
                      
Forfeited/Cancelled/Expired    (128,000)   3.74           
                      
Balance as of December 31, 2022    337,471    4.63           
                      
Exercisable as of December 31, 2022    337,471   $4.63    2.4   $- 

  

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

 

As of December 31, 2022, and 2021, the Company had no unvested stock options.

 

 F-21 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The following table summarizes the activities for the Company’s unvested stock options for the year ended December 31, 2022, and 2021:

 

           
    Unvested Options 
         Weighted - 
         Average 
    Number of   Grant 
    Unvested Options   Date Exercise Price 
            
            
Balance at December 31, 2020    10,000   $9.75 
            
Granted    -    - 
            
Vested    (10,000)   9.75 
            
Balance at December 31, 2021    -    - 
            
Granted    -    - 
            
Vested    -    - 
            
Balance at December 31, 2022    -   $- 

 

During the year ended December 31, 2022, and 2021, the Company expensed $0 thousand and $85 thousand with respect to options.

 

As of December 31, 2022, and 2021, there was $0 unrecognized compensation cost related to outstanding stock options.

 

Restricted Stock Awards and Restricted Stock Units

 

The following table summarizes the unvested restricted stock awards as of December 31, 2022 and 2021:

 

           
    Unvested Restricted Stock Awards 
         Weighted - 
         Average 
    Number of   Grant 
    Award Shares   Date Fair Value 
            
Balance at December 31, 2020    267,500    3,80 
            
Granted    89,284    4,32 
            
Vested    (312,142)   3.87 
            
Balance at December 31, 2021    44,642    4.31 
            
Granted    39,308    3.18 
            
Vested    (42,142)   4.32 
            
Balance at December 31, 2022    41,808   $3.24 

 

As of December 31, 2022, and 2021, total unrecognized share-based compensation cost related to unvested restricted stock awards was $2 thousand and $115 thousand respectively, which is expected to be recognized over a weighted-average period of 0.02 years as of December 31, 2022.

 
 F-22 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The following table summarizes the unvested restricted stock units as of December 31, 2022 and 2021:

 

           
    Unvested Restricted Stock Units 
         Weighted - 
         Average 
    Number of   Grant 
    Unit Shares   Date Fair Value 
Unvested at December 31, 2020    -    - 
            
Granted    208,010    4.05 
            
Vested    (21,000)   3.44 
            
Unvested at December 31, 2021    187,010    4.11 
            
Granted    418,041    2.14 
            
Vested    (191,425)   4.07 
            
Balance at December 31, 2022   $413,626   $2.14 

 

As of December 31, 2022, and 2021, total unrecognized share-based compensation cost related to unvested restricted stock units was $284 thousand and $146 thousand respectively, which is expected to be recognized over a weighted-average period of 1.02 years as of December 31, 2022.

 

For RSUs with stock price appreciation targets, we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value of each grant was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the derived service period and there is no ongoing adjustment or reversal based on actual achievement during the period.

 

The following table summarizes the unvested performance restricted stock units as of December 31, 2022. There were no performance restricted stock units prior to the year 2022.:

 

           
    Unvested Performance Restricted Stock Units 
         Weighted - 
         Average 
    Number of   Grant 
    Unit Shares   Date Fair Value 
Unvested at December 31, 2021    -    - 
            
Granted    432,326    2.95 
            
Vested    -    - 
            
Balance at December 31, 2022   $432,326   $2.95 

 

As of December 31, 2022, total unrecognized share-based compensation cost related to unvested restricted stock units was $947 thousand, which is expected to be recognized over a weighted-average period of 2.23 years.

 

 F-23 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

Warrants

 

The following table summarizes the activities for the Company’s warrants for the year ended December 31, 2022 and 2021:

 

                    
   Warrants Outstanding (Excluding Pre-Funded Warrants) 
   Number of
Warrant Shares		  

Weighted-

Average

Exercise

Price

  

Weighted -

Average

Remaining

Contractual

Term

in years)

  

Aggregate

Intrinsic

Value

(in thousands)(1)

 
Balance at December 31, 2020   3,779,243   $5.89               
                     
Granted   -    -           
                     
Expired   -    -           
                     
Balance at December 31, 2021   3,779,243    5.89           
                     
Granted   1,590,150    3.22           
                     
Expired   (265,938)   19.21           
                     
Balance at December 31, 2022   5,103,455   $4.34    3.0      
                     
Exercisable at December 31, 2022   5,103,455   $4.34    3.0   $- 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022.

 

For the year ended December 31, 2022, and 2021, the Company granted 34,942 warrants and 0 warrants to warrant holders pursuant to anti-dilution provisions, 1,555,208 warrants and 0 warrants in conjunction with the Securities Purchase Agreement, respectively (see Note 9 – Stockholders’ Equity). As the fair value of the warrants granted would have had a net zero impact to equity (increasing additional paid in capital and offering costs for the same amount), the Company did not break out or complete a separate valuation of the warrants granted in association with either capital raise. 

 

Pre-funded Warrants

 

On April 14, 2022, in connection with our Securities Purchase Agreement (see Note 9 – Stockholders’ Equity), the Company issued 675,000 pre-funded warrants to purchase up to an aggregate of 675,000 shares of common stock at a purchase price of $3.214 per pre-funded warrant, which represented the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. In August 2022, 675,000 pre-funded warrants with an exercise price of $0.001 per share were exercised, and 675,000 shares of the Company’s common stock were issued. No pre-funded warrants are outstanding as of December 31, 2022.

 

 F-24 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

NOTE 11—EARNINGS (LOSS) PER SHARE

 

Basic earnings/(loss) per share (EPS) is computed by dividing net income/(loss) by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution of common stock equivalent shares that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

 

The dilutive common stock equivalent shares consist of preferred stock, stock options, warrants, restricted stock awards and restricted stock units computed under the treasury stock method, using the average market price during the period.

 

The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except share and per share data):

 

               
    Years Ended December 31,  
    2022     2021  
Numerator:            
Net Income/(Loss)   $ (14,398)     $ 3,612  
Denominator:                
Weighted average shares of common stock – basic     8,466,075       7,110,907  
                 
Effect of dilutive securities                
                 
Preferred Stock     -       144,444  
Stock Options     -       48,212  
Warrants     -       23  
Stock Purchase Plan     -       2,362  
Restricted Stock Units & Restricted Stock Awards     -       77,416  
Weighted average shares of common
stock – diluted		     8,466,075       7,383,364  
                 
(Loss)/Earnings per share                
                 
Basic   $ (1.70)     $ 0.51  
                 
Diluted   $ (1.70)     $ 0.49  

 

 
 F-25 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The following table represents the weighted average number of anti-dilutive instruments excluded from the computation of diluted (loss)/earnings per share:

 

        
   Years Ended
December 31,		 
   2022   2021 
Anti-dilutive instruments excluded from computation of diluted net income/(loss) per share:        
         
Preferred Stock   144,444    - 
           
Stock Options   337,471    177,334 
           
Warrants   5,103,455    3,779,048 
           
Stock purchase plan   57,245    - 
           
Restricted Stock Units and Restricted Stock Awards   887,760    13,196 

 

NOTE 12—LONG TERM DERIVATIVE LIABILITY

 

On April 7, 2022, the Company granted two directors 11,250 restricted stock units each (“SPAC RSUs”) with respect to the common stock, $0.0001 par value per share, of G3 VRM Acquisition Corp. The SPAC RSUs were to vest upon the initial business combination of the SPAC (see Note 2 – Equity Investments) subject to continuous service to the Company through the vesting date. Each vested SPAC RSU represented the right to receive the value of one share of stock in G3 VRM Acquisition Corp., which would have been paid to the director as soon as practicable after the fifteen-month anniversary of the vesting date.

 

On September 17, 2021, the Company granted two directors SPAC RSUs with respect to the common stock, $0.0001 par value per share, of G3 VRM Acquisition Corp. The SPAC RSUs were to vest upon the initial business combination of the SPAC (see Note 2 – Equity Investments) subject to continuous service to the Company through the vesting date. Each vested SPAC RSU represented the right to receive the value of one share of stock in G3 VRM Acquisition Corp., which was to be paid to the director as soon as practicable after the fifteen-month anniversary of the vesting date. The grant date fair value of the SPAC RSUs for each director was $98 thousand. As the underlying awards were not the Company’s stock but an unrelated, publicly traded entity’s shares, the Company accounted for the awards under ASC 815 – Derivatives and Hedging, with the expense included in stock-based compensation under General and Administrative expenses in the accompanying Consolidated Statements of Operations.

 

In June 2022, the Sponsor Entity decided not to fund the extension for the time that the SPAC had to complete its initial business combination. As a result, the SPAC was dissolved and liquidated in accordance with its charter and under ASC 815, and the derivative instrument was terminated. As a result, the SPAC RSUs were forfeited. For the year ended December 31, 2022, the Company has recorded the effect of termination to reduce the fair value and recorded a credit to share-based compensation expense of $71 thousand in relation to these awards. The fair value of the derivative liability was $0 as of December 31, 2022, and $71 thousand as of December 31, 2021.

 

Effective October 17, 2022, the Company entered into an interest rate swap agreement (see Note 7 – Debt for details). The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and $0 as of December 31, 2021.

 
 F-26 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

NOTE 13 –EMPLOYEE BENEFIT PLAN

 

We offer the VRME Retirement Savings Plan (the “Plan”) to our employees. Eligible employees can elect to participate in the Plan, as soon as administratively feasible after enrollment. The Plan permits pre-tax contributions to the Plan by participants pursuant to Section 401(k) of the Internal Revenue Code (IRC). We make matching contributions at our discretion. In 2022 and 2021 we contributed a value of approximately $103 thousand and $10 thousand respectively and is recognized as compensation expense in the consolidated statements of operations for matching contributions to the Plan.

 

NOTE 14 –LEASES

 

The Company accounts for its leases under Accounting Standard Codification (“ASC”) Topic 842, Leases. The Company determines at its inception whether an arrangement that provides us control over the use of an asset is a lease. We recognize at lease commencement a right-of-use (ROU) asset and lease liability based on the present value of the future lease payments over the lease term. We have elected not to recognize a ROU asset and lease liability for leases with terms of 12 months or less. Our current long-term lease includes an option to extend the term of the lease prior to the end of the initial term. It is not reasonably certain that we will exercise the option and have not included the impact of the option in the lease term for purposes of determining total future lease payments. As our lease agreement does not explicitly state the discount rate implicit in the lease, we use our promissory note borrowing rate to calculate the present value of future payments.

 

In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. For our real estate leases, we apply a practical expedient to include these non-lease components in calculating the ROU asset and lease liability. For all other types of leases, non-lease components are excluded from our ROU assets and lease liabilities and expensed as incurred.

 

We have operating leases for office facilities. We do not have any finance leases.

 

Lease expense is included in General & Administrative Expenses on the accompanying Consolidated Statements of Operations. The components of lease expense were as follows (in thousands):

 

          
   Years ended December 31, 
   2022   2021 
Operating lease cost  $85   $- 
Short-term lease cost   18    14 
Total lease costs  $103   $14 

 

Supplemental information related to leases was as follows (dollars in thousands):

 

          
   December 31, 2022   December 31, 2021 
Operating Lease right-of-use asset  $469   $- 
           
Current portion of operating lease liabilities  $115   $- 
Non-current portion of operating lease liabilities  $359   $- 
Total operating lease liabilities  $474   $- 
           
Cash paid for amounts included in the measurement of operating lease liabilities  $80   $- 
           
Right-of-use assets obtained in exchange for operating lease liabilities  $552   $- 
           
Weighted-average remaining lease term for operating leases (years)   4.3      
Weighted average discount rate for operating leases   6.0%     

 

 F-27 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities on our consolidated balance sheets as of December 31, 2022 (in thousands):

 

     
Year ended December 31,    
2023  $122 
2024   126 
2025   130 
2026   134 
Thereafter   45 
Total future lease payments   557 
Less: imputed interest   (83)
Present value of future lease payments   474 
Less: current portion of lease liabilities   (115)
Long-term lease liabilities  $359 

 

NOTE 15 – CONCENTRATIONS

 

During the year ended December 31, 2022, one customer represented 13% of revenues and five customers represented 95% of revenues for the year ended December 31, 2021.

 

As of December 31, 2022, two customers made up 23% of accounts receivable. As of December 31, 2021, three customers accounted for 91% of total accounts receivable.

 

During the year ended December 31, 2022, one vendor accounted for 99% of transportation costs, in our PeriShip Global Solutions segment.

 

NOTE 16 – SEGMENT REPORTING

 

As of December 31, 2022, we operated through two reportable business segments: (i) PeriShip Global Solutions and (ii) VerifyMe Solutions.

 

PeriShip Global Solutions: This segment offers a value-added service provider for time and temperature sensitive parcel management. Through logistics management from a sophisticated IT platform with proprietary databases, package and flight-tracking software, weather, traffic, and flight status monitoring systems, as well as dynamic dashboards with real-time visibility into shipment transit and last-mile events that are managed by a call center Using our proprietary IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries.

 

VerifyMe Solutions. This segment specializes in solutions that connect brands with consumers through their products. Consumers can authenticate products with their smart phone prior to usage, and brand owners have the ability to gather business intelligence while engaging directly with their consumers. Our VerifyMe Solutions also provide brand protection and supply chain functions such as counterfeit prevention.

 

We do not allocate the following items to the segments: general and administrative expenses, research and development expense, sales and marketing expenses, and other income (expense).

 

 F-28 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

The following table sets forth the revenue and operating results attributable to each reportable segment and includes a reconciliation of segment revenue to consolidated revenue and operating results to consolidated loss before income tax expense (in thousands):

 

          
   Years Ended
December 31,		 
   2022   2021 
Revenue        
PeriShip Global Solutions  $18,190   $- 
VerifyMe Solutions   1,386    867 
Total Revenue  $19,576   $867 
           
Gross Profit          
PeriShip Global Solutions  $5,505   $- 
VerifyMe Solutions   983    599 
Total Gross Profit   6,488    599 
           
General and administrative   8,428    4,216 
Research and development   89    51 
Sales and marketing   1,718    1,163 
LOSS BEFORE OTHER (EXPENSE) INCOME   (3,747)   (4,831)
OTHER (EXPENSE) INCOME   (10,651)   8,443 
NET (LOSS) INCOME  $(14,398)  $3,612 

 

Additional information relating to our business segments is as follows (in thousands):

 

Identifiable assets:

 

   Years Ended
December 31,		 
   2022   2021 
         
PeriShip Global Solutions  $17,302   $- 
VerifyMe Solutions   3,450    21,688 
Total Assets  $20,752   $21,688 

 

NOTE 17 – SUBSEQUENT EVENTS

 

On March 1, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) effective as of February 28, 2023 (the “Effective Date”) by and among the Company, Trust Codes Global, Trust Codes Limited, a New Zealand limited liability company that specializes in unique item level codes for brand protection, data intelligence and consumer engagement technology with an expertise in the food and agriculture industry (“Trust Codes” or “Seller”) and Signum Holdings Limited (“Seller’s Parent”). Pursuant to the terms of the APA Trust Codes Global agreed to purchase from Trust Codes and Trust Codes agreed to sell to Trust Codes Global substantially all of the assets of Trust Codes and certain specified liabilities (the “Transaction”). The Transaction closed simultaneously with the execution of the APA on March 1, 2023 (the “Closing”).

 

The total consideration paid to the Seller at Closing in connection with the Transaction was approximately $1,000,000, which consisted of approximately $350,000 in cash (the “Cash Consideration”); and the issuance of 353,492 shares of restricted common stock of the Company at $1.84 per share (the “Stock Consideration”) (representing $650,000 in Stock Consideration). The total consideration due under the Transaction is subject to certain post-Closing adjustments, which shall be accounted for in the first cash earnout payment, discussed below, if applicable. 

 

 F-29 

 

VerifyMe, Inc.

Notes to the Consolidated Financial Statements

 

 

Under the APA, during the five-year period ending on the fifth anniversary of the Effective Date, Trust Codes Global shall pay the Seller quarterly cash earnout payments equal to 18% of the gross margin earned on existing customers and the Company shall issue to the Seller annual equity earnout payments of restricted shares of the Company’s common stock equal to 20% of gross margin earned on new customers during the applicable 12 month period divided by the VWAP for the 30-day period ending on the last day of the 12-month period, inclusive. If the value of equity earnout shares issued exceeds $3.1 million at any time during the earnout period, then any subsequent amount of equity earnout shall be reduced to 10% of gross margin earned on new customers received during the applicable 12-month period. In certain circumstance Trust Codes Global may pay cash in lieu of the Company issuing restricted common stock for the equity earnout. 

 

The APA is structured to comply with the shareholder approval requirements of the Nasdaq listing rules and contains a blocker provision which prevents the Seller from receiving any equity earnout shares should such earnout shares, in connection with the Stock Consideration, cause the Seller to beneficially own more than 19.99% of the voting securities of the Company. The APA contains customary confidentiality and indemnification provisions and customary representations, warranties and covenants by the parties for transactions of this type and also contains a five-year non-compete and non-solicitation provision applicable to the Seller, Seller’s Parent, and each of their affiliates, in favor of the Company and Trust Codes Global.

 

On February 28, 2023, fourteen participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 57,245 shares were issued with an exercise price of $1.19.

 

Effective March 15, 2023, the Company’s Chief Executive Officer, Patrick White, resigned as an officer and director of the Company. Scott Greenberg, the Company’s executive chairman of the Board, was appointed as Interim Chief Executive Officer. In connection with his resignation, Mr. White will receive payments totaling $159 thousand. In addition the Company awarded him 111,364 restricted stock units, with a grant date value equal to 70% of his annual base salary, each such unit representing the contingent right to receive one share of the Company’s common stock, par value $0.001 per share, subject to the terms of the Company’s 2020 Plan. These restricted stock units, except as otherwise provided in the award agreement, vest within three years in equal tranches provided the Company’s stock price exceeds $2.75 and $3.75 per share for twenty consecutive trading days. In connection with the grant of the restricted stock units Mr. White forfeited his outstanding award of restricted stock units granted pursuant to a Restricted Stock Unit Award Agreement dated February 26, 2022.

 

In connection with his appointment as Interim Chief Executive Officer, Mr. Greenberg was awarded 56,819 restricted stock units, with a grant date value equal to $100,000, each such unit representing the contingent right to receive one share of the Common Stock, subject to the terms of the 2020 Plan. These restricted stock units, except as otherwise provided in the award agreement, vest within three years in equal tranches provided the Company’s stock price exceeds $2.75 and $3.75 per share for twenty consecutive trading days.

 

 

F-30

 

 

 

 EX-4.8 2 ex4_8.htm EXHIBIT 4.8

 

Exhibit 4.8

 

DESCRIPTION OF SECURITIES

 

The following is a brief description of (i) the common stock, par value $0.001 per share (the “common stock”) and (ii) warrants to purchase common stock (the “warrants”), of VerifyMe, Inc. (the “Company,” “we,” “our” or “us”), which are the only securities of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended. This description is not complete, and we qualify it by referring to our amended and restated articles of incorporation, as amended (the “Articles of Incorporation”), our amended and restated bylaws, as amended (the “Bylaws”), the form of warrant, the form of Representative Warrant and the terms of the Warrant Agent Agreement, dated June 22, 2020, (the “Warrant Agreements”) for our outstanding warrants registered under Section 12, each of which is filed as an exhibit to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

 

Our Articles of Incorporation authorize us to issue 750,000,000 shares of capital stock, divided into two classes:

 

·650,000,000 shares of common stock, $0.001 par value per share; and
·75,000,000 shares of preferred stock, $0.001 par value per share (“preferred stock”)

 

Common Stock

 

Holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders. Subject to any rights of holders of our preferred stock, holders of shares of our common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our board of directors out of funds legally available for dividend payments. Upon our liquidation, dissolution or winding up, after payment of creditors and holders of outstanding shares of our preferred stock, if any, holders of shares of our common stock will be entitled to share ratably in any of the remaining assets of the Company. Our shares of our common stock are not subject to any liability for further assessments. There are no redemption or sinking fund provisions applicable to the common stock. Our common stock is not subject to call. The holders of our common stock have no cumulative voting, conversion, or pre-emptive or other subscription rights.

 

Preferred Stock

 

Our Articles of Incorporation provides our board of directors the authority, without further action by the stockholders, to issue, from time to time, up to 75,000,000 shares of preferred stock in one or more series. Our board of directors has the authority to determine the terms of each series of preferred stock, within the limits of the Articles of Incorporation and the laws of the state of Nevada. These terms include the number of shares in a series, dividend rights, liquidation preferences, terms of redemption, conversion rights, and voting rights.

 

The issuance of any preferred stock may negatively affect the holders of our common stock. These possible negative effects include diluting the voting power of shares of our common stock, affecting the market price or value of our common stock and delaying, deterring or preventing a change of control of us or an unsolicited acquisition proposal.

 

Series B Convertible Preferred Stock. Holders of our Series B Convertible Preferred Stock are entitled to participate pro rata with holders of common stock with respect to dividends and other distributions, including the distribution of assets upon liquidation. Each share of Series B Convertible Preferred Stock is convertible at any time into 169,934 shares of common stock; provided, that holders of Series B Convertible Preferred Stock are prohibited from converting Series B Convertible Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of common stock then issued and outstanding. Holders of our Series B Convertible Preferred Stock are not entitled to vote, except (i) as otherwise required by law and (ii) that each issued and outstanding share of Series B Convertible Preferred Stock is entitled to the number of votes equal to the number of shares of common stock into which each such share of Series B Convertible Preferred Stock is convertible in connection with (A) certain fundamental transactions or (B) the issuance by the Company, directly or indirectly, in one or more related transactions or series of related transactions, of shares of common stock, options or convertible securities if, in the aggregate, the number of such shares of common stock together with the number of shares of common stock issuable upon the conversion or exercise, as applicable, of such options and convertible securities is more than 20% of the number of shares of common stock issued and outstanding prior to any such issuance.

 

  
 

 

Warrants

 

As of December 31, 2022, the Company had outstanding warrants, which are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “VRMEW,” to purchase an aggregate of 3,073,379 shares of common stock as follows:

 

·2,173,913 warrants to purchase up to 2,173,913 shares of common stock that were issued by the Company on June 22, 2020 in connection with its underwritten public offering (the “Offering”) and listing on Nasdaq (the “Offering Warrants”);
·325,987 warrants to purchase up to 325,987 shares of common stock that were issued by the Company to the representative of the underwriters of the Offering upon it partially exercising its over-allotment option to purchase up to 326,087 warrants for 326,087 shares of common stock (the “Over-Allotment Warrants”); and
·573,479 warrants to purchase up to 573,479 shares of common stock that were issued by the Company upon closing of the Offering to certain persons in exchange for the cancellation of their warrants that were issued in connection with a private placement that was completed on March 6, 2020 (“Exchange Warrants” and together with the “Offering Warrants” and “Over-Allotment Warrants,” collectively, the “Uplist Warrants”).

 

Uplist Warrants

 

The Uplist Warrants are exercisable at an exercise price of $4.60 per share and will expire on June 22, 2025. Each Uplist Warrant is exercisable for one share of common stock. The exercise price and number of shares of common stock issuable upon exercise of the Uplist Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization, reorganization, merger or consolidation. However, the Uplist Warrants will not be adjusted for issuances of common stock at prices below its exercise price. The terms of the Uplist Warrants are governed by a Warrant Agreement, dated as of June 22, 2020, between the Company and West Coast Stock Transfer, Inc., as the warrant agent.

 

Representative’s Warrants

 

In connection with the Offering, we issued warrants to purchase up to 173,913 shares of common stock to the representative of the underwriters of the Offering (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at any time, and from time to time, in whole or in part, during the three-year period commencing 180 days following June 17, 2020 at an exercise price of $5.06. Each Representative’s Warrant is exercisable for one share of common stock. The exercise price and number of shares of common stock issuable upon exercise of the Representative’s Warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization, reorganization, merger or consolidation. However, the Representative’s Warrants will not be adjusted for issuances of common stock at prices below its exercise price.

 

Anti-Takeover Effects of Provisions of our Articles of Incorporation and Bylaws

 

Preferred Stock

 

Our board of directors, without stockholder approval, has the authority under our Articles of Incorporation to issue preferred stock with rights superior to the rights of the holders of common stock. As a result, preferred stock, while not intended as a defensive measure against takeovers, could be issued quickly and easily, could adversely affect the rights of holders of common stock and could be issued with terms calculated to delay or prevent a change of control of the Company or make removal of management more difficult.

 

Board of Directors Vacancies; Removal of Directors for Cause

 

Our Bylaw authorize only our board of directors, subject to our Articles of Incorporation and Nevada law, to create new directorships and to fill any vacant directorships by a majority vote of the directors. These provisions have the effect of preventing a stockholder from gaining control of our board of directors by filling the resulting vacancies with its own nominee. In addition, members of the board of directors may only be removed by the affirmative vote of the holders of not less than two-thirds of the voting power of our issued and outstanding stock entitled to vote generally in the election of directors. This provision may have the effect of delaying a change in control of our board.

 

Advance Notice Provisions for Stockholder Proposals and Stockholder Nominations of Directors

 

Our Bylaws provide for advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders and specify certain requirements regarding the form and content of a stockholder’s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed.

 

  
 

 

Special Meetings of Stockholders

 

Special meetings of the stockholders may be called only by our chief executive officer, the chairman of the board of directors or the president of the company pursuant to the requirements of our Bylaws.

 

Amendment of Bylaws

 

Our Bylaws grant both our stockholders and our board of directors the power to amend or repeal our bylaws by the affirmative vote of a majority of the board of directors or the combined voting stock of the outstanding capital stock of the Company.

 

 

 

 

 

 

 EX-21.1 3 ex21_1.htm EXHIBIT 21.1

 

Exhibit 21.1

 

SUBSIDIARIES OF VERIFYME, INC.

 

 

The following is a list of our subsidiaries as of December 31, 2022 that are required to be disclosed pursuant to Item 601(b)(21) of Regulation S-K.

 

 

Subsidiary Company   Jurisdiction of Organization
PeriShip Global, LLC   Delaware

 

 

 

 

 

 

 EX-31.1 4 ex31_1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

I, Scott Greenberg, certify that:

 

1.       I have reviewed this annual report on Form 10-K of VerifyMe, Inc.;

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.       The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2023.

/s/ Scott Greenberg  

Scott Greenberg

Interim Chief Executive Officer

(Principal Executive Officer)

  

 

 

 

 

 

 EX-31.2 5 ex31_2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

I, Margaret Gezerlis, certify that:

 

1.       I have reviewed this annual report on Form 10-K of VerifyMe, Inc.;

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.       The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2023

/s/ Margaret Gezerlis  

Margaret Gezerlis

Chief Financial Officer

(Principal Financial Officer and
Principal Accounting Officer)

  

 

 

 

 

 

 EX-32.1 6 ex32_1.htm EXHIBIT 32.1

  

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the report of VerifyMe, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, Scott Greenberg, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

 

2.The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Scott Greenberg  

Scott Greenberg

Interim Chief Executive Officer and
Executive Chairman

(Principal Executive Officer)

  

Dated: March 28, 2023

 

 

In connection with the report of VerifyMe, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof, I, Margaret Gezerlis, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

 

2.The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Margaret Gezerlis  

Margaret Gezerlis

Executive Vice President and Chief

Financial Officer

(Principal Financial Officer and
Principal Accounting Officer)

  

Dated: March 28, 2023

 

 

 

 

 

 EX-101.SCH 7 vrme-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Comprehensive Income/(Loss) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - EQUITY INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INTANGIBLE ASSETS AND GOODWILL link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - CONVERTIBLE PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - EARNINGS (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - LONG TERM DERIVATIVE LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - EMPLOYEE BENEFIT PLAN link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - EQUITY INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - BUSINESS COMBINATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - BUSINESS COMBINATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - BUSINESS COMBINATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - INCOME TAXES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - CONVERTIBLE PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - EARNINGS (LOSS) PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - EARNINGS (LOSS) PER SHARE (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - LONG TERM DERIVATIVE LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - LEASES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - LEASES (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SEGMENT REPORTING (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 vrme-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 vrme-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 vrme-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants to Purchase Common Stock Series A Preferred Stock [Member] Series B Preferred Stock [Member] Equity Components [Axis] Series A Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stocks [Member] AOCI Attributable to Parent [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Equipment For Lease [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 2 [Member] Investment, Name [Axis] Co Sponsor [Member] Sale of Stock [Axis] IPO [Member] Over-Allotment Option [Member] Private Placement [Member] Sponsor Entity [Member] Maxim Partners L L C [Member] Related Party Transaction [Axis] G V R M Holdings L L Cand Maxim Partners L L C [Member] Beneficial Owner [Member] G V R M Holdings L L C [Member] Series D Preferred Stock [Member] Consolidated Entities [Axis] Parent Company [Member] Product and Service [Axis] Proactive Services [Member] Subsidiaries [Member] Premium Services [Member] Brand Protection Services [Member] Business Acquisition [Axis] Business Combination [Member] Award Type [Axis] Restricted Stock [Member] Peri Ship [Member] Finite-Lived Intangible Assets by Major Class [Axis] Developed Technology Rights [Member] Trademarks [Member] Customer Relationships [Member] Noncompete Agreements [Member] Capitalized Software [Member] Internally Used Software [Member] Income Tax Authority [Axis] Foreign Tax Authority [Member] Domestic Tax Authority [Member] Credit Facility [Axis] Promissory Note [Member] Debt Instrument [Axis] Paycheck Protection Program Term Note [Member] P N C Bank N A [Member] Stock Options Restricted Stockand Unitsand Other Stockbased Awards [Member] Plan Name [Axis] Omnibus Equity Compensation Plan2013 [Member] Title of Individual [Axis] Board of Directors Chairman [Member] Equity Incentive Plan2017 [Member] Incentive Stock Options [Member] Issued Under The2020 Plan [Member] Plan2019 [Member] Restricted Stock Units [Member] Nonvested Stock Options [Member] Director And Officer [Member] Class of Warrant or Right [Axis] Debentures 2022 [Member] Debentures2020 [Member] Share-Based Payment Arrangement, Option [Member] Unvested Performance Restricted Stock Units [Member] Investment Type [Axis] Warrant [Member] Antidilutive Securities [Axis] Preferred Stock [Member] Stock Options [Member] Stock Purchase Plan [Member] Restricted Stock Units And Restricted Stock Awards [Member] G 3 V R M [Member] Director [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Customer [Member] Five Customer [Member] Accounts Receivable [Member] Two Customer [Member] Three Customer [Member] Transportation Cost [Member] Product Concentration Risk [Member] One Vendor [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Nonqualified Stock Purchase Plan [Member] N 2020 Plan [Member] Counterparty Name [Axis] Former Chief Executive Officer [Member] Greenberg [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Firm ID Auditor Name Auditor Location ASSETS CURRENT ASSETS Cash and cash equivalents, including restricted cash Accounts receivable, net of allowance for credit loss reserve, $37 and $0 as of December 31, 2022 and December 31, 2021, respectively Unbilled revenue Prepaid expenses and other current assets Inventory TOTAL CURRENT ASSETS INVESTMENTS Equity Investment PROPERTY AND EQUIPMENT, NET RIGHT OF USE ASSET INTANGIBLE ASSETS, NET GOODWILL DEFERRED IMPLEMENTATION COSTS TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Current portion of debt Accounts payable Other accrued expense Lease liability- current TOTAL CURRENT LIABILITIES LONG-TERM LIABILITIES Long-term lease liability Long-term derivative liability Term note TOTAL LIABILITIES STOCKHOLDERS' EQUITY Convertible preferred stock Common stock, $0.001 par value; 675,000,000 authorized; 9,341,002 and 7,420,633 issued, 8,951,035 and 7,196,677 shares outstanding as of December 31, 2022 and December 31, 2021, respectively Additional paid in capital Treasury stock as cost; 389,967 and 223,956 shares at December 31, 2022 and December 31, 2021, respectively Accumulated deficit Accumulated other comprehensive loss STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Accounts and Financing Receivable, Allowance for Credit Loss Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding [custom:TreasuryStocksShare-0] Income Statement [Abstract] NET REVENUE COST OF REVENUE GROSS PROFIT OPERATING EXPENSES General and administrative Research and development Sales and marketing Total operating expenses LOSS BEFORE OTHER INCOME (EXPENSE) OTHER INCOME (EXPENSE) Interest income (expenses), net Loss on equity investment Unrealized gain on equity investment Other income, net Gain on extinguishment of debt Payroll protection program debt forgiveness TOTAL OTHER INCOME (EXPENSE), NET NET (LOSS)/ INCOME EARNINGS / (LOSS) PER SHARE BASIC DILUTED WEIGHTED AVERAGE COMMON SHARE OUTSTANDING BASIC DILUTED NET (LOSS)/INCOME Change in fair value of interest rate, swap TOTAL COMPREHENSIVE (LOSS)/INCOME Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net (Loss) Income Adjustments to reconcile net (loss) income to net cash used in operating activities: Allowance for bad debt Stock based compensation Fair value of options in exchange for services Fair value of restricted stock awards issued in exchange for services Fair value of restricted stock units issued in exchange for services Payroll Protection Program Debt Forgiveness Loss on equity investment Unrealized gain on equity investment Gain on extinguishment of debt Amortization and depreciation Changes in operating assets and liabilities: Accounts receivable Unbilled revenue Inventory Prepaid expenses and other current assets Accounts payable, other accrued expenses and net change in operating leases Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of patents Purchase of equipment for lease Purchase of equity investment Purchase of office equipment Acquisition of PeriShip Equity received from SPAC Equity Investment Deferred implementation costs Capitalized software costs Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from public offering of securities Proceeds from issuance of notes payable Proceeds from exercise of pre-funded warrant Proceeds from SPP Plan Tax withholding payments for employee stock-based compensation in exchange for shares surrendered Increase in treasury shares (share repurchase program) Repayment of Debt Net cash provided by financing activities NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH – BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH - END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for: Interest Income taxes SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Initial recognition of right-of-use asset and lease liability during the period Change in fair value of interest rate, swap Beginning balance, value Beginning balance, shares Fair value of stock options Restricted stock awards, net of shares withheld for employee tax Restricted stock awards, net of shares withheld for employee tax, shares Restricted Stock Units Stock Purchase Plan Common stock issued in relation to Stock Purchase Plan Common stock issued in relation to Stock Purchase Plan, shares Common stock issued in relation to private placement Common stock issued in relation to private placement, shares Common stock issued for services Common stock issued for services, shares Common stock issued in relation to Acquisition Common stock issued in relation to Acquisition, shares Exercise of Pre-funded Warrants Exercise of Pre-funded Warrants, shares Accumulated other comprehensive loss Common stock issued in relation to public offering of securities Common stock issued in relation to public offering of securities, shares Repurchase of Common Stock Repurchase of Common Stock, shares Net loss Ending balance, value Ending balance, shares Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Equity Method Investments and Joint Ventures [Abstract] EQUITY INVESTMENTS Revenue from Contract with Customer [Abstract] REVENUE Business Combination and Asset Acquisition [Abstract] BUSINESS COMBINATION Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS AND GOODWILL Income Tax Disclosure [Abstract] INCOME TAXES Debt Disclosure [Abstract] DEBT Equity [Abstract] CONVERTIBLE PREFERRED STOCK STOCKHOLDERS’ EQUITY STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS Earnings Per Share [Abstract] EARNINGS (LOSS) PER SHARE Long Term Derivative Liability LONG TERM DERIVATIVE LIABILITY Retirement Benefits [Abstract] EMPLOYEE BENEFIT PLAN Leases LEASES Risks and Uncertainties [Abstract] CONCENTRATIONS Segment Reporting [Abstract] SEGMENT REPORTING Subsequent Events [Abstract] SUBSEQUENT EVENTS Nature of the Business Basis of Presentation Segment Reporting Use of Estimates Recent Accounting Pronouncements Fair Value of Financial Instruments Variable Interest Entity Equity Investments Goodwill Business Combinations Basic and Diluted Net Loss per Share of Common Stock Cash and Cash Equivalents Accounts Receivable Concentration of Credit Risk Involving Cash and Cash Equivalents Inventory Equipment for Lease Capitalized Software Long-Lived Assets Derivative Instruments Reclassifications Revenue Recognition Income Taxes Stock-Based Compensation Advertising Costs Research and Development Costs Basic and Diluted Earnings (Loss) per Share of Common Stock Schedule of fair value assets measured on recurring basis Schedule of disaggregation of revenue Schedule of business acquisitions Schedule of financial information Schedule of goodwill by reportable business segment Schedule of intangible assets subject to amortization Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of reconciliation of federal statutory tax rate Schedule of deferred tax assets and liabilities Schedule of stock options Schedule of Unvested Options Schedule of unvested restricted stock awards Schedule of unvested restricted stock units Schedule of unvested performance restricted stock units Schedule of warrants outstanding Schedule of basic and diluted earnings/(loss) per share Schedule of anti-dilutiv e earnings per share Schedule of components of lease expense Schedule of supplemental information related to leases Schedule of operating lease liabilities maturities Schedule of segment reporting information Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Short Term Investment at beginning Derivative Liability at beginning Realized loss on fair value recognized in other (expense)/income Distribution from Sponsor Entity Unrealized gain on fair value recognized in other (expense)/income Change in fair value to interest rate, SWAP, recognized in other comprehensive loss Short-Term Investments at end Derivative Liability at end Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Common stock, par value (in dollars per share) Cash Allowance for doubtful accounts FDIC insured limit Description of lease terms Maturity terms of lease Advertising cost Research and development costs Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Line Items] Equity Method Investment, Ownership Percentage Number of units issued in transaction Sale of Stock, Consideration Received on Transaction Equity Securities, FV-NI, Cost Equity Securities, FV-NI, Unrealized Loss Cumulative convertible preferred stock value Cumulative convertible preferred stock ratio Cumulative convertible preferred stock price Equity investments fair value Fair value of equity investment Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenues Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Promissory note Stock (issuance of 305,473 shares of restricted common stock) Total purchase price Accounts receivable, net Prepaid expenses Intangible Assets Amortization Period Property and Equipment, net Goodwill Accounts payable and other accrued expenses Revenues Net Income (loss) Purchase price Consideration transferred Promissory note Investment Interest Rate Common stock shares, issued Beginning balance Acquisition Ending balance Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Gross Carrying Amount Accumulated Amortization Net Carrying Amount 2023 2024 2025 2026 2027 Thereafter Total Amortization of Intangible Assets Income (loss) before income taxes Taxes under statutory US tax rates Increase (decrease) in taxes resulting from: Increase (decrease) in valuation allowance Change in State tax rate All other State taxes Income tax expense Net operating loss carryforwards Restricted Stock (RSA’s, RSU’s) Stock Options Stock Purchase Plan (SPP) Depreciation Intangibles Acquisition Transaction Costs Capitalized Research and Development Unrealized Gain on Investment Bad Debt Dividend Income Gross deferred tax assets Less valuation allowance Total deferred tax assets Deferred tax liabilities: Total deferred tax liabilities Net deferred tax assets / (liabilities) Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Description of ownership change Operating Loss Carryforwards Effective income tax rate Deferred tax assets valuation allowance Unrecognized tax benefits Accrual for interest and penalties Taxes payable Line of Credit Facility [Table] Line of Credit Facility [Line Items] Unsecured promissory note Intrest rate Gain (Loss) on Extinguishment of Debt Notional amount Interest rate Short term debt outstanding Long-term debt outstanding Maturity date Interest rate Loan forgiveness Interest payable Repayments of loan payable Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, par value (in dollars per share) Convertible Preferred Stock, outstanding Number of shares converted Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Restricted stock/restricted stock units, expense Restricted stock/restricted stock award, expense Stock issued for services Stock-based compensation expense Prefunded warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Stock Issued During Period, Value, Other Stock Issued During Period, Shares, Other Common stock issued Non-Qualified Stock Purchase Plan expenses Treasury stock share Treasury stock value Non-qualified stock purchase plan Non-qualified stock purchase exercise price Share repurchase program Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Balance at ending Weighted Average Exercise Price, Balance at ending Granted Weighted Average Exercise Price, Granted Forfeited/Cancelled/Expired Weighted Average Exercise Price, Forfeited/Cancelled/Expired Vested and Exercisable at ending Weighted Average Exercise Price, Exercisable at ending Weighted Average Remaining Contractual Term, Exercisable at ending Vested and Exercisable at ending Balance at ending Weighted Average Exercise Price, Balance at ending Balance at ending Balance at ending Granted Vested Vested Balance at ending Balance at ending Balance at beginning Weighted - Average Grant Date Fair Value, Balance at beginning Granted Weighted - Average Grant Date Fair Value, Granted Vested Weighted - Average Grant Date Fair Value, Vested Balance at ending Weighted - Average Grant Date Fair Value, Balance at ending Vested Investment Income [Table] Net Investment Income [Line Items] Number of warrants outstanding, beginning balance Weighted average exercise price, beginning balance Number of warrants outstanding, granted Weighted average exercise price, granted Number of warrants outstanding, expired Weighted average exercise price, expired Number of warrants outstanding, ending Balance Weighted average exercise price, ending balance Weighted average remaining contractual terms Number of warrants outstanding, exercisable Weighted average exercise price, exercisable Weighted average remaining contractual terms, exercisable Exercise price (in dollars per share) Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Number of shares authorized to grand awards Stock issued during period shares new issues Exercise price, description Incentive stock options granted Stock or Unit Option Plan Expense Unrecognized compensation cost Unvested restricted stock awards Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Per share public offering price(in dollars per share) Stock Issued During Period, Shares, Issued for Services Numerator: Denominator: Weighted average shares of common stock – basic Effect of dilutive securities Preferred Stock Stock Options Warrants Stock Purchase Plan Restricted Stock Units & Restricted Stock Awards Weighted average shares of common stock – diluted (Loss)/Earnings per share Basic Diluted Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive shares Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Grant fair value Fair value of the derivative liability Long term debt description Contributions Operating lease cost Short-term lease cost Total lease costs Operating Lease right-of-use asset Current portion of operating lease liabilities Non-current portion of operating lease liabilities Total operating lease liabilities Cash paid for amounts included in the measurement of operating lease liabilities Right-of-use assets obtained in exchange for operating lease liabilities Weighted-average remaining lease term for operating leases (years) Weighted average discount rate for operating leases 2023 2024 2025 2026 Thereafter Total future lease payments Less: imputed interest Present value of future lease payments Less: current portion of lease liabilities Long-term lease liabilities Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk, percentage Gross Profit LOSS BEFORE OTHER INCOME (EXPENSE) OTHER INCOME (EXPENSE) Total Assets Subsequent Event [Table] Subsequent Event [Line Items] Total consideration paid Cash Consideration Restricted common stock issued Share price Stock consideration Stock option exercised Exercise Price Restricted stock awarded Grant date value The element represents custom stock purchase plan1. The element represents custom stock issued during period value common stock issued in relation to public offering of securities. The element represents custom maturity terms of lease. The element represents custom equipment for lease member. The element represents custom description of lease terms. The element represents custom sponsor entity member. The element represents custom maxim partners l l c member. The element represents custom income tax reconciliation all other. The element represents custom description of ownership change. The element represents deferred tax assets valuation allowance1. The element represents custom loan forgiveness amount. The element represents custom stock issued during period value restricted stock award net. The element represents custom stock options restricted stockand unitsand other stockbased awards member. The element represents custom omnibus equity compensation plan2013 member. The element represents custom equity incentive plan2017 member. The element represents custom share based compensation arrangement by share based payment award options exercise price description. The element represents custom incentive stock options member. The element represents custom issued under the2020 plan member. The element represents custom plan2019 member. The element represents custom restricted stock units member. The element represents custom nonvested stock options member. The element represents custom director and officer member. The element represents custom debentures2020 member. The element represents custom numerator abstract. The element represents custom denominator abstract. The element represents custom amount of dilutive securities e s o p convertible preferred stock shares1. The element represents custom amount of dilutive securities stock options and restrictive stock units shares1. The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price. The element represents custom share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average exercise price. The element represents custom share based compensation arrangement by share based payment award equity instruments other than options forfeited in period weighted average exercise price. The element represents custom share based compensation arrangement by share based payment award non option equity instruments exercisable number. The element represents custom share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average exercise price. The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding exercisable weighted average remaining contractual terms. The element represents custom sharebased compensation arrangement by sharebased payment award restricted stock. The element represents custom sharebased compensation arrangement by sharebased payment award restricted stock weighted average grant date fair value. The element represents custom share based compensation arrangement by share based payment award restricted stock grants in period gross. The element represents custom share based compensation arrangement by share based payment award restricted stock grants in period weighted average grant date fair value. The element represents custom sharebased compensation arrangement by sharebased payment award restricted stock vested number of shares. The element represents custom share based compensation arrangement by share based payment award restricted stock vested in period weighted average grant date fair value1. Assets, Current Liabilities, Current Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Nonoperating Income (Expense) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Conversion Gains and Losses on Foreign Investments Income (Loss) from Equity Method Investments Increase (Decrease) in Accounts Receivable OpratingUnbilledRevenue Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Intangible Assets Payments to Acquire Equipment on Lease PurchaseOfEquityInvestment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Other Productive Assets DeferredImplementationCosts Payments for Software Net Cash Provided by (Used in) Investing Activities Payment, Tax Withholding, Share-Based Payment Arrangement Payments for Repurchase of Equity Repayments of Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Income Taxes Paid NoncashChangeInFairValueOfInterestRateSwap Shares, Outstanding Other Comprehensive Income (Loss), Net of Tax Stock Repurchased During Period, Value Inventory, Policy [Policy Text Block] Short-Term Investments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable PromissoryNote BookValue Deferred Tax Assets, Property, Plant and Equipment Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss Deferred Tax Assets, Valuation Allowance Debt Instrument, Interest Rate, Stated Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Grants In Period Gross Vested [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations  Stock Options Stock Issued During Period, Shares, Employee Stock Purchase Plans Lease, Cost Lessee, Operating Lease, Liability, Payments, Due Next Rolling 12 Months Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount EX-101.PRE 11 vrme-20221231_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Mar. 23, 2023
Jun. 30, 2022
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-39332    
Entity Registrant Name VERIFYME, INC.    
Entity Central Index Key 0001104038    
Entity Tax Identification Number 23-3023677    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 801 International Parkway    
Entity Address, Address Line Two Fifth Floor    
Entity Address, City or Town Lake Mary    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 32746    
City Area Code (585)    
Local Phone Number 736-9400    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 14,839,432
Entity Common Stock, Shares Outstanding   9,361,772  
Documents Incorporated by Reference [Text Block] Portions of VerifyMe, Inc.’s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with its 2023 annual meeting of stockholders are incorporated by reference into Part III Items 10, 11, 12, 13 and 14 of this Annual Report on Form 10-K.    
Auditor Firm ID 206    
Auditor Name MaloneBailey, LLP    
Auditor Location Houston, Texas    
Common Stock, par value $0.001 per share      
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol VRME    
Security Exchange Name NASDAQ    
Warrants to Purchase Common Stock      
Title of 12(b) Security Warrants to Purchase Common Stock    
Trading Symbol VRMEW    
Security Exchange Name NASDAQ    
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents, including restricted cash $ 3,411 $ 9,422
Accounts receivable, net of allowance for credit loss reserve, $37 and $0 as of December 31, 2022 and December 31, 2021, respectively 4,448 297
Unbilled revenue 1,185
Prepaid expenses and other current assets 333 240
Inventory 81 52
TOTAL CURRENT ASSETS 9,458 10,011
INVESTMENTS    
Equity Investment 10,964
PROPERTY AND EQUIPMENT, NET 292 204
RIGHT OF USE ASSET 469
INTANGIBLE ASSETS, NET 6,412 509
GOODWILL 3,988
DEFERRED IMPLEMENTATION COSTS 133
TOTAL ASSETS 20,752 21,688
CURRENT LIABILITIES    
Current portion of debt 500
Accounts payable 3,912 341
Other accrued expense 902 109
Lease liability- current 115
TOTAL CURRENT LIABILITIES 5,429 450
LONG-TERM LIABILITIES    
Long-term lease liability 359
Long-term derivative liability 3 71
Term note 1,375
TOTAL LIABILITIES 7,166 521
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value; 675,000,000 authorized; 9,341,002 and 7,420,633 issued, 8,951,035 and 7,196,677 shares outstanding as of December 31, 2022 and December 31, 2021, respectively 10 7
Additional paid in capital 92,987 86,059
Treasury stock as cost; 389,967 and 223,956 shares at December 31, 2022 and December 31, 2021, respectively (949) (838)
Accumulated deficit (78,459) (64,061)
Accumulated other comprehensive loss (3)
STOCKHOLDERS' EQUITY 13,586 21,167
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 20,752 21,688
Series A Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock
Series B Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accounts and Financing Receivable, Allowance for Credit Loss $ 37 $ 0
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized   675,000,000
Common Stock, Shares, Issued 9,341,002 7,420,633
Common Stock, Shares, Outstanding 8,951,035 7,196,677
[custom:TreasuryStocksShare-0] 389,967 223,956
Series A Preferred Stock [Member]    
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized   37,564,767
Preferred Stock, Shares Outstanding 0 0
Series B Preferred Stock [Member]    
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized   85
Preferred Stock, Shares Outstanding 0.85 0.85
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
NET REVENUE $ 19,576 $ 867
COST OF REVENUE 13,088 268
GROSS PROFIT 6,488 599
OPERATING EXPENSES    
General and administrative [1] 8,428 4,216
Research and development 89 51
Sales and marketing [1] 1,718 1,163
Total operating expenses 10,235 5,430
LOSS BEFORE OTHER INCOME (EXPENSE) (3,747) (4,831)
OTHER INCOME (EXPENSE)    
Interest income (expenses), net (88) 2
Loss on equity investment (10,932)
Unrealized gain on equity investment 12 8,371
Other income, net 31
Gain on extinguishment of debt 326
Payroll protection program debt forgiveness 70
TOTAL OTHER INCOME (EXPENSE), NET (10,651) 8,443
NET (LOSS)/ INCOME $ (14,398) $ 3,612
EARNINGS / (LOSS) PER SHARE    
BASIC $ (1.70) $ 0.51
DILUTED $ (1.70) $ 0.49
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING    
BASIC 8,466,075 7,110,907
DILUTED 8,466,075 7,383,364
[1] Includes share-based compensation of $1,468 thousand for the year ended December 31, 2022, and $1,716 thousand for the year ended December 31, 2021.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Comprehensive Income/(Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
NET (LOSS)/INCOME $ (14,398) $ 3,612
Change in fair value of interest rate, swap (3)
TOTAL COMPREHENSIVE (LOSS)/INCOME $ (14,401) $ 3,612
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (Loss) Income $ (14,398) $ 3,612
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Allowance for bad debt 37
Stock based compensation 145 151
Fair value of options in exchange for services 85
Fair value of restricted stock awards issued in exchange for services 239 784
Fair value of restricted stock units issued in exchange for services 1,084 696
Payroll Protection Program Debt Forgiveness (70)
Loss on equity investment 10,932
Unrealized gain on equity investment (12) (8,371)
Gain on extinguishment of debt (326)
Amortization and depreciation 770 117
Changes in operating assets and liabilities:    
Accounts receivable (3,352) (354)
Unbilled revenue (1,185)
Inventory (29) 2
Prepaid expenses and other current assets (77) 25
Accounts payable, other accrued expenses and net change in operating leases 3,621 69
Net cash used in operating activities (2,551) (3,254)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of patents (40) (95)
Purchase of equipment for lease (45)
Purchase of equity investment (2,593)
Purchase of office equipment (12)
Acquisition of PeriShip (7,500)
Equity received from SPAC Equity Investment 32
Deferred implementation costs (140)
Capitalized software costs (236) (106)
Net cash used in investing activities (7,884) (2,851)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from public offering of securities 4,528 8,447
Proceeds from issuance of notes payable 2,000 (3)
Proceeds from exercise of pre-funded warrant 1
Proceeds from SPP Plan 102
Tax withholding payments for employee stock-based compensation in exchange for shares surrendered (34) (131)
Increase in treasury shares (share repurchase program) (291) (725)
Repayment of Debt (1,882)
Net cash provided by financing activities 4,424 7,588
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (6,011) 1,483
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH – BEGINNING OF PERIOD 9,422 7,939
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH - END OF PERIOD 3,411 9,422
Cash paid during the period for:    
Interest 33
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Initial recognition of right-of-use asset and lease liability during the period 552
Change in fair value of interest rate, swap $ (3)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stocks [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 6 $ 76,099 $ (113) $ (67,673) $ 8,319
Beginning balance, shares at Dec. 31, 2020 0.85 5,596,877   7,011      
Fair value of stock options 85   85
Restricted stock awards, net of shares withheld for employee tax 654   654
Restricted stock awards, net of shares withheld for employee tax, shares     56,971          
Restricted Stock Units 696   696
Stock Purchase Plan 40   40
Common stock issued for services 39   39
Common stock issued for services, shares     9,774          
Common stock issued in relation to public offering of securities $ 1 8,446   8,447
Common stock issued in relation to public offering of securities, shares     1,750,000          
Repurchase of Common Stock $ (725)   (725)
Repurchase of Common Stock, shares     (216,945)   216,945      
Net loss 3,612 3,612
Ending balance, value at Dec. 31, 2021 $ 7 86,059 $ (838) (64,061) 21,167
Ending balance, shares at Dec. 31, 2021 0.85 7,196,677   223,956      
Restricted stock awards, net of shares withheld for employee tax 205 205
Restricted stock awards, net of shares withheld for employee tax, shares     29,688          
Restricted Stock Units 1,084 1,084
Stock Purchase Plan 121 121
Common stock issued in relation to Stock Purchase Plan (78) $ 180 102
Common stock issued in relation to Stock Purchase Plan, shares     53,895   (53,895)      
Common stock issued in relation to private placement $ 2 4,526 4,528
Common stock issued in relation to private placement, shares     880,208          
Common stock issued for services 96 96
Common stock issued for services, shares     30,000          
Common stock issued in relation to Acquisition 974 974
Common stock issued in relation to Acquisition, shares     305,473          
Exercise of Pre-funded Warrants $ 1 1
Exercise of Pre-funded Warrants, shares     675,000          
Accumulated other comprehensive loss (3) (3)
Repurchase of Common Stock $ (291) (291)
Repurchase of Common Stock, shares     (219,906)   219,906      
Net loss (14,398) (14,398)
Ending balance, value at Dec. 31, 2022 $ 10 $ 92,987 $ (949) $ (3) $ (78,459) $ 13,586
Ending balance, shares at Dec. 31, 2022 0.85 8,951,035   389,967      
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of the Business

 

VerifyMe, Inc. (“VerifyMe”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, together with its subsidiaries, including PeriShip Global LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”) is based in Lake Mary, Florida and its common stock, par value $0.001 per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.

 

VerifyMe, through PeriShip Global, is a software driven predictive analytics logistics provider of high-touch, end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions, which includes Trust Codes Global. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.

 

Basis of Presentation

 

The accompanying consolidated financial statements include the accounts of VerifyMe and its wholly owned subsidiary PeriShip Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

Segment Reporting

 

Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) PeriShip Global Solutions and (ii) VerifyMe Solutions. See Note 16 Segment Reporting, for further discussion of the Company’s segment reporting structure. 

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, (“CECL”), which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded.  This guidance was to be effective for reporting periods beginning after December 15, 2022, with early adoption permitted. The Company has elected to early adopt ASU 2016-13, as of January 1, 2022, and the impact has been disclosed on the face of the Consolidated Balance Sheets. The Company’s accounts receivable is currently the only financial instrument subject to the new CECL model. The Company has considered relevant internal and/or external information about past events, e.g., historical loss experience with similar assets, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the reported amount of financial assets in determining the credit loss.

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, equity investments, and long-term derivative liabilities. The carrying value of accounts receivable, unbilled revenue, accounts payable and accrued expenses approximate their fair value because of their short maturities.  The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.

 

The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures,” and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities

 

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data

 

Level 3: Unobservable inputs that are not corroborated by market data

 

The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

 

The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of December 31, 2022 and December 31, 2021.

 

Amounts in Thousands ('000)

 

                
   Short Term Investment   Equity Investment   Derivative Liability   Derivative Liability 
   (Level 1)   (Level 3)   (Level 2)   (Level 3) 
                 
Balance as of December 31, 2021  $88    10,964    -    (71)
                     
Realized loss on fair value recognized in other (expense)/income   -    (10,932)   -    - 
                     
Distribution from Sponsor Entity   -    (32)   -    - 
              -    - 
Unrealized gain on fair value recognized in other (expense)/income   12    -    -    - 
                     
Realized gain on fair value recognized in share-based compensation   -    -         71 
                     
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss             (3)   - 
    -    -           
Balance at December 31, 2022  $100   $-   $(3)  $- 

 

Variable Interest Entity

 

The Company determined that G3 VRM Acquisition Corp. (NASDAQ: GGGVU) (the “SPAC”, see Note 2 – Equity Investments), a Delaware corporation and special purpose acquisition company, was a variable interest entity (“VIE”) in which the Company had a variable interest but was not the primary beneficiary. Making the determination as to whether a VIE should be consolidated requires judgement in assessing if the Company is the primary beneficiary. To make this determination, the Company evaluated its power to direct the activities that most significantly impacted the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the SPAC. The Company concluded that it was not the primary beneficiary of the VIE and as such, did not consolidate the SPAC. The Company reassessed its evaluation of whether an entity is a VIE and if it continues to be a VIE, whether the Company is the primary beneficiary of the VIE, on an ongoing basis based on the current facts and circumstances surrounding the entity. The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO, and the Sponsor Entity made the decision not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved, and liquidated according to its charter. The SPAC redeemed 100% of the public shares for cash, the rights have expired worthless, and the founder shares and the private placement securities have become worthless.

 

Equity Investments

 

When the Company does not have a controlling financial interest in an entity but can exert influence over the entity’s operations and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under applicable generally accepted accounting policies. The Company has elected the fair value option for its equity investment in the SPAC (see Note 2 –Equity Investments) and its equity security under short term investment on the balance sheets, as it has determined the fair value best reflects the economic performance of the equity investment. Changes in unrealized gain on equity investment include unrealized gain of the fair value of the equity investments and loss on equity investment includes realized loss on equity investments on the accompanying Consolidated Statements of Operations.

 

Goodwill

 

Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

 

Business Combinations

 

The Company applies the provisions of Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, in the accounting for business acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the Consolidated Statements of Operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results.

 

Basic and Diluted Net Loss per Share of Common Stock

 

The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents. As of December 31, 2022, the Company held $63 thousand subject to restrictions.

 

Accounts Receivable

 

Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. Bad debts expense or write offs of receivables are determined on the basis of loss experience, known and inherent risks in the receivable portfolio and current economic conditions. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, such allowances may be required. The Company recognized $37 thousand and $0 for allowance for credit losses as of December 31, 2022, and 2021, respectively.

 

Concentration of Credit Risk Involving Cash and Cash Equivalents

 

The Company’s cash and cash equivalents are held at various financial institutions. At times, the Company’s deposits may exceed Federal Deposit Insurance Corporation (FDIC) coverage limits which are currently set at $250,000 per depositor. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.

 

Inventory

 

Inventory principally consists of canisters and pigments and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.

 

Equipment for Lease

 

Equipment for lease principally consists of costs associated with the development, certification and production of the VerifyChecker™ and the VerifyAuthenticatorTM Smartphone Authenticator technology. These technologies are leased to customers typically for a period of one year in length with automatically renewable leases cancellable by either party by written notice provided 90 days in advance. We examined the effect of Accounting Standards Update (“ASU”) No. 2016-02- “Lease (Topic 842)” and determined the impact is not material. Our policy is to capitalize the costs related to this equipment and depreciate on a straight-line basis over the estimated lives of the equipment which was determined to be 5 years.

 

Capitalized Software  

 

Costs incurred in connection with the development of software related to our proprietary proactive end-to-end logistics management products are accounted for in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 “Hosting Arrangements and Internally Used Software.” Costs incurred prior to the establishment of technological feasibility are charged to research and development expense. Software development costs are capitalized after a product is determined to be technologically feasible and is in the process of being developed for market. Amortization of capitalized software development costs begins once the product is available to the market. Capitalized software development costs are amortized over the estimated life of the related product, generally six years, using the straight-line method. The Company will evaluate its software assets for impairment whenever events or change in circumstances indicate that the carrying amount of such assets may not be recoverable.

 

Long-Lived Assets

 

The Company evaluates the recoverability of its long-lived assets in accordance with ASC 360 “Property, Plant, and Equipment.” The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.

 

Derivative Instruments

 

The Company evaluates its equity investments, long-term derivative liabilities, preferred stock, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguish by Liabilities from Equity” (FASB ASC 480), and FASB ASC 815, “Derivatives and Hedging” (“FASB ASC 815”). The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the Consolidated Statement of Operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

 

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified as liabilities at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

 

Reclassifications

 

Certain accounts in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements. These reclassifications had no effect on the previously reported net income (loss).

 

 Revenue Recognition

 

The Company accounts for revenues according to Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. 

 

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

·identify the contract with a customer;
·identify the performance obligations in the contract;
·determine the transaction price;
·allocate the transaction price to performance obligations in the contract; and
·recognize revenue as the performance obligation is satisfied.

 

During the year ended December 31, 2022, over 90% of the Company’s revenues primarily consisted of revenue related to our logistics management for time and temperature sensitive packages generated by our subsidiary PeriShip Global. During the year ended December 31, 2021, the Company’s revenue primarily consisted of VerifyInkTM and labels with our VerifyMe traceability solutions.

 

Income Taxes

 

The Company follows FASB ASC 740, “Income Taxes,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2003 remain subject to examination by major tax jurisdictions due the carryforward of unutilized NOLs.

 

Stock-Based Compensation

 

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. We recognize forfeitures as they occur with a reduction in compensation expense in the period of forfeiture. For performance restricted stock units with stock price appreciation targets (see Note 10 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.

We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.

  

All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed. 

 

Advertising Costs

 

Advertising costs are expensed as incurred. Advertising costs were $60 thousand and $51 thousand for the years ended December 31, 2022, and 2021, respectively, and are included in Sales and Marketing on the Consolidated Statements of Operations.

 

Research and Development Costs

 

In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the years ended December 31, 2022, and 2021 were $89 thousand and $51 thousand, respectively.

 

Basic and Diluted Earnings (Loss) per Share of Common Stock

 

The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the year ended December 31, 2022, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same. 

 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
EQUITY INVESTMENTS
 12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
EQUITY INVESTMENTS

NOTE 2 – EQUITY INVESTMENTS

 

On February 26, 2021, the Company formed VMEA Holdings Inc. (the “Sponsor Entity”), a Delaware corporation that was the founder of G3 VRM Acquisition Corp. (the “SPAC”) that was being co-sponsored by the Company.  The SPAC was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

 

On April 12, 2021, the Sponsor Entity converted to a Delaware limited liability company, changed its name to “G3 VRM Holdings LLC” and a co-sponsor was added as a member of the Sponsor Entity resulting in an equity interest of 44.40% attributed to the Company. On July 6, 2021, the SPAC consummated the IPO of 10,626,000 units (the “Units”), including 626,000 Units pursuant to the partial exercise of the underwriter’s over-allotment option, generating gross proceeds of $106,260 thousand. Each Unit consisted of one share of SPAC common stock, $0.0001 par value, and one right to receive one-tenth (1/10) of a share of SPAC common stock upon the consummation of an initial business combination. Simultaneously with the closing of the IPO, the SPAC consummated the Private Placement of an aggregate of 569,410 Units with the Sponsor Entity purchasing 516,280 Units and Maxim Partners LLC purchasing 53,130 Units, generating total proceeds of $5,694 thousand. Of this amount, the Company was the indirect beneficial owner of 229,228 Units purchased by the Sponsor Entity for a total of $2,581 thousand. Upon consummation of the IPO, VerifyMe, as co-sponsor, indirectly through the Sponsor Entity, beneficially owned approximately 9.42% of the outstanding shares of the SPAC, which shares were subject to forfeiture upon certain conditions and restrictions on transfer.

 

As a result of ceasing to have a controlling financial interest in the Sponsor Entity on April 12, 2021, the Company accounted for the Sponsor Entity as an equity investment and has elected the fair value option.

The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO and the Sponsor Entity decided not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved and liquidated in accordance with its charter. The SPAC redeemed 100% of the public shares for cash on July 19, 2022, the rights expired worthless, and the founder shares and private placement securities became worthless. The SPAC was dissolved on July 29, 2022, and no distributions were made to the Sponsors. In December 2022, it was determined that the costs to dissolve the SPAC were ultimately less than the remaining assets of the SPAC and the SPAC made a distribution to the Company of $32 thousand.

 

The fair value of the equity investment was $0 million as of December 31, 2022 and $11.0 million as of December 31, 2021. The fair value of the equity investment was classified as Level 3 in the fair value hierarchy as the calculation was dependent upon company specific adjustments to the observable trading price of the SPAC’s public units and shares, and related risk of forfeiture should no business combination occur. The Company recognized a loss on equity investments of $10,932 thousand for the year ended December 31, 2022, included in the Loss on equity investments in the accompanying Consolidated Statements of Operations.

 

In December 2021, the Company acquired 8,841 shares of 10% Cumulative Convertible Series D Preferred Stock at a price of $10.00 per share as payment for a customer’s outstanding AR balance of $88,410. This instrument is considered an equity security within the scope of Topic 321 since the issuing entity has the option but no contractual obligation to redeem the preferred stock, and the Company can convert the preferred shares to common stock. For the year ended December 31, 2022, a fair value gain of $12 thousand, was recognized and included in Loss on equity investments, in the accompanying Consolidated Statements of Operations. The fair value of the equity investment was $100 thousand as of December 31, 2022, and $88 thousand as of December 31, 2021, and included in Prepaid expenses and other current assets on the accompanying Consolidated Balance Sheets. The fair value of the equity investment is classified as Level 1 in the fair value hierarchy as the calculation is dependent upon the quoted market price of the entity.

 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
REVENUE

NOTE 3 – REVENUE

 

Revenue by Category

 

The following table presents our revenue disaggregated by various categories (dollars in thousands).

 

                              
   VerifyMe   PeriShip Global   Consolidated 
Revenue  Year Ended
December 31,		   Year Ended
December 31,		   Year Ended
December 31,		 
   2022   2021   2022   2021   2022   2021 
                         
Proactive services  $-    -   $15,202    -   $15,202   $- 
Premium services   -    -    2,988    -    2,988    - 
Brand protection services   1,386    867    -    -    1,386    867 
   $1,386   $867   $18,190   $-   $19,576   $867 

 

Contract Balances

 

The timing of revenue recognition, billings and cash collections results in unbilled revenue (contract assets) and deferred revenue (contract liabilities) on the consolidated balance sheets. Amounts charged to our clients become billable according to the contract terms, which usually consider the delivery completion. Unbilled amounts will generally be billed and collected within 30 days but typically no longer than 60 days. When we advance bill clients prior to the work being performed, generally, such amounts will be earned and recognized in revenue within the 30 days. These assets and liabilities are reported on the consolidated balance sheet on a contract-by-contract basis at the end of each reporting period. Changes in the contract asset and liability balances during the year ended December 31, 2022, were not materially impacted by any other factors.

 

Applying the practical expedient in ASC Topic 606, we recognize the incremental costs of obtaining contracts (i.e. sales commissions) as an expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. As of December 31, 2022, we did not have any capitalized sales commissions.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS COMBINATION
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
BUSINESS COMBINATION

NOTE 4 – BUSINESS COMBINATION

 

PeriShip LLC

On April 22, 2022, we acquired, through PeriShip Global, the business and certain assets of PeriShip, LLC (“PeriShip”), a value-added service provider for time and temperature sensitive parcel management.  PeriShip Global provides shipping logistics services utilizing proprietary predictive analytics software and supporting call center services.  Using our proprietary software platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. The purchase price was $10.5 million which consisted of $7.5 million in cash paid at closing, a promissory note of $2.0 million with a fixed interest rate of 6% per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing, and 305,473 shares of common stock of the Company, representing $1.0 million in stock consideration. The goodwill recognized is due to the expected synergies from combining the operations of the acquire with the Company. All of the goodwill recorded for financial statement purposes is deductible for tax purposes. The acquired PeriShip business is included in the PeriShip Global Solutions segment and the results of its operations have been included in the consolidated financial statements beginning April 22, 2022. 

 

On September 22, 2022, the Company entered into an agreement with the owner of PeriShip, LLC to resolve certain disputes among the parties, reduce the principal and interest on the promissory note, repay the amended promissory note in full, and repurchased 61,000 shares of the Company’s common stock (see Note 9). The Company accounted for the agreement in accordance with Topic 250, through earnings, with the full amount included as a Gain on extinguishment of debt on the accompanying Consolidated Statements of Operations for a total of $326 thousand, for the year ended December 31, 2022.

 

The following table summarizes the purchase price allocation for the acquisition (dollars in thousands).

 

             
Cash   7,500         
Promissory note   2,000         
Stock (issuance of 305,473 shares of common stock) (1)   974         
Total purchase price   10,474         
         
       Amortization 
       Period 
Purchase price allocation:          
Accounts receivable, net   836      
Prepaid expenses   5      
Developed Technology   3,143    6 years 
Trade Names/Trademarks   1,111    13 years 
Customer Relationships   1,839    10 years 
Non-Compete Agreement   191    5 years 
Property and Equipment, net   193      
Goodwill   3,988      
Accounts payable and other accrued expenses   (832)     
    10,474      

 

(1)Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736.

 

Unaudited Pro forma Financial Information

 

The following unaudited proforma financial information presents the combined results of operations of the Company and gives effect to the acquisition discussed above for the years ended December 31, 2022, and 2021, as if the acquisition had occurred as of the beginning of the first period presented instead of on April 22, 2022.

 

The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations that would have been realized if the acquisition had been completed on January 1, 2021, nor does it purport to project the results of operations of the combined company in future periods. The pro forma financial information does not give effect to any anticipated integration costs related to the acquired company during the periods presented.

 

The below table summarizes proforma financial information for the Company, and the acquired PeriShip business, assuming the acquisition date of PeriShip occurred on January 1, 2021 (dollars in thousands):

 

        
   Years Ended
December 31,		 
Description  2022   2021 
         
Revenues  $25,397   $29,500 
Net Income (loss)  $(14,298)  $5,465 

 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS AND GOODWILL

NOTE 5 – INTANGIBLE ASSETS AND GOODWILL

 

Goodwill

 

Goodwill represents costs in excess of values assigned to the underlying net assets of acquired businesses. Intangible assets acquired are recorded at estimated fair value. Goodwill is deemed to have an indefinite life and is not amortized but is tested for impairment annually, and at any time when events suggest an impairment more likely than not has occurred. We test goodwill at the reporting unit level.

 

ASC Topic 350, Intangibles - Goodwill and Other (ASC Topic 350), permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test.  Under ASC Topic 350, an entity is not required to perform a quantitative goodwill impairment test for a reporting unit if it is more likely than not that its fair value is greater than its carrying amount. A reporting unit is an operating segment, or one level below an operating segment, as defined by U.S. GAAP.

 

Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, future economic and market conditions and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The timing and frequency of our goodwill impairment tests are based on an ongoing assessment of events and circumstances that would indicate a possible impairment. We will continue to monitor our goodwill and intangible assets for impairment and conduct formal tests when impairment indicators are present.

 

Each of our two reportable segments represents an operating segment under ASC Topic 280, Segment Reporting. We test our goodwill at the reporting unit level, or one level below an operating segment, under ASC Topic 350, Intangibles - Goodwill and Other. We determined that we have two reporting units for purposes of goodwill impairment testing, which represent our two reportable business segments, as discussed below.

 

For the year ended December 31, 2021, there were no goodwill activities. Changes in the carrying amount of goodwill by reportable business segment for the year ended December 31, 2022, were as follows (in thousands):

 

            
   VerifyMe   PeriShip Global   Total 
Net book value at            
January 1, 2022  $ -   $ -   $ - 
             
2022 Activity               
Acquisition   -    3,988    3,988 
                
Net book value at               
December 31, 2022  $-   $3,988   $3,988 

 

Intangible Assets Subject to Amortization

 

Our intangible assets include amounts recognized in connection with patents and trademarks, capitalized software and acquisitions, including customer relationships, tradenames, developed technology and non-compete agreements. Intangible assets are initially valued at fair market value using generally accepted valuation methods appropriate for the type of intangible asset. Amortization is recognized on a straight-line basis over the estimated useful life of the intangible assets. Intangible assets with definite lives are reviewed for impairment if indicators of impairment arise. Except for goodwill, we do not have any intangible assets with indefinite useful lives.

 

Intangible assets with finite lives are subject to amortization over their estimated useful lives. The primary assets included in this category and their respective balances were as follows (in thousands):

 

               
December 31, 2022  Gross Carrying
Amount		   Accumulated
Amortization		   Net Carrying
Amount		 
Patents and Trademarks  $1,858   $(445)  $1,413 
Capitalized Software   206    (91)   115 
Customer Relationships   1,839    (133)   1,706 
Developed Technology   3,143    (360)   2,783 
Internally Used Software   236    (4)   232 
Non-Compete Agreement   191    (28)   163 
   $7,473   $(1,061)  $6,412 
December 31, 2021               
Patents and Trademarks  $707   $(354)  $353 
Capitalized Software   206    (50)   156 
   $913   $(404)  $509 

 

Amortization expense for intangible assets was $657 thousand and $64 thousand for the year ended December 31, 2022, and 2021, respectively.

 

Patents and Trademarks

 

As of December 31, 2022, the current patent and trademark portfolios consist of eleven granted U.S. patents and one granted European patent validated in four countries (France, Germany, United Kingdom, and Italy), six pending U.S. and foreign patent applications, fifteen registered U.S. trademarks (of which seven trademarks were acquired through our wholly owned subsidiary, PeriShip Global), two EU trademark registrations, one Colombian trademark registration, one Australian trademark registration, one Japanese trademark registration, one Mexican trademark registration, one Singaporean trademark registration, two UK trademark registrations, and twenty-one pending US and foreign trademark applications.

 

The Company expects to record amortization expense of intangible assets over the next 5 years and thereafter as follows (in thousands):

 

      
Fiscal Year ending December 31,     
2023   $1,057 
2024    877 
2025    857 
2026    842 
2027    836 
Thereafter    1,943 
Total   $6,412 

 

As of December 31, 2022, our intangible assets with definite lives had a weighted average remaining useful life of 8.4 years.  We have no amortizable intangible assets with indefinite useful lives.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 6 – INCOME TAXES

 

The reconciliation of income tax expense computed at the U.S. federal statutory rate to the income tax provision for the years ended December 31, 2022, and 2021 is as follows (in thousands):

 

          
   Year Ended December 31, 
US  2022   2021 
         
Income (loss) before income taxes  $(14,400)  $(3,612)
Taxes under statutory US tax rates   (3,024)   759 
Increase (decrease) in taxes resulting from:          
Increase (decrease) in valuation allowance   (1,188)   (6,149)
Change in State tax rate   (57)   - 
All other   5,045    5,204 
State taxes   (776)   186 
Income tax expense  $-   $- 

  

The decrease in the Company's net valuation allowance was due primarily to a realized loss in our equity investment (See Note 2-Equity Investment), and to net operating losses which will expire unutilized due to limitations resulting from application of Section 382 of the Internal Revenue Code of 1986, as amended (“IRC”).

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities consist of the following (in thousands):

 

          
   December 31, 
   2022   2021 
US        
Net operating loss carryforwards  $6,495   $5,208 
Restricted Stock (RSA’s, RSU’s)   503    180 
Stock Options   562    678 
Stock Purchase Plan (SPP)   8    - 
Depreciation   (71)   (33)
Intangibles   22    9 
Acquisition Transaction Costs   110    - 
Capitalized Research and Development   17    - 
Unrealized Gain on Investment   (1)   (2,188)
Bad Debt   9    - 
Dividend Income   (2)   - 
Gross deferred tax assets  $7,652   $3,854 
           
Less valuation allowance   (7,652)   (3,854)
Total deferred tax assets  $-   $- 
           
Deferred tax liabilities:          
Total deferred tax liabilities   -    - 
Net deferred tax assets / (liabilities)  $-   $- 

 

 

Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.

 

In 2022, the Company completed the IRC Section 382 analysis, and determined that an ownership change occurred sufficient to impose additional limitations on the use of NOL carryforwards. For the year ended December 31, 2022, Federal and state NOLs of $23.1 million and $0, respectively, will expire unutilized due to the limitations of Section 382, leaving Federal and state NOL carryforwards of $24.4 million and $13.1 million, respectively that may be offset against future taxable income. Some of the Federal and state tax NOL carryforwards will expire at various dates through 2037. Generally, these can be carried forward and applied against future taxable income at the tax rate applicable at that time. We are currently using an effective income tax rate of 26.6% for our projected available net operating loss carry-forward. No tax benefit has been reported in the December 31, 2022, due to the uncertainty surrounding the realizability of the benefit.

 

In accordance with FASB ASC 740 “Income Taxes”, valuation allowances are provided against deferred tax assets, if based on the weight of available evidence, some or all of the deferred tax assets may or will not be realized. The Company has evaluated its ability to realize some or all of the deferred tax assets on its balance sheet and has established a valuation allowance of approximately $7.7 million at December 31, 2022. The Company did not utilize any NOL deductions for the year ended December 31, 2022.

The Company applied the "more-likely-than-not" recognition threshold to all tax positions taken or expected to be taken in a tax return, which resulted in no unrecognized tax benefits as of December 31, 2022, and December 31, 2021, respectively.

 

The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest and penalties on the balance sheets and has not recognized interest and/or penalties in the Statements of Operations for the years ended December 31, 2022, and 2021.

 

The Company is subject to taxation in the United States and various state jurisdictions. The Company’s tax years from 2003 are subject to examination by the United States and state taxing authorities due to the carryforward of unutilized NOLs.

 

There are no taxes payable as of December 31, 2022, or December 31, 2021.

 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
DEBT

NOTE 7—DEBT

 

On April 22, 2022, the Company issued a $2.0 million unsecured promissory note through our subsidiary PeriShip Global as part of the acquisition of the PeriShip business. The note had a fixed interest rate of 6% per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing. On September 22, 2022, the Company entered into an agreement with the note holder whereby the Company repaid the outstanding principal balance and accrued interest outstanding on the note and redeemed 61,000 shares of its common stock from the holder of the note, for a total of $1.8 million, at which point the guarantee agreement entered into by the Company in connection therewith was automatically terminated and has no further effect.

 

The Company accounted for the early extinguishment of debt in accordance with ASC 405-20 - Extinguishment of Liabilities, and recognized a gain included in Gain on extinguishment of debt on the accompanying Consolidated Statements of Operations of $326 thousand for the year ended December 31, 2022.

 

Contemporaneously, the Company entered into a new debt facility with PNC Bank, National Association (the “PNC Facility”). The PNC Facility includes a $1 million revolving line of credit (the “RLOC”) with a term of one-year, expiring in September 2023. The RLOC has no scheduled payments of principal until maturity, and bears interest per annum at a rate equal to the sum of Daily SOFR plus 2.85% with monthly interest payments. The PNC Facility also includes a four-year term note (the “Term Note”) for $2 million which matures in September of 2026 and requires equal quarterly payments of principal and interest. The Term Note incurs interest per annum at a rate equal to the sum of Daily SOFR plus 3.1%.  The RLOC and Term Note are guaranteed by the Company and secured by the assets of PeriShip Global and the Company.

 

The PNC Facility includes a number of affirmative and restrictive covenants applicable to PeriShip Global, including, among others, a financial covenant to maintain a fixed charge coverage ratio of at least 1.10 to 1.00 at the end of each fiscal year, affirmative covenants regarding delivery of financial statements, payment of taxes, and establishing primary depository accounts with PNC Bank, and restrictive covenants regarding dispositions of property, acquisitions, incurrence of additional indebtedness or liens, investments and transactions with affiliates. PeriShip Global is also restricted from paying dividends or making other distributions or payments on its capital stock if an event of default (as defined in the PNC Facility) has occurred or would occur upon such declaration of dividend. PeriShip Global was in compliance with all affirmative and restrictive covenants under the PNC Facility at December 31, 2022.

 

Effective October 17, 2022, the Company entered into an interest rate swap agreement, with a notional amount of $1,958 thousand, effectively fixing the interest rate on the Company’s outstanding debt at 7.602%. The Company has designated the intertest rate swap, expiring September 2026, as a cash flow hedge and have applied hedge accounting. The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and is included in Long-term Derivative Liability on the Consolidated Balance Sheets.

 

As of December 31, 2022, our short-term debt outstanding under the Term Note was $0.5 million and total long-term debt outstanding under the Term Note was $1.4 million.

 

No amounts were drawn on the RLOC as of December 31, 2022.

 

On May 17, 2020, the Company entered into a paycheck protection program term note for $72 thousand (the “SBA Loan”) with PNC Bank, N.A. under the recently enacted Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) pursuant to the Paycheck Protection Program (the “PPP”), which is administered by the U.S. Small Business Administration. The SBA Loan was scheduled to mature on May 17, 2022, and bore interest at a rate of 1.00% per annum and is subject to the terms and conditions applicable to loans administered by the U.S. Small Business Administration under the CARES Act.

 

The Company applied for and was notified in June 2021 that $69 thousand in eligible payroll expenditures as described in the CARES Act, has been forgiven. Loan forgiveness is reflected in Other Income (Expense), Net in the accompanying Consolidated Statements of Operations. The forgiveness recognized during the year ended December 31, 2021, included principal of $69 thousand, and interest payable of $1 thousand. The remaining loan balance of $3 thousand was paid in full in June 2021.

 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
CONVERTIBLE PREFERRED STOCK
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
CONVERTIBLE PREFERRED STOCK

 NOTE 8 – CONVERTIBLE PREFERRED STOCK

 

The Company is authorized to issue Series A Convertible Preferred Stock, par value of $0.001 per share (the “Series A”) and Series B Convertible Preferred Stock, par value of $0.001 per share (the “Series B”). As of December 31, 2022, and 2021, there were no shares of Series A outstanding and 0.85 of a share of Series B outstanding convertible into 144,444 shares of common stock. Each share of Series A and Series B has limited voting rights, is entitled to participate with the common stock on liquidation and holders of Series A and Series B are subject to beneficial ownership limitations.

 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

 

The Company expensed $239 thousand and $784 thousand related to restricted stock awards for the years ended December 31, 2022, and December 31, 2021, respectively.

 

The Company expensed $1,084 thousand and $696 thousand related to restricted stock units for the years ended December 31, 2022, and December 31, 2021, respectively.

 

During the year ended December 31, 2022, and 2021, the Company issued 30,000 and 9,774 shares of common stock in relation to services with a stock-based compensation expense of $96 thousand and $39 thousand, respectively.

 

On August 11, 2022, we received an exercise notice to exercise 675,000 pre-funded warrants with an exercise price of $0.001 per share. Upon receipt of $675 the Company issued 675,000 shares of its common stock.

 

On April 22, 2022, 305,473 shares of common stock were issued in relation to the acquisition of the PeriShip business, see Note 4 – Business Combinations, for details.

 

On April 15, 2022, the Company withheld and retired 750 shares of common stock in order to satisfy U.S. payroll tax withholding obligations on restricted stock awards held by our Chief Financial Officer. 

 

On April 12, 2022, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with a selling stockholder and certain directors, providing for the issuance and sale to purchasers therein of an aggregate of 880,208 shares of our common stock, pre-funded warrants to purchase up to 675,000 shares of our common stock, and warrants to purchase up to 1,555,208 shares of our common stock, for gross proceeds to us of approximately $5.0 million and net proceeds of $4.6 million. The pre-funded warrant is exercisable immediately and shall terminate when fully exercised and has an exercise price of $0.001 per share. The pre-funded warrant was exercised in full on August 11, 2022. The warrants will be exercisable for a period of five years commencing six months from the date of issuance and have an exercise price of $3.215 per share. Both the pre-funded warrants and warrants contain price adjustment provisions which may, under certain circumstances, reduce the applicable exercise price. The transaction closed on April 14, 2022.

 

On March 29, 2022, the Company withheld and retired 8,870 shares of common stock in order to satisfy U.S. payroll tax withholding obligations on restricted stock awards held by our Chief Executive Officer.

 

Non-Qualified Stock Purchase Plan

 

On June 10, 2021, the stockholders of the Company approved a non-qualified stock purchase plan (the “2021 Plan”). The 2021 Plan provides eligible participants, including employees, directors and consultants of the Company, the opportunity to purchase shares of the Company’s common stock thereby increasing their interest in the Company’s continued success. The maximum numbers of common stock reserved and available for issuance under the 2021 Plan is 500,000 shares. The purchase price of shares of common stock acquired pursuant to the exercise of an option will be the lesser of 85% of the fair market value of a share (a) on the enrollment date, and (b) on the exercise date. The 2021 Plan is not intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”). The Company applied FASB ASC 718, “Compensation-Stock Compensation” and estimated the fair value using the Black-Scholes model, as the plan is considered compensatory. In relation to the non-qualified stock purchase plan the Company expensed $122 thousand and $40 thousand for the years ended December 31, 2022 and December 31, 2021, respectively.

 

Shares Held in Treasury

 

As of December 31, 2022, and December 31, 2021, the Company had 389,967 and 223,956 shares, respectively, held in treasury with a value of approximately $949 thousand and $838 thousand, respectively.  

 

On February 28, 2022, five participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 25,000 shares were issued from treasury with a purchase price of $2.69 per share.

 

On August 31, 2022, four participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 28,895 shares were issued from treasury with a purchase price of $1.20 per share.

 

On September 22, 2022, the Company paid $1.8 million of the $2.0 million principal amount promissory note issued to the seller in connection with the PeriShip acquisition, inclusive of the Company redeeming 61,000 shares of its common stock from the seller, pursuant to an agreement with the seller, see Note 4.

 

Shares Repurchase Program

 

In November 2020, the Company’s Board of Directors approved a share repurchase program for up to $1.5 million of the Company’s common stock until August 16, 2021. On August 12, 2021, the Company’s Board of Directors extended the share repurchase program to expire on August 16, 2022. Effective July 1, 2022, the Company’s Board of Directors terminated the existing share repurchase program and approved a new share repurchase program to replace the existing program due to expire on August 16, 2022, to allow the Company to spend up to $1.5 million to repurchase shares of its common stock, so long as the price does not exceed $5.00 until July 1, 2023. During year ended December 31, 2022, the Company repurchased 158,906 shares of common stock under the Company’s current program.

 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS

NOTE 10– STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS

 

During 2013, the Company adopted the 2013 Omnibus Equity Compensation Plan (the “2013 Plan”). Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards up to an aggregate of 400,000 shares of common stock.  The 2013 Plan is intended to permit certain stock options granted to employees under the 2013 Plan to qualify as incentive stock options.  All options granted under the 2013 Plan, which are not intended to qualify as incentive stock options are deemed to be non-qualified stock options.  

 

On November 14, 2017, the Executive Committee of the Company’s Board of Directors adopted the 2017 Equity Incentive Plan (the “2017 Plan”) which covered the potential issuance of 260,000 shares of common stock. The 2017 Plan provided that directors, officers, employees, and consultants of the Company were eligible to receive equity incentives under the 2017 Plan at the discretion of the Board or the Board’s Compensation Committee.

 

On August 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”), subject to stockholder approval, which authorizes the potential issuance of up to 1,069,110 shares of common stock. On September 30, 2020, the Company’s stockholders approved the 2020 Plan, and upon such approval the 2020 Plan became effective and the 2017 Plan was terminated. Shares of common stock underlying existing awards under the 2017 Plan may become available for issuance pursuant to the terms of the 2020 Plan under certain circumstances. Employees and non-employee directors of the Company or its affiliates, and other individuals who perform services for the Company or any of its affiliates, are eligible to receive awards under the 2020 Plan at the discretion of the Board of Directors or the Board’s Compensation Committee.

 

The 2020 Plan is administered by the Compensation Committee which determines the persons to whom awards will be granted, the number of awards to be granted and the specific terms of each grant, including the vesting thereof, subject to the provisions of the plan.

 

In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate, 1,000,000.

 

The Company has issued non-qualified stock options pursuant to contractual agreements with non-employees. Options granted under the agreements are expensed when the related service or product is provided. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value represent management’s best estimates and involve inherent uncertainties and judgements.

 

Stock Options

 

                     
    Options Outstanding 
              Weighted -      
              Average      
              Remaining   Aggregate 
         Weighted-   Contractual   Intrinsic 
    Number of   Average   Term   Value 
    Shares   Exercise Price   (in years)   (in thousands)(1) 
Balance as of December 31, 2020    473,771   $4.48           
                      
Granted    -    -           
                      
Forfeited/Cancelled/Expired    (8,300)   9.72           
                      
Balance as of December 31, 2021    465,471    4.38           
                      
Exercisable as of December 31, 2021    465,471   $4.38    3.2   $47 
                      
Granted    -    -           
                      
Forfeited/Cancelled/Expired    (128,000)   3.74           
                      
Balance as of December 31, 2022    337,471    4.63           
                      
Exercisable as of December 31, 2022    337,471   $4.63    2.4   $- 

  

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

 

As of December 31, 2022, and 2021, the Company had no unvested stock options.

 

The following table summarizes the activities for the Company’s unvested stock options for the year ended December 31, 2022, and 2021:

 

           
    Unvested Options 
         Weighted - 
         Average 
    Number of   Grant 
    Unvested Options   Date Exercise Price 
            
            
Balance at December 31, 2020    10,000   $9.75 
            
Granted    -    - 
            
Vested    (10,000)   9.75 
            
Balance at December 31, 2021    -    - 
            
Granted    -    - 
            
Vested    -    - 
            
Balance at December 31, 2022    -   $- 

 

During the year ended December 31, 2022, and 2021, the Company expensed $0 thousand and $85 thousand with respect to options.

 

As of December 31, 2022, and 2021, there was $0 unrecognized compensation cost related to outstanding stock options.

 

Restricted Stock Awards and Restricted Stock Units

 

The following table summarizes the unvested restricted stock awards as of December 31, 2022 and 2021:

 

           
    Unvested Restricted Stock Awards 
         Weighted - 
         Average 
    Number of   Grant 
    Award Shares   Date Fair Value 
            
Balance at December 31, 2020    267,500    3,80 
            
Granted    89,284    4,32 
            
Vested    (312,142)   3.87 
            
Balance at December 31, 2021    44,642    4.31 
            
Granted    39,308    3.18 
            
Vested    (42,142)   4.32 
            
Balance at December 31, 2022    41,808   $3.24 

 

As of December 31, 2022, and 2021, total unrecognized share-based compensation cost related to unvested restricted stock awards was $2 thousand and $115 thousand respectively, which is expected to be recognized over a weighted-average period of 0.02 years as of December 31, 2022.

 

The following table summarizes the unvested restricted stock units as of December 31, 2022 and 2021:

 

           
    Unvested Restricted Stock Units 
         Weighted - 
         Average 
    Number of   Grant 
    Unit Shares   Date Fair Value 
Unvested at December 31, 2020    -    - 
            
Granted    208,010    4.05 
            
Vested    (21,000)   3.44 
            
Unvested at December 31, 2021    187,010    4.11 
            
Granted    418,041    2.14 
            
Vested    (191,425)   4.07 
            
Balance at December 31, 2022   $413,626   $2.14 

 

As of December 31, 2022, and 2021, total unrecognized share-based compensation cost related to unvested restricted stock units was $284 thousand and $146 thousand respectively, which is expected to be recognized over a weighted-average period of 1.02 years as of December 31, 2022.

 

For RSUs with stock price appreciation targets, we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value of each grant was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the derived service period and there is no ongoing adjustment or reversal based on actual achievement during the period.

 

The following table summarizes the unvested performance restricted stock units as of December 31, 2022. There were no performance restricted stock units prior to the year 2022.:

 

           
    Unvested Performance Restricted Stock Units 
         Weighted - 
         Average 
    Number of   Grant 
    Unit Shares   Date Fair Value 
Unvested at December 31, 2021    -    - 
            
Granted    432,326    2.95 
            
Vested    -    - 
            
Balance at December 31, 2022   $432,326   $2.95 

 

As of December 31, 2022, total unrecognized share-based compensation cost related to unvested restricted stock units was $947 thousand, which is expected to be recognized over a weighted-average period of 2.23 years.

 

Warrants

 

The following table summarizes the activities for the Company’s warrants for the year ended December 31, 2022 and 2021:

 

                    
   Warrants Outstanding (Excluding Pre-Funded Warrants) 
   Number of
Warrant Shares		  

Weighted-

Average

Exercise

Price

  

Weighted -

Average

Remaining

Contractual

Term

in years)

  

Aggregate

Intrinsic

Value

(in thousands)(1)

 
Balance at December 31, 2020   3,779,243   $5.89               
                     
Granted   -    -           
                     
Expired   -    -           
                     
Balance at December 31, 2021   3,779,243    5.89           
                     
Granted   1,590,150    3.22           
                     
Expired   (265,938)   19.21           
                     
Balance at December 31, 2022   5,103,455   $4.34    3.0      
                     
Exercisable at December 31, 2022   5,103,455   $4.34    3.0   $- 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022.

 

For the year ended December 31, 2022, and 2021, the Company granted 34,942 warrants and 0 warrants to warrant holders pursuant to anti-dilution provisions, 1,555,208 warrants and 0 warrants in conjunction with the Securities Purchase Agreement, respectively (see Note 9 – Stockholders’ Equity). As the fair value of the warrants granted would have had a net zero impact to equity (increasing additional paid in capital and offering costs for the same amount), the Company did not break out or complete a separate valuation of the warrants granted in association with either capital raise. 

 

Pre-funded Warrants

 

On April 14, 2022, in connection with our Securities Purchase Agreement (see Note 9 – Stockholders’ Equity), the Company issued 675,000 pre-funded warrants to purchase up to an aggregate of 675,000 shares of common stock at a purchase price of $3.214 per pre-funded warrant, which represented the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. In August 2022, 675,000 pre-funded warrants with an exercise price of $0.001 per share were exercised, and 675,000 shares of the Company’s common stock were issued. No pre-funded warrants are outstanding as of December 31, 2022.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS (LOSS) PER SHARE
 12 Months Ended
Dec. 31, 2022
EARNINGS / (LOSS) PER SHARE  
EARNINGS (LOSS) PER SHARE

NOTE 11—EARNINGS (LOSS) PER SHARE

 

Basic earnings/(loss) per share (EPS) is computed by dividing net income/(loss) by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution of common stock equivalent shares that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

 

The dilutive common stock equivalent shares consist of preferred stock, stock options, warrants, restricted stock awards and restricted stock units computed under the treasury stock method, using the average market price during the period.

 

The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except share and per share data):

 

               
    Years Ended December 31,  
    2022     2021  
Numerator:            
Net Income/(Loss)   $ (14,398)     $ 3,612  
Denominator:                
Weighted average shares of common stock – basic     8,466,075       7,110,907  
                 
Effect of dilutive securities                
                 
Preferred Stock     -       144,444  
Stock Options     -       48,212  
Warrants     -       23  
Stock Purchase Plan     -       2,362  
Restricted Stock Units & Restricted Stock Awards     -       77,416  
Weighted average shares of common
stock – diluted		     8,466,075       7,383,364  
                 
(Loss)/Earnings per share                
                 
Basic   $ (1.70)     $ 0.51  
                 
Diluted   $ (1.70)     $ 0.49  

 

The following table represents the weighted average number of anti-dilutive instruments excluded from the computation of diluted (loss)/earnings per share:

 

        
   Years Ended
December 31,		 
   2022   2021 
Anti-dilutive instruments excluded from computation of diluted net income/(loss) per share:        
         
Preferred Stock   144,444    - 
           
Stock Options   337,471    177,334 
           
Warrants   5,103,455    3,779,048 
           
Stock purchase plan   57,245    - 
           
Restricted Stock Units and Restricted Stock Awards   887,760    13,196 

 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
LONG TERM DERIVATIVE LIABILITY
 12 Months Ended
Dec. 31, 2022
Long Term Derivative Liability  
LONG TERM DERIVATIVE LIABILITY

NOTE 12—LONG TERM DERIVATIVE LIABILITY

 

On April 7, 2022, the Company granted two directors 11,250 restricted stock units each (“SPAC RSUs”) with respect to the common stock, $0.0001 par value per share, of G3 VRM Acquisition Corp. The SPAC RSUs were to vest upon the initial business combination of the SPAC (see Note 2 – Equity Investments) subject to continuous service to the Company through the vesting date. Each vested SPAC RSU represented the right to receive the value of one share of stock in G3 VRM Acquisition Corp., which would have been paid to the director as soon as practicable after the fifteen-month anniversary of the vesting date.

 

On September 17, 2021, the Company granted two directors SPAC RSUs with respect to the common stock, $0.0001 par value per share, of G3 VRM Acquisition Corp. The SPAC RSUs were to vest upon the initial business combination of the SPAC (see Note 2 – Equity Investments) subject to continuous service to the Company through the vesting date. Each vested SPAC RSU represented the right to receive the value of one share of stock in G3 VRM Acquisition Corp., which was to be paid to the director as soon as practicable after the fifteen-month anniversary of the vesting date. The grant date fair value of the SPAC RSUs for each director was $98 thousand. As the underlying awards were not the Company’s stock but an unrelated, publicly traded entity’s shares, the Company accounted for the awards under ASC 815 – Derivatives and Hedging, with the expense included in stock-based compensation under General and Administrative expenses in the accompanying Consolidated Statements of Operations.

 

In June 2022, the Sponsor Entity decided not to fund the extension for the time that the SPAC had to complete its initial business combination. As a result, the SPAC was dissolved and liquidated in accordance with its charter and under ASC 815, and the derivative instrument was terminated. As a result, the SPAC RSUs were forfeited. For the year ended December 31, 2022, the Company has recorded the effect of termination to reduce the fair value and recorded a credit to share-based compensation expense of $71 thousand in relation to these awards. The fair value of the derivative liability was $0 as of December 31, 2022, and $71 thousand as of December 31, 2021.

 

Effective October 17, 2022, the Company entered into an interest rate swap agreement (see Note 7 – Debt for details). The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and $0 as of December 31, 2021.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
EMPLOYEE BENEFIT PLAN
 12 Months Ended
Dec. 31, 2022
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLAN

NOTE 13 –EMPLOYEE BENEFIT PLAN

 

We offer the VRME Retirement Savings Plan (the “Plan”) to our employees. Eligible employees can elect to participate in the Plan, as soon as administratively feasible after enrollment. The Plan permits pre-tax contributions to the Plan by participants pursuant to Section 401(k) of the Internal Revenue Code (IRC). We make matching contributions at our discretion. In 2022 and 2021 we contributed a value of approximately $103 thousand and $10 thousand respectively and is recognized as compensation expense in the consolidated statements of operations for matching contributions to the Plan.

 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES
 12 Months Ended
Dec. 31, 2022
Leases  
LEASES

NOTE 14 –LEASES

 

The Company accounts for its leases under Accounting Standard Codification (“ASC”) Topic 842, Leases. The Company determines at its inception whether an arrangement that provides us control over the use of an asset is a lease. We recognize at lease commencement a right-of-use (ROU) asset and lease liability based on the present value of the future lease payments over the lease term. We have elected not to recognize a ROU asset and lease liability for leases with terms of 12 months or less. Our current long-term lease includes an option to extend the term of the lease prior to the end of the initial term. It is not reasonably certain that we will exercise the option and have not included the impact of the option in the lease term for purposes of determining total future lease payments. As our lease agreement does not explicitly state the discount rate implicit in the lease, we use our promissory note borrowing rate to calculate the present value of future payments.

 

In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. For our real estate leases, we apply a practical expedient to include these non-lease components in calculating the ROU asset and lease liability. For all other types of leases, non-lease components are excluded from our ROU assets and lease liabilities and expensed as incurred.

 

We have operating leases for office facilities. We do not have any finance leases.

 

Lease expense is included in General & Administrative Expenses on the accompanying Consolidated Statements of Operations. The components of lease expense were as follows (in thousands):

 

          
   Years ended December 31, 
   2022   2021 
Operating lease cost  $85   $- 
Short-term lease cost   18    14 
Total lease costs  $103   $14 

 

Supplemental information related to leases was as follows (dollars in thousands):

 

          
   December 31, 2022   December 31, 2021 
Operating Lease right-of-use asset  $469   $- 
           
Current portion of operating lease liabilities  $115   $- 
Non-current portion of operating lease liabilities  $359   $- 
Total operating lease liabilities  $474   $- 
           
Cash paid for amounts included in the measurement of operating lease liabilities  $80   $- 
           
Right-of-use assets obtained in exchange for operating lease liabilities  $552   $- 
           
Weighted-average remaining lease term for operating leases (years)   4.3      
Weighted average discount rate for operating leases   6.0%     

 

The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities on our consolidated balance sheets as of December 31, 2022 (in thousands):

 

     
Year ended December 31,    
2023  $122 
2024   126 
2025   130 
2026   134 
Thereafter   45 
Total future lease payments   557 
Less: imputed interest   (83)
Present value of future lease payments   474 
Less: current portion of lease liabilities   (115)
Long-term lease liabilities  $359 

 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS
 12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
CONCENTRATIONS

NOTE 15 – CONCENTRATIONS

 

During the year ended December 31, 2022, one customer represented 13% of revenues and five customers represented 95% of revenues for the year ended December 31, 2021.

 

As of December 31, 2022, two customers made up 23% of accounts receivable. As of December 31, 2021, three customers accounted for 91% of total accounts receivable.

 

During the year ended December 31, 2022, one vendor accounted for 99% of transportation costs, in our PeriShip Global Solutions segment.

 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 16 – SEGMENT REPORTING

 

As of December 31, 2022, we operated through two reportable business segments: (i) PeriShip Global Solutions and (ii) VerifyMe Solutions.

 

PeriShip Global Solutions: This segment offers a value-added service provider for time and temperature sensitive parcel management. Through logistics management from a sophisticated IT platform with proprietary databases, package and flight-tracking software, weather, traffic, and flight status monitoring systems, as well as dynamic dashboards with real-time visibility into shipment transit and last-mile events that are managed by a call center Using our proprietary IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries.

 

VerifyMe Solutions. This segment specializes in solutions that connect brands with consumers through their products. Consumers can authenticate products with their smart phone prior to usage, and brand owners have the ability to gather business intelligence while engaging directly with their consumers. Our VerifyMe Solutions also provide brand protection and supply chain functions such as counterfeit prevention.

 

We do not allocate the following items to the segments: general and administrative expenses, research and development expense, sales and marketing expenses, and other income (expense).

The following table sets forth the revenue and operating results attributable to each reportable segment and includes a reconciliation of segment revenue to consolidated revenue and operating results to consolidated loss before income tax expense (in thousands):

 

          
   Years Ended
December 31,		 
   2022   2021 
Revenue        
PeriShip Global Solutions  $18,190   $- 
VerifyMe Solutions   1,386    867 
Total Revenue  $19,576   $867 
           
Gross Profit          
PeriShip Global Solutions  $5,505   $- 
VerifyMe Solutions   983    599 
Total Gross Profit   6,488    599 
           
General and administrative   8,428    4,216 
Research and development   89    51 
Sales and marketing   1,718    1,163 
LOSS BEFORE OTHER (EXPENSE) INCOME   (3,747)   (4,831)
OTHER (EXPENSE) INCOME   (10,651)   8,443 
NET (LOSS) INCOME  $(14,398)  $3,612 

 

Additional information relating to our business segments is as follows (in thousands):

 

Identifiable assets:

 

   Years Ended
December 31,		 
   2022   2021 
         
PeriShip Global Solutions  $17,302   $- 
VerifyMe Solutions   3,450    21,688 
Total Assets  $20,752   $21,688 

 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 17 – SUBSEQUENT EVENTS

 

On March 1, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) effective as of February 28, 2023 (the “Effective Date”) by and among the Company, Trust Codes Global, Trust Codes Limited, a New Zealand limited liability company that specializes in unique item level codes for brand protection, data intelligence and consumer engagement technology with an expertise in the food and agriculture industry (“Trust Codes” or “Seller”) and Signum Holdings Limited (“Seller’s Parent”). Pursuant to the terms of the APA Trust Codes Global agreed to purchase from Trust Codes and Trust Codes agreed to sell to Trust Codes Global substantially all of the assets of Trust Codes and certain specified liabilities (the “Transaction”). The Transaction closed simultaneously with the execution of the APA on March 1, 2023 (the “Closing”).

 

The total consideration paid to the Seller at Closing in connection with the Transaction was approximately $1,000,000, which consisted of approximately $350,000 in cash (the “Cash Consideration”); and the issuance of 353,492 shares of restricted common stock of the Company at $1.84 per share (the “Stock Consideration”) (representing $650,000 in Stock Consideration). The total consideration due under the Transaction is subject to certain post-Closing adjustments, which shall be accounted for in the first cash earnout payment, discussed below, if applicable. 

 

 

Under the APA, during the five-year period ending on the fifth anniversary of the Effective Date, Trust Codes Global shall pay the Seller quarterly cash earnout payments equal to 18% of the gross margin earned on existing customers and the Company shall issue to the Seller annual equity earnout payments of restricted shares of the Company’s common stock equal to 20% of gross margin earned on new customers during the applicable 12 month period divided by the VWAP for the 30-day period ending on the last day of the 12-month period, inclusive. If the value of equity earnout shares issued exceeds $3.1 million at any time during the earnout period, then any subsequent amount of equity earnout shall be reduced to 10% of gross margin earned on new customers received during the applicable 12-month period. In certain circumstance Trust Codes Global may pay cash in lieu of the Company issuing restricted common stock for the equity earnout. 

 

The APA is structured to comply with the shareholder approval requirements of the Nasdaq listing rules and contains a blocker provision which prevents the Seller from receiving any equity earnout shares should such earnout shares, in connection with the Stock Consideration, cause the Seller to beneficially own more than 19.99% of the voting securities of the Company. The APA contains customary confidentiality and indemnification provisions and customary representations, warranties and covenants by the parties for transactions of this type and also contains a five-year non-compete and non-solicitation provision applicable to the Seller, Seller’s Parent, and each of their affiliates, in favor of the Company and Trust Codes Global.

On February 28, 2023, fourteen participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, 57,245 shares were issued with an exercise price of $1.19.

 

Effective March 15, 2023, the Company’s Chief Executive Officer, Patrick White, resigned as an officer and director of the Company. Scott Greenberg, the Company’s executive chairman of the Board, was appointed as Interim Chief Executive Officer. In connection with his resignation, Mr. White will receive payments totaling $159 thousand. In addition the Company awarded him 111,364 restricted stock units, with a grant date value equal to 70% of his annual base salary, each such unit representing the contingent right to receive one share of the Company’s common stock, par value $0.001 per share, subject to the terms of the Company’s 2020 Plan. These restricted stock units, except as otherwise provided in the award agreement, vest within three years in equal tranches provided the Company’s stock price exceeds $2.75 and $3.75 per share for twenty consecutive trading days. In connection with the grant of the restricted stock units Mr. White forfeited his outstanding award of restricted stock units granted pursuant to a Restricted Stock Unit Award Agreement dated February 26, 2022.

 

In connection with his appointment as Interim Chief Executive Officer, Mr. Greenberg was awarded 56,819 restricted stock units, with a grant date value equal to $100,000, each such unit representing the contingent right to receive one share of the Common Stock, subject to the terms of the 2020 Plan. These restricted stock units, except as otherwise provided in the award agreement, vest within three years in equal tranches provided the Company’s stock price exceeds $2.75 and $3.75 per share for twenty consecutive trading days.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Nature of the Business

Nature of the Business

 

VerifyMe, Inc. (“VerifyMe”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, together with its subsidiaries, including PeriShip Global LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”) is based in Lake Mary, Florida and its common stock, par value $0.001 per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.

 

VerifyMe, through PeriShip Global, is a software driven predictive analytics logistics provider of high-touch, end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions, which includes Trust Codes Global. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.

 
Basis of Presentation

Basis of Presentation

 

The accompanying consolidated financial statements include the accounts of VerifyMe and its wholly owned subsidiary PeriShip Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 
Segment Reporting

Segment Reporting

 

Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) PeriShip Global Solutions and (ii) VerifyMe Solutions. See Note 16 Segment Reporting, for further discussion of the Company’s segment reporting structure. 

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments, (“CECL”), which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded.  This guidance was to be effective for reporting periods beginning after December 15, 2022, with early adoption permitted. The Company has elected to early adopt ASU 2016-13, as of January 1, 2022, and the impact has been disclosed on the face of the Consolidated Balance Sheets. The Company’s accounts receivable is currently the only financial instrument subject to the new CECL model. The Company has considered relevant internal and/or external information about past events, e.g., historical loss experience with similar assets, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the reported amount of financial assets in determining the credit loss.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, equity investments, and long-term derivative liabilities. The carrying value of accounts receivable, unbilled revenue, accounts payable and accrued expenses approximate their fair value because of their short maturities.  The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.

 

The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures,” and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities

 

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data

 

Level 3: Unobservable inputs that are not corroborated by market data

 

The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

 

The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of December 31, 2022 and December 31, 2021.

 

Amounts in Thousands ('000)

 

                
   Short Term Investment   Equity Investment   Derivative Liability   Derivative Liability 
   (Level 1)   (Level 3)   (Level 2)   (Level 3) 
                 
Balance as of December 31, 2021  $88    10,964    -    (71)
                     
Realized loss on fair value recognized in other (expense)/income   -    (10,932)   -    - 
                     
Distribution from Sponsor Entity   -    (32)   -    - 
              -    - 
Unrealized gain on fair value recognized in other (expense)/income   12    -    -    - 
                     
Realized gain on fair value recognized in share-based compensation   -    -         71 
                     
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss             (3)   - 
    -    -           
Balance at December 31, 2022  $100   $-   $(3)  $- 

 
Variable Interest Entity

Variable Interest Entity

 

The Company determined that G3 VRM Acquisition Corp. (NASDAQ: GGGVU) (the “SPAC”, see Note 2 – Equity Investments), a Delaware corporation and special purpose acquisition company, was a variable interest entity (“VIE”) in which the Company had a variable interest but was not the primary beneficiary. Making the determination as to whether a VIE should be consolidated requires judgement in assessing if the Company is the primary beneficiary. To make this determination, the Company evaluated its power to direct the activities that most significantly impacted the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the SPAC. The Company concluded that it was not the primary beneficiary of the VIE and as such, did not consolidate the SPAC. The Company reassessed its evaluation of whether an entity is a VIE and if it continues to be a VIE, whether the Company is the primary beneficiary of the VIE, on an ongoing basis based on the current facts and circumstances surrounding the entity. The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO, and the Sponsor Entity made the decision not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved, and liquidated according to its charter. The SPAC redeemed 100% of the public shares for cash, the rights have expired worthless, and the founder shares and the private placement securities have become worthless.

 
Equity Investments

Equity Investments

 

When the Company does not have a controlling financial interest in an entity but can exert influence over the entity’s operations and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under applicable generally accepted accounting policies. The Company has elected the fair value option for its equity investment in the SPAC (see Note 2 –Equity Investments) and its equity security under short term investment on the balance sheets, as it has determined the fair value best reflects the economic performance of the equity investment. Changes in unrealized gain on equity investment include unrealized gain of the fair value of the equity investments and loss on equity investment includes realized loss on equity investments on the accompanying Consolidated Statements of Operations.

 
Goodwill

Goodwill

 

Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

 
Business Combinations

Business Combinations

 

The Company applies the provisions of Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, in the accounting for business acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the Consolidated Statements of Operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results.

 
Basic and Diluted Net Loss per Share of Common Stock

Basic and Diluted Net Loss per Share of Common Stock

 

The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents. As of December 31, 2022, the Company held $63 thousand subject to restrictions.

 
Accounts Receivable

Accounts Receivable

 

Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. Bad debts expense or write offs of receivables are determined on the basis of loss experience, known and inherent risks in the receivable portfolio and current economic conditions. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, such allowances may be required. The Company recognized $37 thousand and $0 for allowance for credit losses as of December 31, 2022, and 2021, respectively.

 
Concentration of Credit Risk Involving Cash and Cash Equivalents

Concentration of Credit Risk Involving Cash and Cash Equivalents

 

The Company’s cash and cash equivalents are held at various financial institutions. At times, the Company’s deposits may exceed Federal Deposit Insurance Corporation (FDIC) coverage limits which are currently set at $250,000 per depositor. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.

 
Inventory

Inventory

 

Inventory principally consists of canisters and pigments and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.

 
Equipment for Lease

Equipment for Lease

 

Equipment for lease principally consists of costs associated with the development, certification and production of the VerifyChecker™ and the VerifyAuthenticatorTM Smartphone Authenticator technology. These technologies are leased to customers typically for a period of one year in length with automatically renewable leases cancellable by either party by written notice provided 90 days in advance. We examined the effect of Accounting Standards Update (“ASU”) No. 2016-02- “Lease (Topic 842)” and determined the impact is not material. Our policy is to capitalize the costs related to this equipment and depreciate on a straight-line basis over the estimated lives of the equipment which was determined to be 5 years.

 
Capitalized Software

Capitalized Software  

 

Costs incurred in connection with the development of software related to our proprietary proactive end-to-end logistics management products are accounted for in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 “Hosting Arrangements and Internally Used Software.” Costs incurred prior to the establishment of technological feasibility are charged to research and development expense. Software development costs are capitalized after a product is determined to be technologically feasible and is in the process of being developed for market. Amortization of capitalized software development costs begins once the product is available to the market. Capitalized software development costs are amortized over the estimated life of the related product, generally six years, using the straight-line method. The Company will evaluate its software assets for impairment whenever events or change in circumstances indicate that the carrying amount of such assets may not be recoverable.

 
Long-Lived Assets

Long-Lived Assets

 

The Company evaluates the recoverability of its long-lived assets in accordance with ASC 360 “Property, Plant, and Equipment.” The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.

 
Derivative Instruments

Derivative Instruments

 

The Company evaluates its equity investments, long-term derivative liabilities, preferred stock, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguish by Liabilities from Equity” (FASB ASC 480), and FASB ASC 815, “Derivatives and Hedging” (“FASB ASC 815”). The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the Consolidated Statement of Operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.

 

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified as liabilities at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

 
Reclassifications

Reclassifications

 

Certain accounts in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements. These reclassifications had no effect on the previously reported net income (loss).

 
Revenue Recognition

 Revenue Recognition

 

The Company accounts for revenues according to Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. 

 

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

·identify the contract with a customer;
·identify the performance obligations in the contract;
·determine the transaction price;
·allocate the transaction price to performance obligations in the contract; and
·recognize revenue as the performance obligation is satisfied.

 

During the year ended December 31, 2022, over 90% of the Company’s revenues primarily consisted of revenue related to our logistics management for time and temperature sensitive packages generated by our subsidiary PeriShip Global. During the year ended December 31, 2021, the Company’s revenue primarily consisted of VerifyInkTM and labels with our VerifyMe traceability solutions.

 
Income Taxes

Income Taxes

 

The Company follows FASB ASC 740, “Income Taxes,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2003 remain subject to examination by major tax jurisdictions due the carryforward of unutilized NOLs.

 
Stock-Based Compensation

Stock-Based Compensation

 

We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. We recognize forfeitures as they occur with a reduction in compensation expense in the period of forfeiture. For performance restricted stock units with stock price appreciation targets (see Note 10 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.

We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.

  

All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed. 

 
Advertising Costs

Advertising Costs

 

Advertising costs are expensed as incurred. Advertising costs were $60 thousand and $51 thousand for the years ended December 31, 2022, and 2021, respectively, and are included in Sales and Marketing on the Consolidated Statements of Operations.

 
Research and Development Costs

Research and Development Costs

 

In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the years ended December 31, 2022, and 2021 were $89 thousand and $51 thousand, respectively.

 
Basic and Diluted Earnings (Loss) per Share of Common Stock

Basic and Diluted Earnings (Loss) per Share of Common Stock

 

The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the year ended December 31, 2022, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same. 

 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of fair value assets measured on recurring basis
                
   Short Term Investment   Equity Investment   Derivative Liability   Derivative Liability 
   (Level 1)   (Level 3)   (Level 2)   (Level 3) 
                 
Balance as of December 31, 2021  $88    10,964    -    (71)
                     
Realized loss on fair value recognized in other (expense)/income   -    (10,932)   -    - 
                     
Distribution from Sponsor Entity   -    (32)   -    - 
              -    - 
Unrealized gain on fair value recognized in other (expense)/income   12    -    -    - 
                     
Realized gain on fair value recognized in share-based compensation   -    -         71 
                     
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss             (3)   - 
    -    -           
Balance at December 31, 2022  $100   $-   $(3)  $- 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE (Tables)
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue
                              
   VerifyMe   PeriShip Global   Consolidated 
Revenue  Year Ended
December 31,		   Year Ended
December 31,		   Year Ended
December 31,		 
   2022   2021   2022   2021   2022   2021 
                         
Proactive services  $-    -   $15,202    -   $15,202   $- 
Premium services   -    -    2,988    -    2,988    - 
Brand protection services   1,386    867    -    -    1,386    867 
   $1,386   $867   $18,190   $-   $19,576   $867 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS COMBINATION (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of business acquisitions
             
Cash   7,500         
Promissory note   2,000         
Stock (issuance of 305,473 shares of common stock) (1)   974         
Total purchase price   10,474         
         
       Amortization 
       Period 
Purchase price allocation:          
Accounts receivable, net   836      
Prepaid expenses   5      
Developed Technology   3,143    6 years 
Trade Names/Trademarks   1,111    13 years 
Customer Relationships   1,839    10 years 
Non-Compete Agreement   191    5 years 
Property and Equipment, net   193      
Goodwill   3,988      
Accounts payable and other accrued expenses   (832)     
    10,474      

 

(1)Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736.
Schedule of financial information
        
   Years Ended
December 31,		 
Description  2022   2021 
         
Revenues  $25,397   $29,500 
Net Income (loss)  $(14,298)  $5,465 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill by reportable business segment
            
   VerifyMe   PeriShip Global   Total 
Net book value at            
January 1, 2022  $ -   $ -   $ - 
             
2022 Activity               
Acquisition   -    3,988    3,988 
                
Net book value at               
December 31, 2022  $-   $3,988   $3,988 
Schedule of intangible assets subject to amortization
               
December 31, 2022  Gross Carrying
Amount		   Accumulated
Amortization		   Net Carrying
Amount		 
Patents and Trademarks  $1,858   $(445)  $1,413 
Capitalized Software   206    (91)   115 
Customer Relationships   1,839    (133)   1,706 
Developed Technology   3,143    (360)   2,783 
Internally Used Software   236    (4)   232 
Non-Compete Agreement   191    (28)   163 
   $7,473   $(1,061)  $6,412 
December 31, 2021               
Patents and Trademarks  $707   $(354)  $353 
Capitalized Software   206    (50)   156 
   $913   $(404)  $509 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
      
Fiscal Year ending December 31,     
2023   $1,057 
2024    877 
2025    857 
2026    842 
2027    836 
Thereafter    1,943 
Total   $6,412 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of reconciliation of federal statutory tax rate
          
   Year Ended December 31, 
US  2022   2021 
         
Income (loss) before income taxes  $(14,400)  $(3,612)
Taxes under statutory US tax rates   (3,024)   759 
Increase (decrease) in taxes resulting from:          
Increase (decrease) in valuation allowance   (1,188)   (6,149)
Change in State tax rate   (57)   - 
All other   5,045    5,204 
State taxes   (776)   186 
Income tax expense  $-   $- 
Schedule of deferred tax assets and liabilities
          
   December 31, 
   2022   2021 
US        
Net operating loss carryforwards  $6,495   $5,208 
Restricted Stock (RSA’s, RSU’s)   503    180 
Stock Options   562    678 
Stock Purchase Plan (SPP)   8    - 
Depreciation   (71)   (33)
Intangibles   22    9 
Acquisition Transaction Costs   110    - 
Capitalized Research and Development   17    - 
Unrealized Gain on Investment   (1)   (2,188)
Bad Debt   9    - 
Dividend Income   (2)   - 
Gross deferred tax assets  $7,652   $3,854 
           
Less valuation allowance   (7,652)   (3,854)
Total deferred tax assets  $-   $- 
           
Deferred tax liabilities:          
Total deferred tax liabilities   -    - 
Net deferred tax assets / (liabilities)  $-   $- 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of stock options
                     
    Options Outstanding 
              Weighted -      
              Average      
              Remaining   Aggregate 
         Weighted-   Contractual   Intrinsic 
    Number of   Average   Term   Value 
    Shares   Exercise Price   (in years)   (in thousands)(1) 
Balance as of December 31, 2020    473,771   $4.48           
                      
Granted    -    -           
                      
Forfeited/Cancelled/Expired    (8,300)   9.72           
                      
Balance as of December 31, 2021    465,471    4.38           
                      
Exercisable as of December 31, 2021    465,471   $4.38    3.2   $47 
                      
Granted    -    -           
                      
Forfeited/Cancelled/Expired    (128,000)   3.74           
                      
Balance as of December 31, 2022    337,471    4.63           
                      
Exercisable as of December 31, 2022    337,471   $4.63    2.4   $- 

  

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 
Schedule of Unvested Options
           
    Unvested Options 
         Weighted - 
         Average 
    Number of   Grant 
    Unvested Options   Date Exercise Price 
            
            
Balance at December 31, 2020    10,000   $9.75 
            
Granted    -    - 
            
Vested    (10,000)   9.75 
            
Balance at December 31, 2021    -    - 
            
Granted    -    - 
            
Vested    -    - 
            
Balance at December 31, 2022    -   $- 
Schedule of unvested restricted stock awards
           
    Unvested Restricted Stock Awards 
         Weighted - 
         Average 
    Number of   Grant 
    Award Shares   Date Fair Value 
            
Balance at December 31, 2020    267,500    3,80 
            
Granted    89,284    4,32 
            
Vested    (312,142)   3.87 
            
Balance at December 31, 2021    44,642    4.31 
            
Granted    39,308    3.18 
            
Vested    (42,142)   4.32 
            
Balance at December 31, 2022    41,808   $3.24 
Schedule of unvested restricted stock units
           
    Unvested Restricted Stock Units 
         Weighted - 
         Average 
    Number of   Grant 
    Unit Shares   Date Fair Value 
Unvested at December 31, 2020    -    - 
            
Granted    208,010    4.05 
            
Vested    (21,000)   3.44 
            
Unvested at December 31, 2021    187,010    4.11 
            
Granted    418,041    2.14 
            
Vested    (191,425)   4.07 
            
Balance at December 31, 2022   $413,626   $2.14 
Schedule of unvested performance restricted stock units
           
    Unvested Performance Restricted Stock Units 
         Weighted - 
         Average 
    Number of   Grant 
    Unit Shares   Date Fair Value 
Unvested at December 31, 2021    -    - 
            
Granted    432,326    2.95 
            
Vested    -    - 
            
Balance at December 31, 2022   $432,326   $2.95 
Schedule of warrants outstanding
                    
   Warrants Outstanding (Excluding Pre-Funded Warrants) 
   Number of
Warrant Shares		  

Weighted-

Average

Exercise

Price

  

Weighted -

Average

Remaining

Contractual

Term

in years)

  

Aggregate

Intrinsic

Value

(in thousands)(1)

 
Balance at December 31, 2020   3,779,243   $5.89               
                     
Granted   -    -           
                     
Expired   -    -           
                     
Balance at December 31, 2021   3,779,243    5.89           
                     
Granted   1,590,150    3.22           
                     
Expired   (265,938)   19.21           
                     
Balance at December 31, 2022   5,103,455   $4.34    3.0      
                     
Exercisable at December 31, 2022   5,103,455   $4.34    3.0   $- 

 

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022.
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS (LOSS) PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2022
EARNINGS / (LOSS) PER SHARE  
Schedule of basic and diluted earnings/(loss) per share
               
    Years Ended December 31,  
    2022     2021  
Numerator:            
Net Income/(Loss)   $ (14,398)     $ 3,612  
Denominator:                
Weighted average shares of common stock – basic     8,466,075       7,110,907  
                 
Effect of dilutive securities                
                 
Preferred Stock     -       144,444  
Stock Options     -       48,212  
Warrants     -       23  
Stock Purchase Plan     -       2,362  
Restricted Stock Units & Restricted Stock Awards     -       77,416  
Weighted average shares of common
stock – diluted		     8,466,075       7,383,364  
                 
(Loss)/Earnings per share                
                 
Basic   $ (1.70)     $ 0.51  
                 
Diluted   $ (1.70)     $ 0.49  
Schedule of anti-dilutiv e earnings per share
        
   Years Ended
December 31,		 
   2022   2021 
Anti-dilutive instruments excluded from computation of diluted net income/(loss) per share:        
         
Preferred Stock   144,444    - 
           
Stock Options   337,471    177,334 
           
Warrants   5,103,455    3,779,048 
           
Stock purchase plan   57,245    - 
           
Restricted Stock Units and Restricted Stock Awards   887,760    13,196 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2022
Leases  
Schedule of components of lease expense
          
   Years ended December 31, 
   2022   2021 
Operating lease cost  $85   $- 
Short-term lease cost   18    14 
Total lease costs  $103   $14 
Schedule of supplemental information related to leases
          
   December 31, 2022   December 31, 2021 
Operating Lease right-of-use asset  $469   $- 
           
Current portion of operating lease liabilities  $115   $- 
Non-current portion of operating lease liabilities  $359   $- 
Total operating lease liabilities  $474   $- 
           
Cash paid for amounts included in the measurement of operating lease liabilities  $80   $- 
           
Right-of-use assets obtained in exchange for operating lease liabilities  $552   $- 
           
Weighted-average remaining lease term for operating leases (years)   4.3      
Weighted average discount rate for operating leases   6.0%     
Schedule of operating lease liabilities maturities
     
Year ended December 31,    
2023  $122 
2024   126 
2025   130 
2026   134 
Thereafter   45 
Total future lease payments   557 
Less: imputed interest   (83)
Present value of future lease payments   474 
Less: current portion of lease liabilities   (115)
Long-term lease liabilities  $359 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of segment reporting information
          
   Years Ended
December 31,		 
   2022   2021 
Revenue        
PeriShip Global Solutions  $18,190   $- 
VerifyMe Solutions   1,386    867 
Total Revenue  $19,576   $867 
           
Gross Profit          
PeriShip Global Solutions  $5,505   $- 
VerifyMe Solutions   983    599 
Total Gross Profit   6,488    599 
           
General and administrative   8,428    4,216 
Research and development   89    51 
Sales and marketing   1,718    1,163 
LOSS BEFORE OTHER (EXPENSE) INCOME   (3,747)   (4,831)
OTHER (EXPENSE) INCOME   (10,651)   8,443 
NET (LOSS) INCOME  $(14,398)  $3,612 

 

Additional information relating to our business segments is as follows (in thousands):

 

Identifiable assets:

 

   Years Ended
December 31,		 
   2022   2021 
         
PeriShip Global Solutions  $17,302   $- 
VerifyMe Solutions   3,450    21,688 
Total Assets  $20,752   $21,688 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]    
Equity Investment $ 10,964
Derivative Liability at beginning 71  
Derivative Liability at end 3  
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short Term Investment at beginning 88  
Unrealized gain on fair value recognized in other (expense)/income 12  
Short-Term Investments at end 100  
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Equity Investment   $ 10,964
Derivative Liability at beginning (71)  
Realized loss on fair value recognized in other (expense)/income (10,932)  
Distribution from Sponsor Entity (32)  
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss 71  
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Change in fair value to interest rate, SWAP, recognized in other comprehensive loss (3)  
Derivative Liability at end $ (3)  
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Cash $ 63,000  
Allowance for doubtful accounts 37,000 $ 0
FDIC insured limit 250,000  
Advertising cost 60,000 51,000
Research and development costs $ 89,000 $ 51,000
Equipment For Lease [Member]    
Property, Plant and Equipment [Line Items]    
Description of lease terms automatically renewable leases cancellable by either party by written notice provided 90 days in advance.  
Maturity terms of lease 5 years  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
EQUITY INVESTMENTS (Details Narrative)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jul. 06, 2021
USD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
$ / shares
Apr. 12, 2021
Schedule of Equity Method Investments [Line Items]        
Equity Securities, FV-NI, Cost   $ 0 $ 11,000  
Equity Securities, FV-NI, Unrealized Loss   10,932    
Equity investments fair value   12    
Fair value of equity investment   $ 100 88  
Series D Preferred Stock [Member]        
Schedule of Equity Method Investments [Line Items]        
Cumulative convertible preferred stock value     $ 8,841  
Cumulative convertible preferred stock ratio     0.10  
Cumulative convertible preferred stock price | $ / shares     $ 10.00  
IPO [Member]        
Schedule of Equity Method Investments [Line Items]        
Number of units issued in transaction | shares 10,626,000      
Over-Allotment Option [Member]        
Schedule of Equity Method Investments [Line Items]        
Number of units issued in transaction | shares 626,000      
Private Placement [Member]        
Schedule of Equity Method Investments [Line Items]        
Number of units issued in transaction | shares 569,410      
Private Placement [Member] | G V R M Holdings L L Cand Maxim Partners L L C [Member]        
Schedule of Equity Method Investments [Line Items]        
Sale of Stock, Consideration Received on Transaction $ 5,694      
Private Placement [Member] | Beneficial Owner [Member]        
Schedule of Equity Method Investments [Line Items]        
Number of units issued in transaction | shares 229,228      
Sale of Stock, Consideration Received on Transaction $ 2,581      
Sponsor Entity [Member]        
Schedule of Equity Method Investments [Line Items]        
Number of units issued in transaction | shares 516,280      
Maxim Partners L L C [Member]        
Schedule of Equity Method Investments [Line Items]        
Number of units issued in transaction | shares 53,130      
Co Sponsor [Member]        
Schedule of Equity Method Investments [Line Items]        
Equity Method Investment, Ownership Percentage       44.40%
G V R M Holdings L L C [Member]        
Schedule of Equity Method Investments [Line Items]        
Equity Method Investment, Ownership Percentage 9.42%      
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
REVENUE (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]    
Revenues $ 19,576 $ 867
Proactive Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 15,202
Premium Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 2,988
Brand Protection Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 1,386 867
Parent Company [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 1,386 867
Parent Company [Member] | Proactive Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues
Parent Company [Member] | Premium Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues
Parent Company [Member] | Brand Protection Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 1,386 867
Subsidiaries [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 18,190
Subsidiaries [Member] | Proactive Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 15,202
Subsidiaries [Member] | Premium Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues 2,988
Subsidiaries [Member] | Brand Protection Services [Member]    
Disaggregation of Revenue [Line Items]    
Revenues
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS COMBINATION (Details) - USD ($)
$ in Thousands
Apr. 22, 2022
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]      
Cash   $ 63  
Goodwill   $ 3,988
Developed Technology Rights [Member]      
Business Acquisition [Line Items]      
Amortization Period 6 years    
Trademarks [Member]      
Business Acquisition [Line Items]      
Amortization Period 13 years    
Customer Relationships [Member]      
Business Acquisition [Line Items]      
Amortization Period 10 years    
Noncompete Agreements [Member]      
Business Acquisition [Line Items]      
Amortization Period 5 years    
Peri Ship [Member]      
Business Acquisition [Line Items]      
Cash $ 7,500    
Promissory note 2,000    
Stock (issuance of 305,473 shares of restricted common stock) [1] 974    
Total purchase price 10,474    
Accounts receivable, net 836    
Prepaid expenses 5    
Property and Equipment, net 193    
Goodwill 3,988    
Accounts payable and other accrued expenses (832)    
Peri Ship [Member] | Developed Technology Rights [Member]      
Business Acquisition [Line Items]      
Intangible Assets 3,143    
Peri Ship [Member] | Trademarks [Member]      
Business Acquisition [Line Items]      
Intangible Assets 1,111    
Peri Ship [Member] | Customer Relationships [Member]      
Business Acquisition [Line Items]      
Intangible Assets 1,839    
Peri Ship [Member] | Noncompete Agreements [Member]      
Business Acquisition [Line Items]      
Intangible Assets 191    
Business Combination [Member]      
Business Acquisition [Line Items]      
Total purchase price $ 10,474    
[1] Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736.
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS COMBINATION (Details 1) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]    
Revenues $ 25,397 $ 29,500
Net Income (loss) $ (14,298) $ 5,465
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
BUSINESS COMBINATION (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Apr. 22, 2022
Apr. 22, 2022
Dec. 31, 2022
Dec. 31, 2021
Sep. 22, 2022
Business Acquisition [Line Items]          
Consideration transferred   $ 7,500      
Common stock shares, issued 305,473 305,473 9,341,002 7,420,633  
Gain on extinguishment of debt     $ 326  
Business Combination [Member]          
Business Acquisition [Line Items]          
Purchase price $ 10,500        
Promissory note $ 2,000        
Investment Interest Rate 6.00% 6.00%      
Gain on extinguishment of debt     $ 326    
Business Combination [Member] | Restricted Stock [Member]          
Business Acquisition [Line Items]          
Common stock shares, issued 305,473 305,473     61,000
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Beginning balance
Acquisition 3,988
Ending balance 3,988
Parent Company [Member]  
Beginning balance
Acquisition
Ending balance
Subsidiaries [Member]  
Beginning balance
Acquisition 3,988
Ending balance $ 3,988
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL (Details 1) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 7,473 $ 913
Accumulated Amortization (1,061) (404)
Net Carrying Amount 6,412 509
Trademarks [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1,858 707
Accumulated Amortization (445) (354)
Net Carrying Amount 1,413 353
Capitalized Software [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 206 206
Accumulated Amortization (91) (50)
Net Carrying Amount 115 $ 156
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1,839  
Accumulated Amortization (133)  
Net Carrying Amount 1,706  
Developed Technology Rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 3,143  
Accumulated Amortization (360)  
Net Carrying Amount 2,783  
Internally Used Software [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 236  
Accumulated Amortization (4)  
Net Carrying Amount 232  
Noncompete Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 191  
Accumulated Amortization (28)  
Net Carrying Amount $ 163  
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL (Details 2) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
2023 $ 1,057  
2024 877  
2025 857  
2026 842  
2027 836  
Thereafter 1,943  
Total $ 6,412 $ 509
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of Intangible Assets $ 657 $ 64
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Income (loss) before income taxes $ (14,400) $ (3,612)
Taxes under statutory US tax rates (3,024) 759
Increase (decrease) in taxes resulting from:    
Increase (decrease) in valuation allowance (1,188) (6,149)
Change in State tax rate (57)
All other 5,045 5,204
State taxes (776) 186
Income tax expense
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 1) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 6,495 $ 5,208
Restricted Stock (RSA’s, RSU’s) 503 180
Stock Options 562 678
Stock Purchase Plan (SPP) 8
Depreciation (71) (33)
Intangibles 22 9
Acquisition Transaction Costs 110
Capitalized Research and Development 17
Unrealized Gain on Investment (1) (2,188)
Bad Debt 9
Dividend Income (2)
Gross deferred tax assets 7,652 3,854
Less valuation allowance (7,652) (3,854)
Total deferred tax assets
Deferred tax liabilities:    
Total deferred tax liabilities
Net deferred tax assets / (liabilities)
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]    
Description of ownership change Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.  
Effective income tax rate 26.60%  
Deferred tax assets valuation allowance $ 7,700  
Unrecognized tax benefits 0 $ 0
Accrual for interest and penalties 0 0
Taxes payable 0 $ 0
Foreign Tax Authority [Member]    
Operating Loss Carryforwards [Line Items]    
Operating Loss Carryforwards 23,100  
Domestic Tax Authority [Member]    
Operating Loss Carryforwards [Line Items]    
Operating Loss Carryforwards $ 0  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
DEBT (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Apr. 22, 2022
May 17, 2020
Oct. 17, 2022
Dec. 31, 2022
Dec. 31, 2021
Line of Credit Facility [Line Items]          
Gain (Loss) on Extinguishment of Debt       $ 326
Notional amount     $ 1,958    
Interest rate     7.602%    
Short term debt outstanding       500  
Long-term debt outstanding       $ 1,400  
Loan forgiveness         69
Interest payable         1
Repayments of loan payable         $ 3
Paycheck Protection Program Term Note [Member] | P N C Bank N A [Member]          
Line of Credit Facility [Line Items]          
Long-term debt outstanding   $ 72      
Maturity date   May 17, 2022      
Interest rate   1.00%      
Promissory Note [Member]          
Line of Credit Facility [Line Items]          
Unsecured promissory note $ 2,000        
Intrest rate 6.00%        
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
CONVERTIBLE PREFERRED STOCK (Details Narrative) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Series A Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Convertible Preferred Stock, outstanding 0 0
Series B Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Convertible Preferred Stock, outstanding 0.85 0.85
Number of shares converted 144,444 144,444
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Aug. 11, 2022
Nov. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Aug. 31, 2022
Apr. 22, 2022
Feb. 28, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Restricted stock/restricted stock units, expense     $ 239 $ 784      
Restricted stock/restricted stock award, expense     1,084 696      
Stock-based compensation expense     $ 96 $ 39      
Prefunded warrants 675,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.001            
Stock Issued During Period, Value, Other $ 675            
Stock Issued During Period, Shares, Other 675,000            
Common stock issued     9,341,002 7,420,633   305,473  
Non-Qualified Stock Purchase Plan expenses     $ 122 $ 40      
Treasury stock share     389,967 223,956      
Treasury stock value     $ 949 $ 838      
Non-qualified stock purchase plan         28,895   25,000
Non-qualified stock purchase exercise price         $ 1.20   $ 2.69
Share repurchase program   $ 1,500          
Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Stock issued for services     30,000 9,774      
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details) - Share-Based Payment Arrangement, Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Balance at ending 465,471 473,771
Weighted Average Exercise Price, Balance at ending $ 4.38 $ 4.48
Granted
Weighted Average Exercise Price, Granted
Forfeited/Cancelled/Expired (128,000) (8,300)
Weighted Average Exercise Price, Forfeited/Cancelled/Expired $ 3.74 $ 9.72
Vested and Exercisable at ending 337,471 465,471
Weighted Average Exercise Price, Exercisable at ending $ 4.63 $ 4.38
Weighted Average Remaining Contractual Term, Exercisable at ending 2 years 4 months 24 days 3 years 2 months 12 days
Vested and Exercisable at ending [1] $ 47
Balance at ending 337,471 465,471
Weighted Average Exercise Price, Balance at ending $ 4.63 $ 4.38
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1) - Nonvested Stock Options [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Balance at ending 10,000
Balance at ending $ 9.75
Granted
Granted
Vested (10,000)
Vested $ 9.75
Balance at ending
Balance at ending
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2) - Restricted Stock [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Balance at beginning 44,642 267,500
Weighted - Average Grant Date Fair Value, Balance at beginning $ 4.31 $ 3.80
Granted 39,308 89,284
Weighted - Average Grant Date Fair Value, Granted $ 3.18 $ 4.32
Vested (42,142) (312,142)
Weighted - Average Grant Date Fair Value, Vested $ 4.32 $ 3.87
Balance at ending 41,808 44,642
Weighted - Average Grant Date Fair Value, Balance at ending $ 3.24 $ 4.31
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3) - Restricted Stock Units [Member] - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Balance at beginning 187,010
Weighted - Average Grant Date Fair Value, Balance at beginning $ 4.11
Granted 418,041 208,010
Weighted - Average Grant Date Fair Value, Granted $ 2.14 $ 4.05
Vested (191,425) (21,000)
Weighted - Average Grant Date Fair Value, Vested $ 4.07 $ 3.44
Balance at ending 413,626 187,010
Weighted - Average Grant Date Fair Value, Balance at ending $ 2.14 $ 4.11
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4) - Unvested Performance Restricted Stock Units [Member]
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Balance at beginning | shares
Weighted - Average Grant Date Fair Value, Balance at beginning | $ / shares
Granted | shares 432,326
Weighted - Average Grant Date Fair Value, Granted | $ / shares $ 2.95
Vested | shares
Weighted - Average Grant Date Fair Value, Vested | $ / shares
Balance at ending | shares 432,326
Weighted - Average Grant Date Fair Value, Balance at ending | $ / shares $ 2.95
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Aug. 11, 2022
Net Investment Income [Line Items]      
Number of warrants outstanding, beginning balance 3,779,243 3,779,243  
Weighted average exercise price, beginning balance $ 5.89 $ 5.89  
Number of warrants outstanding, granted 1,590,150  
Weighted average exercise price, granted $ 3.22  
Number of warrants outstanding, expired (265,938)  
Weighted average exercise price, expired $ 19.21  
Number of warrants outstanding, ending Balance 5,103,455 3,779,243  
Weighted average exercise price, ending balance $ 4.34 $ 5.89  
Weighted average remaining contractual terms 3 years    
Number of warrants outstanding, exercisable 5,103,455    
Weighted average exercise price, exercisable $ 4.34    
Weighted average remaining contractual terms, exercisable 3 years    
Exercise price (in dollars per share)     $ 0.001
Warrant [Member]      
Net Investment Income [Line Items]      
Exercise price (in dollars per share) [1]    
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022.
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Aug. 10, 2020
Nov. 14, 2017
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Aug. 11, 2022
Apr. 14, 2022
Dec. 31, 2013
Class of Warrant or Right [Line Items]                
Per share public offering price(in dollars per share)           $ 0.001    
Director And Officer [Member] | Debentures 2022 [Member]                
Class of Warrant or Right [Line Items]                
Per share public offering price(in dollars per share)             $ 0.001  
Director And Officer [Member] | Debentures2020 [Member]                
Class of Warrant or Right [Line Items]                
Stock Issued During Period, Shares, Issued for Services         675,000      
Equity Incentive Plan2017 [Member] | Board of Directors Chairman [Member]                
Class of Warrant or Right [Line Items]                
Stock issued during period shares new issues 1,069,110 260,000            
Issued Under The2020 Plan [Member]                
Class of Warrant or Right [Line Items]                
Incentive stock options granted     1,000,000          
Plan2019 [Member]                
Class of Warrant or Right [Line Items]                
Stock or Unit Option Plan Expense     $ 0 $ 85        
Unrecognized compensation cost     $ 0 0        
Stock Options Restricted Stockand Unitsand Other Stockbased Awards [Member] | Omnibus Equity Compensation Plan2013 [Member]                
Class of Warrant or Right [Line Items]                
Number of shares authorized to grand awards               400,000
Incentive Stock Options [Member]                
Class of Warrant or Right [Line Items]                
Exercise price, description     In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate, 1,000,000.          
Restricted Stock [Member]                
Class of Warrant or Right [Line Items]                
Unvested restricted stock awards     $ 2 115        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term     7 days          
Restricted Stock Units [Member]                
Class of Warrant or Right [Line Items]                
Unvested restricted stock awards     $ 284 $ 146        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term     1 year 7 days          
Nonvested Stock Options [Member]                
Class of Warrant or Right [Line Items]                
Incentive stock options granted            
Unvested restricted stock awards     $ 947          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term     2 years 2 months 23 days          
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS (LOSS) PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Numerator:    
NET (LOSS)/INCOME $ (14,398) $ 3,612
Denominator:    
Weighted average shares of common stock – basic 8,466,075 7,110,907
Effect of dilutive securities    
Preferred Stock 144,444
Stock Options 48,212
Warrants 23
Stock Purchase Plan 2,362
Restricted Stock Units & Restricted Stock Awards 77,416
Weighted average shares of common stock – diluted 8,466,075 7,383,364
(Loss)/Earnings per share    
Basic $ (1.70) $ 0.51
Diluted $ (1.70) $ 0.49
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS (LOSS) PER SHARE (Details 1) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive shares 144,444
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive shares 337,471 177,334
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive shares 5,103,455 3,779,048
Stock Purchase Plan [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive shares 57,245
Restricted Stock Units And Restricted Stock Awards [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive shares 887,760 13,196
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
LONG TERM DERIVATIVE LIABILITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Sep. 17, 2021
Dec. 31, 2022
Apr. 07, 2022
Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Common stock, par value (in dollars per share)   $ 0.001   $ 0.001
Fair value of the derivative liability   $ 0   $ 71
Long term debt description   The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and $0 as of December 31, 2021.    
G 3 V R M [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Common stock, par value (in dollars per share)     $ 0.0001  
Director [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Grant fair value $ 98      
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
EMPLOYEE BENEFIT PLAN (Details Narrative) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Retirement Benefits [Abstract]    
Contributions $ 103 $ 10
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases    
Operating lease cost $ 85
Short-term lease cost 18 14
Total lease costs $ 103 $ 14
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Details 1) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Leases    
Operating Lease right-of-use asset $ 469
Current portion of operating lease liabilities 115
Non-current portion of operating lease liabilities 359
Total operating lease liabilities 474
Cash paid for amounts included in the measurement of operating lease liabilities 80
Right-of-use assets obtained in exchange for operating lease liabilities $ 552
Weighted-average remaining lease term for operating leases (years) 4 years 3 months 18 days  
Weighted average discount rate for operating leases 6.00%  
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.23.1
LEASES (Details 2) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Leases    
2023 $ 122  
2024 126  
2025 130  
2026 134  
Thereafter 45  
Total future lease payments 557  
Less: imputed interest (83)  
Present value of future lease payments 474  
Less: current portion of lease liabilities (115)
Long-term lease liabilities $ 359
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.23.1
CONCENTRATIONS (Details Narrative)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 13.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Five Customer [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage   95.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customer [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 23.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customer [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage   91.00%
Transportation Cost [Member] | Product Concentration Risk [Member] | One Vendor [Member]    
Concentration Risk [Line Items]    
Concentration risk, percentage 99.00%  
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.23.1
SEGMENT REPORTING (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues $ 19,576 $ 867
Gross Profit 6,488 599
General and administrative [1] 8,428 4,216
Research and development 89 51
Sales and marketing [1] 1,718 1,163
LOSS BEFORE OTHER INCOME (EXPENSE) (3,747) (4,831)
OTHER INCOME (EXPENSE) (10,651) 8,443
NET (LOSS)/INCOME (14,398) 3,612
Total Assets 20,752 21,688
Subsidiaries [Member]    
Revenues 18,190
Gross Profit 5,505
Total Assets 17,302
Parent Company [Member]    
Revenues 1,386 867
Gross Profit 983 599
Total Assets $ 3,450 $ 21,688
[1] Includes share-based compensation of $1,468 thousand for the year ended December 31, 2022, and $1,716 thousand for the year ended December 31, 2021.
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended
Mar. 15, 2023
Mar. 01, 2023
Feb. 28, 2023
Subsequent Event [Line Items]      
Total consideration paid   $ 1,000  
Cash Consideration   $ 350  
Restricted common stock issued   353,492  
Share price   $ 1.84  
Stock consideration   $ 650  
Nonqualified Stock Purchase Plan [Member]      
Subsequent Event [Line Items]      
Stock option exercised     57,245
Exercise Price     $ 1.19
N 2020 Plan [Member] | Former Chief Executive Officer [Member]      
Subsequent Event [Line Items]      
Restricted stock awarded 111,364    
N 2020 Plan [Member] | Greenberg [Member]      
Subsequent Event [Line Items]      
Restricted stock awarded 56,819    
Grant date value $ 100    
XML 80 vm32123010k_htm.xml IDEA: XBRL DOCUMENT 0001104038 2022-01-01 2022-12-31 0001104038 vrme:CommonStockParValue0.001PerShareMember 2022-01-01 2022-12-31 0001104038 vrme:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-12-31 0001104038 2022-06-30 0001104038 2023-03-23 0001104038 2022-12-31 0001104038 2021-12-31 0001104038 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001104038 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001104038 2021-01-01 2021-12-31 0001104038 2020-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2020-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2020-12-31 0001104038 us-gaap:CommonStockMember 2020-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001104038 vrme:TreasuryStocksMember 2020-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001104038 us-gaap:RetainedEarningsMember 2020-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2021-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2021-12-31 0001104038 us-gaap:CommonStockMember 2021-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001104038 vrme:TreasuryStocksMember 2021-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001104038 us-gaap:RetainedEarningsMember 2021-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001104038 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001104038 vrme:TreasuryStocksMember 2021-01-01 2021-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001104038 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001104038 vrme:TreasuryStocksMember 2022-01-01 2022-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001104038 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001104038 vrme:SeriesAConvertiblePreferredStockMember 2022-12-31 0001104038 vrme:SeriesBConvertiblePreferredStockMember 2022-12-31 0001104038 us-gaap:CommonStockMember 2022-12-31 0001104038 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001104038 vrme:TreasuryStocksMember 2022-12-31 0001104038 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001104038 us-gaap:RetainedEarningsMember 2022-12-31 0001104038 vrme:EquipmentForLeaseMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001104038 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001104038 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001104038 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001104038 vrme:CoSponsorMember 2021-04-12 0001104038 us-gaap:IPOMember 2021-07-05 2021-07-06 0001104038 us-gaap:OverAllotmentOptionMember 2021-07-05 2021-07-06 0001104038 us-gaap:PrivatePlacementMember 2021-07-05 2021-07-06 0001104038 vrme:SponsorEntityMember 2021-07-05 2021-07-06 0001104038 vrme:MaximPartnersLLCMember 2021-07-05 2021-07-06 0001104038 vrme:GVRMHoldingsLLCandMaximPartnersLLCMember us-gaap:PrivatePlacementMember 2021-07-05 2021-07-06 0001104038 us-gaap:BeneficialOwnerMember us-gaap:PrivatePlacementMember 2021-07-05 2021-07-06 0001104038 vrme:GVRMHoldingsLLCMember 2021-07-06 0001104038 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001104038 srt:ParentCompanyMember vrme:ProactiveServicesMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember vrme:ProactiveServicesMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember vrme:ProactiveServicesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember vrme:ProactiveServicesMember 2021-01-01 2021-12-31 0001104038 vrme:ProactiveServicesMember 2022-01-01 2022-12-31 0001104038 vrme:ProactiveServicesMember 2021-01-01 2021-12-31 0001104038 srt:ParentCompanyMember vrme:PremiumServicesMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember vrme:PremiumServicesMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember vrme:PremiumServicesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember vrme:PremiumServicesMember 2021-01-01 2021-12-31 0001104038 vrme:PremiumServicesMember 2022-01-01 2022-12-31 0001104038 vrme:PremiumServicesMember 2021-01-01 2021-12-31 0001104038 srt:ParentCompanyMember vrme:BrandProtectionServicesMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember vrme:BrandProtectionServicesMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember vrme:BrandProtectionServicesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember vrme:BrandProtectionServicesMember 2021-01-01 2021-12-31 0001104038 vrme:BrandProtectionServicesMember 2022-01-01 2022-12-31 0001104038 vrme:BrandProtectionServicesMember 2021-01-01 2021-12-31 0001104038 srt:ParentCompanyMember 2022-01-01 2022-12-31 0001104038 srt:ParentCompanyMember 2021-01-01 2021-12-31 0001104038 srt:SubsidiariesMember 2022-01-01 2022-12-31 0001104038 srt:SubsidiariesMember 2021-01-01 2021-12-31 0001104038 vrme:BusinessCombinationMember 2022-04-21 2022-04-22 0001104038 2022-04-01 2022-04-22 0001104038 vrme:BusinessCombinationMember 2022-04-22 0001104038 us-gaap:RestrictedStockMember vrme:BusinessCombinationMember 2022-04-22 0001104038 us-gaap:RestrictedStockMember vrme:BusinessCombinationMember 2022-09-22 0001104038 vrme:BusinessCombinationMember 2022-01-01 2022-12-31 0001104038 vrme:PeriShipMember 2022-04-22 0001104038 vrme:PeriShipMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:DevelopedTechnologyRightsMember 2022-04-22 0001104038 us-gaap:DevelopedTechnologyRightsMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:TrademarksMember 2022-04-22 0001104038 us-gaap:TrademarksMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:CustomerRelationshipsMember 2022-04-22 0001104038 us-gaap:CustomerRelationshipsMember 2022-04-21 2022-04-22 0001104038 vrme:PeriShipMember us-gaap:NoncompeteAgreementsMember 2022-04-22 0001104038 us-gaap:NoncompeteAgreementsMember 2022-04-21 2022-04-22 0001104038 srt:ParentCompanyMember 2021-12-31 0001104038 srt:SubsidiariesMember 2021-12-31 0001104038 srt:ParentCompanyMember 2022-12-31 0001104038 srt:SubsidiariesMember 2022-12-31 0001104038 us-gaap:TrademarksMember 2022-12-31 0001104038 vrme:CapitalizedSoftwareMember 2022-12-31 0001104038 us-gaap:CustomerRelationshipsMember 2022-12-31 0001104038 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001104038 vrme:InternallyUsedSoftwareMember 2022-12-31 0001104038 us-gaap:NoncompeteAgreementsMember 2022-12-31 0001104038 us-gaap:TrademarksMember 2021-12-31 0001104038 vrme:CapitalizedSoftwareMember 2021-12-31 0001104038 us-gaap:ForeignCountryMember 2022-12-31 0001104038 us-gaap:DomesticCountryMember 2022-12-31 0001104038 vrme:PromissoryNoteMember 2022-04-22 0001104038 vrme:PromissoryNoteMember 2022-04-21 2022-04-22 0001104038 2022-10-17 0001104038 2022-10-01 2022-10-17 0001104038 vrme:PaycheckProtectionProgramTermNoteMember vrme:PNCBankNAMember 2020-05-17 0001104038 vrme:PaycheckProtectionProgramTermNoteMember vrme:PNCBankNAMember 2020-05-16 2020-05-17 0001104038 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001104038 2022-08-11 0001104038 2022-08-01 2022-08-11 0001104038 2022-04-22 0001104038 2022-02-28 0001104038 2022-08-31 0001104038 2020-11-01 2020-11-30 0001104038 vrme:StockOptionsRestrictedStockandUnitsandOtherStockbasedAwardsMember vrme:OmnibusEquityCompensationPlan2013Member 2013-12-31 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2017Member 2017-11-13 2017-11-14 0001104038 srt:BoardOfDirectorsChairmanMember vrme:EquityIncentivePlan2017Member 2020-08-09 2020-08-10 0001104038 vrme:IncentiveStockOptionsMember 2022-01-01 2022-12-31 0001104038 vrme:IssuedUnderThe2020PlanMember 2022-01-01 2022-12-31 0001104038 vrme:Plan2019Member 2022-01-01 2022-12-31 0001104038 vrme:Plan2019Member 2021-01-01 2021-12-31 0001104038 vrme:Plan2019Member 2022-12-31 0001104038 vrme:Plan2019Member 2021-12-31 0001104038 us-gaap:RestrictedStockMember 2022-12-31 0001104038 us-gaap:RestrictedStockMember 2021-12-31 0001104038 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001104038 vrme:RestrictedStockUnitsMember 2022-12-31 0001104038 vrme:RestrictedStockUnitsMember 2021-12-31 0001104038 vrme:RestrictedStockUnitsMember 2022-01-01 2022-12-31 0001104038 vrme:NonvestedStockOptionsMember 2022-12-31 0001104038 vrme:NonvestedStockOptionsMember 2022-01-01 2022-12-31 0001104038 vrme:DirectorAndOfficerMember vrme:Debentures2022Member 2022-04-14 0001104038 vrme:DirectorAndOfficerMember vrme:Debentures2020Member 2020-01-01 2020-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2020-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2021-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001104038 us-gaap:EmployeeStockOptionMember 2022-12-31 0001104038 vrme:NonvestedStockOptionsMember 2020-12-31 0001104038 vrme:NonvestedStockOptionsMember 2021-01-01 2021-12-31 0001104038 vrme:NonvestedStockOptionsMember 2021-12-31 0001104038 us-gaap:RestrictedStockMember 2020-12-31 0001104038 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001104038 vrme:RestrictedStockUnitsMember 2020-12-31 0001104038 vrme:RestrictedStockUnitsMember 2021-01-01 2021-12-31 0001104038 vrme:UnvestedPerformanceRestrictedStockUnitsMember 2021-12-31 0001104038 vrme:UnvestedPerformanceRestrictedStockUnitsMember 2022-01-01 2022-12-31 0001104038 vrme:UnvestedPerformanceRestrictedStockUnitsMember 2022-12-31 0001104038 us-gaap:WarrantMember 2022-12-31 0001104038 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001104038 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001104038 vrme:StockOptionsMember 2022-01-01 2022-12-31 0001104038 vrme:StockOptionsMember 2021-01-01 2021-12-31 0001104038 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001104038 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001104038 vrme:StockPurchasePlanMember 2022-01-01 2022-12-31 0001104038 vrme:StockPurchasePlanMember 2021-01-01 2021-12-31 0001104038 vrme:RestrictedStockUnitsAndRestrictedStockAwardsMember 2022-01-01 2022-12-31 0001104038 vrme:RestrictedStockUnitsAndRestrictedStockAwardsMember 2021-01-01 2021-12-31 0001104038 vrme:G3VRMMember 2022-04-07 0001104038 srt:DirectorMember 2021-09-16 2021-09-17 0001104038 vrme:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001104038 vrme:FiveCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001104038 vrme:TwoCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001104038 vrme:ThreeCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001104038 vrme:OneVendorMember vrme:TransportationCostMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-12-31 0001104038 us-gaap:SubsequentEventMember 2023-02-27 2023-03-01 0001104038 us-gaap:SubsequentEventMember 2023-03-01 0001104038 vrme:NonqualifiedStockPurchasePlanMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 0001104038 vrme:FormerChiefExecutiveOfficerMember vrme:N2020PlanMember us-gaap:SubsequentEventMember 2023-03-02 2023-03-15 0001104038 vrme:GreenbergMember vrme:N2020PlanMember us-gaap:SubsequentEventMember 2023-03-02 2023-03-15 iso4217:USD shares iso4217:USD shares pure 0001104038 false 2022 FY 10-K true 2022-12-31 --12-31 false 001-39332 VERIFYME, INC. NV 23-3023677 801 International Parkway Fifth Floor Lake Mary FL 32746 (585) 736-9400 Common Stock, par value $0.001 per share VRME NASDAQ Warrants to Purchase Common Stock VRMEW NASDAQ No No Yes Yes Non-accelerated Filer true false false 14839432000 9361772 Portions of VerifyMe, Inc.’s definitive proxy statement to be filed with the Securities and Exchange Commission in connection with its 2023 annual meeting of stockholders are incorporated by reference into Part III Items 10, 11, 12, 13 and 14 of this Annual Report on Form 10-K. 206 MaloneBailey, LLP Houston, Texas 3411000 9422000 37000 0 4448000 297000 1185000 333000 240000 81000 52000 9458000 10011000 10964000 292000 204000 469000 6412000 509000 3988000 133000 20752000 21688000 500000 3912000 341000 902000 109000 115000 5429000 450000 359000 3000 71000 1375000 7166000 521000 0.001 37564767 0 0.001 85 0.85 0.001 675000000 9341002 7420633 8951035 7196677 10000 7000 92987000 86059000 389967 223956 949000 838000 -78459000 -64061000 -3000 13586000 21167000 20752000 21688000 19576000 867000 13088000 268000 6488000 599000 8428000 4216000 89000 51000 1718000 1163000 10235000 5430000 -3747000 -4831000 -88000 2000 -10932000 12000 8371000 31000 326000 70000 -10651000 8443000 -14398000 3612000 -1.70 0.51 -1.70 0.49 8466075 7110907 8466075 7383364 -14398000 3612000 -3000 -14401000 3612000 -14398000 3612000 37000 145000 151000 85000 239000 784000 1084000 696000 70000 -10932000 12000 8371000 326000 770000 117000 3352000 354000 -1185000 29000 -2000 77000 -25000 3621000 69000 -2551000 -3254000 40000 95000 45000 2593000 12000 7500000 32000 140000 236000 106000 -7884000 -2851000 4528000 8447000 2000000 -3000 1000 102000 34000 131000 291000 725000 1882000 4424000 7588000 -6011000 1483000 9422000 7939000 3411000 9422000 33000 552000 -3000 0.85 5596877 6000 76099000 7011 -113000 -67673000 8319000 85000 85000 56971 654000 654000 696000 696000 40000 40000 9774 39000 39000 1750000 1000 8446000 8447000 -216945 216945 725000 725000 3612000 3612000 0.85 7196677 7000 86059000 223956 -838000 -64061000 21167000 0.85 7196677 7000 86059000 223956 -838000 -64061000 21167000 29688 205000 205000 1084000 1084000 121000 121000 53895 -78000 -53895 180000 102000 880208 2000 4526000 4528000 30000 96000 96000 305473 974000 974000 -219906 219906 291000 291000 675000 1000 1000 -3000 -3000 -14398000 -14398000 0.85 8951035 10000 92987000 389967 -949000 -3000 -78459000 13586000 <p id="xdx_804_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zoELlH6scDcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – <span id="xdx_82A_zDUKuRqWFLG3">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_848_ecustom--NatureOfBusinessPolicyTextBlock_zGIT71phawCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_863_zswu6U8JjwHf">Nature of the Business</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VerifyMe, Inc. (“VerifyMe”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, together with its subsidiaries, including PeriShip Global LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”) is based in Lake Mary, Florida and its common stock, par value $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20221231_pdd" title="Common stock, par value (in dollars per share)"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd" title="Common stock, par value (in dollars per share)">0.001</span></span> per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VerifyMe, through PeriShip Global, is a software driven predictive analytics logistics provider of high-touch, end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions, which includes Trust Codes Global. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzbSSkE9B2Pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_866_zRm5vaH9wEk8">Basis of Presentation</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The accompanying consolidated financial statements include the accounts of VerifyMe and its wholly owned subsidiary PeriShip Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84B_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z1Qsdy9vX8J5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_863_zpQLRcTZEbNc">Segment Reporting</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) PeriShip Global Solutions and (ii) VerifyMe Solutions. See Note 16 Segment Reporting, for further discussion of the Company’s segment reporting structure. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--UseOfEstimates_z4bRz1B5JNDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zUB5xaVrqFy8">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2YKReJLOWH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86C_zY9s0tcyxwe2">Recent Accounting Pronouncements</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments</i>, (“CECL”), which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded.  This guidance was to be effective for reporting periods beginning after December 15, 2022, with early adoption permitted. The Company has elected to early adopt ASU 2016-13, as of January 1, 2022, and the impact has been disclosed on the face of the Consolidated Balance Sheets. The Company’s accounts receivable is currently the only financial instrument subject to the new CECL model. The Company has considered relevant internal and/or external information about past events, e.g., historical loss experience with similar assets, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the reported amount of financial assets in determining the credit loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbgoDppkpzwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_862_zF7ZZWFjxivk">Fair Value of Financial Instruments</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, equity investments, and long-term derivative liabilities. The carrying value of accounts receivable, unbilled revenue, accounts payable and accrued expenses approximate their fair value because of their short maturities.  The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures,” and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Quoted market prices in active markets for identical assets or liabilities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Level 3: Unobservable inputs that are not corroborated by market data</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of December 31, 2022 and December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amounts in Thousands ('000)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zPiA8hE7mfHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8B7_zlrFFMnfzTX1" style="display: none">Schedule of fair value assets measured on recurring basis</span></td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Short Term Investment</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Equity Investment</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Derivative Liability</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Derivative Liability</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 3)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Balance as of December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermInvestments_iS_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxsIk0kT7ab1" style="width: 12%; text-align: right" title="Short Term Investment at beginning">88</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestments_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="width: 12%; text-align: right" title="Equity Investment">10,964</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMZvQ0WyDuFc" style="width: 12%; text-align: right" title="Derivative Liability at beginning">(71</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Realized loss on fair value recognized in other (expense)/income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DebtSecuritiesAvailableForSaleRealizedLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Realized loss on fair value recognized in other (expense)/income">(10,932</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Distribution from Sponsor Entity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--DistributionFromSponsorEntity_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Distribution from Sponsor Entity">(32</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrealized gain on fair value recognized in other (expense)/income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Unrealized gain on fair value recognized in other (expense)/income">12</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Realized gain on fair value recognized in share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Change in fair value to interest rate, SWAP, recognized in other comprehensive loss">71</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value to interest rate, SWAP, recognized in other comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Change in fair value to interest rate, SWAP, recognized in other comprehensive loss">(3</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iE_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUNI6HhmXUea" style="text-align: right" title="Short-Term Investments at end">100</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRYvakwEyhBh" style="text-align: right" title="Derivative Liability at end">(3</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_845_ecustom--VariableInterestEntityPolicyTextBlock_zfckk3hczk4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_861_ze1MAw9qCwXf">Variable Interest Entity</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined that G3 VRM Acquisition Corp. (NASDAQ: GGGVU) (the “SPAC”, see Note 2 – Equity Investments), a Delaware corporation and special purpose acquisition company, was a variable interest entity (“VIE”) in which the Company had a variable interest but was not the primary beneficiary. Making the determination as to whether a VIE should be consolidated requires judgement in assessing if the Company is the primary beneficiary. To make this determination, the Company evaluated its power to direct the activities that most significantly impacted the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the SPAC. The Company concluded that it was not the primary beneficiary of the VIE and as such, did not consolidate the SPAC. The Company reassessed its evaluation of whether an entity is a VIE and if it continues to be a VIE, whether the Company is the primary beneficiary of the VIE, on an ongoing basis based on the current facts and circumstances surrounding the entity. The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO, and the Sponsor Entity made the decision not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved, and liquidated according to its charter. The SPAC redeemed 100% of the public shares for cash, the rights have expired worthless, and the founder shares and the private placement securities have become worthless.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_zNMIv3aNcX31" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_867_zR0N8ktRYoq8">Equity Investments</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Company does not have a controlling financial interest in an entity but can exert influence over the entity’s operations and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under applicable generally accepted accounting policies. The Company has elected the fair value option for its equity investment in the SPAC (see Note 2 –Equity Investments) and its equity security under short term investment on the balance sheets, as it has determined the fair value best reflects the economic performance of the equity investment. Changes in unrealized gain on equity investment include unrealized gain of the fair value of the equity investments and loss on equity investment includes realized loss on equity investments on the accompanying Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zRzb9fojG3qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zw05BYRp3rrc">Goodwill</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zJHgEdgBBAU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_866_z3JQpla6SYA7">Business Combinations</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies the provisions of Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, in the accounting for business acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the Consolidated Statements of Operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zKuIdbubBfWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_863_z44Uq4VGwSQ7">Basic and Diluted Net Loss per Share of Common Stock</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCntCTFXr47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_861_z5OFEzZRkM33">Cash and Cash Equivalents</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents. As of December 31, 2022, the Company held $<span id="xdx_90D_eus-gaap--Cash_c20221231_pn3n3" title="Cash">63</span> thousand subject to restrictions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p id="xdx_841_eus-gaap--ReceivablesPolicyTextBlock_zPYjT3Y8jlGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_860_zVdXDAXxPU5l">Accounts Receivable</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. Bad debts expense or write offs of receivables are determined on the basis of loss experience, known and inherent risks in the receivable portfolio and current economic conditions. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, such allowances may be required. The Company recognized $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20221231_pn3n3" title="Allowance for doubtful accounts">37</span> thousand and $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20211231_pn3n3" title="Allowance for doubtful accounts">0</span> for allowance for credit losses as of December 31, 2022, and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_ecustom--ConcentrationOfCreditRiskInvolvingCashAndCashEquivalentsPolicyTextBlock_zTzEOhyb4684" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_861_zQEITb4DZ1Sh">Concentration of Credit Risk Involving Cash and Cash Equivalents</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s cash and cash equivalents are held at various financial institutions. At times, the Company’s deposits may exceed Federal Deposit Insurance Corporation (FDIC) coverage limits which are currently set at $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zl7kOWJzTmmc" title="FDIC insured limit">250,000</span> per depositor. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zs4b3hSGAAv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86F_z2JlS8d5Puwj">Inventory</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory principally consists of canisters and pigments and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWJEdM4yLNNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zAhPOpZmdQ9h">Equipment for Lease</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equipment for lease principally consists of costs associated with the development, certification and production of the VerifyChecker™ and the VerifyAuthenticator<sup>TM</sup> Smartphone Authenticator technology. These technologies are leased to customers typically for a period of one year in length with <span id="xdx_90D_ecustom--DescriptionOfLeaseTerms_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentForLeaseMember" title="Description of lease terms">automatically renewable leases cancellable by either party by written notice provided 90 days in advance.</span> We examined the effect of Accounting Standards Update (“ASU”) No. 2016-02- “Lease (Topic 842)” and determined the impact is not material. Our policy is to capitalize the costs related to this equipment and depreciate on a straight-line basis over the estimated lives of the equipment which was determined to be <span id="xdx_902_ecustom--MaturityTermsOfLease_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentForLeaseMember_zWet4WalzFuh" title="Maturity terms of lease">5</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--InternalUseSoftwarePolicy_z7dI9b2dLJHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86B_zzeKoLiSoVd9">Capitalized Software</span> </span></i></b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs incurred in connection with the development of software related to our proprietary proactive end-to-end logistics management products are accounted for in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 “Hosting Arrangements and Internally Used Software.” Costs incurred prior to the establishment of technological feasibility are charged to research and development expense. Software development costs are capitalized after a product is determined to be technologically feasible and is in the process of being developed for market. Amortization of capitalized software development costs begins once the product is available to the market. Capitalized software development costs are amortized over the estimated life of the related product, generally six years, using the straight-line method. The Company will evaluate its software assets for impairment whenever events or change in circumstances indicate that the carrying amount of such assets may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zVeOpuf92ho4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_865_zmvcXRrFXdEi">Long-Lived Assets</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates the recoverability of its long-lived assets in accordance with ASC 360 “Property, Plant, and Equipment.” The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--DerivativesPolicyTextBlock_zEPEoTj76Yuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_860_z4vQC3fZnjd1">Derivative Instruments</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its equity investments, long-term derivative liabilities, preferred stock, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguish by Liabilities from Equity” (FASB ASC 480), and FASB ASC 815, “Derivatives and Hedging” (“FASB ASC 815”). The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the Consolidated Statement of Operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified as liabilities at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--Reclassifications_z5wS2JnH9Fsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_863_zR32dygDmrak">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain accounts in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements. These reclassifications had no effect on the previously reported net income (loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zfvk3ErnK5Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b><i><span style="text-decoration: underline"><span id="xdx_864_zJuIqcNHQtrj">Revenue Recognition</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for revenues according to Accounting Standards Codification (“ASC”) Topic 606, “<i>Revenue from Contracts with Customers”</i> which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>identify the contract with a customer;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>identify the performance obligations in the contract;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>determine the transaction price;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>allocate the transaction price to performance obligations in the contract; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>recognize revenue as the performance obligation is satisfied.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, over 90% of the Company’s revenues primarily consisted of revenue related to our logistics management for time and temperature sensitive packages generated by our subsidiary PeriShip Global. During the year ended December 31, 2021, the Company’s revenue primarily consisted of VerifyInk<sup>TM</sup> and labels with our VerifyMe traceability solutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z9yuqcfyOS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86F_zUDm6RiQZfP8">Income Taxes</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows FASB ASC 740, “Income Taxes,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2003 remain subject to examination by major tax jurisdictions due the carryforward of unutilized NOLs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z6SLw5Ulc6tj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_866_zlpLD64HHlLk">Stock-Based Compensation</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. We recognize forfeitures as they occur with a reduction in compensation expense in the period of forfeiture. For performance restricted stock units with stock price appreciation targets (see Note 10 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed.<b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zd8Fhuh74OD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_864_zjpUCNa2qFX8">Advertising Costs</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred. Advertising costs were $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20220101__20221231_pn3n3" title="Advertising cost">60</span> thousand and $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20210101__20211231_pn3n3" title="Advertising cost">51</span> thousand for the years ended December 31, 2022, and 2021, respectively, and are included in Sales and Marketing on the Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--ResearchAndDevelopmentExpensePolicy_zXkTBsZLplS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_867_zE9kCheFk84a">Research and Development Costs</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the years ended December 31, 2022, and 2021 were $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_pn3n3" title="Research and development costs">89</span> thousand and $<span id="xdx_906_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_pn3n3" title="Research and development costs">51</span> thousand, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_842_ecustom--EarningsPerSharesPolicyTextBlock_zBojaqwKiXN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_864_z4qjCBATEbLi">Basic and Diluted Earnings (Loss) per Share of Common Stock</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the year ended December 31, 2022, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_ecustom--NatureOfBusinessPolicyTextBlock_zGIT71phawCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_863_zswu6U8JjwHf">Nature of the Business</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VerifyMe, Inc. (“VerifyMe”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, together with its subsidiaries, including PeriShip Global LLC (“PeriShip Global”) and Trust Codes Global Limited (“Trust Codes Global”), (together the “Company,” “we,” “us,” or “our”) is based in Lake Mary, Florida and its common stock, par value $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20221231_pdd" title="Common stock, par value (in dollars per share)"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd" title="Common stock, par value (in dollars per share)">0.001</span></span> per share, and warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VerifyMe, through PeriShip Global, is a software driven predictive analytics logistics provider of high-touch, end-to-end logistics management, which represents most of our current revenue stream. In addition, VerifyMe technologies provide product traceability, brand protections services, and consumer engagement solutions. Our operations are split into two segments: PeriShip Global Solutions and VerifyMe Solutions, which includes Trust Codes Global. Through our PeriShip Global Solutions segment we provide a value-added service for time and temperature sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as flight-tracking, weather, and traffic, all delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events, with dynamic dashboards. All aspects of the of the shipping journey is managed by a dedicated call center. Using our proprietary logistics solution, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. Through our VerifyMe Solutions segment, our technologies provide unit level traceability, brand protection, and consumer engagement solutions allowing brand owners to gather business intelligence, cross-sell products, monitor product diversion through the supply chain and build brand loyalty through interaction utilizing our unique dynamic codes which are read by consumers with their smart phones. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> 0.001 0.001 <p id="xdx_841_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzbSSkE9B2Pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_866_zRm5vaH9wEk8">Basis of Presentation</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The accompanying consolidated financial statements include the accounts of VerifyMe and its wholly owned subsidiary PeriShip Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84B_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z1Qsdy9vX8J5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_863_zpQLRcTZEbNc">Segment Reporting</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) PeriShip Global Solutions and (ii) VerifyMe Solutions. See Note 16 Segment Reporting, for further discussion of the Company’s segment reporting structure. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--UseOfEstimates_z4bRz1B5JNDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zUB5xaVrqFy8">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z2YKReJLOWH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86C_zY9s0tcyxwe2">Recent Accounting Pronouncements</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments</i>, (“CECL”), which changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded.  This guidance was to be effective for reporting periods beginning after December 15, 2022, with early adoption permitted. The Company has elected to early adopt ASU 2016-13, as of January 1, 2022, and the impact has been disclosed on the face of the Consolidated Balance Sheets. The Company’s accounts receivable is currently the only financial instrument subject to the new CECL model. The Company has considered relevant internal and/or external information about past events, e.g., historical loss experience with similar assets, current conditions, and reasonable and supportable forecasts that affect the expected collectability of the reported amount of financial assets in determining the credit loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbgoDppkpzwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_862_zF7ZZWFjxivk">Fair Value of Financial Instruments</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, equity investments, and long-term derivative liabilities. The carrying value of accounts receivable, unbilled revenue, accounts payable and accrued expenses approximate their fair value because of their short maturities.  The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows FASB ASC 820, “Fair Value Measurements and Disclosures,” and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1: Quoted market prices in active markets for identical assets or liabilities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Level 3: Unobservable inputs that are not corroborated by market data</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of December 31, 2022 and December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amounts in Thousands ('000)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zPiA8hE7mfHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8B7_zlrFFMnfzTX1" style="display: none">Schedule of fair value assets measured on recurring basis</span></td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Short Term Investment</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Equity Investment</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Derivative Liability</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Derivative Liability</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 3)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Balance as of December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermInvestments_iS_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxsIk0kT7ab1" style="width: 12%; text-align: right" title="Short Term Investment at beginning">88</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestments_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="width: 12%; text-align: right" title="Equity Investment">10,964</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMZvQ0WyDuFc" style="width: 12%; text-align: right" title="Derivative Liability at beginning">(71</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Realized loss on fair value recognized in other (expense)/income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DebtSecuritiesAvailableForSaleRealizedLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Realized loss on fair value recognized in other (expense)/income">(10,932</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Distribution from Sponsor Entity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--DistributionFromSponsorEntity_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Distribution from Sponsor Entity">(32</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrealized gain on fair value recognized in other (expense)/income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Unrealized gain on fair value recognized in other (expense)/income">12</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Realized gain on fair value recognized in share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Change in fair value to interest rate, SWAP, recognized in other comprehensive loss">71</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value to interest rate, SWAP, recognized in other comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Change in fair value to interest rate, SWAP, recognized in other comprehensive loss">(3</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iE_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUNI6HhmXUea" style="text-align: right" title="Short-Term Investments at end">100</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRYvakwEyhBh" style="text-align: right" title="Derivative Liability at end">(3</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zPiA8hE7mfHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8B7_zlrFFMnfzTX1" style="display: none">Schedule of fair value assets measured on recurring basis</span></td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Short Term Investment</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Equity Investment</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Derivative Liability</td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Derivative Liability</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 3)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">(Level 3)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Balance as of December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermInvestments_iS_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxsIk0kT7ab1" style="width: 12%; text-align: right" title="Short Term Investment at beginning">88</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestments_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="width: 12%; text-align: right" title="Equity Investment">10,964</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_pn3n3_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMZvQ0WyDuFc" style="width: 12%; text-align: right" title="Derivative Liability at beginning">(71</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Realized loss on fair value recognized in other (expense)/income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DebtSecuritiesAvailableForSaleRealizedLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Realized loss on fair value recognized in other (expense)/income">(10,932</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Distribution from Sponsor Entity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--DistributionFromSponsorEntity_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Distribution from Sponsor Entity">(32</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unrealized gain on fair value recognized in other (expense)/income</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AvailableForSaleDebtSecuritiesGrossUnrealizedGain_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Unrealized gain on fair value recognized in other (expense)/income">12</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Realized gain on fair value recognized in share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Change in fair value to interest rate, SWAP, recognized in other comprehensive loss">71</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value to interest rate, SWAP, recognized in other comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="text-align: right" title="Change in fair value to interest rate, SWAP, recognized in other comprehensive loss">(3</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iE_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zUNI6HhmXUea" style="text-align: right" title="Short-Term Investments at end">100</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRYvakwEyhBh" style="text-align: right" title="Derivative Liability at end">(3</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 88000 10964000 -71000 -10932000 -32000 12000 71000 -3000 100000 -3000 <p id="xdx_845_ecustom--VariableInterestEntityPolicyTextBlock_zfckk3hczk4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_861_ze1MAw9qCwXf">Variable Interest Entity</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined that G3 VRM Acquisition Corp. (NASDAQ: GGGVU) (the “SPAC”, see Note 2 – Equity Investments), a Delaware corporation and special purpose acquisition company, was a variable interest entity (“VIE”) in which the Company had a variable interest but was not the primary beneficiary. Making the determination as to whether a VIE should be consolidated requires judgement in assessing if the Company is the primary beneficiary. To make this determination, the Company evaluated its power to direct the activities that most significantly impacted the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the SPAC. The Company concluded that it was not the primary beneficiary of the VIE and as such, did not consolidate the SPAC. The Company reassessed its evaluation of whether an entity is a VIE and if it continues to be a VIE, whether the Company is the primary beneficiary of the VIE, on an ongoing basis based on the current facts and circumstances surrounding the entity. The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO, and the Sponsor Entity made the decision not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved, and liquidated according to its charter. The SPAC redeemed 100% of the public shares for cash, the rights have expired worthless, and the founder shares and the private placement securities have become worthless.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_zNMIv3aNcX31" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_867_zR0N8ktRYoq8">Equity Investments</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Company does not have a controlling financial interest in an entity but can exert influence over the entity’s operations and financial policies, the investment is accounted for either (i) under the equity method of accounting or (ii) at fair value by electing the fair value option available under applicable generally accepted accounting policies. The Company has elected the fair value option for its equity investment in the SPAC (see Note 2 –Equity Investments) and its equity security under short term investment on the balance sheets, as it has determined the fair value best reflects the economic performance of the equity investment. Changes in unrealized gain on equity investment include unrealized gain of the fair value of the equity investments and loss on equity investment includes realized loss on equity investments on the accompanying Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zRzb9fojG3qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zw05BYRp3rrc">Goodwill</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zJHgEdgBBAU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_866_z3JQpla6SYA7">Business Combinations</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies the provisions of Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, in the accounting for business acquisitions. ASC 805 requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the identifiable assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately apply preliminary value to assets acquired and liabilities assumed at the acquisition date, where applicable, these estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments in the current period, rather than a revision to a prior period. Upon the conclusion of the measurement period or final determination of the values of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the Consolidated Statements of Operations. Accounting for business combinations requires management to make significant estimates and assumptions, especially at the acquisition date, including estimates for intangible assets where applicable. Although the Company believes the assumptions and estimates made have been reasonable and appropriate, they are based in part on information obtained from management of the acquired companies and are inherently uncertain. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates, or actual results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zKuIdbubBfWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_863_z44Uq4VGwSQ7">Basic and Diluted Net Loss per Share of Common Stock</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zSCntCTFXr47" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_861_z5OFEzZRkM33">Cash and Cash Equivalents</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents. As of December 31, 2022, the Company held $<span id="xdx_90D_eus-gaap--Cash_c20221231_pn3n3" title="Cash">63</span> thousand subject to restrictions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> 63000 <p id="xdx_841_eus-gaap--ReceivablesPolicyTextBlock_zPYjT3Y8jlGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_860_zVdXDAXxPU5l">Accounts Receivable</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. Bad debts expense or write offs of receivables are determined on the basis of loss experience, known and inherent risks in the receivable portfolio and current economic conditions. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to make payments, such allowances may be required. The Company recognized $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20221231_pn3n3" title="Allowance for doubtful accounts">37</span> thousand and $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20211231_pn3n3" title="Allowance for doubtful accounts">0</span> for allowance for credit losses as of December 31, 2022, and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 37000 0 <p id="xdx_84D_ecustom--ConcentrationOfCreditRiskInvolvingCashAndCashEquivalentsPolicyTextBlock_zTzEOhyb4684" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_861_zQEITb4DZ1Sh">Concentration of Credit Risk Involving Cash and Cash Equivalents</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s cash and cash equivalents are held at various financial institutions. At times, the Company’s deposits may exceed Federal Deposit Insurance Corporation (FDIC) coverage limits which are currently set at $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zl7kOWJzTmmc" title="FDIC insured limit">250,000</span> per depositor. The Company has not experienced any losses from maintaining cash accounts in excess of federally insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 250000 <p id="xdx_84B_eus-gaap--InventoryPolicyTextBlock_zs4b3hSGAAv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86F_z2JlS8d5Puwj">Inventory</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory principally consists of canisters and pigments and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWJEdM4yLNNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zAhPOpZmdQ9h">Equipment for Lease</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equipment for lease principally consists of costs associated with the development, certification and production of the VerifyChecker™ and the VerifyAuthenticator<sup>TM</sup> Smartphone Authenticator technology. These technologies are leased to customers typically for a period of one year in length with <span id="xdx_90D_ecustom--DescriptionOfLeaseTerms_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentForLeaseMember" title="Description of lease terms">automatically renewable leases cancellable by either party by written notice provided 90 days in advance.</span> We examined the effect of Accounting Standards Update (“ASU”) No. 2016-02- “Lease (Topic 842)” and determined the impact is not material. Our policy is to capitalize the costs related to this equipment and depreciate on a straight-line basis over the estimated lives of the equipment which was determined to be <span id="xdx_902_ecustom--MaturityTermsOfLease_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--EquipmentForLeaseMember_zWet4WalzFuh" title="Maturity terms of lease">5</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> automatically renewable leases cancellable by either party by written notice provided 90 days in advance. P5Y <p id="xdx_840_eus-gaap--InternalUseSoftwarePolicy_z7dI9b2dLJHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86B_zzeKoLiSoVd9">Capitalized Software</span> </span></i></b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs incurred in connection with the development of software related to our proprietary proactive end-to-end logistics management products are accounted for in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350 “Hosting Arrangements and Internally Used Software.” Costs incurred prior to the establishment of technological feasibility are charged to research and development expense. Software development costs are capitalized after a product is determined to be technologically feasible and is in the process of being developed for market. Amortization of capitalized software development costs begins once the product is available to the market. Capitalized software development costs are amortized over the estimated life of the related product, generally six years, using the straight-line method. The Company will evaluate its software assets for impairment whenever events or change in circumstances indicate that the carrying amount of such assets may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zVeOpuf92ho4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_865_zmvcXRrFXdEi">Long-Lived Assets</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates the recoverability of its long-lived assets in accordance with ASC 360 “Property, Plant, and Equipment.” The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets are measured by a comparison of the carrying amount of an asset to future cash flows expected to be generated by the asset, undiscounted and without interest or independent appraisals. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--DerivativesPolicyTextBlock_zEPEoTj76Yuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_860_z4vQC3fZnjd1">Derivative Instruments</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its equity investments, long-term derivative liabilities, preferred stock, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguish by Liabilities from Equity” (FASB ASC 480), and FASB ASC 815, “Derivatives and Hedging” (“FASB ASC 815”). The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the Consolidated Statement of Operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified as liabilities at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--Reclassifications_z5wS2JnH9Fsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_863_zR32dygDmrak">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain accounts in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements. These reclassifications had no effect on the previously reported net income (loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zfvk3ErnK5Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b><i><span style="text-decoration: underline"><span id="xdx_864_zJuIqcNHQtrj">Revenue Recognition</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for revenues according to Accounting Standards Codification (“ASC”) Topic 606, “<i>Revenue from Contracts with Customers”</i> which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>identify the contract with a customer;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>identify the performance obligations in the contract;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>determine the transaction price;</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>allocate the transaction price to performance obligations in the contract; and</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>recognize revenue as the performance obligation is satisfied.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, over 90% of the Company’s revenues primarily consisted of revenue related to our logistics management for time and temperature sensitive packages generated by our subsidiary PeriShip Global. During the year ended December 31, 2021, the Company’s revenue primarily consisted of VerifyInk<sup>TM</sup> and labels with our VerifyMe traceability solutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_z9yuqcfyOS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86F_zUDm6RiQZfP8">Income Taxes</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows FASB ASC 740, “Income Taxes,” when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Tax years from 2003 remain subject to examination by major tax jurisdictions due the carryforward of unutilized NOLs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z6SLw5Ulc6tj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_866_zlpLD64HHlLk">Stock-Based Compensation</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for stock-based compensation under the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. We recognize forfeitures as they occur with a reduction in compensation expense in the period of forfeiture. For performance restricted stock units with stock price appreciation targets (see Note 10 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed.<b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zd8Fhuh74OD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_864_zjpUCNa2qFX8">Advertising Costs</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising costs are expensed as incurred. Advertising costs were $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20220101__20221231_pn3n3" title="Advertising cost">60</span> thousand and $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20210101__20211231_pn3n3" title="Advertising cost">51</span> thousand for the years ended December 31, 2022, and 2021, respectively, and are included in Sales and Marketing on the Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 60000 51000 <p id="xdx_84A_eus-gaap--ResearchAndDevelopmentExpensePolicy_zXkTBsZLplS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_867_zE9kCheFk84a">Research and Development Costs</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with FASB ASC 730, research and development costs are expensed when incurred. Research and development costs for the years ended December 31, 2022, and 2021 were $<span id="xdx_904_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20221231_pn3n3" title="Research and development costs">89</span> thousand and $<span id="xdx_906_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_pn3n3" title="Research and development costs">51</span> thousand, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 89000 51000 <p id="xdx_842_ecustom--EarningsPerSharesPolicyTextBlock_zBojaqwKiXN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_864_z4qjCBATEbLi">Basic and Diluted Earnings (Loss) per Share of Common Stock</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows Financial Accounting Standards Board (“FASB”) ASC 260, “Earnings Per Share,” when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the year ended December 31, 2022, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_80B_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zbpx1X283hWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 – <span id="xdx_823_z5MsL6wL5DA4">EQUITY INVESTMENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 26, 2021, the Company formed VMEA Holdings Inc. (the “Sponsor Entity”), a Delaware corporation that was the founder of G3 VRM Acquisition Corp. (the “SPAC”) that was being co-sponsored by the Company.  The SPAC was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 12, 2021, the Sponsor Entity converted to a Delaware limited liability company, changed its name to “G3 VRM Holdings LLC” and a co-sponsor was added as a member of the Sponsor Entity resulting in an equity interest of <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20210412__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CoSponsorMember_zS2TzRkyku5j" title="Equity Method Investment, Ownership Percentage">44.40</span>% attributed to the Company. On July 6, 2021, the SPAC consummated the IPO of <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210705__20210706__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Number of units issued in transaction">10,626,000</span> units (the “Units”), including <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210705__20210706__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Number of units issued in transaction">626,000</span> Units pursuant to the partial exercise of the underwriter’s over-allotment option, generating gross proceeds of $106,260 thousand. Each Unit consisted of one share of SPAC common stock, $0.0001 par value, and one right to receive one-tenth (1/10) of a share of SPAC common stock upon the consummation of an initial business combination. Simultaneously with the closing of the IPO, the SPAC consummated the Private Placement of an aggregate of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210705__20210706__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Number of units issued in transaction">569,410</span> Units with the Sponsor Entity purchasing <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210705__20210706__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorEntityMember_pdd" title="Number of units issued in transaction">516,280</span> Units and Maxim Partners LLC purchasing <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210705__20210706__us-gaap--SubsidiarySaleOfStockAxis__custom--MaximPartnersLLCMember_pdd" title="Number of units issued in transaction">53,130</span> Units, generating total proceeds of $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210705__20210706__us-gaap--RelatedPartyTransactionAxis__custom--GVRMHoldingsLLCandMaximPartnersLLCMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pn3n3" title="Sale of Stock, Consideration Received on Transaction">5,694</span> thousand. Of this amount, the Company was the indirect beneficial owner of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210705__20210706__us-gaap--RelatedPartyTransactionAxis__us-gaap--BeneficialOwnerMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Number of units issued in transaction">229,228</span> Units purchased by the Sponsor Entity for a total of $<span id="xdx_90B_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210705__20210706__us-gaap--RelatedPartyTransactionAxis__us-gaap--BeneficialOwnerMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pn3n3" title="Sale of Stock, Consideration Received on Transaction">2,581</span> thousand. Upon consummation of the IPO, VerifyMe, as co-sponsor, indirectly through the Sponsor Entity, beneficially owned approximately <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20210706__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GVRMHoldingsLLCMember_zJdbyhrkP5U3" title="Equity Method Investment, Ownership Percentage">9.42</span>% of the outstanding shares of the SPAC, which shares were subject to forfeiture upon certain conditions and restrictions on transfer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of ceasing to have a controlling financial interest in the Sponsor Entity on April 12, 2021, the Company accounted for the Sponsor Entity as an equity investment and has elected the fair value option.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SPAC was unable to complete its initial business combination within 12 months from the closing of the IPO and the Sponsor Entity decided not to fund the extension and did not deposit additional funds into the trust account. As a result, the SPAC was dissolved and liquidated in accordance with its charter. The SPAC redeemed 100% of the public shares for cash on July 19, 2022, the rights expired worthless, and the founder shares and private placement securities became worthless. The SPAC was dissolved on July 29, 2022, and no distributions were made to the Sponsors. In December 2022, it was determined that the costs to dissolve the SPAC were ultimately less than the remaining assets of the SPAC and the SPAC made a distribution to the Company of $32 thousand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the equity investment was $<span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_dm_c20221231_zhvP8N8xbhP6" title="Equity Securities, FV-NI, Cost">0</span> million as of December 31, 2022 and $<span id="xdx_90C_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_dm_c20211231_zLsmj094si47" title="Equity Securities, FV-NI, Cost">11.0</span> million as of December 31, 2021. The fair value of the equity investment was classified as Level 3 in the fair value hierarchy as the calculation was dependent upon company specific adjustments to the observable trading price of the SPAC’s public units and shares, and related risk of forfeiture should no business combination occur. The Company recognized a loss on equity investments of $<span id="xdx_902_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20220101__20221231_pn3n3" title="Equity Securities, FV-NI, Unrealized Loss">10,932</span> thousand for the year ended December 31, 2022, included in the Loss on equity investments in the accompanying Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2021, the Company acquired <span id="xdx_905_eus-gaap--ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_pn3n3" title="Cumulative convertible preferred stock value">8,841</span> shares of <span id="xdx_900_eus-gaap--PreferredStockConvertibleConversionRatio_iI_dp_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_z1DpzFIJ68xa" title="Cumulative convertible preferred stock ratio">10</span>% Cumulative Convertible Series D Preferred Stock at a price of $<span id="xdx_90D_eus-gaap--PreferredStockConvertibleConversionPrice_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_pdd" title="Cumulative convertible preferred stock price">10.00</span> per share as payment for a customer’s outstanding AR balance of $88,410. This instrument is considered an equity security within the scope of Topic 321 since the issuing entity has the option but no contractual obligation to redeem the preferred stock, and the Company can convert the preferred shares to common stock. For the year ended December 31, 2022, a fair value gain of $<span id="xdx_906_ecustom--EquityInvestmentsFairValue_c20220101__20221231_pn3n3" title="Equity investments fair value">12</span> thousand, was recognized and included in Loss on equity investments, in the accompanying Consolidated Statements of Operations. The fair value of the equity investment was $<span id="xdx_908_ecustom--EquityInvestmentsFairValue1_c20221231_pn3n3" title="Fair value of equity investment">100</span> thousand as of December 31, 2022, and $<span id="xdx_90F_ecustom--EquityInvestmentsFairValue1_c20211231_pn3n3" title="Fair value of equity investment">88</span> thousand as of December 31, 2021, and included in Prepaid expenses and other current assets on the accompanying Consolidated Balance Sheets. The fair value of the equity investment is classified as Level 1 in the fair value hierarchy as the calculation is dependent upon the quoted market price of the entity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.4440 10626000 626000 569410 516280 53130 5694000 229228 2581000 0.0942 0 11000000.0 10932000 8841000 0.10 10.00 12000 100000 88000 <p id="xdx_804_eus-gaap--RevenueFromContractWithCustomerTextBlock_zMaP0scJpuz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 – <span id="xdx_82C_z2yaE5ovd9w6">REVENUE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline">Revenue by Category</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents our revenue disaggregated by various categories (dollars in thousands).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_z9W0sVkaRxv1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BE_zzI6ECD50uZi" style="display: none">Schedule of disaggregation of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">VerifyMe</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">PeriShip Global</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Consolidated</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap">Revenue</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Proactive services</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0837">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0839">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues">15,202</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0843">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues">15,202</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0847">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Premium services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0851">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues">2,988</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues">2,988</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Brand protection services</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0865">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0867">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">18,190</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">19,576</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Contract Balances</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The timing of revenue recognition, billings and cash collections results in unbilled revenue (contract assets) and deferred revenue (contract liabilities) on the consolidated balance sheets. Amounts charged to our clients become billable according to the contract terms, which usually consider the delivery completion. Unbilled amounts will generally be billed and collected within 30 days but typically no longer than 60 days. When we advance bill clients prior to the work being performed, generally, such amounts will be earned and recognized in revenue within the 30 days. These assets and liabilities are reported on the consolidated balance sheet on a contract-by-contract basis at the end of each reporting period. Changes in the contract asset and liability balances during the year ended December 31, 2022, were not materially impacted by any other factors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Applying the practical expedient in ASC Topic 606, we recognize the incremental costs of obtaining contracts (i.e. sales commissions) as an expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. As of December 31, 2022, we did not have any capitalized sales commissions.</p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_z9W0sVkaRxv1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BE_zzI6ECD50uZi" style="display: none">Schedule of disaggregation of revenue</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">VerifyMe</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">PeriShip Global</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Consolidated</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap">Revenue</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Proactive services</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0837">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0839">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues">15,202</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0843">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues">15,202</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--ProactiveServicesMember_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0847">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Premium services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0851">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues">2,988</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues">2,988</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--PremiumServicesMember_pn3n3" style="text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Brand protection services</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0865">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0867">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20221231__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20210101__20211231__srt--ProductOrServiceAxis__custom--BrandProtectionServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">18,190</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl0879">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">19,576</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 15202000 15202000 2988000 2988000 1386000 867000 1386000 867000 1386000 867000 18190000 19576000 867000 <p id="xdx_800_eus-gaap--BusinessCombinationDisclosureTextBlock_zEVAnIO3pB3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 – <span id="xdx_828_z2REIigVT2O4">BUSINESS COMBINATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">PeriShip LLC</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 22, 2022, we acquired, through PeriShip Global, the business and certain assets of PeriShip, LLC (“PeriShip”), a value-added service provider for time and temperature sensitive parcel management.  PeriShip Global provides shipping logistics services utilizing proprietary predictive analytics software and supporting call center services.  Using our proprietary software platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries. The purchase price was $<span id="xdx_909_ecustom--BusinessCombinationConsiderationTransferred2_pn3n3_dm_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zx9UxWQb8Hhg" title="Purchase price">10.5</span> million which consisted of $<span id="xdx_903_ecustom--BusinessCombinationConsiderationTransferred_pn3n3_dm_c20220401__20220422_zaKOFAWQ5cql" title="Consideration transferred">7.5</span> million in cash paid at closing, a promissory note of $<span id="xdx_903_ecustom--PromissoryNote_pn3n3_dm_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zaIVmm5fc66h" title="Promissory note">2.0</span> million with a fixed interest rate of <span id="xdx_904_eus-gaap--InvestmentInterestRate_iI_dp_c20220422__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zf9WRqc9cbi5" title="Investment Interest Rate">6</span>% per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing, and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_c20220422__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_pdd" title="Common stock shares, issued">305,473</span> shares of common stock of the Company, representing $1.0 million in stock consideration. The goodwill recognized is due to the expected synergies from combining the operations of the acquire with the Company. All of the goodwill recorded for financial statement purposes is deductible for tax purposes. The acquired PeriShip business is included in the PeriShip Global Solutions segment and the results of its operations have been included in the consolidated financial statements beginning April 22, 2022. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 22, 2022, the Company entered into an agreement with the owner of PeriShip, LLC to resolve certain disputes among the parties, reduce the principal and interest on the promissory note, repay the amended promissory note in full, and repurchased <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_c20220922__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_pdd" title="Common stock shares, issued">61,000</span> shares of the Company’s common stock (see Note 9). The Company accounted for the agreement in accordance with Topic 250, through earnings, with the full amount included as a Gain on extinguishment of debt on the accompanying Consolidated Statements of Operations for a total of $<span id="xdx_90B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_pn3n3" title="Gain on extinguishment of debt">326</span> thousand, for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the purchase price allocation for the acquisition (dollars in thousands).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_pn3n3_zwGgMPVcVK8g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS COMBINATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zSWqjlEA4N33" style="display: none">Schedule of business acquisitions</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Cash</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--Cash_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="width: 15%; text-align: right" title="Cash">7,500</td><td style="background-color: White; white-space: nowrap; width: 1%; text-align: left"> </td> <td style="background-color: White; width: 1%"> </td> <td style="background-color: White; width: 1%"> </td> <td style="background-color: White; width: 15%"> </td> <td style="background-color: White; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Promissory note</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayable_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Promissory note">2,000</td><td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Stock (issuance of 305,473 shares of common stock) <sup>(1)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--StockAmount_pn3n3_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_fMQ_____z3m55Jae5NVd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock (issuance of 305,473 shares of restricted common stock)">974</td><td style="background-color: White; white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="background-color: White"> </td> <td style="background-color: White"> </td> <td style="background-color: White"> </td> <td style="background-color: White"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: 9.5pt">Total purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total purchase price">10,474</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Amortization</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Period</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Purchase price allocation:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Accounts receivable, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="width: 15%; text-align: right" title="Accounts receivable, net">836</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Prepaid expenses">5</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Developed Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Intangible Assets">3,143</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_z3NcRVxQGl2c" title="Amortization Period">6</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names/Trademarks</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Intangible Assets">1,111</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zCvIAqgX2Mg8" title="Amortization Period">13</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Intangible Assets">1,839</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zzA0aC288ick" title="Amortization Period">10</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-Compete Agreement</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Intangible Assets">191</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHoosidYPA4f" title="Amortization Period">5</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and Equipment, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Property and Equipment, net">193</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Goodwill_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Goodwill">3,988</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accounts payable and other accrued expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_zS0UotrluFE3" style="border-bottom: Black 1pt solid; text-align: right" title="Accounts payable and other accrued expenses">(832</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zwHrHtmE91wa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total purchase price">10,474</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0pt"/><td style="width: 18pt; text-align: left"><sup id="xdx_F0F_z1sDuFocLxr2">(1)</sup></td><td id="xdx_F19_z0DvK6HkyOkk">Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736.</td> </tr></table> <p id="xdx_8A7_zrbcrTLRvAof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Unaudited Pro forma Financial Information</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following unaudited proforma financial information presents the combined results of operations of the Company and gives effect to the acquisition discussed above for the years ended December 31, 2022, and 2021, as if the acquisition had occurred as of the beginning of the first period presented instead of on April 22, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations that would have been realized if the acquisition had been completed on January 1, 2021, nor does it purport to project the results of operations of the combined company in future periods. The pro forma financial information does not give effect to any anticipated integration costs related to the acquired company during the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The below table summarizes proforma financial information for the Company, and the acquired PeriShip business, assuming the acquisition date of PeriShip occurred on January 1, 2021 (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFinancialInformationTableTextBlock_pn3n3_zmv7cCKJ8oLe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - BUSINESS COMBINATION (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8B3_zg6TI634erVc" style="display: none">Schedule of financial information</span></td><td> </td> <td colspan="2" id="xdx_497_20220101__20221231_zOvlRk3C9cGi" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20210101__20211231_zBdmm22NsTn9" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Years Ended<br/> December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_40D_ecustom--Revenue1_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Revenues</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">25,397</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">29,500</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--NetIncomeLoss1_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net Income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(14,298</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,465</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8A2_z32gITzmwq75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> 10500000 7500000 2000000.0 0.06 305473 61000 326000 <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_pn3n3_zwGgMPVcVK8g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS COMBINATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_zSWqjlEA4N33" style="display: none">Schedule of business acquisitions</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Cash</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--Cash_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="width: 15%; text-align: right" title="Cash">7,500</td><td style="background-color: White; white-space: nowrap; width: 1%; text-align: left"> </td> <td style="background-color: White; width: 1%"> </td> <td style="background-color: White; width: 1%"> </td> <td style="background-color: White; width: 15%"> </td> <td style="background-color: White; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Promissory note</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--NotesPayable_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Promissory note">2,000</td><td style="white-space: nowrap; text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Stock (issuance of 305,473 shares of common stock) <sup>(1)</sup></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--StockAmount_pn3n3_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_fMQ_____z3m55Jae5NVd" style="border-bottom: Black 1pt solid; text-align: right" title="Stock (issuance of 305,473 shares of restricted common stock)">974</td><td style="background-color: White; white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td> <td style="background-color: White"> </td> <td style="background-color: White"> </td> <td style="background-color: White"> </td> <td style="background-color: White"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: 9.5pt">Total purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total purchase price">10,474</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center">Amortization</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Period</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Purchase price allocation:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Accounts receivable, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="width: 15%; text-align: right" title="Accounts receivable, net">836</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Prepaid expenses">5</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Developed Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Intangible Assets">3,143</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_z3NcRVxQGl2c" title="Amortization Period">6</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade Names/Trademarks</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Intangible Assets">1,111</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zCvIAqgX2Mg8" title="Amortization Period">13</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Intangible Assets">1,839</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zzA0aC288ick" title="Amortization Period">10</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Non-Compete Agreement</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Intangible Assets">191</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220421__20220422__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zHoosidYPA4f" title="Amortization Period">5</span> years</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and Equipment, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Property and Equipment, net">193</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Goodwill_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_pn3n3" style="text-align: right" title="Goodwill">3,988</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accounts payable and other accrued expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pn3n3_di_c20220422__us-gaap--BusinessAcquisitionAxis__custom--PeriShipMember_zS0UotrluFE3" style="border-bottom: Black 1pt solid; text-align: right" title="Accounts payable and other accrued expenses">(832</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--BusinessCombinationConsiderationTransferred1_pn3n3_c20220421__20220422__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zwHrHtmE91wa" style="border-bottom: Black 2.5pt double; text-align: right" title="Total purchase price">10,474</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0pt"/><td style="width: 18pt; text-align: left"><sup id="xdx_F0F_z1sDuFocLxr2">(1)</sup></td><td id="xdx_F19_z0DvK6HkyOkk">Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736.</td> </tr></table> 7500000 2000000 974000 10474000 836000 5000 3143000 P6Y 1111000 P13Y 1839000 P10Y 191000 P5Y 193000 3988000 832000 10474000 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfFinancialInformationTableTextBlock_pn3n3_zmv7cCKJ8oLe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - BUSINESS COMBINATION (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8B3_zg6TI634erVc" style="display: none">Schedule of financial information</span></td><td> </td> <td colspan="2" id="xdx_497_20220101__20221231_zOvlRk3C9cGi" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20210101__20211231_zBdmm22NsTn9" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Years Ended<br/> December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap">Description</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_40D_ecustom--Revenue1_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Revenues</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">25,397</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">29,500</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--NetIncomeLoss1_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net Income (loss)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(14,298</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,465</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 25397000 29500000 -14298000 5465000 <p id="xdx_80F_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zxyg7pYnltr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 – <span id="xdx_827_zyF2jrCOLDF3">INTANGIBLE ASSETS AND GOODWILL</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Goodwill</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents costs in excess of values assigned to the underlying net assets of acquired businesses. Intangible assets acquired are recorded at estimated fair value. Goodwill is deemed to have an indefinite life and is not amortized but is tested for impairment annually, and at any time when events suggest an impairment more likely than not has occurred. We test goodwill at the reporting unit level.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 350, <i>Intangibles - Goodwill and Other </i>(ASC Topic 350), permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test.  Under ASC Topic 350, an entity is not required to perform a quantitative goodwill impairment test for a reporting unit if it is more likely than not that its fair value is greater than its carrying amount. A reporting unit is an operating segment, or one level below an operating segment, as defined by U.S. GAAP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, future economic and market conditions and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The timing and frequency of our goodwill impairment tests are based on an ongoing assessment of events and circumstances that would indicate a possible impairment. We will continue to monitor our goodwill and intangible assets for impairment and conduct formal tests when impairment indicators are present.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of our two reportable segments represents an operating segment under ASC Topic 280, <i>Segment Reporting</i>. We test our goodwill at the reporting unit level, or one level below an operating segment, under ASC Topic 350, <i>Intangibles - Goodwill and Other</i>. We determined that we have two reporting units for purposes of goodwill impairment testing, which represent our two reportable business segments, as discussed below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021, there were no goodwill activities. Changes in the carrying amount of goodwill by reportable business segment for the year ended December 31, 2022, were as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--IntangibleAssetsDisclosureTextBlock_pn3n3_zWhFhEnrBhQ4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"><span id="xdx_8BA_zG23H1TVj2le" style="display: none">Schedule of goodwill by reportable business segment</span></td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">VerifyMe</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">PeriShip Global</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold">Net book value at</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold">January 1, 2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td id="xdx_983_ecustom--BookValue_iS_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zAszh5cwYd4f" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td id="xdx_984_ecustom--BookValue_iS_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zNY5ugu68nsl" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td id="xdx_980_ecustom--BookValue_iS_pn3n3_c20220101__20221231_z0r6vKaJWYq4" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">2022 Activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 55%">Acquisition</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AcquisitionCosts_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="width: 12%; text-align: right" title="Acquisition"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AcquisitionCosts_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="width: 12%; text-align: right" title="Acquisition">3,988</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AcquisitionCosts_c20220101__20221231_pn3n3" style="width: 12%; text-align: right" title="Acquisition">3,988</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net book value at</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--BookValue_iE_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zqwtjCTtr9Y2" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--BookValue_iE_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zlwmdMq3Fk8d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">3,988</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--BookValue_iE_pn3n3_c20220101__20221231_zcMeR5omHKa" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">3,988</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zFnm8PFHwiUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Intangible Assets Subject to Amortization</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our intangible assets include amounts recognized in connection with patents and trademarks, capitalized software and acquisitions, including customer relationships, tradenames, developed technology and non-compete agreements. Intangible assets are initially valued at fair market value using generally accepted valuation methods appropriate for the type of intangible asset. Amortization is recognized on a straight-line basis over the estimated useful life of the intangible assets. Intangible assets with definite lives are reviewed for impairment if indicators of impairment arise. Except for goodwill, we do not have any intangible assets with indefinite useful lives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets with finite lives are subject to amortization over their estimated useful lives. The primary assets included in this category and their respective balances were as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_pn3n3_zamay218SZ9j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B5_zHd3vRUh2TAd" style="display: none">Schedule of intangible assets subject to amortization</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold">December 31, 2022</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap">Gross Carrying <br/> Amount</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap">Accumulated <br/> Amortization</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap">Net Carrying <br/> Amount</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: justify">Patents and Trademarks</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="width: 12%; text-align: right" title="Gross Carrying Amount">1,858</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="width: 12%; text-align: right" title="Accumulated Amortization">(445</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="width: 12%; text-align: right" title="Net Carrying Amount">1,413</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Capitalized Software</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">206</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(91</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="text-align: right" title="Net Carrying Amount">115</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">1,839</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(133</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Net Carrying Amount">1,706</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Developed Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">3,143</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(360</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Net Carrying Amount">2,783</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Internally Used Software</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyUsedSoftwareMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">236</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyUsedSoftwareMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(4</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyUsedSoftwareMember_pn3n3" style="text-align: right" title="Net Carrying Amount">232</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Non-Compete Agreement</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">191</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(28</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">163</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">7,473</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(1,061</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">6,412</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">December 31, 2021</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Patents and Trademarks</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">707</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(354</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Net Carrying Amount">353</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Capitalized Software</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">206</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(50</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">156</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">913</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(404</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">509</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zh36n5FgKDqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for intangible assets was $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220101__20221231_pn3n3" title="Amortization of Intangible Assets">657</span> thousand and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210101__20211231_pn3n3" title="Amortization of Intangible Assets">64</span> thousand for the year ended December 31, 2022, and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patents and Trademarks</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, the current patent and trademark portfolios consist of eleven granted U.S. patents and one granted European patent validated in four countries (France, Germany, United Kingdom, and Italy), six pending U.S. and foreign patent applications, fifteen registered U.S. trademarks (of which seven trademarks were acquired through our wholly owned subsidiary, PeriShip Global), two EU trademark registrations, one Colombian trademark registration, one Australian trademark registration, one Japanese trademark registration, one Mexican trademark registration, one Singaporean trademark registration, two UK trademark registrations, and twenty-one pending US and foreign trademark applications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects to record amortization expense of intangible assets over the next 5 years and thereafter as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zRm0eaTHv0b6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_zfA51mTOxpSk" style="display: none">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold">Fiscal Year ending December 31,</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzyYY_z6FNIeJ4pdcc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2023</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,057</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzyYY_zj9GKDt4MIT4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">877</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzyYY_z0iK2uS4glua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">857</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzyYY_zfCqCAWyKGIa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">842</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_maFLIANzyYY_zcFbsAbYYCq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">836</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzyYY_zkceLq9pgBpl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,943</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzyYY_ze6bBO3w7FRc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,412</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zsv8atw0lCQ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, our intangible assets with definite lives had a weighted average remaining useful life of 8.4 years.  We have no amortizable intangible assets with indefinite useful lives.</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--IntangibleAssetsDisclosureTextBlock_pn3n3_zWhFhEnrBhQ4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"><span id="xdx_8BA_zG23H1TVj2le" style="display: none">Schedule of goodwill by reportable business segment</span></td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">VerifyMe</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">PeriShip Global</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold">Net book value at</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; white-space: nowrap; font-weight: bold">January 1, 2022</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td id="xdx_983_ecustom--BookValue_iS_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zAszh5cwYd4f" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td id="xdx_984_ecustom--BookValue_iS_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zNY5ugu68nsl" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">$</td> <td id="xdx_980_ecustom--BookValue_iS_pn3n3_c20220101__20221231_z0r6vKaJWYq4" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">2022 Activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 55%">Acquisition</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AcquisitionCosts_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="width: 12%; text-align: right" title="Acquisition"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AcquisitionCosts_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="width: 12%; text-align: right" title="Acquisition">3,988</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AcquisitionCosts_c20220101__20221231_pn3n3" style="width: 12%; text-align: right" title="Acquisition">3,988</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net book value at</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_ecustom--BookValue_iE_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zqwtjCTtr9Y2" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--BookValue_iE_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zlwmdMq3Fk8d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">3,988</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--BookValue_iE_pn3n3_c20220101__20221231_zcMeR5omHKa" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance">3,988</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3988000 3988000 3988000 3988000 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_pn3n3_zamay218SZ9j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B5_zHd3vRUh2TAd" style="display: none">Schedule of intangible assets subject to amortization</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold">December 31, 2022</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap">Gross Carrying <br/> Amount</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap">Accumulated <br/> Amortization</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap">Net Carrying <br/> Amount</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; text-align: justify">Patents and Trademarks</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="width: 12%; text-align: right" title="Gross Carrying Amount">1,858</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="width: 12%; text-align: right" title="Accumulated Amortization">(445</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="width: 12%; text-align: right" title="Net Carrying Amount">1,413</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Capitalized Software</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">206</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(91</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="text-align: right" title="Net Carrying Amount">115</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">1,839</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(133</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Net Carrying Amount">1,706</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Developed Technology</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">3,143</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(360</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Net Carrying Amount">2,783</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Internally Used Software</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyUsedSoftwareMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">236</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyUsedSoftwareMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(4</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyUsedSoftwareMember_pn3n3" style="text-align: right" title="Net Carrying Amount">232</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Non-Compete Agreement</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">191</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(28</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">163</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">7,473</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(1,061</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">6,412</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font-weight: bold; padding-bottom: 1pt">December 31, 2021</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Patents and Trademarks</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Gross Carrying Amount">707</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Accumulated Amortization">(354</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pn3n3" style="text-align: right" title="Net Carrying Amount">353</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Capitalized Software</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying Amount">206</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated Amortization">(50</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedSoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Net Carrying Amount">156</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying Amount">913</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated Amortization">(404</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Carrying Amount">509</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1858000 -445000 1413000 206000 -91000 115000 1839000 -133000 1706000 3143000 -360000 2783000 236000 -4000 232000 191000 -28000 163000 7473000 -1061000 6412000 707000 -354000 353000 206000 -50000 156000 913000 -404000 509000 657000 64000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_pn3n3_zRm0eaTHv0b6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_zfA51mTOxpSk" style="display: none">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_496_20221231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold">Fiscal Year ending December 31,</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzyYY_z6FNIeJ4pdcc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2023</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,057</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzyYY_zj9GKDt4MIT4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">877</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzyYY_z0iK2uS4glua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">857</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzyYY_zfCqCAWyKGIa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">842</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pn3n3_maFLIANzyYY_zcFbsAbYYCq2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2027</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">836</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzyYY_zkceLq9pgBpl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Thereafter</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,943</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzyYY_ze6bBO3w7FRc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,412</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 1057000 877000 857000 842000 836000 1943000 6412000 <p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_zZTO5sHaBxq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 – <span id="xdx_820_zvkzmwo1e2Cb">INCOME TAXES</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income tax expense computed at the U.S. federal statutory rate to the income tax provision for the years ended December 31, 2022, and 2021 is as follows <i>(in thousands)</i>:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_pn3n3_z98wARHxE0w9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BC_zBjTRvxMhOC" style="display: none">Schedule of reconciliation of federal statutory tax rate</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20220101_20221231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101_20211231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold">US</td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Income (loss) before income taxes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(14,400</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(3,612</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Taxes under statutory US tax rates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,024</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">759</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Increase (decrease) in taxes resulting from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i01_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Increase (decrease) in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,188</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,149</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--ChangeInStateTaxRate_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in State tax rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(57</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--IncomeTaxReconciliationAllOther_i01_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">All other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,045</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,204</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">State taxes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(776</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">186</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_i01_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zx3gNQ6qft0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The decrease in the Company's net valuation allowance was due primarily to a realized loss in our equity investment (See Note 2-Equity Investment), and to net operating losses which will expire unutilized due to limitations resulting from application of Section 382 of the Internal Revenue Code of 1986, as amended (“IRC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities consist of the following (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_z0u2W7z3Jxq" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BF_z40bp713XxVl" style="display: none">Schedule of deferred tax assets and liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231_zjfKPVY7Bhf6" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20211231_zUNxNY37ybhl" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">US</td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: 22pt">Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">6,495</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">5,208</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--RestrictedStockRsasRsus_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Restricted Stock (RSA’s, RSU’s)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">503</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--StockOptions_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Stock Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">562</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">678</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--StockPurchasePlanSpp_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Stock Purchase Plan (SPP)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1110">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iNI_pn3n3_di_zBFRjZNBbxgd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 22pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(71</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-indent: 22pt">Intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AcquisitionTransactionCosts_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Acquisition Transaction Costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">110</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1119">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Capitalized Research and Development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_iNI_pn3n3_di_z4D4hZ0BN2R" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Unrealized Gain on Investment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,188</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--BadDebt_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Bad Debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--DividendIncome_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Dividend Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 22pt">Gross deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">7,652</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,854</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_zZJsI9nnf7Fl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,652</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,854</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1140">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1145">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax assets / (liabilities)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1149">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zK95qsyYyJM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_903_ecustom--DescriptionOfOwnershipChange_c20220101__20221231" title="Description of ownership change">Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2022, the Company completed the IRC Section 382 analysis, and determined that an ownership change occurred sufficient to impose additional limitations on the use of NOL carryforwards. For the year ended December 31, 2022, Federal and state NOLs of $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_dm_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zsKZpWetIP1j" title="Operating Loss Carryforwards">23.1</span> million and $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pn3n3" title="Operating Loss Carryforwards">0</span>, respectively, will expire unutilized due to the limitations of Section 382, leaving Federal and state NOL carryforwards of $24.4 million and $13.1 million, respectively that may be offset against future taxable income. Some of the Federal and state tax NOL carryforwards will expire at various dates through 2037. Generally, these can be carried forward and applied against future taxable income at the tax rate applicable at that time. We are currently using an effective income tax rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20220101__20221231_zTCZK92jxdH3" title="Effective income tax rate">26.6%</span> for our projected available net operating loss carry-forward. No tax benefit has been reported in the December 31, 2022, due to the uncertainty surrounding the realizability of the benefit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In accordance with FASB ASC 740 “Income Taxes”, valuation allowances are provided against deferred tax assets, if based on the weight of available evidence, some or all of the deferred tax assets may or will not be realized. The Company has evaluated its ability to realize some or all of the deferred tax assets on its balance sheet and has established a valuation allowance of approximately $<span id="xdx_90C_ecustom--DeferredTaxAssetsValuationAllowance1_iI_pn3n3_dm_c20221231_z8YnF6iBo4M9" title="Deferred tax assets valuation allowance">7.7</span> million at December 31, 2022. The Company did not utilize any NOL deductions for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applied the "more-likely-than-not" recognition threshold to all tax positions taken or expected to be taken in a tax return, which resulted in <span id="xdx_909_eus-gaap--UnrecognizedTaxBenefits_iI_pn3n3_do_c20221231_z4ygmNUbmtWl" title="Unrecognized tax benefits"><span id="xdx_90E_eus-gaap--UnrecognizedTaxBenefits_iI_pn3n3_do_c20211231_zfpkyLEv79f8" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits as of December 31, 2022, and December 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had no accrual for interest and penalties on the balance sheets and has <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pn3n3_do_c20221231_zZZXM2pPHbWl" title="Accrual for interest and penalties"><span id="xdx_901_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pn3n3_do_c20211231_zWvzVwMhyHc6" title="Accrual for interest and penalties">no</span></span>t recognized interest and/or penalties in the Statements of Operations for the years ended December 31, 2022, and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is subject to taxation in the United States and various state jurisdictions. The Company’s tax years from 2003 are subject to examination by the United States and state taxing authorities due to the carryforward of unutilized NOLs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are <span id="xdx_901_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_do_c20221231_zvMOiHU7oecg" title="Taxes payable"><span id="xdx_90E_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_do_c20211231_zMWRbIc9I20c" title="Taxes payable">no</span></span> taxes payable as of December 31, 2022, or December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_pn3n3_z98wARHxE0w9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BC_zBjTRvxMhOC" style="display: none">Schedule of reconciliation of federal statutory tax rate</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20220101_20221231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101_20211231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold">US</td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Income (loss) before income taxes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(14,400</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(3,612</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Taxes under statutory US tax rates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,024</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">759</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Increase (decrease) in taxes resulting from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i01_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Increase (decrease) in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,188</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,149</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_40C_ecustom--ChangeInStateTaxRate_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in State tax rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(57</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--IncomeTaxReconciliationAllOther_i01_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">All other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,045</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,204</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">State taxes</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(776</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">186</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_i01_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -14400000 -3612000 -3024000 759000 -1188000 -6149000 -57000 5045000 5204000 -776000 186000 <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_pn3n3_z0u2W7z3Jxq" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BF_z40bp713XxVl" style="display: none">Schedule of deferred tax assets and liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20221231_zjfKPVY7Bhf6" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20211231_zUNxNY37ybhl" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">US</td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: 22pt">Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">6,495</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">5,208</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--RestrictedStockRsasRsus_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Restricted Stock (RSA’s, RSU’s)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">503</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">180</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--StockOptions_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Stock Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">562</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">678</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--StockPurchasePlanSpp_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Stock Purchase Plan (SPP)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1110">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iNI_pn3n3_di_zBFRjZNBbxgd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 22pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(71</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-indent: 22pt">Intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AcquisitionTransactionCosts_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Acquisition Transaction Costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">110</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1119">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Capitalized Research and Development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1122">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_iNI_pn3n3_di_z4D4hZ0BN2R" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Unrealized Gain on Investment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,188</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--BadDebt_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 22pt">Bad Debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--DividendIncome_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 22pt">Dividend Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1131">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 22pt">Gross deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">7,652</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,854</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_zZJsI9nnf7Fl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,652</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,854</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total deferred tax assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1139">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1140">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1145">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1146">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax assets / (liabilities)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1149">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6495000 5208000 503000 180000 562000 678000 8000 71000 33000 22000 9000 110000 17000 1000 2188000 9000 -2000 7652000 3854000 7652000 3854000 Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income. 23100000 0 0.266 7700000 0 0 0 0 0 0 <p id="xdx_80F_eus-gaap--DebtDisclosureTextBlock_z8fFo7IM2R75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7—<span id="xdx_82C_zbo3f33wxeRe">DEBT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 22, 2022, the Company issued a $<span id="xdx_90A_ecustom--UnsecuredPromissoryNote_iI_pn3n3_dm_c20220422__us-gaap--CreditFacilityAxis__custom--PromissoryNoteMember_z4AJL9qQjPdc" title="Unsecured promissory note">2.0</span> million unsecured promissory note through our subsidiary PeriShip Global as part of the acquisition of the PeriShip business. The note had a fixed interest rate of <span id="xdx_904_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_c20220421__20220422__us-gaap--CreditFacilityAxis__custom--PromissoryNoteMember_pdd" title="Intrest rate">6%</span> per annum on the unpaid principal balance, to be paid in three installments on the sixth, fifteenth, and eighteenth month anniversaries of the closing. On September 22, 2022, the Company entered into an agreement with the note holder whereby the Company repaid the outstanding principal balance and accrued interest outstanding on the note and redeemed 61,000 shares of its common stock from the holder of the note, for a total of $1.8 million, at which point the guarantee agreement entered into by the Company in connection therewith was automatically terminated and has no further effect.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounted for the early extinguishment of debt in accordance with ASC 405-20 - <i>Extinguishment of Liabilities</i>, and recognized a gain included in Gain on extinguishment of debt on the accompanying Consolidated Statements of Operations of $<span id="xdx_90B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20220101__20221231_pn3n3" title="Gain (Loss) on Extinguishment of Debt">326</span> thousand for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contemporaneously, the Company entered into a new debt facility with PNC Bank, National Association (the “PNC Facility”). The PNC Facility includes a $1 million revolving line of credit (the “RLOC”) with a term of one-year, expiring in September 2023. The RLOC has no scheduled payments of principal until maturity, and bears interest per annum at a rate equal to the sum of Daily SOFR plus 2.85% with monthly interest payments. The PNC Facility also includes a four-year term note (the “Term Note”) for $2 million which matures in September of 2026 and requires equal quarterly payments of principal and interest. The Term Note incurs interest per annum at a rate equal to the sum of Daily SOFR plus 3.1%.  The RLOC and Term Note are guaranteed by the Company and secured by the assets of PeriShip Global and the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The PNC Facility includes a number of affirmative and restrictive covenants applicable to PeriShip Global, including, among others, a financial covenant to maintain a fixed charge coverage ratio of at least 1.10 to 1.00 at the end of each fiscal year, affirmative covenants regarding delivery of financial statements, payment of taxes, and establishing primary depository accounts with PNC Bank, and restrictive covenants regarding dispositions of property, acquisitions, incurrence of additional indebtedness or liens, investments and transactions with affiliates. PeriShip Global is also restricted from paying dividends or making other distributions or payments on its capital stock if an event of default (as defined in the PNC Facility) has occurred or would occur upon such declaration of dividend. PeriShip Global was in compliance with all affirmative and restrictive covenants under the PNC Facility at December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective October 17, 2022, the Company entered into an interest rate swap agreement, with a notional amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_c20221017_pn3n3" title="Notional amount">1,958</span> thousand, effectively fixing the interest rate on the Company’s outstanding debt at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20221001__20221017_pdd" title="Interest rate">7.602%</span>. The Company has designated the intertest rate swap, expiring September 2026, as a cash flow hedge and have applied hedge accounting. The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and is included in Long-term Derivative Liability on the Consolidated Balance Sheets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, our short-term debt outstanding under the Term Note was $<span id="xdx_902_eus-gaap--ShortTermBorrowings_iI_pn3n3_dm_c20221231_zdKq3szyGRI3" title="Short term debt outstanding">0.5</span> million and total long-term debt outstanding under the Term Note was $<span id="xdx_902_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20221231_z8sl1iA3tnxl" title="Long-term debt outstanding">1.4</span> million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No amounts were drawn on the RLOC as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On May 17, 2020, the Company entered into a paycheck protection program term note for $<span id="xdx_904_eus-gaap--LongTermDebt_c20200517__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramTermNoteMember__us-gaap--RelatedPartyTransactionAxis__custom--PNCBankNAMember_pn3n3" title="Long-term debt outstanding">72</span> thousand (the “SBA Loan”) with PNC Bank, N.A. under the recently enacted Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) pursuant to the Paycheck Protection Program (the “PPP”), which is administered by the U.S. Small Business Administration. The SBA Loan was scheduled to mature on <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_c20200516__20200517__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramTermNoteMember__us-gaap--RelatedPartyTransactionAxis__custom--PNCBankNAMember" title="Maturity date">May 17, 2022</span>, and bore interest at a rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_c20200517__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramTermNoteMember__us-gaap--RelatedPartyTransactionAxis__custom--PNCBankNAMember_pdd" title="Interest rate">1.00%</span> per annum and is subject to the terms and conditions applicable to loans administered by the U.S. Small Business Administration under the CARES Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529"><span style="background-color: white">The Company applied for and was notified in June 2021 that $69 thousand in eligible payroll expenditures as described in the CARES Act, has been forgiven. Loan forgiveness is reflected in Other Income (Expense), Net in the accompanying Consolidated Statements of Operations. The forgiveness recognized during the year ended December 31, 2021, included principal of $<span id="xdx_90C_ecustom--LoanForgivenessAmount_c20210101__20211231_pn3n3" title="Loan forgiveness">69</span> thousand, and interest payable of $<span id="xdx_90D_eus-gaap--InterestPayableCurrent_c20211231_pn3n3" title="Interest payable">1</span> thousand. The remaining loan balance of $<span id="xdx_903_eus-gaap--RepaymentsOfNotesPayable_c20210101__20211231_pn3n3" title="Repayments of loan payable">3</span> thousand was paid in full in June 2021. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 2000000.0 0.06 326000 1958000 0.07602 500000 1400000 72000 2022-05-17 0.0100 69000 1000 3000 <p id="xdx_807_eus-gaap--PreferredStockTextBlock_zVWBVAU1AfA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b>NOTE 8 – <span id="xdx_82D_zdjVrGsG1t5">CONVERTIBLE PREFERRED STOCK</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is authorized to issue Series A Convertible Preferred Stock, par value of $0<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, par value (in dollars per share)"><span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zDQbPjeB2Tvd" title="Preferred stock, par value (in dollars per share)"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zsHuxspMAKs3" title="Preferred stock, par value (in dollars per share)">.001</span></span></span> per share (the “Series A”) and Series B Convertible Preferred Stock, par value of $0<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Preferred stock, par value (in dollars per share)"><span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Preferred stock, par value (in dollars per share)">.001</span></span> per share (the “Series B”). As of December 31, 2022, and 2021, there were <span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zw3QJSRWuap" title="Convertible Preferred Stock, outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLdfFkku8on7" title="Convertible Preferred Stock, outstanding">no</span></span> shares of Series A outstanding and <span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Convertible Preferred Stock, outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Convertible Preferred Stock, outstanding">0.85</span></span> of a share of Series B outstanding convertible into <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Number of shares converted"><span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfNUHbj63Ca6" title="Number of shares converted">144,444</span> </span>shares of common stock. Each share of Series A and Series B has limited voting rights, is entitled to participate with the common stock on liquidation and holders of Series A and Series B are subject to beneficial ownership limitations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"> </p> 0.001 0.001 0.001 0.001 0.001 0 0 0.85 0.85 144444 144444 <p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zP4HTcjnrKk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 – <span id="xdx_82B_zO7k5w0QOE2i">STOCKHOLDERS’ EQUITY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expensed $<span id="xdx_906_eus-gaap--RestrictedStockExpense_c20220101__20221231_pn3n3" title="Restricted stock/restricted stock units, expense">239</span> thousand and $<span id="xdx_904_eus-gaap--RestrictedStockExpense_c20210101__20211231_pn3n3" title="Restricted stock/restricted stock units, expense">784</span> thousand related to restricted stock awards for the years ended December 31, 2022, and December 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expensed $<span id="xdx_903_ecustom--StockIssuedDuringPeriodValueRestrictedStockAwardNet_c20220101__20221231_pn3n3" title="Restricted stock/restricted stock award, expense">1,084</span> thousand and $<span id="xdx_901_ecustom--StockIssuedDuringPeriodValueRestrictedStockAwardNet_c20210101__20211231_pn3n3" title="Restricted stock/restricted stock award, expense">696</span> thousand related to restricted stock units for the years ended December 31, 2022, and December 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, and 2021, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Stock issued for services">30,000</span> and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Stock issued for services">9,774</span> shares of common stock in relation to services with a stock-based compensation expense of $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20220101__20221231_pn3n3" title="Stock-based compensation expense">96</span> thousand and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20210101__20211231_pn3n3" title="Stock-based compensation expense">39</span> thousand, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 11, 2022, we received an exercise notice to exercise <span id="xdx_909_ecustom--PrefundedWarrants_c20220811_pdd" title="Prefunded warrants">675,000</span> pre-funded warrants with an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220811_pdd" title="Class of Warrant or Right, Exercise Price of Warrants or Rights">0.001</span> per share. Upon receipt of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueOther_c20220801__20220811_pn3n3" title="Stock Issued During Period, Value, Other">675</span> the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220801__20220811_pdd" title="Stock Issued During Period, Shares, Other">675,000</span> shares of its common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 22, 2022, <span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20220422_pdd" title="Common stock issued">305,473</span> shares of common stock were issued in relation to the acquisition of the PeriShip business, see Note 4 – Business Combinations, for details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On April 15, 2022, the Company withheld and retired 750 shares of common stock in order to satisfy U.S. payroll tax withholding obligations on restricted stock awards held by our Chief Financial Officer.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 12, 2022, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with a selling stockholder and certain directors, providing for the issuance and sale to purchasers therein of an aggregate of 880,208 shares of our common stock, pre-funded warrants to purchase up to 675,000 shares of our common stock, and warrants to purchase up to 1,555,208 shares of our common stock, for gross proceeds to us of approximately $5.0 million and net proceeds of $4.6 million. The pre-funded warrant is exercisable immediately and shall terminate when fully exercised and has an exercise price of $0.001 per share. The pre-funded warrant was exercised in full on August 11, 2022. The warrants will be exercisable for a period of five years commencing six months from the date of issuance and have an exercise price of $3.215 per share. Both the pre-funded warrants and warrants contain price adjustment provisions which may, under certain circumstances, reduce the applicable exercise price. The transaction closed on April 14, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 29, 2022, the Company withheld and retired 8,870 shares of common stock in order to satisfy U.S. payroll tax withholding obligations on restricted stock awards held by our Chief Executive Officer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Non-Qualified Stock Purchase Plan</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 10, 2021, the stockholders of the Company approved a non-qualified stock purchase plan (the “2021 Plan”). The 2021 Plan provides eligible participants, including employees, directors and consultants of the Company, the opportunity to purchase shares of the Company’s common stock thereby increasing their interest in the Company’s continued success. The maximum numbers of common stock reserved and available for issuance under the 2021 Plan is 500,000 shares. The purchase price of shares of common stock acquired pursuant to the exercise of an option will be the lesser of 85% of the fair market value of a share (a) on the enrollment date, and (b) on the exercise date. The 2021 Plan is not intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”). The Company applied FASB ASC 718, “Compensation-Stock Compensation” and estimated the fair value using the Black-Scholes model, as the plan is considered compensatory. In relation to the non-qualified stock purchase plan the Company expensed $<span id="xdx_909_ecustom--NonqualifiedStockPurchasePlanExpenses_c20220101__20221231_pn3n3" title="Non-Qualified Stock Purchase Plan expenses">122</span> thousand and $<span id="xdx_90F_ecustom--NonqualifiedStockPurchasePlanExpenses_c20210101__20211231_pn3n3" title="Non-Qualified Stock Purchase Plan expenses">40</span> thousand for the years ended December 31, 2022 and December 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Shares Held in Treasury</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, and December 31, 2021, the Company had <span id="xdx_90C_eus-gaap--TreasuryStockCommonShares_c20221231_pdd" title="Treasury stock share">389,967</span> and <span id="xdx_90F_eus-gaap--TreasuryStockCommonShares_c20211231_pdd" title="Treasury stock share">223,956</span> shares, respectively, held in treasury with a value of approximately $<span id="xdx_902_eus-gaap--TreasuryStockCommonValue_c20221231_pn3n3" title="Treasury stock value">949</span> thousand and $<span id="xdx_903_eus-gaap--TreasuryStockCommonValue_c20211231_pn3n3" title="Treasury stock value">838</span> thousand, respectively.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2022, five participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, <span id="xdx_90D_ecustom--NonqualifiedStockPurchasePlan_c20220228_pdd" title="Non-qualified stock purchase plan">25,000</span> shares were issued from treasury with a purchase price of $<span id="xdx_907_ecustom--NonqualifiedStockPurchaseExercisePrice_c20220228_pdd" title="Non-qualified stock purchase exercise price">2.69</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 31, 2022, four participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, <span id="xdx_90D_ecustom--NonqualifiedStockPurchasePlan_c20220831_pdd" title="Non-qualified stock purchase plan">28,895 </span>shares were issued from treasury with a purchase price of $<span id="xdx_907_ecustom--NonqualifiedStockPurchaseExercisePrice_c20220831_pdd" title="Non-qualified stock purchase exercise price">1.20</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 22, 2022, the Company paid $1.8 million of the $2.0 million principal amount promissory note issued to the seller in connection with the PeriShip acquisition, inclusive of the Company redeeming 61,000 shares of its common stock from the seller, pursuant to an agreement with the seller, see Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Shares Repurchase Program</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2020, the Company’s Board of Directors approved a share repurchase program for up to $1.5 million of the Company’s common stock until August 16, 2021. On August 12, 2021, the Company’s Board of Directors extended the share repurchase program to expire on August 16, 2022. Effective July 1, 2022, the Company’s Board of Directors terminated the existing share repurchase program and approved a new share repurchase program to replace the existing program due to expire on August 16, 2022, to allow the Company to spend up to $<span id="xdx_909_eus-gaap--AcceleratedShareRepurchasesAdjustmentToRecordedAmount_pn3n3_dm_c20201101__20201130_zgga2ef1KHTl" title="Share repurchase program">1.5</span> million to repurchase shares of its common stock, so long as the price does not exceed $5.00 until July 1, 2023. During year ended December 31, 2022, the Company repurchased 158,906 shares of common stock under the Company’s current program.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 239000 784000 1084000 696000 30000 9774 96000 39000 675000 0.001 675000 675000 305473 122000 40000 389967 223956 949000 838000 25000 2.69 28895 1.20 1500000 <p id="xdx_80C_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zknPCwt5hrV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>NOTE 10–<span id="xdx_827_zeUdohKxCKB7"> STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2013, the Company adopted the 2013 Omnibus Equity Compensation Plan (the “2013 Plan”). Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards up to an aggregate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20131231__us-gaap--AwardTypeAxis__custom--StockOptionsRestrictedStockandUnitsandOtherStockbasedAwardsMember__us-gaap--PlanNameAxis__custom--OmnibusEquityCompensationPlan2013Member_pdd" title="Number of shares authorized to grand awards">400,000</span> shares of common stock.  The 2013 Plan is intended to permit certain stock options granted to employees under the 2013 Plan to qualify as incentive stock options.  All options granted under the 2013 Plan, which are not intended to qualify as incentive stock options are deemed to be non-qualified stock options.  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 14, 2017, the Executive Committee of the Company’s Board of Directors adopted the 2017 Equity Incentive Plan (the “2017 Plan”) which covered the potential issuance of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20171113__20171114__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2017Member_pdd" title="Stock issued during period shares new issues">260,000</span> shares of common stock. The 2017 Plan provided that directors, officers, employees, and consultants of the Company were eligible to receive equity incentives under the 2017 Plan at the discretion of the Board or the Board’s Compensation Committee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”), subject to stockholder approval, which authorizes the potential issuance of up to <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200809__20200810__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlan2017Member_pdd" title="Stock issued during period shares new issues">1,069,110</span> shares of common stock. On September 30, 2020, the Company’s stockholders approved the 2020 Plan, and upon such approval the 2020 Plan became effective and the 2017 Plan was terminated. Shares of common stock underlying existing awards under the 2017 Plan may become available for issuance pursuant to the terms of the 2020 Plan under certain circumstances. Employees and non-employee directors of the Company or its affiliates, and other individuals who perform services for the Company or any of its affiliates, are eligible to receive awards under the 2020 Plan at the discretion of the Board of Directors or the Board’s Compensation Committee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2020 Plan is administered by the Compensation Committee which determines the persons to whom awards will be granted, the number of awards to be granted and the specific terms of each grant, including the vesting thereof, subject to the provisions of the plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceDescription_c20220101__20221231__us-gaap--AwardTypeAxis__custom--IncentiveStockOptionsMember" title="Exercise price, description">In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231__us-gaap--PlanNameAxis__custom--IssuedUnderThe2020PlanMember_pdd" title="Incentive stock options granted">1,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has issued non-qualified stock options pursuant to contractual agreements with non-employees. Options granted under the agreements are expensed when the related service or product is provided. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value represent management’s best estimates and involve inherent uncertainties and judgements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Stock Options</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_zOGccp0ZsMK" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_zmwqFlhJoZ57" style="display: none">Schedule of stock options</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Options Outstanding</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Remaining</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Aggregate</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted-</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Contractual</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Intrinsic</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Term</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Value</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Exercise Price</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>(in years)</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>(in thousands)<sup>(1)</sup></b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 39%; text-align: left">Balance as of December 31, 2020</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zVWyxqZuYqBh" style="width: 12%; text-align: right" title="Balance at beginning">473,771</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLSHMocovVGk" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning">4.48</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsvq5DNaR7Q7" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zI8mYKT3BgZh" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forfeited/Cancelled/Expired</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdLlgTuYIeVe" style="text-align: right" title="Forfeited/Cancelled/Expired">(8,300</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7G6ZjWeszgf" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled/Expired">9.72</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance as of December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkvtMgnpKQH" style="text-align: right" title="Balance at ending">465,471</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zWgY6wDnV6wh" style="text-align: right" title="Weighted Average Exercise Price, Balance at ending">4.38</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt; padding-bottom: 2.5pt; text-align: left">Exercisable as of December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIuFdcmIeUjf" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable at ending">465,471</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zziH5gi2urV7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable at ending">4.38</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zcM0djRBDxBj" title="Weighted Average Remaining Contractual Term, Exercisable at ending">3.2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fMQ_____zcotLgoXHKK" title="Vested and Exercisable at ending">47</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZtXxT7pu3L" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1331">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztYe0KZWwdOf" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forfeited/Cancelled/Expired</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbNUNEQ8peJ1" style="text-align: right" title="Forfeited/Cancelled/Expired">(128,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zq0LBZfNr5Z9" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled/Expired">3.74</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance as of December 31, 2022</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zz6wvENxalfb" style="text-align: right" title="Balance at ending">337,471</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zD9nDV1Gpgm2" style="text-align: right" title="Weighted Average Exercise Price, Balance at ending">4.63</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt; padding-bottom: 2.5pt; text-align: left">Exercisable as of December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeCbBnBfd5N6" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable at ending">337,471</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzWvAHIxkFD" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable at ending">4.63</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLzIXqboOP2d" title="Weighted Average Remaining Contractual Term, Exercisable at ending">2.4</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fMQ_____z8tOBWtquXWg" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable at ending"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td id="xdx_F09_zTyzuQgwkaFc" style="width: 27pt">(1)</td><td id="xdx_F12_zD3PYXCh0a9k" style="text-align: justify">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. </td></tr></table> <p id="xdx_8A7_zsXMVuwHesT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2022, and 2021, the Company had no unvested stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes the activities for the Company’s unvested stock options for the year ended December 31, 2022, and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_zfEtnfOa8KM4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B8_z4w6lhcdb4o7" style="display: none">Schedule of Unvested Options</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Options</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Options</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Exercise Price</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Balance at December 31, 2020</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zuunZLgAoBYk" style="width: 15%; text-align: right" title="Balance at beginning">10,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zp5moXmCRG0g" style="width: 15%; text-align: right" title="Balance at beginning">9.75</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zkAKM7JR4MHd" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1362">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zM48mB6xkS31" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1364">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Vested</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zPD3BADLl2gi" style="border-bottom: Black 1pt solid; text-align: right" title="Vested">(10,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zMN640TfBBCj" style="border-bottom: Black 1pt solid; text-align: right" title="Vested">9.75</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zmWf89usEhAi" style="text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zd9yMQgbpmgd" style="text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zT7PCYvWbKSe" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zF87m7Lyxbfc" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1376">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zvGtCdj7QmU1" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1378">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zFbB4AzTlr97" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1380">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zPTyKx4dH7Od" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zBXJOWaY8rE6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zUVYBwnoLVJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, and 2021, the Company expensed $<span id="xdx_90A_eus-gaap--StockOptionPlanExpense_c20220101__20221231__us-gaap--PlanNameAxis__custom--Plan2019Member_pn3n3" title="Stock or Unit Option Plan Expense">0</span> thousand and $<span id="xdx_90C_eus-gaap--StockOptionPlanExpense_c20210101__20211231__us-gaap--PlanNameAxis__custom--Plan2019Member_pn3n3" title="Stock or Unit Option Plan Expense">85</span> thousand with respect to options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, and 2021, there was $<span id="xdx_903_ecustom--UnrecognizedCompensationCostOutstanding_c20221231__us-gaap--PlanNameAxis__custom--Plan2019Member_pn3n3" title="Unrecognized compensation cost"><span id="xdx_900_ecustom--UnrecognizedCompensationCostOutstanding_c20211231__us-gaap--PlanNameAxis__custom--Plan2019Member_pn3n3" title="Unrecognized compensation cost">0</span></span> unrecognized compensation cost related to outstanding stock options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Restricted Stock Awards and Restricted Stock Units</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the unvested restricted stock awards as of December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_zY9GByrSVEr5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zWItkevchMZe" style="display: none">Schedule of unvested restricted stock awards</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Restricted Stock Awards</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Award Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Fair Value</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Balance at December 31, 2020</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zDSbby02hNQ8" style="width: 15%; text-align: right" title="Balance at beginning">267,500</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zwegKuMUTag3" style="width: 15%; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning">3,80</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zHn3FfslSAsd" style="text-align: right" title="Granted">89,284</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zeMkg6NMSPkh" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">4,32</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Vested</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLlip6rxMQ5l" style="border-bottom: Black 1pt solid; text-align: right" title="Vested">(312,142</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjsdVCDC9NUf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">3.87</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z4vNZIHJwEP5" style="text-align: right" title="Balance at beginning">44,642</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z7HaDN9gVMg8" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning">4.31</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zy9bvUrX5uxb" style="text-align: right" title="Granted">39,308</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zY4Mt3LVumf" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">3.18</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNHc4CJsoqOe" style="text-align: right" title="Vested">(42,142</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVbia3DAau39" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">4.32</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zj5mRnnEZr22" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">41,808</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpfUQzOFduF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at ending">3.24</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zNzwsCTAhrB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, and 2021, total unrecognized share-based compensation cost related to unvested restricted stock awards was $<span id="xdx_90C_ecustom--UnrecognizedCompensationCost_c20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_pn3n3" title="Unvested restricted stock awards">2</span> thousand and $<span id="xdx_902_ecustom--UnrecognizedCompensationCost_c20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_pn3n3" title="Unvested restricted stock awards">115 </span>thousand respectively, which is expected to be recognized over a weighted-average period of <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zu8OQWpKVNvi" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term">0.02</span> years as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the unvested restricted stock units as of December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_z16B3iJ6CC24" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BD_zg0SKN17taEk" style="display: none">Schedule of unvested restricted stock units</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Restricted Stock Units</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unit Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Fair Value</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unvested at December 31, 2020</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zpJdCEnuteQf" style="text-align: right" title="Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1436">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zxyDC4hfCmR4" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1438">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Granted</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zZTTcql4Avj4" style="width: 15%; text-align: right" title="Granted">208,010</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zYCpAB2a2pzb" style="width: 15%; text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">4.05</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z28oBGm4LgU2" style="text-align: right" title="Vested">(21,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zWse3NYhVNPf" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">3.44</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unvested at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGbM98kOfnQ6" style="text-align: right" title="Balance at ending">187,010</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zEWWwWxpp1Rd" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning">4.11</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGpdpJliLu1e" style="text-align: right" title="Granted">418,041</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zkpLB67gD4sd" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">2.14</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zXqmJatC8IK9" style="text-align: right" title="Vested">(191,425</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zoeaBOvGa8Ji" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">4.07</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHLOsl5O88Vb" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">413,626</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zcdYG5Gy1Wfc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at ending">2.14</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zJyYOEGlcvR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, and 2021, total unrecognized share-based compensation cost related to unvested restricted stock units was $<span id="xdx_90A_ecustom--UnrecognizedCompensationCost_c20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_pn3n3" title="Unvested restricted stock awards">284</span> thousand and $<span id="xdx_904_ecustom--UnrecognizedCompensationCost_c20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_pn3n3" title="Unvested restricted stock awards">146 </span>thousand respectively, which is expected to be recognized over a weighted-average period of <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zDBUnPv7gCgi" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term">1.02</span> years as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For RSUs with stock price appreciation targets, we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value of each grant was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the derived service period and there is no ongoing adjustment or reversal based on actual achievement during the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the unvested performance restricted stock units as of December 31, 2022. There were no performance restricted stock units prior to the year 2022.:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_zkINbSBKqUu" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B8_zwXeLsyWQq8d" style="display: none">Schedule of unvested performance restricted stock units</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Performance Restricted Stock Units</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unit Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Fair Value</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unvested at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zDE11xvJ9Jva" style="text-align: right" title="Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1472">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zKZRoUhHJu76" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1474">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Granted</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zjjfobWNsAN1" style="width: 15%; text-align: right" title="Granted">432,326</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zdvj9KiyMjQg" style="width: 15%; text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">2.95</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zkWWnFBCGNM6" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zsPrTpmITSOk" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_z1kM6cHXgNZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">432,326</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zf0XJ2zLcj35" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at ending">2.95</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zbISZKZCveBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, total unrecognized share-based compensation cost related to unvested restricted stock units was $<span id="xdx_905_ecustom--UnrecognizedCompensationCost_c20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_pn3n3" title="Unvested restricted stock awards">947</span> thousand, which is expected to be recognized over a weighted-average period of <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zs2Fhci8DHrg" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term">2.23</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Warrants</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the activities for the Company’s warrants for the year ended December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_pn3n3_zKOvl7eTM2ig" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BF_zw0Jc21rxhD7" style="display: none">Schedule of warrants outstanding</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Warrants Outstanding (Excluding Pre-Funded Warrants)</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Number of<br/> Warrant Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted-</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted -</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>in years)</b></p> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Intrinsic</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Value</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(in thousands)<sup>(1)</sup></b></p> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Balance at December 31, 2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_zsOx5IDUfV9k" style="width: 12%; text-align: right" title="Number of warrants outstanding, beginning balance">3,779,243</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zebpsyrhvjf5" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning balance">5.89</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">     </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231_zejjKL0xNTz" style="text-align: right" title="Number of warrants outstanding, granted"><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zLouub7GfzK8" style="text-align: right" title="Weighted average exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20210101__20211231_zyjEACD3Iald" style="text-align: right" title="Number of warrants outstanding, expired"><span style="-sec-ix-hidden: xdx2ixbrl1507">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zNUR82fw4gkj" style="text-align: right" title="Weighted average exercise price, expired"><span style="-sec-ix-hidden: xdx2ixbrl1509">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_z8fEf4OoxlE" style="text-align: right" title="Number of warrants outstanding, beginning balance">3,779,243</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_z9F5RQv8Nlv4" style="text-align: right" title="Weighted average exercise price, beginning balance">5.89</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231_zt53t7LYrUj7" style="text-align: right" title="Number of warrants outstanding, granted">1,590,150</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zlPodgUKNXX5" style="text-align: right" title="Weighted average exercise price, granted">3.22</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20220101__20221231_zQy5pQlFuy0a" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants outstanding, expired">(265,938</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zYBAWDxgfNgj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired">19.21</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_z0Ecpv1Qoiu2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, ending Balance">5,103,455</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zcgKjchnwK1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">4.34</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_ztoLgiT2hPFk" title="Weighted average remaining contractual terms">3.0</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_pid_c20221231_zJsccC3miwJk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, exercisable">5,103,455</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231_zpAHAMe2Q5e3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">4.34</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zBoRCk9FLOdf" title="Weighted average remaining contractual terms, exercisable">3.0</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--WarrantMember_fMQ_____zxClbTan3xcg" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercise price (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1535">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 19.95pt"/><td id="xdx_F00_zuqmt2tjx81f" style="width: 34.05pt">(1)</td><td id="xdx_F1A_zXbck02mNwma" style="text-align: justify">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022.</td></tr></table> <p id="xdx_8A4_znbqJpiMHjPd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2022, and 2021, the Company granted 34,942 warrants and 0 warrants to warrant holders pursuant to anti-dilution provisions, 1,555,208 warrants and 0 warrants in conjunction with the Securities Purchase Agreement, respectively (see Note 9 – Stockholders’ Equity). As the fair value of the warrants granted would have had a net zero impact to equity (increasing additional paid in capital and offering costs for the same amount), the Company did not break out or complete a separate valuation of the warrants granted in association with either capital raise. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline">Pre-funded Warrants </span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 14, 2022, in connection with our Securities Purchase Agreement (see Note 9 – Stockholders’ Equity), the Company issued 675,000 pre-funded warrants to purchase up to an aggregate of 675,000 shares of common stock at a purchase price of $3.214 per pre-funded warrant, which represented the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. In August 2022, 675,000 pre-funded warrants with an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220414__srt--TitleOfIndividualAxis__custom--DirectorAndOfficerMember__us-gaap--ClassOfWarrantOrRightAxis__custom--Debentures2022Member_pdd" title="Per share public offering price(in dollars per share)">0.001</span> per share were exercised, and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200101__20201231__srt--TitleOfIndividualAxis__custom--DirectorAndOfficerMember__us-gaap--ClassOfWarrantOrRightAxis__custom--Debentures2020Member_pdd" title="Stock Issued During Period, Shares, Issued for Services">675,000</span> shares of the Company’s common stock were issued. No pre-funded warrants are outstanding as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> 400000 260000 1069110 In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate, 1,000,000. 1000000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_pn3n3_zOGccp0ZsMK" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_zmwqFlhJoZ57" style="display: none">Schedule of stock options</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Options Outstanding</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Remaining</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Aggregate</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted-</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Contractual</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Intrinsic</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Term</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Value</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Exercise Price</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>(in years)</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>(in thousands)<sup>(1)</sup></b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 39%; text-align: left">Balance as of December 31, 2020</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zVWyxqZuYqBh" style="width: 12%; text-align: right" title="Balance at beginning">473,771</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLSHMocovVGk" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Balance at beginning">4.48</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zsvq5DNaR7Q7" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zI8mYKT3BgZh" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forfeited/Cancelled/Expired</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdLlgTuYIeVe" style="text-align: right" title="Forfeited/Cancelled/Expired">(8,300</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z7G6ZjWeszgf" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled/Expired">9.72</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance as of December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkvtMgnpKQH" style="text-align: right" title="Balance at ending">465,471</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zWgY6wDnV6wh" style="text-align: right" title="Weighted Average Exercise Price, Balance at ending">4.38</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt; padding-bottom: 2.5pt; text-align: left">Exercisable as of December 31, 2021</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zIuFdcmIeUjf" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable at ending">465,471</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zziH5gi2urV7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable at ending">4.38</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zcM0djRBDxBj" title="Weighted Average Remaining Contractual Term, Exercisable at ending">3.2</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_c20211231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fMQ_____zcotLgoXHKK" title="Vested and Exercisable at ending">47</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zZtXxT7pu3L" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1331">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_ztYe0KZWwdOf" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forfeited/Cancelled/Expired</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbNUNEQ8peJ1" style="text-align: right" title="Forfeited/Cancelled/Expired">(128,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zq0LBZfNr5Z9" style="text-align: right" title="Weighted Average Exercise Price, Forfeited/Cancelled/Expired">3.74</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance as of December 31, 2022</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zz6wvENxalfb" style="text-align: right" title="Balance at ending">337,471</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zD9nDV1Gpgm2" style="text-align: right" title="Weighted Average Exercise Price, Balance at ending">4.63</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt; padding-bottom: 2.5pt; text-align: left">Exercisable as of December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pid_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeCbBnBfd5N6" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable at ending">337,471</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzWvAHIxkFD" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable at ending">4.63</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zLzIXqboOP2d" title="Weighted Average Remaining Contractual Term, Exercisable at ending">2.4</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pn3n3_c20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fMQ_____z8tOBWtquXWg" style="border-bottom: Black 2.5pt double; text-align: right" title="Vested and Exercisable at ending"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td id="xdx_F09_zTyzuQgwkaFc" style="width: 27pt">(1)</td><td id="xdx_F12_zD3PYXCh0a9k" style="text-align: justify">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. </td></tr></table> 473771 4.48 8300 9.72 465471 4.38 465471 4.38 P3Y2M12D 47000 128000 3.74 337471 4.63 337471 4.63 P2Y4M24D <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_zfEtnfOa8KM4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B8_z4w6lhcdb4o7" style="display: none">Schedule of Unvested Options</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Options</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Options</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Exercise Price</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Balance at December 31, 2020</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zuunZLgAoBYk" style="width: 15%; text-align: right" title="Balance at beginning">10,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zp5moXmCRG0g" style="width: 15%; text-align: right" title="Balance at beginning">9.75</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zkAKM7JR4MHd" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1362">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zM48mB6xkS31" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1364">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Vested</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zPD3BADLl2gi" style="border-bottom: Black 1pt solid; text-align: right" title="Vested">(10,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zMN640TfBBCj" style="border-bottom: Black 1pt solid; text-align: right" title="Vested">9.75</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zmWf89usEhAi" style="text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1370">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zd9yMQgbpmgd" style="text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1372">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zT7PCYvWbKSe" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zF87m7Lyxbfc" style="text-align: right" title="Granted"><span style="-sec-ix-hidden: xdx2ixbrl1376">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zvGtCdj7QmU1" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1378">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zFbB4AzTlr97" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1380">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zPTyKx4dH7Od" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--NonvestedStockOptionsMember_zBXJOWaY8rE6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10000 9.75 10000 9.75 0 85000 0 0 <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_zY9GByrSVEr5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B9_zWItkevchMZe" style="display: none">Schedule of unvested restricted stock awards</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Restricted Stock Awards</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Award Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Fair Value</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Balance at December 31, 2020</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zDSbby02hNQ8" style="width: 15%; text-align: right" title="Balance at beginning">267,500</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zwegKuMUTag3" style="width: 15%; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning">3,80</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zHn3FfslSAsd" style="text-align: right" title="Granted">89,284</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zeMkg6NMSPkh" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">4,32</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Vested</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zLlip6rxMQ5l" style="border-bottom: Black 1pt solid; text-align: right" title="Vested">(312,142</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjsdVCDC9NUf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">3.87</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Balance at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z4vNZIHJwEP5" style="text-align: right" title="Balance at beginning">44,642</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z7HaDN9gVMg8" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning">4.31</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zy9bvUrX5uxb" style="text-align: right" title="Granted">39,308</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zY4Mt3LVumf" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">3.18</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zNHc4CJsoqOe" style="text-align: right" title="Vested">(42,142</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zVbia3DAau39" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">4.32</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zj5mRnnEZr22" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">41,808</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zpfUQzOFduF3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at ending">3.24</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 267500 3.80 89284 4.32 312142 3.87 44642 4.31 39308 3.18 42142 4.32 41808 3.24 2000 115000 P0Y7D <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_z16B3iJ6CC24" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BD_zg0SKN17taEk" style="display: none">Schedule of unvested restricted stock units</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Restricted Stock Units</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unit Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Fair Value</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unvested at December 31, 2020</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zpJdCEnuteQf" style="text-align: right" title="Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1436">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zxyDC4hfCmR4" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1438">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Granted</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zZTTcql4Avj4" style="width: 15%; text-align: right" title="Granted">208,010</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zYCpAB2a2pzb" style="width: 15%; text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">4.05</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z28oBGm4LgU2" style="text-align: right" title="Vested">(21,000</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zWse3NYhVNPf" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">3.44</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unvested at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGbM98kOfnQ6" style="text-align: right" title="Balance at ending">187,010</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zEWWwWxpp1Rd" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning">4.11</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Granted</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zGpdpJliLu1e" style="text-align: right" title="Granted">418,041</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zkpLB67gD4sd" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">2.14</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zXqmJatC8IK9" style="text-align: right" title="Vested">(191,425</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zoeaBOvGa8Ji" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested">4.07</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zHLOsl5O88Vb" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">413,626</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_zcdYG5Gy1Wfc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at ending">2.14</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 208010 4.05 21000 3.44 187010 4.11 418041 2.14 191425 4.07 413626 2.14 284000 146000 P1Y7D <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_zkINbSBKqUu" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B8_zwXeLsyWQq8d" style="display: none">Schedule of unvested performance restricted stock units</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unvested Performance Restricted Stock Units</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Weighted -</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Average</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Number of</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"><b>Grant</b></td><td style="white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Unit Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Date Fair Value</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Unvested at December 31, 2021</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zDE11xvJ9Jva" style="text-align: right" title="Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1472">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zKZRoUhHJu76" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at beginning"><span style="-sec-ix-hidden: xdx2ixbrl1474">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 63%; text-align: left">Granted</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zjjfobWNsAN1" style="width: 15%; text-align: right" title="Granted">432,326</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zdvj9KiyMjQg" style="width: 15%; text-align: right" title="Weighted - Average Grant Date Fair Value, Granted">2.95</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zkWWnFBCGNM6" style="text-align: right" title="Vested"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zsPrTpmITSOk" style="text-align: right" title="Weighted - Average Grant Date Fair Value, Vested"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Balance at December 31, 2022</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_z1kM6cHXgNZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">432,326</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--UnvestedPerformanceRestrictedStockUnitsMember_zf0XJ2zLcj35" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted - Average Grant Date Fair Value, Balance at ending">2.95</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 432326 2.95 432326 2.95 947000 P2Y2M23D <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_pn3n3_zKOvl7eTM2ig" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BF_zw0Jc21rxhD7" style="display: none">Schedule of warrants outstanding</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Warrants Outstanding (Excluding Pre-Funded Warrants)</b></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Number of<br/> Warrant Shares</b></td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted-</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price</b></p> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted -</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>in years)</b></p> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Aggregate</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Intrinsic</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Value</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(in thousands)<sup>(1)</sup></b></p> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Balance at December 31, 2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_zsOx5IDUfV9k" style="width: 12%; text-align: right" title="Number of warrants outstanding, beginning balance">3,779,243</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zebpsyrhvjf5" style="width: 12%; text-align: right" title="Weighted average exercise price, beginning balance">5.89</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">     </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231_zejjKL0xNTz" style="text-align: right" title="Number of warrants outstanding, granted"><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zLouub7GfzK8" style="text-align: right" title="Weighted average exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20210101__20211231_zyjEACD3Iald" style="text-align: right" title="Number of warrants outstanding, expired"><span style="-sec-ix-hidden: xdx2ixbrl1507">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zNUR82fw4gkj" style="text-align: right" title="Weighted average exercise price, expired"><span style="-sec-ix-hidden: xdx2ixbrl1509">-</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_z8fEf4OoxlE" style="text-align: right" title="Number of warrants outstanding, beginning balance">3,779,243</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_z9F5RQv8Nlv4" style="text-align: right" title="Weighted average exercise price, beginning balance">5.89</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20220101__20221231_zt53t7LYrUj7" style="text-align: right" title="Number of warrants outstanding, granted">1,590,150</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zlPodgUKNXX5" style="text-align: right" title="Weighted average exercise price, granted">3.22</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20220101__20221231_zQy5pQlFuy0a" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants outstanding, expired">(265,938</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zYBAWDxgfNgj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, expired">19.21</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_z0Ecpv1Qoiu2" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, ending Balance">5,103,455</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_zcgKjchnwK1d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">4.34</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_ztoLgiT2hPFk" title="Weighted average remaining contractual terms">3.0</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_pid_c20221231_zJsccC3miwJk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding, exercisable">5,103,455</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20221231_zpAHAMe2Q5e3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">4.34</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zBoRCk9FLOdf" title="Weighted average remaining contractual terms, exercisable">3.0</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--InvestmentTypeAxis__us-gaap--WarrantMember_fMQ_____zxClbTan3xcg" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercise price (in dollars per share)"><span style="-sec-ix-hidden: xdx2ixbrl1535">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 19.95pt"/><td id="xdx_F00_zuqmt2tjx81f" style="width: 34.05pt">(1)</td><td id="xdx_F1A_zXbck02mNwma" style="text-align: justify">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022.</td></tr></table> 3779243 5.89 3779243 5.89 1590150 3.22 265938 19.21 5103455 4.34 P3Y 5103455 4.34 P3Y 0.001 675000 <p id="xdx_803_eus-gaap--EarningsPerShareTextBlock_zrZNug0zbcFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11—<span id="xdx_820_zjwaDmgKePQ3">EARNINGS (LOSS) PER SHARE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic earnings/(loss) per share (EPS) is computed by dividing net income/(loss) by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution of common stock equivalent shares that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The dilutive common stock equivalent shares consist of preferred stock, stock options, warrants, restricted stock awards and restricted stock units computed under the treasury stock method, using the average market price during the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except share and per share data):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zs9jFqiazDn4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 30pt; width: 90%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BE_zLZLoRjNpNhi" style="display: none">Schedule of basic and diluted earnings/(loss) per share</span></td> <td> </td> <td> </td> <td id="xdx_49B_20220101__20221231_z96CsHRiytN8" style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td id="xdx_49D_20210101__20211231_zD15u18FPY9e" style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center">Years Ended December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center">2022</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center">2021</td> <td> </td></tr> <tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td> <td> </td> <td colspan="2" style="white-space: nowrap"> </td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap"> </td> <td> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt; width: 64%">Net Income/(Loss)</td> <td style="width: 1%"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 15%; text-align: right">(14,398)</td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 1%"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 15%; text-align: right">3,612</td> <td style="white-space: nowrap; width: 1%"> </td></tr> <tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: White"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average shares of common stock – basic</td> <td> </td> <td> </td> <td style="text-align: right">8,466,075</td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">7,110,907</td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Effect of dilutive securities</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_400_ecustom--AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Preferred Stock</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">144,444</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40A_ecustom--AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsShares1_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Stock Options</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1569">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">48,212</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Warrants</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1572">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">23</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Stock Purchase Plan</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1575">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">2,362</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40E_ecustom--RestrictedStockUnitsRestrictedStockAwards_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Restricted Stock Units &amp; Restricted Stock Awards</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1578">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">77,416</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White"> <td>Weighted average shares of common <br/> stock – diluted</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">8,466,075</td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">7,383,364</td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareBasicAbstract_iB_zfbafwTxThPh" style="vertical-align: bottom; background-color: White"> <td>(Loss)/Earnings per share</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Basic</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1.70)</td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.51</td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Diluted</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1.70)</td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.49</td> <td style="white-space: nowrap"> </td></tr> </table> <p id="xdx_8AA_zdiikvHENmc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table represents the weighted average number of anti-dilutive instruments excluded from the computation of diluted (loss)/earnings per share:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_z57uycTyU3bc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 30pt; width: 90%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BC_zfjfDG6H6St5" style="display: none">Schedule of anti-dilutiv e earnings per share</span></td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Years Ended <br/> December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Anti-dilutive instruments excluded from computation of diluted net income/(loss) per share:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 3pt">Preferred Stock</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="width: 15%; text-align: right" title="Anti-dilutive shares">144,444</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="width: 15%; text-align: right" title="Anti-dilutive shares"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 3pt">Stock Options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_pdd" style="text-align: right" title="Anti-dilutive shares">337,471</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_pdd" style="text-align: right" title="Anti-dilutive shares">177,334</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Anti-dilutive shares">5,103,455</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Anti-dilutive shares">3,779,048</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock purchase plan</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockPurchasePlanMember_pdd" style="text-align: right" title="Anti-dilutive shares">57,245</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockPurchasePlanMember_pdd" style="text-align: right" title="Anti-dilutive shares"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 3pt">Restricted Stock Units and Restricted Stock Awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsAndRestrictedStockAwardsMember_pdd" style="text-align: right" title="Anti-dilutive shares">887,760</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsAndRestrictedStockAwardsMember_pdd" style="text-align: right" title="Anti-dilutive shares">13,196</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zZce915Mh8V9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zs9jFqiazDn4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 30pt; width: 90%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8BE_zLZLoRjNpNhi" style="display: none">Schedule of basic and diluted earnings/(loss) per share</span></td> <td> </td> <td> </td> <td id="xdx_49B_20220101__20221231_z96CsHRiytN8" style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td id="xdx_49D_20210101__20211231_zD15u18FPY9e" style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center">Years Ended December 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center">2022</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center">2021</td> <td> </td></tr> <tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td> <td> </td> <td colspan="2" style="white-space: nowrap"> </td> <td> </td> <td> </td> <td colspan="2" style="white-space: nowrap"> </td> <td> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt; width: 64%">Net Income/(Loss)</td> <td style="width: 1%"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 15%; text-align: right">(14,398)</td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 1%"> </td> <td style="border-bottom: black 2.25pt double; width: 1%">$</td> <td style="border-bottom: black 2.25pt double; width: 15%; text-align: right">3,612</td> <td style="white-space: nowrap; width: 1%"> </td></tr> <tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: White"> <td>Denominator:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average shares of common stock – basic</td> <td> </td> <td> </td> <td style="text-align: right">8,466,075</td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">7,110,907</td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_406_eus-gaap--DilutiveSecuritiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Effect of dilutive securities</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_400_ecustom--AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Preferred Stock</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">144,444</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40A_ecustom--AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsShares1_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Stock Options</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1569">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">48,212</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Warrants</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1572">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">23</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Stock Purchase Plan</td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1575">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right">2,362</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40E_ecustom--RestrictedStockUnitsRestrictedStockAwards_i01_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Restricted Stock Units &amp; Restricted Stock Awards</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1578">-</span></td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">77,416</td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White"> <td>Weighted average shares of common <br/> stock – diluted</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">8,466,075</td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">7,383,364</td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareBasicAbstract_iB_zfbafwTxThPh" style="vertical-align: bottom; background-color: White"> <td>(Loss)/Earnings per share</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Basic</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1.70)</td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.51</td> <td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td style="white-space: nowrap"> </td></tr> <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 3pt">Diluted</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(1.70)</td> <td style="white-space: nowrap"> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.49</td> <td style="white-space: nowrap"> </td></tr> </table> -14398000 3612000 8466075 7110907 144444 48212 23 2362 77416 8466075 7383364 -1.70 0.51 -1.70 0.49 <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_z57uycTyU3bc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 30pt; width: 90%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BC_zfjfDG6H6St5" style="display: none">Schedule of anti-dilutiv e earnings per share</span></td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Years Ended <br/> December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: right"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Anti-dilutive instruments excluded from computation of diluted net income/(loss) per share:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 3pt">Preferred Stock</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="width: 15%; text-align: right" title="Anti-dilutive shares">144,444</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="width: 15%; text-align: right" title="Anti-dilutive shares"><span style="-sec-ix-hidden: xdx2ixbrl1602">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 3pt">Stock Options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_pdd" style="text-align: right" title="Anti-dilutive shares">337,471</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_pdd" style="text-align: right" title="Anti-dilutive shares">177,334</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 3pt">Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Anti-dilutive shares">5,103,455</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Anti-dilutive shares">3,779,048</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock purchase plan</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockPurchasePlanMember_pdd" style="text-align: right" title="Anti-dilutive shares">57,245</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockPurchasePlanMember_pdd" style="text-align: right" title="Anti-dilutive shares"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 3pt">Restricted Stock Units and Restricted Stock Awards</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsAndRestrictedStockAwardsMember_pdd" style="text-align: right" title="Anti-dilutive shares">887,760</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsAndRestrictedStockAwardsMember_pdd" style="text-align: right" title="Anti-dilutive shares">13,196</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 144444 337471 177334 5103455 3779048 57245 887760 13196 <p id="xdx_80F_ecustom--LongTermDerivativeLiabilityTextBlock_zF6FysvoWV3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12—<span id="xdx_823_zGC6lYMif91l">LONG TERM DERIVATIVE LIABILITY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 7, 2022, the Company granted two directors 11,250 restricted stock units each (“SPAC RSUs”) with respect to the common stock, $0.0001 par value per share, of G3 VRM Acquisition Corp. The SPAC RSUs were to vest upon the initial business combination of the SPAC (see Note 2 – Equity Investments) subject to continuous service to the Company through the vesting date. Each vested SPAC RSU represented the right to receive the value of one share of stock in G3 VRM Acquisition Corp., which would have been paid to the director as soon as practicable after the fifteen-month anniversary of the vesting date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 17, 2021, the Company granted two directors SPAC RSUs with respect to the common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20220407__srt--TitleOfIndividualAxis__custom--G3VRMMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span> par value per share, of G3 VRM Acquisition Corp. The SPAC RSUs were to vest upon the initial business combination of the SPAC (see Note 2 – Equity Investments) subject to continuous service to the Company through the vesting date. Each vested SPAC RSU represented the right to receive the value of one share of stock in G3 VRM Acquisition Corp., which was to be paid to the director as soon as practicable after the fifteen-month anniversary of the vesting date. The grant date fair value of the SPAC RSUs for each director was $<span id="xdx_907_ecustom--GrantFairValue_c20210916__20210917__srt--TitleOfIndividualAxis__srt--DirectorMember_pn3n3" title="Grant fair value">98</span> thousand. As the underlying awards were not the Company’s stock but an unrelated, publicly traded entity’s shares, the Company accounted for the awards under ASC 815 – Derivatives and Hedging, with the expense included in stock-based compensation under General and Administrative expenses in the accompanying Consolidated Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2022, the Sponsor Entity decided not to fund the extension for the time that the SPAC had to complete its initial business combination. As a result, the SPAC was dissolved and liquidated in accordance with its charter and under ASC 815, and the derivative instrument was terminated. As a result, the SPAC RSUs were forfeited. For the year ended December 31, 2022, the Company has recorded the effect of termination to reduce the fair value and recorded a credit to share-based compensation expense of $71 thousand in relation to these awards. The fair value of the derivative liability was $<span id="xdx_904_eus-gaap--DerivativeFairValueOfDerivativeLiability_c20221231_pn3n3" title="Fair value of the derivative liability">0</span> as of December 31, 2022, and $<span id="xdx_905_eus-gaap--DerivativeFairValueOfDerivativeLiability_c20211231_pn3n3" title="Fair value of the derivative liability">71</span> thousand as of December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective October 17, 2022, the Company entered into an interest rate swap agreement (see Note 7 – Debt for details). <span id="xdx_901_eus-gaap--LongTermDebtDescription_c20220101__20221231" title="Long term debt description">The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and $0 as of December 31, 2021.</span></p> 0.0001 98000 0 71000 The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and $0 as of December 31, 2021. <p id="xdx_80B_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zL71wCd44ere" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 13 –<span id="xdx_829_zK4V9nunOtc3">EMPLOYEE BENEFIT PLAN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We offer the VRME Retirement Savings Plan (the “Plan”) to our employees. Eligible employees can elect to participate in the Plan, as soon as administratively feasible after enrollment. The Plan permits pre-tax contributions to the Plan by participants pursuant to Section 401(k) of the Internal Revenue Code (IRC). We make matching contributions at our discretion. In 2022 and 2021 we contributed a value of approximately $<span id="xdx_905_eus-gaap--DefinedBenefitPlanContributionsByEmployer_pn3n3_c20220101__20221231_z3AUKYtIiEH5" title="Contributions">103</span> thousand and $<span id="xdx_908_eus-gaap--DefinedBenefitPlanContributionsByEmployer_pn3n3_c20210101__20211231_zjnrYIkDAwnj" title="Contributions">10</span> thousand respectively and is recognized as compensation expense in the consolidated statements of operations for matching contributions to the Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 103000 10000 <p id="xdx_804_eus-gaap--OperatingLeasesOfLessorDisclosureTextBlock_zB06rBW0MYxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 14 –<span id="xdx_82F_zBqyWAzpbhQ1">LEASES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for its leases under Accounting Standard Codification (“ASC”) Topic 842, Leases. The Company determines at its inception whether an arrangement that provides us control over the use of an asset is a lease. We recognize at lease commencement a right-of-use (ROU) asset and lease liability based on the present value of the future lease payments over the lease term. We have elected not to recognize a ROU asset and lease liability for leases with terms of 12 months or less. Our current long-term lease includes an option to extend the term of the lease prior to the end of the initial term. It is not reasonably certain that we will exercise the option and have not included the impact of the option in the lease term for purposes of determining total future lease payments. As our lease agreement does not explicitly state the discount rate implicit in the lease, we use our promissory note borrowing rate to calculate the present value of future payments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. For our real estate leases, we apply a practical expedient to include these non-lease components in calculating the ROU asset and lease liability. For all other types of leases, non-lease components are excluded from our ROU assets and lease liabilities and expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have operating leases for office facilities. We do not have any finance leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lease expense is included in General &amp; Administrative Expenses on the accompanying Consolidated Statements of Operations. The components of lease expense were as follows (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--LeaseCostTableTextBlock_pn3n3_zY95BjnY5i1l" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BF_zWxNgLfDIBm4" style="display: none">Schedule of components of lease expense</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20220101__20221231_z5JPNrcptSGf" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20210101__20211231_zdSIfYNYYbfd" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseCost_maLCzU8X_zuBI1zNjpJS" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Operating lease cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">85</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ShortTermLeaseCost_maLCzU8X_zUyC7RKDc7v1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Short-term lease cost</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">14</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LeaseCost_iT_pn3n3_mtLCzU8X_zOzLgp86iw2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease costs</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">103</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zKwrqEMliRhi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental information related to leases was as follows (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfSupplementalInformationRelatedToLeasesTableTextBlock_pn3n3_zEfyb7J5aSz2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - LEASES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B4_zjAn525hDYzi" style="display: none">Schedule of supplemental information related to leases</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20221231_zGg3xNkNGufc" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20211231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right">December 31, 2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right">December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Operating Lease right-of-use asset</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">469</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z2LrQgr9ulxg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion of operating lease liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">115</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1662">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zMWnNvQ6KiBd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Non-current portion of operating lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">359</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1665">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--TotalOperatingLeaseLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">474</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Cash paid for amounts included in the measurement of operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">80</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1671">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use assets obtained in exchange for operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">552</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term for operating leases (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zgDih1ibRfk8" title="Weighted-average remaining lease term for operating leases (years)">4.3</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted average discount rate for operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231_zaXia6WNuGbl" title="Weighted average discount rate for operating leases">6.0</span></td><td style="white-space: nowrap; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zgER9UmSFxx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities on our consolidated balance sheets as of December 31, 2022 (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zsGGA2caYykh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - LEASES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_z8P8pSgCcAy7" style="display: none">Schedule of operating lease liabilities maturities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zpw7TPARbgYc" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap">Year ended December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maLOLLPzBUi_zGP2kyUVjhm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: right">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">122</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maLOLLPzBUi_zMApIttsVJol" style="vertical-align: bottom; background-color: White"> <td style="text-align: right">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">126</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maLOLLPzBUi_z0JQbh0rONA5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maLOLLPzBUi_z2k6hJEv720i" style="vertical-align: bottom; background-color: White"> <td style="text-align: right">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_maLOLLPzBUi_zG83G83sbDgc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzBUi_zxveNujM5wc4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total future lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">557</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zujrNmUg6jBb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(83</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Present value of future lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">474</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zSOPiOrqFl23" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion of lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(115</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">359</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zUtp7A0lB4w5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--LeaseCostTableTextBlock_pn3n3_zY95BjnY5i1l" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - LEASES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BF_zWxNgLfDIBm4" style="display: none">Schedule of components of lease expense</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20220101__20221231_z5JPNrcptSGf" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_490_20210101__20211231_zdSIfYNYYbfd" style="text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Years ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseCost_maLCzU8X_zuBI1zNjpJS" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Operating lease cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">85</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ShortTermLeaseCost_maLCzU8X_zUyC7RKDc7v1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Short-term lease cost</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">14</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LeaseCost_iT_pn3n3_mtLCzU8X_zOzLgp86iw2l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease costs</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">103</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 85000 18000 14000 103000 14000 <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfSupplementalInformationRelatedToLeasesTableTextBlock_pn3n3_zEfyb7J5aSz2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - LEASES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B4_zjAn525hDYzi" style="display: none">Schedule of supplemental information related to leases</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20221231_zGg3xNkNGufc" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20211231" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right">December 31, 2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right">December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Operating Lease right-of-use asset</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">469</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3_z2LrQgr9ulxg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current portion of operating lease liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">115</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1662">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3_zMWnNvQ6KiBd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Non-current portion of operating lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">359</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1665">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--TotalOperatingLeaseLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">474</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1668">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Cash paid for amounts included in the measurement of operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">80</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1671">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use assets obtained in exchange for operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">552</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average remaining lease term for operating leases (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zgDih1ibRfk8" title="Weighted-average remaining lease term for operating leases (years)">4.3</span></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted average discount rate for operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231_zaXia6WNuGbl" title="Weighted average discount rate for operating leases">6.0</span></td><td style="white-space: nowrap; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> 469000 115000 359000 474000 80000 552000 P4Y3M18D 0.060 <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zsGGA2caYykh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - LEASES (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_z8P8pSgCcAy7" style="display: none">Schedule of operating lease liabilities maturities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zpw7TPARbgYc" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap">Year ended December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maLOLLPzBUi_zGP2kyUVjhm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: right">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 21%; text-align: right">122</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maLOLLPzBUi_zMApIttsVJol" style="vertical-align: bottom; background-color: White"> <td style="text-align: right">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">126</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maLOLLPzBUi_z0JQbh0rONA5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: right">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maLOLLPzBUi_z2k6hJEv720i" style="vertical-align: bottom; background-color: White"> <td style="text-align: right">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_maLOLLPzBUi_zG83G83sbDgc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtLOLLPzBUi_zxveNujM5wc4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total future lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">557</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pn3n3_di_zujrNmUg6jBb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: imputed interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(83</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiability_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Present value of future lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">474</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zSOPiOrqFl23" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion of lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(115</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">359</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 122000 126000 130000 134000 45000 557000 83000 474000 115000 359000 <p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zzhpK0hxHf57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 15 – <span id="xdx_824_zAcXnhc2Mqd">CONCENTRATIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, one customer represented <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_pdd" title="Concentration risk, percentage">13% </span>of revenues and five customers represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FiveCustomerMember_pdd" title="Concentration risk, percentage">95%</span> of revenues for the year ended December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, two customers made up <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomerMember_zd07itIz69Jc" title="Concentration risk, percentage">23%</span> of accounts receivable. As of December 31, 2021, three customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomerMember_zBKKVrGqG2" title="Concentration risk, percentage">91%</span> of total accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year ended December 31, 2022, one vendor accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--TransportationCostMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zhrt6UPhgEB5" title="Concentration risk, percentage">99%</span> of transportation costs, in our PeriShip Global Solutions segment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 0.13 0.95 0.23 0.91 0.99 <p id="xdx_802_eus-gaap--SegmentReportingDisclosureTextBlock_zs3WVxTgJz7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 16 – <span id="xdx_822_zqN801KBvaBg">SEGMENT REPORTING</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2022, we operated through two reportable business segments: (i) PeriShip Global Solutions and (ii) VerifyMe Solutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PeriShip Global Solutions: </b>This segment offers a value-added service provider for time and temperature sensitive parcel management. Through logistics management from a sophisticated IT platform with proprietary databases, package and flight-tracking software, weather, traffic, and flight status monitoring systems, as well as dynamic dashboards with real-time visibility into shipment transit and last-mile events that are managed by a call center Using our proprietary IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>VerifyMe Solutions</b>. This segment specializes in solutions that connect brands with consumers through their products. Consumers can authenticate products with their smart phone prior to usage, and brand owners have the ability to gather business intelligence while engaging directly with their consumers. Our VerifyMe Solutions also provide brand protection and supply chain functions such as counterfeit prevention.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not allocate the following items to the segments: general and administrative expenses, research and development expense, sales and marketing expenses, and other income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the revenue and operating results attributable to each reportable segment and includes a reconciliation of segment revenue to consolidated revenue and operating results to consolidated loss before income tax expense (in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_z5wljZSNeyHj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zUvmSH2oUKak" style="display: none">Schedule of segment reporting information</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Years Ended<br/> December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Revenue</td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">PeriShip Global Solutions</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zqGx7pajYTR6" style="width: 18%; text-align: right" title="Revenues">18,190</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_z6H6sp31rHbk" style="width: 18%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl1729">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">VerifyMe Solutions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zi9TTKpSeFra" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zIn1uSGLMQhe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20221231_z61mqE8l5E1h" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">19,576</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20210101__20211231_zmf6saClO0u1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross Profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PeriShip Global Solutions</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right" title="Gross Profit">5,505</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--GrossProfit_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right" title="Gross Profit"><span style="-sec-ix-hidden: xdx2ixbrl1741">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">VerifyMe Solutions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Profit">983</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--GrossProfit_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Profit">599</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Gross Profit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--GrossProfit_c20220101__20221231_pn3n3" style="text-align: right" title="Gross Profit">6,488</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--GrossProfit_c20210101__20211231_pn3n3" style="text-align: right" title="Gross Profit">599</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231_zzfh8QSjq5R5" style="text-align: right" title="General and administrative">8,428</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20210101__20211231_zerqPvPPIv55" style="text-align: right" title="General and administrative">4,216</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20220101__20221231_zRuJ5rlO797" style="text-align: right" title="Research and development">89</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_pn3n3" style="text-align: right" title="Research and development">51</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Sales and marketing</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231_znzFaCMWLF99" style="border-bottom: Black 1pt solid; text-align: right" title="Sales and marketing">1,718</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zt2Ig2Jivoo2" style="border-bottom: Black 1pt solid; text-align: right" title="Sales and marketing">1,163</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">LOSS BEFORE OTHER (EXPENSE) INCOME</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="LOSS BEFORE OTHER INCOME (EXPENSE)">(3,747</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20210101__20211231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="LOSS BEFORE OTHER INCOME (EXPENSE)">(4,831</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">OTHER (EXPENSE) INCOME</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--NonoperatingIncomeExpense_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="OTHER INCOME (EXPENSE)">(10,651</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--NonoperatingIncomeExpense_c20210101__20211231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="OTHER INCOME (EXPENSE)">8,443</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="NET (LOSS) INCOME">(14,398</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="NET (LOSS) INCOME">3,612</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional information relating to our business segments is as follows (in thousands):</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Identifiable assets:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Years Ended<br/> December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">PeriShip Global Solutions</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_c20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="width: 18%; text-align: right" title="Total Assets">17,302</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_iI_pn3n3_c20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zjg9YrX93Id9" style="width: 18%; text-align: right" title="Total Assets"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">VerifyMe Solutions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_c20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">3,450</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zQpZDT9QrXjc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">21,688</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Assets">20,752</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_pn3n3_c20211231_zEUs7nSZX6Nl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Assets">21,688</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zbgiuGDvn3q1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_z5wljZSNeyHj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - SEGMENT REPORTING (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zUvmSH2oUKak" style="display: none">Schedule of segment reporting information</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Years Ended<br/> December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Revenue</td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">PeriShip Global Solutions</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zqGx7pajYTR6" style="width: 18%; text-align: right" title="Revenues">18,190</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_z6H6sp31rHbk" style="width: 18%; text-align: right" title="Revenues"><span style="-sec-ix-hidden: xdx2ixbrl1729">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">VerifyMe Solutions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zi9TTKpSeFra" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,386</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zIn1uSGLMQhe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20221231_z61mqE8l5E1h" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">19,576</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20210101__20211231_zmf6saClO0u1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">867</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross Profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">PeriShip Global Solutions</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right" title="Gross Profit">5,505</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--GrossProfit_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="text-align: right" title="Gross Profit"><span style="-sec-ix-hidden: xdx2ixbrl1741">-</span></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">VerifyMe Solutions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Profit">983</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--GrossProfit_c20210101__20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Profit">599</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Gross Profit</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--GrossProfit_c20220101__20221231_pn3n3" style="text-align: right" title="Gross Profit">6,488</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--GrossProfit_c20210101__20211231_pn3n3" style="text-align: right" title="Gross Profit">599</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20220101__20221231_zzfh8QSjq5R5" style="text-align: right" title="General and administrative">8,428</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--GeneralAndAdministrativeExpense_pn3n3_c20210101__20211231_zerqPvPPIv55" style="text-align: right" title="General and administrative">4,216</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Research and development</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ResearchAndDevelopmentExpense_pn3n3_c20220101__20221231_zRuJ5rlO797" style="text-align: right" title="Research and development">89</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ResearchAndDevelopmentExpense_c20210101__20211231_pn3n3" style="text-align: right" title="Research and development">51</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Sales and marketing</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--SellingAndMarketingExpense_pn3n3_c20220101__20221231_znzFaCMWLF99" style="border-bottom: Black 1pt solid; text-align: right" title="Sales and marketing">1,718</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--SellingAndMarketingExpense_pn3n3_c20210101__20211231_zt2Ig2Jivoo2" style="border-bottom: Black 1pt solid; text-align: right" title="Sales and marketing">1,163</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">LOSS BEFORE OTHER (EXPENSE) INCOME</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="LOSS BEFORE OTHER INCOME (EXPENSE)">(3,747</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20210101__20211231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="LOSS BEFORE OTHER INCOME (EXPENSE)">(4,831</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">OTHER (EXPENSE) INCOME</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--NonoperatingIncomeExpense_c20220101__20221231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="OTHER INCOME (EXPENSE)">(10,651</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--NonoperatingIncomeExpense_c20210101__20211231_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="OTHER INCOME (EXPENSE)">8,443</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="NET (LOSS) INCOME">(14,398</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20211231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="NET (LOSS) INCOME">3,612</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional information relating to our business segments is as follows (in thousands):</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Identifiable assets:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Years Ended<br/> December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">PeriShip Global Solutions</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_c20221231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_pn3n3" style="width: 18%; text-align: right" title="Total Assets">17,302</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_iI_pn3n3_c20211231__srt--ConsolidatedEntitiesAxis__srt--SubsidiariesMember_zjg9YrX93Id9" style="width: 18%; text-align: right" title="Total Assets"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">VerifyMe Solutions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_c20221231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">3,450</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20211231__srt--ConsolidatedEntitiesAxis__srt--ParentCompanyMember_zQpZDT9QrXjc" style="border-bottom: Black 1pt solid; text-align: right" title="Total Assets">21,688</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_c20221231_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Assets">20,752</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--Assets_iI_pn3n3_c20211231_zEUs7nSZX6Nl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Assets">21,688</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 18190000 1386000 867000 19576000 867000 5505000 983000 599000 6488000 599000 8428000 4216000 89000 51000 1718000 1163000 -3747000 -4831000 -10651000 8443000 -14398000 3612000 17302000 3450000 21688000 20752000 21688000 <p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_z2xWb2NAwDm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 17 – <span id="xdx_82F_zG6RyDbQvjGa">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 1, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) <span style="background-color: white">effective as of February 28, 2023 (the “Effective Date”) by and among the Company, Trust Codes Global, Trust Codes Limited, a New Zealand limited liability company </span>that specializes in unique item level codes for brand protection, data intelligence and consumer engagement technology with an expertise in the food and agriculture industry <span style="background-color: white">(“Trust Codes” or “Seller”) and Signum Holdings Limited (“Seller’s Parent”). Pursuant to the terms of the APA Trust Codes Global agreed to purchase from Trust Codes and Trust Codes agreed to sell to Trust Codes Global substantially all of the assets of Trust Codes and certain specified liabilities (the “Transaction”). The Transaction closed simultaneously with the execution of the APA on </span>March 1<span style="background-color: white">, 2023 (the “Closing”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">The total consideration paid to the Seller at Closing in connection with the Transaction was approximately $<span id="xdx_909_ecustom--TotalConsiderationPaid_pn3p0_c20230227__20230301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2oPCkKrzqZa" title="Total consideration paid">1,000,000</span>, which consisted of approximately $<span id="xdx_90D_ecustom--CashConsideration_pn3p0_c20230227__20230301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zkzsiXLGqUmd" title="Cash Consideration">350,000</span> in cash (the “Cash Consideration”); and the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c20230227__20230301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pdd" title="Restricted common stock issued">353,492</span> shares of restricted common stock of the Company at $<span id="xdx_902_eus-gaap--SharePrice_c20230301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pdd" title="Share price">1.84</span> per share (the “Stock Consideration”) (representing $<span id="xdx_901_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn3p0_c20230227__20230301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCiVU0Il4Ic5" title="Stock consideration">650,000</span> in Stock Consideration). The total consideration due under the Transaction is subject to certain post-Closing adjustments, which shall be accounted for in the first cash earnout payment, discussed below, if applicable.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="background-color: white">Under the APA, during the five-year period ending on the fifth anniversary of the Effective Date, Trust Codes Global shall pay the Seller quarterly cash earnout payments equal to 18% of the gross margin earned on existing customers and the Company shall issue to the Seller annual equity earnout payments of restricted shares of the Company’s common stock equal to 20% of gross margin earned on new customers during the applicable 12 month period divided by the VWAP for the 30-day period </span>ending on the last day of the 12-month period, inclusive. If the value of equity earnout shares issued exceeds $3.1 million at any time during the earnout period, then any subsequent amount of equity earnout shall be reduced to 10% of gross margin earned on new customers received during the applicable 12-month period. In certain circumstance Trust Codes Global may pay cash in lieu of the Company issuing restricted common stock for the equity earnout. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The APA is structured to comply with the shareholder approval requirements of the Nasdaq listing rules and contains a blocker provision which prevents the Seller from receiving any equity earnout shares should such earnout shares, in connection with the Stock Consideration, cause the Seller to beneficially own more than 19.99% of the voting securities of the Company. <span style="background-color: white">The APA contains customary confidentiality and indemnification provisions and customary representations, warranties and covenants by the parties for transactions of this type and also contains a five-year non-compete and non-solicitation provision applicable to the Seller, Seller’s Parent, and each of their affiliates, in favor of the Company and Trust Codes Global.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2023, fourteen participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result, <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20230201__20230228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--NonqualifiedStockPurchasePlanMember_pdd" title="Stock option exercised">57,245</span> shares were issued with an exercise price of $<span id="xdx_90D_eus-gaap--StockOptionExercisePriceIncrease_c20230201__20230228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--NonqualifiedStockPurchasePlanMember_pdd" title="Exercise Price">1.19</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; background-color: white"> Effective March 15, 2023, the Company’s Chief Executive Officer, Patrick White, resigned as an officer and director of the Company. Scott Greenberg, the Company’s executive chairman of the Board, was appointed as Interim Chief Executive Officer. In connection with his resignation, Mr. White will receive payments totaling $159 thousand. In addition the Company awarded him <span id="xdx_909_ecustom--RestrictedStockAwarded_c20230302__20230315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--N2020PlanMember__srt--CounterpartyNameAxis__custom--FormerChiefExecutiveOfficerMember_pdd" title="Restricted stock awarded">111,364</span> restricted stock units, with a grant date value <span style="background-color: white">equal to 70% of his annual base salary, each such unit representing the contingent right to receive one share of the Company’s common stock, par value $0.001 per share, subject to the terms of the Company’s 2020 Plan. These restricted stock units, except as otherwise provided in the award agreement, </span>vest within three years in equal tranches provided the Company’s stock price exceeds $2.75 and $3.75 per share for twenty consecutive trading days. In connection with the grant of the restricted stock units Mr. White forfeited his outstanding award of restricted stock units granted pursuant to a Restricted Stock Unit Award Agreement dated February 26, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="background-color: white">In connection with his appointment as Interim Chief Executive Officer, </span> Mr. Greenberg was awarded <span id="xdx_90A_ecustom--RestrictedStockAwarded_c20230302__20230315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--N2020PlanMember__srt--CounterpartyNameAxis__custom--GreenbergMember_pdd" title="Restricted stock awarded">56,819</span> restricted stock units, with a grant date value equal to $<span id="xdx_90B_ecustom--GrantDateValue_pn3p0_c20230302__20230315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--N2020PlanMember__srt--CounterpartyNameAxis__custom--GreenbergMember_z1NPURmgenCh" title="Grant date value">100,000</span>, each such unit representing the contingent right to receive one share of the Common Stock, subject to the terms of the 2020 Plan. These restricted stock units, except as otherwise provided in the award agreement, vest within three years in equal tranches provided the Company’s stock price exceeds $2.75 and $3.75 per share for twenty consecutive trading days.</span></p> 1000000 350000 353492 1.84 650000 57245 1.19 111364 56819 100000 Includes share-based compensation of $1,468 thousand for the year ended December 31, 2022, and $1,716 thousand for the year ended December 31, 2021. Stock issued was calculated based on the 15 days prior to April 22, 2022, volume-weighted average price (“VWAP”) calculated at $3.2736. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period.  The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.16 for our common stock on December 31, 2022. EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 84 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 189 396 1 true 82 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://verifyme.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://verifyme.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://verifyme.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://verifyme.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Comprehensive Income/(Loss) Sheet http://verifyme.com/role/StatementsOfComprehensiveIncomeloss Consolidated Statements of Comprehensive Income/(Loss) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://verifyme.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://verifyme.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://verifyme.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - EQUITY INVESTMENTS Sheet http://verifyme.com/role/EquityInvestments EQUITY INVESTMENTS Notes 9 false false R10.htm 00000010 - Disclosure - REVENUE Sheet http://verifyme.com/role/Revenue REVENUE Notes 10 false false R11.htm 00000011 - Disclosure - BUSINESS COMBINATION Sheet http://verifyme.com/role/BusinessCombination BUSINESS COMBINATION Notes 11 false false R12.htm 00000012 - Disclosure - INTANGIBLE ASSETS AND GOODWILL Sheet http://verifyme.com/role/IntangibleAssetsAndGoodwill INTANGIBLE ASSETS AND GOODWILL Notes 12 false false R13.htm 00000013 - Disclosure - INCOME TAXES Sheet http://verifyme.com/role/IncomeTaxes INCOME TAXES Notes 13 false false R14.htm 00000014 - Disclosure - DEBT Sheet http://verifyme.com/role/Debt DEBT Notes 14 false false R15.htm 00000015 - Disclosure - CONVERTIBLE PREFERRED STOCK Sheet http://verifyme.com/role/ConvertiblePreferredStock CONVERTIBLE PREFERRED STOCK Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://verifyme.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrants STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS Notes 17 false false R18.htm 00000018 - Disclosure - EARNINGS (LOSS) PER SHARE Sheet http://verifyme.com/role/EarningsLossPerShare EARNINGS (LOSS) PER SHARE Notes 18 false false R19.htm 00000019 - Disclosure - LONG TERM DERIVATIVE LIABILITY Sheet http://verifyme.com/role/LongTermDerivativeLiability LONG TERM DERIVATIVE LIABILITY Notes 19 false false R20.htm 00000020 - Disclosure - EMPLOYEE BENEFIT PLAN Sheet http://verifyme.com/role/EmployeeBenefitPlan EMPLOYEE BENEFIT PLAN Notes 20 false false R21.htm 00000021 - Disclosure - LEASES Sheet http://verifyme.com/role/Leases LEASES Notes 21 false false R22.htm 00000022 - Disclosure - CONCENTRATIONS Sheet http://verifyme.com/role/Concentrations CONCENTRATIONS Notes 22 false false R23.htm 00000023 - Disclosure - SEGMENT REPORTING Sheet http://verifyme.com/role/SegmentReporting SEGMENT REPORTING Notes 23 false false R24.htm 00000024 - Disclosure - SUBSEQUENT EVENTS Sheet http://verifyme.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://verifyme.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 00000027 - Disclosure - REVENUE (Tables) Sheet http://verifyme.com/role/RevenueTables REVENUE (Tables) Tables http://verifyme.com/role/Revenue 27 false false R28.htm 00000028 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://verifyme.com/role/BusinessCombinationTables BUSINESS COMBINATION (Tables) Tables http://verifyme.com/role/BusinessCombination 28 false false R29.htm 00000029 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) Sheet http://verifyme.com/role/IntangibleAssetsAndGoodwillTables INTANGIBLE ASSETS AND GOODWILL (Tables) Tables http://verifyme.com/role/IntangibleAssetsAndGoodwill 29 false false R30.htm 00000030 - Disclosure - INCOME TAXES (Tables) Sheet http://verifyme.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://verifyme.com/role/IncomeTaxes 30 false false R31.htm 00000031 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables) Tables http://verifyme.com/role/StockOptionsRestrictedStockAndWarrants 31 false false R32.htm 00000032 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) Sheet http://verifyme.com/role/EarningsLossPerShareTables EARNINGS (LOSS) PER SHARE (Tables) Tables http://verifyme.com/role/EarningsLossPerShare 32 false false R33.htm 00000033 - Disclosure - LEASES (Tables) Sheet http://verifyme.com/role/LeasesTables LEASES (Tables) Tables http://verifyme.com/role/Leases 33 false false R34.htm 00000034 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://verifyme.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://verifyme.com/role/SegmentReporting 34 false false R35.htm 00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 00000037 - Disclosure - EQUITY INVESTMENTS (Details Narrative) Sheet http://verifyme.com/role/EquityInvestmentsDetailsNarrative EQUITY INVESTMENTS (Details Narrative) Details http://verifyme.com/role/EquityInvestments 37 false false R38.htm 00000038 - Disclosure - REVENUE (Details) Sheet http://verifyme.com/role/RevenueDetails REVENUE (Details) Details http://verifyme.com/role/RevenueTables 38 false false R39.htm 00000039 - Disclosure - BUSINESS COMBINATION (Details) Sheet http://verifyme.com/role/BusinessCombinationDetails BUSINESS COMBINATION (Details) Details http://verifyme.com/role/BusinessCombinationTables 39 false false R40.htm 00000040 - Disclosure - BUSINESS COMBINATION (Details 1) Sheet http://verifyme.com/role/BusinessCombinationDetails1 BUSINESS COMBINATION (Details 1) Details http://verifyme.com/role/BusinessCombinationTables 40 false false R41.htm 00000041 - Disclosure - BUSINESS COMBINATION (Details Narrative) Sheet http://verifyme.com/role/BusinessCombinationDetailsNarrative BUSINESS COMBINATION (Details Narrative) Details http://verifyme.com/role/BusinessCombinationTables 41 false false R42.htm 00000042 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details) Sheet http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails INTANGIBLE ASSETS AND GOODWILL (Details) Details http://verifyme.com/role/IntangibleAssetsAndGoodwillTables 42 false false R43.htm 00000043 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1) Sheet http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1 INTANGIBLE ASSETS AND GOODWILL (Details 1) Details http://verifyme.com/role/IntangibleAssetsAndGoodwillTables 43 false false R44.htm 00000044 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 2) Sheet http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2 INTANGIBLE ASSETS AND GOODWILL (Details 2) Details http://verifyme.com/role/IntangibleAssetsAndGoodwillTables 44 false false R45.htm 00000045 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Sheet http://verifyme.com/role/IntangibleAssetsAndGoodwillDetailsNarrative INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Details http://verifyme.com/role/IntangibleAssetsAndGoodwillTables 45 false false R46.htm 00000046 - Disclosure - INCOME TAXES (Details) Sheet http://verifyme.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://verifyme.com/role/IncomeTaxesTables 46 false false R47.htm 00000047 - Disclosure - INCOME TAXES (Details 1) Sheet http://verifyme.com/role/IncomeTaxesDetails1 INCOME TAXES (Details 1) Details http://verifyme.com/role/IncomeTaxesTables 47 false false R48.htm 00000048 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://verifyme.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://verifyme.com/role/IncomeTaxesTables 48 false false R49.htm 00000049 - Disclosure - DEBT (Details Narrative) Sheet http://verifyme.com/role/DebtDetailsNarrative DEBT (Details Narrative) Details http://verifyme.com/role/Debt 49 false false R50.htm 00000050 - Disclosure - CONVERTIBLE PREFERRED STOCK (Details Narrative) Sheet http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative CONVERTIBLE PREFERRED STOCK (Details Narrative) Details http://verifyme.com/role/ConvertiblePreferredStock 50 false false R51.htm 00000051 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://verifyme.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://verifyme.com/role/StockholdersEquity 51 false false R52.htm 00000052 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 52 false false R53.htm 00000053 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1 STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 53 false false R54.htm 00000054 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2 STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 54 false false R55.htm 00000055 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3 STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 55 false false R56.htm 00000056 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4 STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 56 false false R57.htm 00000057 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5 STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 57 false false R58.htm 00000058 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative) Sheet http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative) Details http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables 58 false false R59.htm 00000059 - Disclosure - EARNINGS (LOSS) PER SHARE (Details) Sheet http://verifyme.com/role/EarningsLossPerShareDetails EARNINGS (LOSS) PER SHARE (Details) Details http://verifyme.com/role/EarningsLossPerShareTables 59 false false R60.htm 00000060 - Disclosure - EARNINGS (LOSS) PER SHARE (Details 1) Sheet http://verifyme.com/role/EarningsLossPerShareDetails1 EARNINGS (LOSS) PER SHARE (Details 1) Details http://verifyme.com/role/EarningsLossPerShareTables 60 false false R61.htm 00000061 - Disclosure - LONG TERM DERIVATIVE LIABILITY (Details Narrative) Sheet http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative LONG TERM DERIVATIVE LIABILITY (Details Narrative) Details http://verifyme.com/role/LongTermDerivativeLiability 61 false false R62.htm 00000062 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative) Sheet http://verifyme.com/role/EmployeeBenefitPlanDetailsNarrative EMPLOYEE BENEFIT PLAN (Details Narrative) Details http://verifyme.com/role/EmployeeBenefitPlan 62 false false R63.htm 00000063 - Disclosure - LEASES (Details) Sheet http://verifyme.com/role/LeasesDetails LEASES (Details) Details http://verifyme.com/role/LeasesTables 63 false false R64.htm 00000064 - Disclosure - LEASES (Details 1) Sheet http://verifyme.com/role/LeasesDetails1 LEASES (Details 1) Details http://verifyme.com/role/LeasesTables 64 false false R65.htm 00000065 - Disclosure - LEASES (Details 2) Sheet http://verifyme.com/role/LeasesDetails2 LEASES (Details 2) Details http://verifyme.com/role/LeasesTables 65 false false R66.htm 00000066 - Disclosure - CONCENTRATIONS (Details Narrative) Sheet http://verifyme.com/role/ConcentrationsDetailsNarrative CONCENTRATIONS (Details Narrative) Details http://verifyme.com/role/Concentrations 66 false false R67.htm 00000067 - Disclosure - SEGMENT REPORTING (Details) Sheet http://verifyme.com/role/SegmentReportingDetails SEGMENT REPORTING (Details) Details http://verifyme.com/role/SegmentReportingTables 67 false false R68.htm 00000068 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://verifyme.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://verifyme.com/role/SubsequentEvents 68 false false All Reports Book All Reports vm32123010k.htm ex21_1.htm ex31_1.htm ex31_2.htm ex32_1.htm ex4_8.htm vrme-20221231.xsd vrme-20221231_cal.xml vrme-20221231_def.xml vrme-20221231_lab.xml vrme-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 86 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "vm32123010k.htm": { "axisCustom": 0, "axisStandard": 26, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 722, "http://xbrl.sec.gov/dei/2022": 40 }, "contextCount": 189, "dts": { "calculationLink": { "local": [ "vrme-20221231_cal.xml" ] }, "definitionLink": { "local": [ "vrme-20221231_def.xml" ] }, "inline": { "local": [ "vm32123010k.htm" ] }, "labelLink": { "local": [ "vrme-20221231_lab.xml" ] }, "presentationLink": { "local": [ "vrme-20221231_pre.xml" ] }, "schema": { "local": [ "vrme-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 633, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 160, "http://verifyme.com/20221231": 71, "http://xbrl.sec.gov/dei/2022": 4, "total": 235 }, "keyCustom": 89, "keyStandard": 307, "memberCustom": 47, "memberStandard": 34, "nsprefix": "vrme", "nsuri": "http://verifyme.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://verifyme.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - REVENUE", "menuCat": "Notes", "order": "10", "role": "http://verifyme.com/role/Revenue", "shortName": "REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - BUSINESS COMBINATION", "menuCat": "Notes", "order": "11", "role": "http://verifyme.com/role/BusinessCombination", "shortName": "BUSINESS COMBINATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INTANGIBLE ASSETS AND GOODWILL", "menuCat": "Notes", "order": "12", "role": "http://verifyme.com/role/IntangibleAssetsAndGoodwill", "shortName": "INTANGIBLE ASSETS AND GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "13", "role": "http://verifyme.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - DEBT", "menuCat": "Notes", "order": "14", "role": "http://verifyme.com/role/Debt", "shortName": "DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - CONVERTIBLE PREFERRED STOCK", "menuCat": "Notes", "order": "15", "role": "http://verifyme.com/role/ConvertiblePreferredStock", "shortName": "CONVERTIBLE PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "16", "role": "http://verifyme.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS", "menuCat": "Notes", "order": "17", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrants", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - EARNINGS (LOSS) PER SHARE", "menuCat": "Notes", "order": "18", "role": "http://verifyme.com/role/EarningsLossPerShare", "shortName": "EARNINGS (LOSS) PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "vrme:LongTermDerivativeLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - LONG TERM DERIVATIVE LIABILITY", "menuCat": "Notes", "order": "19", "role": "http://verifyme.com/role/LongTermDerivativeLiability", "shortName": "LONG TERM DERIVATIVE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "vrme:LongTermDerivativeLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://verifyme.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - EMPLOYEE BENEFIT PLAN", "menuCat": "Notes", "order": "20", "role": "http://verifyme.com/role/EmployeeBenefitPlan", "shortName": "EMPLOYEE BENEFIT PLAN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - LEASES", "menuCat": "Notes", "order": "21", "role": "http://verifyme.com/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - CONCENTRATIONS", "menuCat": "Notes", "order": "22", "role": "http://verifyme.com/role/Concentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SEGMENT REPORTING", "menuCat": "Notes", "order": "23", "role": "http://verifyme.com/role/SegmentReporting", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "24", "role": "http://verifyme.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "vrme:NatureOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "25", "role": "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "vrme:NatureOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "26", "role": "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - REVENUE (Tables)", "menuCat": "Tables", "order": "27", "role": "http://verifyme.com/role/RevenueTables", "shortName": "REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - BUSINESS COMBINATION (Tables)", "menuCat": "Tables", "order": "28", "role": "http://verifyme.com/role/BusinessCombinationTables", "shortName": "BUSINESS COMBINATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)", "menuCat": "Tables", "order": "29", "role": "http://verifyme.com/role/IntangibleAssetsAndGoodwillTables", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://verifyme.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsAndFinancingReceivableAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://verifyme.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)", "menuCat": "Tables", "order": "31", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)", "menuCat": "Tables", "order": "32", "role": "http://verifyme.com/role/EarningsLossPerShareTables", "shortName": "EARNINGS (LOSS) PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "33", "role": "http://verifyme.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - SEGMENT REPORTING (Tables)", "menuCat": "Tables", "order": "34", "role": "http://verifyme.com/role/SegmentReportingTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "menuCat": "Details", "order": "35", "role": "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "-3", "lang": null, "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "p", "vrme:NatureOfBusinessPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "36", "role": "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - EQUITY INVESTMENTS (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://verifyme.com/role/EquityInvestmentsDetailsNarrative", "shortName": "EQUITY INVESTMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesFvNiCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - REVENUE (Details)", "menuCat": "Details", "order": "38", "role": "http://verifyme.com/role/RevenueDetails", "shortName": "REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_custom_ProactiveServicesMember", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - BUSINESS COMBINATION (Details)", "menuCat": "Details", "order": "39", "role": "http://verifyme.com/role/BusinessCombinationDetails", "shortName": "BUSINESS COMBINATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-04-212022-04-22_us-gaap_DevelopedTechnologyRightsMember", "decimals": null, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://verifyme.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "vrme:ScheduleOfFinancialInformationTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "vrme:Revenue1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - BUSINESS COMBINATION (Details 1)", "menuCat": "Details", "order": "40", "role": "http://verifyme.com/role/BusinessCombinationDetails1", "shortName": "BUSINESS COMBINATION (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "vrme:ScheduleOfFinancialInformationTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "vrme:Revenue1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-04-012022-04-22", "decimals": "-3", "first": true, "lang": null, "name": "vrme:BusinessCombinationConsiderationTransferred", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - BUSINESS COMBINATION (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://verifyme.com/role/BusinessCombinationDetailsNarrative", "shortName": "BUSINESS COMBINATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-04-012022-04-22", "decimals": "-3", "first": true, "lang": null, "name": "vrme:BusinessCombinationConsiderationTransferred", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:IntangibleAssetsDisclosureTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AcquisitionCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)", "menuCat": "Details", "order": "42", "role": "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:IntangibleAssetsDisclosureTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AcquisitionCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 1)", "menuCat": "Details", "order": "43", "role": "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details 2)", "menuCat": "Details", "order": "44", "role": "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - INCOME TAXES (Details)", "menuCat": "Details", "order": "46", "role": "http://verifyme.com/role/IncomeTaxesDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - INCOME TAXES (Details 1)", "menuCat": "Details", "order": "47", "role": "http://verifyme.com/role/IncomeTaxesDetails1", "shortName": "INCOME TAXES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "vrme:DescriptionOfOwnershipChange", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://verifyme.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "vrme:DescriptionOfOwnershipChange", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - DEBT (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://verifyme.com/role/DebtDetailsNarrative", "shortName": "DEBT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-10-17", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Comprehensive Income/(Loss)", "menuCat": "Statements", "order": "5", "role": "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss", "shortName": "Consolidated Statements of Comprehensive Income/(Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "vrme:ChangeInFairValueOfInterestRateSwap", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - CONVERTIBLE PREFERRED STOCK (Details Narrative)", "menuCat": "Details", "order": "50", "role": "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative", "shortName": "CONVERTIBLE PREFERRED STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_SeriesBPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:ConversionOfStockSharesConverted1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestrictedStockExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://verifyme.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestrictedStockExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2021-12-31_us-gaap_EmployeeStockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details)", "menuCat": "Details", "order": "52", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31_us-gaap_EmployeeStockOptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31_custom_NonvestedStockOptionsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1)", "menuCat": "Details", "order": "53", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31_custom_NonvestedStockOptionsMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2021-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "first": true, "lang": null, "name": "vrme:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2)", "menuCat": "Details", "order": "54", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "lang": null, "name": "vrme:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2021-12-31_custom_RestrictedStockUnitsMember", "decimals": "INF", "first": true, "lang": null, "name": "vrme:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3)", "menuCat": "Details", "order": "55", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_custom_RestrictedStockUnitsMember", "decimals": "INF", "lang": null, "name": "vrme:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_custom_UnvestedPerformanceRestrictedStockUnitsMember", "decimals": "INF", "first": true, "lang": null, "name": "vrme:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4)", "menuCat": "Details", "order": "56", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_custom_UnvestedPerformanceRestrictedStockUnitsMember", "decimals": "INF", "first": true, "lang": null, "name": "vrme:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5)", "menuCat": "Details", "order": "57", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-08-11", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative", "shortName": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-04-14_custom_DirectorAndOfficerMember_custom_Debentures2022Member", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)", "menuCat": "Details", "order": "59", "role": "http://verifyme.com/role/EarningsLossPerShareDetails", "shortName": "EARNINGS (LOSS) PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "INF", "lang": null, "name": "vrme:AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://verifyme.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:ProvisionForDoubtfulAccounts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_PreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - EARNINGS (LOSS) PER SHARE (Details 1)", "menuCat": "Details", "order": "60", "role": "http://verifyme.com/role/EarningsLossPerShareDetails1", "shortName": "EARNINGS (LOSS) PER SHARE (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_PreferredStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "p", "vrme:NatureOfBusinessPolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - LONG TERM DERIVATIVE LIABILITY (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative", "shortName": "LONG TERM DERIVATIVE LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "vrme:LongTermDerivativeLiabilityTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://verifyme.com/role/EmployeeBenefitPlanDetailsNarrative", "shortName": "EMPLOYEE BENEFIT PLAN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - LEASES (Details)", "menuCat": "Details", "order": "63", "role": "http://verifyme.com/role/LeasesDetails", "shortName": "LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - LEASES (Details 1)", "menuCat": "Details", "order": "64", "role": "http://verifyme.com/role/LeasesDetails1", "shortName": "LEASES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "vrme:ScheduleOfSupplementalInformationRelatedToLeasesTableTextBlock", "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "vrme:TotalOperatingLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - LEASES (Details 2)", "menuCat": "Details", "order": "65", "role": "http://verifyme.com/role/LeasesDetails2", "shortName": "LEASES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - CONCENTRATIONS (Details Narrative)", "menuCat": "Details", "order": "66", "role": "http://verifyme.com/role/ConcentrationsDetailsNarrative", "shortName": "CONCENTRATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - SEGMENT REPORTING (Details)", "menuCat": "Details", "order": "67", "role": "http://verifyme.com/role/SegmentReportingDetails", "shortName": "SEGMENT REPORTING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-012022-12-31_srt_SubsidiariesMember", "decimals": "-3", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2023-02-272023-03-01_us-gaap_SubsequentEventMember", "decimals": "-3", "first": true, "lang": null, "name": "vrme:TotalConsiderationPaid", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "68", "role": "http://verifyme.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2023-02-272023-03-01_us-gaap_SubsequentEventMember", "decimals": "-3", "first": true, "lang": null, "name": "vrme:TotalConsiderationPaid", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "7", "role": "http://verifyme.com/role/StatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://verifyme.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - EQUITY INVESTMENTS", "menuCat": "Notes", "order": "9", "role": "http://verifyme.com/role/EquityInvestments", "shortName": "EQUITY INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vm32123010k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 82, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r625", "r627", "r628" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r625", "r627", "r628" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r625", "r627", "r628" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r625", "r627", "r628" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r614" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r629" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r617" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r621" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r615" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r619" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r618" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r632" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r260", "r492", "r493", "r494", "r495", "r528", "r577", "r668", "r671", "r672" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "http://verifyme.com/role/RevenueDetails", "http://verifyme.com/role/SegmentReportingDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r260", "r492", "r493", "r494", "r495", "r528", "r577", "r668", "r671", "r672" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "http://verifyme.com/role/RevenueDetails", "http://verifyme.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r257", "r258", "r366", "r393", "r581", "r583" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r328", "r599", "r674", "r718" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r328", "r599", "r674", "r718" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ParentCompanyMember": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "label": "Parent Company [Member]" } } }, "localname": "ParentCompanyMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "http://verifyme.com/role/RevenueDetails", "http://verifyme.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r325", "r536", "r597", "r613", "r666", "r667", "r674", "r717" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r325", "r536", "r597", "r613", "r666", "r667", "r674", "r717" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r257", "r258", "r366", "r393", "r582", "r583" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r675", "r710", "r711", "r713" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "http://verifyme.com/role/RevenueDetails", "http://verifyme.com/role/SegmentReportingDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r656", "r712" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchasesAdjustmentToRecordedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment needed to reconcile previously recorded amounts to the actual aggregate amount paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.", "label": "Share repurchase program" } } }, "localname": "AcceleratedShareRepurchasesAdjustmentToRecordedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndFinancingReceivableAllowanceForCreditLoss": { "auth_ref": [ "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss of accounts and financing receivables. Includes, but is not limited to, notes and loan receivable.", "label": "Accounts and Financing Receivable, Allowance for Credit Loss" } } }, "localname": "AccountsAndFinancingReceivableAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r13", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r330", "r331" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net of allowance for credit loss reserve, $37 and $0 as of December 31, 2022 and December 31, 2021, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxes": { "auth_ref": [ "r3", "r5", "r140", "r186", "r199" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.", "label": "Taxes payable" } } }, "localname": "AccruedIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r16" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Other accrued expense" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r25", "r26", "r27", "r225", "r545", "r554", "r555" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r239", "r240", "r507", "r508", "r509", "r510", "r511", "r513" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r24", "r27", "r159", "r525", "r550", "r551", "r642", "r643", "r644", "r650", "r651", "r652" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquisitionCosts": { "auth_ref": [ "r180", "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.", "label": "Acquisition" } } }, "localname": "AcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r459", "r460", "r461", "r650", "r651", "r652", "r705" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentOfWarrantsGrantedForServices": { "auth_ref": [ "r48" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment for noncash service expenses paid for by granting of warrants.", "label": "Fair value of restricted stock units issued in exchange for services" } } }, "localname": "AdjustmentOfWarrantsGrantedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.", "label": "Fair value of stock options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net (loss) income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r465" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising cost" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r226", "r332", "r339", "r340", "r342" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r48", "r81", "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Anti-dilutive shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r184", "r198", "r220", "r254", "r305", "r316", "r321", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r492", "r494", "r506", "r612", "r669", "r670", "r714" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/SegmentReportingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r214", "r229", "r254", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r492", "r494", "r506", "r612", "r669", "r670", "r714" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "TOTAL CURRENT ASSETS" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedGain": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Unrealized gain on fair value recognized in other (expense)/income" } } }, "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r430", "r431", "r432", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r454", "r455", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BeneficialOwnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has shares of the entity with 1) voting power which includes the power to vote, or to direct the voting of, such security, and/or 2) investment power which includes the power to dispose, or to direct the disposition of, such security.", "label": "Beneficial Owner [Member]" } } }, "localname": "BeneficialOwnerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r490", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r146", "r147", "r490", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r154", "r155", "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Total purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r158", "r491" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r149" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Prepaid expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r149" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r149" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable and other accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r148", "r149" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Intangible Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r148", "r149" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Property and Equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock": { "auth_ref": [ "r145", "r157" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.", "label": "Business Combinations" } } }, "localname": "BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r557", "r558", "r612", "r635" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r50", "r217", "r579" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents, including restricted cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS" } } }, "localname": "CashCashEquivalentsAndShortTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r44", "r50", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH - END OF PERIOD", "periodStartLabel": "CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH \u2013 BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r44", "r176" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET (DECREASE) INCREASE\u00a0IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insured limit" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r222", "r223", "r224", "r254", "r276", "r280", "r282", "r284", "r292", "r293", "r336", "r354", "r356", "r357", "r358", "r361", "r362", "r390", "r391", "r395", "r399", "r406", "r506", "r578", "r634", "r647", "r653" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative", "http://verifyme.com/role/Cover", "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r112", "r124" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Per share public offering price(in dollars per share)", "verboseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative", "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r112", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r650", "r651", "r705" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity", "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative", "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued", "verboseLabel": "Common stock shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/BusinessCombinationDetailsNarrative", "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r102" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock,\u00a0$0.001 par value; 675,000,000 authorized; 9,341,002 and 7,420,633\u00a0issued, 8,951,035 and 7,196,677 shares outstanding as of December 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r116", "r117", "r123", "r135" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "EMPLOYEE BENEFIT PLAN" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EmployeeBenefitPlan" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r28", "r235", "r237", "r244", "r541", "r547" ], "calculation": { "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "TOTAL COMPREHENSIVE (LOSS)/INCOME" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r64", "r65", "r171", "r172", "r328", "r574" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r64", "r65", "r171", "r172", "r328", "r556", "r574" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r64", "r65", "r171", "r172", "r328", "r574", "r719" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r64", "r65", "r171", "r172", "r328" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r61", "r64", "r65", "r66", "r171", "r173", "r574" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r64", "r65", "r171", "r172", "r328", "r574" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionGainsAndLossesOnForeignInvestments": { "auth_ref": [ "r175" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents gains or losses resulting from transactions conducted in foreign currencies.", "label": "Conversion Gains and Losses on Foreign Investments", "negatedLabel": "Payroll Protection Program Debt Forgiveness" } } }, "localname": "ConversionGainsAndLossesOnForeignInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r53", "r54", "r55" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": { "auth_ref": [ "r6", "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.", "label": "Cumulative convertible preferred stock value" } } }, "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r34", "r254", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r506", "r669" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "COST OF REVENUE" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r62", "r328" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r221" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Current portion of debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r98", "r252", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r379", "r386", "r387", "r388" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r2", "r3", "r4", "r185", "r187", "r195", "r260", "r363", "r364", "r365", "r366", "r367", "r369", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r515", "r591", "r592", "r593", "r594", "r595", "r648" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r177", "r178", "r363", "r515", "r592", "r593" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Notional amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r18", "r177", "r382" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r18", "r364" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r230", "r591", "r706" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r19", "r260", "r363", "r364", "r365", "r366", "r367", "r369", "r375", "r376", "r377", "r378", "r380", "r381", "r382", "r383", "r384", "r385", "r515", "r591", "r592", "r593", "r594", "r595", "r648" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": { "auth_ref": [ "r333" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Realized loss on fair value recognized in other (expense)/income" } } }, "localname": "DebtSecuritiesAvailableForSaleRealizedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCosts": { "auth_ref": [ "r183", "r197", "r637" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.", "label": "DEFERRED IMPLEMENTATION COSTS" } } }, "localname": "DeferredCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Intangibles" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r476" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r703" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Net deferred tax assets / (liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r703" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r144", "r704" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets, Property, Plant and Equipment", "negatedLabel": "Depreciation" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross": { "auth_ref": [ "r704" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss", "negatedLabel": "Unrealized Gain on Investment" } } }, "localname": "DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r477" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r137", "r703" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Total deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts": { "auth_ref": [ "r144", "r704" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.", "label": "Capitalized Research and Development" } } }, "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r420", "r421", "r427", "r604", "r605", "r606", "r607" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EmployeeBenefitPlanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r48", "r92" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Amortization and depreciation" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r23", "r165", "r179", "r231", "r583" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Fair value of the derivative liability" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r232" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Long-term derivative liability", "periodEndLabel": "Derivative Liability at end", "periodStartLabel": "Derivative Liability at beginning" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r161", "r162", "r163", "r164", "r166", "r259" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivative Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_DilutiveSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of dilutive securities" } } }, "localname": "DilutiveSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r417", "r597", "r598", "r599", "r600", "r601", "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r674" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsSharebasedCompensationStock": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid stock dividends declared for award under share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "DividendsSharebasedCompensationStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EARNINGS / (LOSS) PER SHARE", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r245", "r266", "r267", "r268", "r269", "r270", "r274", "r276", "r282", "r283", "r284", "r288", "r498", "r499", "r542", "r548", "r587" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "BASIC", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "(Loss)/Earnings per share" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r245", "r266", "r267", "r268", "r269", "r270", "r276", "r282", "r283", "r284", "r288", "r498", "r499", "r542", "r548", "r587" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "DILUTED", "verboseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r59", "r60" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Basic and Diluted Net Loss per Share of Common Stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r285", "r286", "r287", "r289" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "EARNINGS (LOSS) PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (decrease) in taxes resulting from:" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r102", "r212", "r239", "r240", "r241", "r261", "r262", "r263", "r265", "r271", "r273", "r291", "r338", "r408", "r459", "r460", "r461", "r481", "r482", "r497", "r507", "r508", "r509", "r510", "r511", "r513", "r525", "r550", "r551", "r552" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity", "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r76", "r306", "r636" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "EQUITY INVESTMENTS" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r43", "r78", "r174" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNiCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.", "label": "Equity Securities, FV-NI, Cost" } } }, "localname": "EquitySecuritiesFvNiCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": { "auth_ref": [ "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Loss" } } }, "localname": "EquitySecuritiesFvNiUnrealizedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r167", "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of fair value assets measured on recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r377", "r421", "r422", "r423", "r424", "r425", "r426", "r501", "r532", "r533", "r534", "r592", "r593", "r604", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r500", "r501", "r502", "r503", "r505" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r377", "r421", "r426", "r501", "r532", "r604", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r377", "r421", "r426", "r501", "r533", "r592", "r593", "r604", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r377", "r421", "r422", "r423", "r424", "r425", "r426", "r501", "r534", "r592", "r593", "r604", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r377", "r421", "r422", "r423", "r424", "r425", "r426", "r532", "r533", "r534", "r592", "r593", "r604", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r504", "r505" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r169", "r170" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r219", "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r87" ], "calculation": { "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r87" ], "calculation": { "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r87" ], "calculation": { "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r87" ], "calculation": { "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r87" ], "calculation": { "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r349", "r350", "r351", "r352", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r85", "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r82", "r84" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r85", "r537" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "INTANGIBLE ASSETS, NET", "totalLabel": "Total", "verboseLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Amortization Period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r48", "r96", "r97" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://verifyme.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain on extinguishment of debt", "negatedLabel": "Gain on extinguishment of debt", "verboseLabel": "Gain (Loss) on Extinguishment of Debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative", "http://verifyme.com/role/DebtDetailsNarrative", "http://verifyme.com/role/StatementsOfCashFlows", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r35" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r218", "r346", "r539", "r590", "r612", "r664", "r665" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "GOODWILL", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "INTANGIBLE ASSETS AND GOODWILL" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r347", "r348", "r590" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r33", "r254", "r305", "r315", "r320", "r323", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r506", "r589", "r669" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r91", "r95" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r30", "r182", "r192", "r207", "r305", "r315", "r320", "r323", "r543", "r589" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r31", "r48", "r76", "r191", "r205", "r303" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Loss on equity investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r255", "r471", "r474", "r479", "r483", "r485", "r487", "r488", "r489" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r256", "r272", "r273", "r304", "r469", "r484", "r486", "r549" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r238", "r467", "r468", "r474", "r475", "r478", "r480" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r702" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Increase (decrease) in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r470" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Taxes under statutory US tax rates" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r702" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "State taxes" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r45", "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "negatedLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r47" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable, other accrued expenses and net change in operating leases" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r47" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r47" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r47" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": { "auth_ref": [ "r277", "r278", "r279", "r284" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.", "label": "Warrants" } } }, "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Schedule of goodwill by reportable business segment" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r194" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income (expenses), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r248", "r250", "r251" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r16" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternalUseSoftwarePolicy": { "auth_ref": [ "r88", "r89" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.", "label": "Capitalized Software" } } }, "localname": "InternalUseSoftwarePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r228", "r580", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r216", "r227", "r290", "r343", "r344", "r345", "r535", "r584" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r661", "r662" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r522", "r611" ], "calculation": { "http://verifyme.com/role/LeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease costs" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of components of lease expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r709" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of operating lease liabilities maturities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r523" ], "calculation": { "http://verifyme.com/role/LeasesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total future lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive": { "auth_ref": [ "r709" ], "calculation": { "http://verifyme.com/role/LeasesDetails2": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five", "verboseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": { "auth_ref": [ "r709" ], "calculation": { "http://verifyme.com/role/LeasesDetails2": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": { "auth_ref": [ "r709" ], "calculation": { "http://verifyme.com/role/LeasesDetails2": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": { "auth_ref": [ "r709" ], "calculation": { "http://verifyme.com/role/LeasesDetails2": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": { "auth_ref": [ "r709" ], "calculation": { "http://verifyme.com/role/LeasesDetails2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling 12 Months", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r523" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r15", "r254", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r493", "r494", "r495", "r506", "r588", "r669", "r714", "r715" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r12", "r188", "r203", "r612", "r649", "r663", "r707" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r17", "r215", "r254", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r493", "r494", "r495", "r506", "r612", "r669", "r714", "r715" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "TOTAL CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG-TERM LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Intrest rate" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r14", "r648" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r4", "r187", "r201", "r376", "r389", "r592", "r593" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-term debt outstanding" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtDescription": { "auth_ref": [ "r19", "r103" ], "lang": { "en-us": { "role": { "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.", "label": "Long term debt description" } } }, "localname": "LongTermDebtDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r19" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Term note" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r249" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r249" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r44", "r46", "r49" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r32", "r49", "r193", "r206", "r213", "r233", "r236", "r241", "r254", "r264", "r266", "r267", "r268", "r269", "r272", "r273", "r281", "r305", "r315", "r320", "r323", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r499", "r506", "r589", "r669" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://verifyme.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "NET (LOSS)/INCOME", "terseLabel": "Net loss", "totalLabel": "NET (LOSS)/ INCOME", "verboseLabel": "Net (Loss) Income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails", "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfCashFlows", "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss", "http://verifyme.com/role/StatementsOfOperations", "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "TOTAL OTHER INCOME (EXPENSE), NET", "verboseLabel": "OTHER INCOME (EXPENSE)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r4", "r187", "r201" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Promissory note" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r305", "r315", "r320", "r323", "r589" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "LOSS BEFORE OTHER INCOME (EXPENSE)", "totalLabel": "LOSS BEFORE OTHER INCOME (EXPENSE)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r518", "r611" ], "calculation": { "http://verifyme.com/role/LeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r517" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of future lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r517" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liability- current", "negatedLabel": "Less: current portion of lease liabilities", "verboseLabel": "Current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/LeasesDetails1", "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r517" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Long-term lease liability", "terseLabel": "Long-term lease liabilities", "verboseLabel": "Non-current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/LeasesDetails1", "http://verifyme.com/role/LeasesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r516" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "RIGHT OF USE ASSET", "verboseLabel": "Operating Lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r521", "r611" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r520", "r611" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted-average remaining lease term for operating leases (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails1" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessor's operating leases.", "label": "LEASES" } } }, "localname": "OperatingLeasesOfLessorDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r142" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r57", "r58", "r70", "r160" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r29", "r102", "r234", "r237", "r243", "r507", "r512", "r513", "r540", "r546", "r642", "r643" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r209" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other income, net" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r41" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Payments for Repurchase of Equity", "negatedLabel": "Increase in treasury shares (share repurchase program)" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForSoftware": { "auth_ref": [ "r39" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments for Software", "negatedLabel": "Capitalized software costs" } } }, "localname": "PaymentsForSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r247" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedLabel": "Tax withholding payments for employee stock-based compensation in exchange for shares surrendered" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquipmentOnLease": { "auth_ref": [ "r39" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for payments to acquire rented equipment which is recorded as an asset.", "label": "Payments to Acquire Equipment on Lease", "negatedLabel": "Purchase of equipment for lease" } } }, "localname": "PaymentsToAcquireEquipmentOnLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r39" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of patents" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherProductiveAssets": { "auth_ref": [ "r39" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.", "label": "Payments to Acquire Other Productive Assets", "negatedLabel": "Acquisition of PeriShip" } } }, "localname": "PaymentsToAcquireOtherProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r39" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of office equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative", "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative", "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Cumulative convertible preferred stock price" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockConvertibleConversionRatio": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.", "label": "Cumulative convertible preferred stock ratio" } } }, "localname": "PreferredStockConvertibleConversionRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r390" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Convertible Preferred Stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "CONVERTIBLE PREFERRED STOCK" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConvertiblePreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Convertible preferred stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r641" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r40" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from public offering of securities" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfNotesPayable": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.", "label": "Proceeds from issuance of notes payable" } } }, "localname": "ProceedsFromRepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r40" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from SPP Plan" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r645" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from exercise of pre-funded warrant" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r94", "r204", "r544", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r94", "r575", "r576" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Equipment for Lease" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r246", "r341" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Allowance for bad debt" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r657", "r658", "r659", "r660" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Reclassifications": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for classifying current financial statements, which may be different from classifications in the prior year's financial statements. Disclose any material changes in classification including an explanation of the reason for the change and the areas impacted.", "label": "Reclassifications" } } }, "localname": "Reclassifications", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r211", "r526", "r527", "r713" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative", "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative", "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r646" ], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of Debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of loan payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r136", "r210", "r716" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "verboseLabel": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations", "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted stock/restricted stock units, expense" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r109", "r202", "r553", "r555", "r612" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r212", "r261", "r262", "r263", "r265", "r271", "r273", "r338", "r459", "r460", "r461", "r481", "r482", "r497", "r550", "r552" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "REVENUE" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r585", "r586" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r242", "r254", "r301", "r302", "r314", "r318", "r319", "r325", "r326", "r328", "r336", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r506", "r543", "r669" ], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "NET REVENUE", "verboseLabel": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/RevenueDetails", "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.", "label": "Stock consideration" } } }, "localname": "SaleOfStockConsiderationReceivedPerTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of units issued in transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r328", "r655" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of acquired indefinite-lived intangible assets. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.", "label": "Schedule of intangible assets subject to amortization" } } }, "localname": "ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of anti-dilutiv e earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r146", "r147", "r490" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r146", "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of business acquisitions" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r114", "r115" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r118", "r119", "r120", "r121", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of basic and diluted earnings/(loss) per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of reconciliation of federal statutory tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r79", "r213", "r254", "r336", "r506" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r82", "r84", "r537" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Net Investment Income [Line Items]" } } }, "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": { "auth_ref": [ "r36", "r38", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.", "label": "Investment Income [Table]" } } }, "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule of unvested performance restricted stock units" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of unvested restricted stock units" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r71", "r72", "r73", "r80" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of segment reporting information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Schedule of Unvested Options" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r428", "r429", "r430", "r431", "r432", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r454", "r455", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r125", "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock options" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r99", "r100", "r101", "r103", "r104", "r105", "r106", "r107", "r108", "r109", "r222", "r223", "r224", "r292", "r390", "r391", "r393", "r395", "r399", "r404", "r406", "r596", "r634", "r647" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r112", "r124" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of warrants outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in restricted stock units (RSUs).", "label": "Schedule of unvested restricted stock awards" } } }, "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r298", "r299", "r300", "r305", "r307", "r317", "r321", "r322", "r323", "r324", "r325", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r308", "r309", "r310", "r311", "r312", "r313", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r638", "r639", "r673" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r638", "r639", "r673" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [ "r638", "r639", "r673" ], "lang": { "en-us": { "role": { "documentation": "Series D preferred stock.", "label": "Series D Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual terms" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "negatedLabel": "Number of warrants outstanding, expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants outstanding, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r126", "r127" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of warrants outstanding, ending Balance", "periodStartLabel": "Number of warrants outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r610" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized to grand awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Vested and Exercisable at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Weighted Average Exercise Price, Exercisable at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Forfeited/Cancelled/Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Granted", "verboseLabel": "Incentive stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Balance at ending", "periodStartLabel": "Balance at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Balance at ending", "periodStartLabel": "Weighted Average Exercise Price, Balance at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r430", "r431", "r432", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r454", "r455", "r456", "r457", "r458" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price, Forfeited/Cancelled/Expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r433", "r452", "r453", "r454", "r455", "r458", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r134" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Vested and Exercisable at ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term, Exercisable at ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Balance at ending", "periodStartLabel": "Balance at ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Balance at ending", "periodStartLabel": "Balance at ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r113", "r135" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r1", "r185", "r200", "r612" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short term debt outstanding" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r189", "r190", "r196", "r640" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "periodEndLabel": "Short-Term Investments at end", "periodStartLabel": "Short Term Investment at beginning" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r519", "r611" ], "calculation": { "http://verifyme.com/role/LeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r222", "r223", "r224", "r254", "r276", "r280", "r282", "r284", "r292", "r293", "r336", "r354", "r356", "r357", "r358", "r361", "r362", "r390", "r391", "r395", "r399", "r406", "r506", "r578", "r634", "r647", "r653" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/ConvertiblePreferredStockDetailsNarrative", "http://verifyme.com/role/Cover", "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r21", "r102", "r212", "r239", "r240", "r241", "r261", "r262", "r263", "r265", "r271", "r273", "r291", "r338", "r408", "r459", "r460", "r461", "r481", "r482", "r497", "r507", "r508", "r509", "r510", "r511", "r513", "r525", "r550", "r551", "r552" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity", "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/Cover", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r261", "r262", "r263", "r291", "r536" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/BalanceSheetsParenthetical", "http://verifyme.com/role/Cover", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails", "http://verifyme.com/role/SegmentReportingDetails", "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r6", "r7", "r102", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "verboseLabel": "Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock issued for services, shares", "terseLabel": "Stock Issued During Period, Shares, Issued for Services", "verboseLabel": "Stock issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative", "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r7", "r102", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock issued during period shares new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r6", "r7", "r102", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Restricted common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r6", "r7", "r102", "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Restricted stock awards, net of shares withheld for employee tax, shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r6", "r7", "r102", "r109", "r439" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock option exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Common stock issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r6", "r7", "r102", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Restricted Stock Units" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r102", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Restricted stock awards, net of shares withheld for employee tax" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionExercisePriceIncrease": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Exercise Price" } } }, "localname": "StockOptionExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Stock or Unit Option Plan Expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r6", "r7", "r102", "r109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of Common Stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r74", "r612", "r649", "r663", "r707" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets", "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r113", "r253", "r391", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r405", "r408", "r496" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r514", "r530" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r514", "r530" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r514", "r530" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r514", "r530" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r529", "r531" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury stock share" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r22", "r110", "r111" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury stock value" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r20", "r110", "r111" ], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock as cost; 389,967 and 223,956 shares at December 31, 2022 and December 31, 2021, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r466", "r473" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r472" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Accrual for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r67", "r68", "r69", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r275", "r284" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares of common stock \u2013 diluted", "verboseLabel": "DILUTED" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WEIGHTED AVERAGE COMMON SHARE OUTSTANDING" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r274", "r284" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares of common stock \u2013 basic", "verboseLabel": "BASIC" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "vrme_AcquisitionTransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Acquisition Transaction Costs" } } }, "localname": "AcquisitionTransactionCosts", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom amount of dilutive securities e s o p convertible preferred stock shares1.", "label": "Preferred Stock" } } }, "localname": "AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "vrme_AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsShares1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom amount of dilutive securities stock options and restrictive stock units shares1.", "label": "&amp;#160;Stock Options", "verboseLabel": "Stock Options" } } }, "localname": "AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsShares1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "vrme_BadDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Bad Debt" } } }, "localname": "BadDebt", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_BookValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "BookValue", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "BookValue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "vrme_BrandProtectionServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Brand Protection Services [Member]" } } }, "localname": "BrandProtectionServicesMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "vrme_BusinessCombinationConsiderationTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_BusinessCombinationConsiderationTransferred2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred2", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_BusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination [Member]" } } }, "localname": "BusinessCombinationMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails", "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_CapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capitalized Software [Member]" } } }, "localname": "CapitalizedSoftwareMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "vrme_CashConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cash Consideration" } } }, "localname": "CashConsideration", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_CashPaidDuringPeriodForAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid during the period for:" } } }, "localname": "CashPaidDuringPeriodForAbstract", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "vrme_CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cash paid for amounts included in the measurement of operating lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_ChangeInFairValueOfInterestRateSwap": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in fair value of interest rate, swap" } } }, "localname": "ChangeInFairValueOfInterestRateSwap", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfComprehensiveIncomeloss" ], "xbrltype": "monetaryItemType" }, "vrme_ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in fair value to interest rate, SWAP, recognized in other comprehensive loss" } } }, "localname": "ChangeInFairValueToInterestRateSwapRecognizedInOtherComprehensiveLoss", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "vrme_ChangeInStateTaxRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in State tax rate" } } }, "localname": "ChangeInStateTaxRate", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "vrme_CoSponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Co Sponsor [Member]" } } }, "localname": "CoSponsorMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_CommonStockIssuedInRelationToAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in relation to Acquisition" } } }, "localname": "CommonStockIssuedInRelationToAcquisition", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "vrme_CommonStockIssuedInRelationToAcquisitionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in relation to Acquisition, shares" } } }, "localname": "CommonStockIssuedInRelationToAcquisitionShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "vrme_CommonStockIssuedInRelationToPrivatePlacement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in relation to private placement" } } }, "localname": "CommonStockIssuedInRelationToPrivatePlacement", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "vrme_CommonStockIssuedInRelationToPrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in relation to private placement, shares" } } }, "localname": "CommonStockIssuedInRelationToPrivatePlacementShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "vrme_CommonStockIssuedInRelationToPublicOfferingOfSecuritiesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in relation to public offering of securities, shares" } } }, "localname": "CommonStockIssuedInRelationToPublicOfferingOfSecuritiesShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "vrme_CommonStockIssuedInRelationToStockPurchasePlan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued in relation to Stock Purchase Plan" } } }, "localname": "CommonStockIssuedInRelationToStockPurchasePlan", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "vrme_CommonStockIssuedInRelationToStockPurchasePlanShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued in relation to Stock Purchase Plan, shares" } } }, "localname": "CommonStockIssuedInRelationToStockPurchasePlanShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "vrme_CommonStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "localname": "CommonStockParValue0.001PerShareMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "domainItemType" }, "vrme_ConcentrationOfCreditRiskInvolvingCashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration of Credit Risk Involving Cash and Cash Equivalents" } } }, "localname": "ConcentrationOfCreditRiskInvolvingCashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vrme_Debentures2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom debentures2020 member.", "label": "Debentures2020 [Member]" } } }, "localname": "Debentures2020Member", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_Debentures2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debentures 2022 [Member]" } } }, "localname": "Debentures2022Member", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_DeferredImplementationCosts": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "DeferredImplementationCosts", "negatedLabel": "Deferred implementation costs" } } }, "localname": "DeferredImplementationCosts", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_DeferredTaxAssetsValuationAllowance1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred tax assets valuation allowance1.", "label": "Deferred tax assets valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom denominator abstract.", "label": "Denominator:" } } }, "localname": "DenominatorAbstract", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "vrme_DescriptionOfLeaseTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom description of lease terms.", "label": "Description of lease terms" } } }, "localname": "DescriptionOfLeaseTerms", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "vrme_DescriptionOfOwnershipChange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom description of ownership change.", "label": "Description of ownership change" } } }, "localname": "DescriptionOfOwnershipChange", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "vrme_DirectorAndOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom director and officer member.", "label": "Director And Officer [Member]" } } }, "localname": "DirectorAndOfficerMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://verifyme.com/20221231", "xbrltype": "stringItemType" }, "vrme_DisclosureLongTermDerivativeLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Derivative Liability" } } }, "localname": "DisclosureLongTermDerivativeLiabilityAbstract", "nsuri": "http://verifyme.com/20221231", "xbrltype": "stringItemType" }, "vrme_DistributionFromSponsorEntity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Distribution from Sponsor Entity" } } }, "localname": "DistributionFromSponsorEntity", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "vrme_DividendIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Dividend Income" } } }, "localname": "DividendIncome", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_EarningsPerSharesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and Diluted Earnings (Loss) per Share of Common Stock" } } }, "localname": "EarningsPerSharesPolicyTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vrme_EquipmentForLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom equipment for lease member.", "label": "Equipment For Lease [Member]" } } }, "localname": "EquipmentForLeaseMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_EquityIncentivePlan2017Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom equity incentive plan2017 member.", "label": "Equity Incentive Plan2017 [Member]" } } }, "localname": "EquityIncentivePlan2017Member", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_EquityInvestmentsFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Equity investments fair value" } } }, "localname": "EquityInvestmentsFairValue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_EquityInvestmentsFairValue1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of equity investment" } } }, "localname": "EquityInvestmentsFairValue1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_EquityReceivedFromSpacEquityInvestment": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Equity received from SPAC Equity Investment" } } }, "localname": "EquityReceivedFromSpacEquityInvestment", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_ExerciseOfPrefundedWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Exercise of Pre-funded Warrants" } } }, "localname": "ExerciseOfPrefundedWarrants", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "vrme_ExerciseOfPrefundedWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise of Pre-funded Warrants, shares" } } }, "localname": "ExerciseOfPrefundedWarrantsShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "vrme_FairValueOfOptionsIssuedInExchangeForServices": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of options in exchange for services" } } }, "localname": "FairValueOfOptionsIssuedInExchangeForServices", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_FairValueOfRestrictedStockIssuedForServices": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of restricted stock awards issued in exchange for services" } } }, "localname": "FairValueOfRestrictedStockIssuedForServices", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_FiveCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Five Customer [Member]" } } }, "localname": "FiveCustomerMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_FormerChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Former Chief Executive Officer [Member]" } } }, "localname": "FormerChiefExecutiveOfficerMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_G3VRMMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G 3 V R M [Member]" } } }, "localname": "G3VRMMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_GVRMHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G V R M Holdings L L C [Member]" } } }, "localname": "GVRMHoldingsLLCMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_GVRMHoldingsLLCandMaximPartnersLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G V R M Holdings L L Cand Maxim Partners L L C [Member]" } } }, "localname": "GVRMHoldingsLLCandMaximPartnersLLCMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_GrantDateValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Grant date value" } } }, "localname": "GrantDateValue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_GrantFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Grant fair value" } } }, "localname": "GrantFairValue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_GreenbergMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Greenberg [Member]" } } }, "localname": "GreenbergMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_IncentiveStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom incentive stock options member.", "label": "Incentive Stock Options [Member]" } } }, "localname": "IncentiveStockOptionsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_IncomeTaxReconciliationAllOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents custom income tax reconciliation all other.", "label": "All other" } } }, "localname": "IncomeTaxReconciliationAllOther", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "vrme_InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Initial recognition of right-of-use asset and lease liability during the period" } } }, "localname": "InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_InternallyUsedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Internally Used Software [Member]" } } }, "localname": "InternallyUsedSoftwareMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IntangibleAssetsAndGoodwillDetails1" ], "xbrltype": "domainItemType" }, "vrme_IssuedUnderThe2020PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom issued under the2020 plan member.", "label": "Issued Under The2020 Plan [Member]" } } }, "localname": "IssuedUnderThe2020PlanMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_LoanForgivenessAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents custom loan forgiveness amount.", "label": "Loan forgiveness" } } }, "localname": "LoanForgivenessAmount", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_LongTermDerivativeLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG TERM DERIVATIVE LIABILITY" } } }, "localname": "LongTermDerivativeLiabilityTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LongTermDerivativeLiability" ], "xbrltype": "textBlockItemType" }, "vrme_LossOnEquityInvestment": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loss on equity investment" } } }, "localname": "LossOnEquityInvestment", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "vrme_MaturityTermsOfLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom maturity terms of lease.", "label": "Maturity terms of lease" } } }, "localname": "MaturityTermsOfLease", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "vrme_MaximPartnersLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom maxim partners l l c member.", "label": "Maxim Partners L L C [Member]" } } }, "localname": "MaximPartnersLLCMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_N2020PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "N 2020 Plan [Member]" } } }, "localname": "N2020PlanMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_NatureOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of the Business" } } }, "localname": "NatureOfBusinessPolicyTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vrme_NetIncomeLoss1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net Income (loss)" } } }, "localname": "NetIncomeLoss1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_NoncashChangeInFairValueOfInterestRateSwap": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NoncashChangeInFairValueOfInterestRateSwap", "verboseLabel": "Change in fair value of interest rate, swap" } } }, "localname": "NoncashChangeInFairValueOfInterestRateSwap", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_NonqualifiedStockPurchaseExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-qualified stock purchase exercise price" } } }, "localname": "NonqualifiedStockPurchaseExercisePrice", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "vrme_NonqualifiedStockPurchasePlan": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-qualified stock purchase plan" } } }, "localname": "NonqualifiedStockPurchasePlan", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "vrme_NonqualifiedStockPurchasePlanExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Non-Qualified Stock Purchase Plan expenses" } } }, "localname": "NonqualifiedStockPurchasePlanExpenses", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_NonqualifiedStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonqualified Stock Purchase Plan [Member]" } } }, "localname": "NonqualifiedStockPurchasePlanMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_NonvestedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom nonvested stock options member.", "label": "Nonvested Stock Options [Member]" } } }, "localname": "NonvestedStockOptionsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails1", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom numerator abstract.", "label": "Numerator:" } } }, "localname": "NumeratorAbstract", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "stringItemType" }, "vrme_OmnibusEquityCompensationPlan2013Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom omnibus equity compensation plan2013 member.", "label": "Omnibus Equity Compensation Plan2013 [Member]" } } }, "localname": "OmnibusEquityCompensationPlan2013Member", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_OneVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_OpratingUnbilledRevenue": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "OpratingUnbilledRevenue", "verboseLabel": "Unbilled revenue" } } }, "localname": "OpratingUnbilledRevenue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_PNCBankNAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "P N C Bank N A [Member]" } } }, "localname": "PNCBankNAMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_PaycheckProtectionProgramTermNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Paycheck Protection Program Term Note [Member]" } } }, "localname": "PaycheckProtectionProgramTermNoteMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_PayrollProtectionProgramDebtForgiveness": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payroll protection program debt forgiveness" } } }, "localname": "PayrollProtectionProgramDebtForgiveness", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "vrme_PeriShipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Peri Ship [Member]" } } }, "localname": "PeriShipMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "vrme_Plan2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom plan2019 member.", "label": "Plan2019 [Member]" } } }, "localname": "Plan2019Member", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_PrefundedWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prefunded warrants" } } }, "localname": "PrefundedWarrants", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "vrme_PremiumServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Premium Services [Member]" } } }, "localname": "PremiumServicesMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "vrme_ProactiveServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proactive Services [Member]" } } }, "localname": "ProactiveServicesMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/RevenueDetails" ], "xbrltype": "domainItemType" }, "vrme_PromissoryNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "PromissoryNote", "verboseLabel": "Promissory note" } } }, "localname": "PromissoryNote", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_PurchaseOfEquityInvestment": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PurchaseOfEquityInvestment", "negatedLabel": "Purchase of equity investment" } } }, "localname": "PurchaseOfEquityInvestment", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrme_RepurchaseOfCommonStockShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchase of Common Stock, shares" } } }, "localname": "RepurchaseOfCommonStockShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "vrme_RestrictedStockAwarded": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted stock awarded" } } }, "localname": "RestrictedStockAwarded", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "vrme_RestrictedStockRsasRsus": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Restricted Stock (RSA\u2019s, RSU\u2019s)" } } }, "localname": "RestrictedStockRsasRsus", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_RestrictedStockUnitsAndRestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock Units And Restricted Stock Awards [Member]" } } }, "localname": "RestrictedStockUnitsAndRestrictedStockAwardsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "domainItemType" }, "vrme_RestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom restricted stock units member.", "label": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_RestrictedStockUnitsRestrictedStockAwards": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock Units & Restricted Stock Awards" } } }, "localname": "RestrictedStockUnitsRestrictedStockAwards", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "vrme_Revenue1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "Revenue1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for operating lease liabilities" } } }, "localname": "RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_ScheduleOfFinancialInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of financial information" } } }, "localname": "ScheduleOfFinancialInformationTableTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "vrme_ScheduleOfSupplementalInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of supplemental information related to leases" } } }, "localname": "ScheduleOfSupplementalInformationRelatedToLeasesTableTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "vrme_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "vrme_SeriesBConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Convertible Preferred Stock [Member]" } } }, "localname": "SeriesBConvertiblePreferredStockMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average exercise price.", "label": "Weighted average exercise price, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "perShareItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award equity instruments other than options forfeited in period weighted average exercise price.", "label": "Weighted average exercise price, expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "perShareItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average exercise price.", "label": "Weighted average exercise price, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "perShareItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding exercisable weighted average remaining contractual terms.", "label": "Weighted average remaining contractual terms, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "durationItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, ending balance", "periodStartLabel": "Weighted average exercise price, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "perShareItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award non option equity instruments exercisable number.", "label": "Number of warrants outstanding, exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails5" ], "xbrltype": "sharesItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award options exercise price description.", "label": "Exercise price, description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceDescription", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award restricted stock grants in period gross.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Grants In Period Gross", "verboseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "sharesItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award restricted stock grants in period weighted average grant date fair value.", "label": "Weighted - Average Grant Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "perShareItemType" }, "vrme_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom share based compensation arrangement by share based payment award restricted stock vested in period weighted average grant date fair value1.", "label": "Weighted - Average Grant Date Fair Value, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockVestedInPeriodWeightedAverageGrantDateFairValue1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "perShareItemType" }, "vrme_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom sharebased compensation arrangement by sharebased payment award restricted stock.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock", "periodEndLabel": "Balance at ending", "periodStartLabel": "Balance at beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "sharesItemType" }, "vrme_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom sharebased compensation arrangement by sharebased payment award restricted stock vested number of shares.", "label": "Vested [Default Label]", "negatedLabel": "Vested", "verboseLabel": "Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockVestedNumberOfShares", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "sharesItemType" }, "vrme_SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom sharebased compensation arrangement by sharebased payment award restricted stock weighted average grant date fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Restricted Stock Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted - Average Grant Date Fair Value, Balance at ending", "periodStartLabel": "Weighted - Average Grant Date Fair Value, Balance at beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockWeightedAverageGrantDateFairValue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails2", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails3", "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "perShareItemType" }, "vrme_SponsorEntityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom sponsor entity member.", "label": "Sponsor Entity [Member]" } } }, "localname": "SponsorEntityMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EquityInvestmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_StockAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock (issuance of 305,473 shares of restricted common stock)" } } }, "localname": "StockAmount", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "vrme_StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents custom stock issued during period value common stock issued in relation to public offering of securities.", "label": "Common stock issued in relation to public offering of securities" } } }, "localname": "StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "vrme_StockIssuedDuringPeriodValueRestrictedStockAwardNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents custom stock issued during period value restricted stock award net.", "label": "Restricted stock/restricted stock award, expense" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNet", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_StockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Options" } } }, "localname": "StockOptions", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "domainItemType" }, "vrme_StockOptionsRestrictedStockandUnitsandOtherStockbasedAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents custom stock options restricted stockand unitsand other stockbased awards member.", "label": "Stock Options Restricted Stockand Unitsand Other Stockbased Awards [Member]" } } }, "localname": "StockOptionsRestrictedStockandUnitsandOtherStockbasedAwardsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_StockPurchasePlan1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents custom stock purchase plan1.", "label": "Stock Purchase Plan" } } }, "localname": "StockPurchasePlan1", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "vrme_StockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Purchase Plan [Member]" } } }, "localname": "StockPurchasePlanMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/EarningsLossPerShareDetails1" ], "xbrltype": "domainItemType" }, "vrme_StockPurchasePlanSpp": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Purchase Plan (SPP)" } } }, "localname": "StockPurchasePlanSpp", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_ThreeCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Customer [Member]" } } }, "localname": "ThreeCustomerMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_TotalConsiderationPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total consideration paid" } } }, "localname": "TotalConsiderationPaid", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_TotalOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total operating lease liabilities" } } }, "localname": "TotalOperatingLeaseLiabilities", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/LeasesDetails1" ], "xbrltype": "monetaryItemType" }, "vrme_TransportationCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transportation Cost [Member]" } } }, "localname": "TransportationCostMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_TreasuryStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stocks [Member]" } } }, "localname": "TreasuryStocksMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "vrme_TreasuryStocksShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:TreasuryStocksShare-0]" } } }, "localname": "TreasuryStocksShare", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "vrme_TwoCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Customer [Member]" } } }, "localname": "TwoCustomerMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "vrme_UnbilledRevenue": { "auth_ref": [], "calculation": { "http://verifyme.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unbilled revenue" } } }, "localname": "UnbilledRevenue", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "vrme_UnrealizedGainOnEquityInvestment": { "auth_ref": [], "calculation": { "http://verifyme.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://verifyme.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrealized gain on equity investment", "negatedLabel": "Unrealized gain on equity investment" } } }, "localname": "UnrealizedGainOnEquityInvestment", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StatementsOfCashFlows", "http://verifyme.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "vrme_UnrecognizedCompensationCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unvested restricted stock awards" } } }, "localname": "UnrecognizedCompensationCost", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_UnrecognizedCompensationCostOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized compensation cost" } } }, "localname": "UnrecognizedCompensationCostOutstanding", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_UnsecuredPromissoryNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unsecured promissory note" } } }, "localname": "UnsecuredPromissoryNote", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/DebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "vrme_UnvestedPerformanceRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Performance Restricted Stock Units [Member]" } } }, "localname": "UnvestedPerformanceRestrictedStockUnitsMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/StockOptionsRestrictedStockAndWarrantsDetails4" ], "xbrltype": "domainItemType" }, "vrme_VariableInterestEntityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Variable Interest Entity" } } }, "localname": "VariableInterestEntityPolicyTextBlock", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vrme_WarrantsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants to Purchase Common Stock" } } }, "localname": "WarrantsToPurchaseCommonStockMember", "nsuri": "http://verifyme.com/20221231", "presentation": [ "http://verifyme.com/role/Cover" ], "xbrltype": "domainItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=116873391&loc=d3e408-128459", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=13988685&loc=d3e8784-128493", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888252", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r614": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r615": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r616": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r617": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r618": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r619": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r621": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r622": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r623": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r624": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r625": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r626": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r627": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r628": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r629": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r631": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r632": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r633": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 87 0001214659-23-004301-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-23-004301-xbrl.zip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�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